Revised List of Pharma Patents - Controller General of Patents ...

Product Patents in Pharmaceuticals granted by Indian Patent Office during 2005-06 to 2009-10S No Application No Patent No* Patent TitleGrant DateApplicantA NOVEL [6,7-BIS(2-ETHOXYETHOXY)1 537/DEL/1996 196774 23-02-2007QUINAZOLIN-4-YL]-(3-ETHYNYLPHENYL)AMINE HYDROCHLORIDE AND A PROCESSPFIZER PRODUCTS, INC.FOR PREPARING THE SAME2 178/MUM/2004 197822 19/12/2005A SYNERGISTIC ANTIBACTERIALFORMULATION AND TO A METHOD OF SANJEEV KHANDELWALMAKING THE SAME3 738/BOM/1999 198002 01-03-2006NOVEL INJECTABLE ANTIMALERIALCOMPOSITIONS OF ARTEMISININDR. DINESH SHANTILAL PATEL4 488/MUM/2000 198178 01-09-2006A SYNERGISTIC AQUEOUS PHARMACEUTICALCOMPOSITION FOR PROPHYLACTICLUPIN LABORATORIES LTDTREATMENT OF MIGRAINE5 890/MUM/2003 198771 06-02-2006A NOVEL PHARMACEUTICAL COMPOSITIONOF A PROTON PUMP INHIBITOR WITH A ARISTO PHARMACEUTICAL LTDPROKINETIC AGENT6 811/BOM/1999 200054 15/04/20063-AZABICYCLO [3,1,0] HEXANE DERIVATIVESUSEFUL IN THERAPYPFIZER INC7 IN/PCT/2000/497/MUM 200057 17/04/2006IMIDAZO PYRIDINE DERIVATIVES AND APROCESS THEREOFASTRAZENECA AB8 IN/PCT/2001/1296/MUM 200062 15/04/2006 A COMPOUND OF FORMULA (I) AMERICAL HOME PRODUCT CORP.9 IN/PCT/2002/774/MUM 200067 15/04/2006COMPOUNDS OF THIAZOLYL AMIDEDERIVATIVESBAYER AKTIENGESELLSCHAFT10 IN/PCT/2002/1000/MUM 200075 17/04/2006A 2- OXO-1-PYRROLIDINE COMPOUND ORPHARMA-CEUTICAL SALTSUCB SA11 IN/PCT/2001/67/KOL 200123 01-12-2006 MEDICINAL AEROSOL FORUMLATIONS JAGO RESEARCH AG12 684/MUM/2003 200339 05-08-2006TOPICAL PHARMACEUTICAL GELCOMPOSITION FOR VALDECOXIBGLENMARK PHARMACEUTICALS LIMITED13 1618/CAL/1997 200646 25-01-2007 SELECTIVE 3 ADRENERGIC AGONISTS ELI LILLY AND COMPANY14 639/MUM NP/2003 200654 21/08/2006PYRIDAZINONE ALDOSE REDUCTASEINHIBITORPFIZER PRODUCT INC15 492/MUM/2003 200878 06-07-2006A PHARMACEUTICAL PREPARATION FOR THETREATMENT OF ADENOCARCINOMA OF SAHAJANAND BIOTECH PRIVATE LTDPROSTATE16 IN/PCT/2001/805/MUM 200884 06-08-2006TRICYCLIC INHIBITOR OF POLY[ ADP- RIBOSE]AGOURON PHARMACEUTICAL INCPOLYMERS17 IN/PCT/2002/1413/MUM 200894 06-05-2006Imidazopyrimidine and triazolopyrimidine compounds BAYER AKTIENGESELLSCHAFT18 IN/PCT/2002/1890/MUM 200903 06-05-2006QUINOLINYL BENZOTHIAZALYL PPAR-GAMMA MODULATORTULARIK INC AND JAPAN TOBACCO INC,

43 1015/KOLNP/2003 201649 16-02-2007NOVEL SUCCINATE SALT OF O-DESMETHYL-VENLAFAXINEWYETH44 IN/PCT/2002/00246/KOL 201928 23-03-2007"A COMPOUND WITH ANTIBACTERIALACTIVITY"SANKYO COMPANY LIMITED45 141/MUM/2000 201976 31/08/2006 A NOVEL BIARYL ETHER COMP, PFIZER PRODUCT INC46 168/MUM/2003 202014 21/06/2006 INHALENT COMPOSITION CIPLA LTD47 1290/MAS/1998 202050 12-09-2006 BENZO 5,6 CYCLOPHEPT PYRIDINE DERV SCHERING CORPORATION48 916/MAS/1998 202053 21-09-2006A PHARMACEUTICAL COMPOSITION IN THEFORM OF AQUOUS PURABLE LIQUIDRECKITT BENCKISER HEALTHCARE LIMITED.49 1300/CHENP/2003 202076 08-09-2006COMPOSITION CONTAINING RURHENIUM (iii)) FAUSTUS FORSCHUNGS CIECOMPLEX AND HETEROCYCLICTRANSLATIONAL CANCER RESEARCH GMBH50 2479/MAS/1998 202085 21-09-2006 DIPEPTIDE NITRILES M/S. NOVARTIS AG51 1678/CHENP/2003 202097 21-09-2006A PHARMACEUTICAL COMPOSITION FORINFLAMMATORY BOWEL DISEASEJAPAN TOBACCO, INC.,52 188/CHENP/2004 202106 05-09-20062-(3-5-BIS-TRIFLUOROMETHYL-PHENYL)-N-[6-(1,1-DIOXO-1 6- THIOMORPHOLIN-4-YL)-4-(2-METHYL OR 4-FLUORO-2-METHYLF. HOFFMANN-LA ROCHE AGSUBSTITUTED) PHENYL-PYRIDIN-3-YL]-N-METHYL-ISOBUTYRAMIDE53 2232/MAS/1998 202128 13-10-2006 CRYSTALLINE ANTIFUNGAL POLYMORPHS SCHERING CORPORATION54 2433/MAS/1997 202141 05-09-2006 NAPHTHYRIDINE DERV NOVARTIS AG55 245/CHENP/2003 202142 05-09-2006CYCLOPENTANOINDOLES, COMPOSITIONSCONTAINING SUCH COMPOUNDSM/S. MERCK FROSST CANADA & CO.56 384/CHENP/2004 202191 21-09-2006A 7-AMINOTRIAZOLOPYRIMIDINE AND APROCESS FOR PREPARING THE SAMEBASF AKTIENGESELLSCHAFT57 405/MAS/1999 202193 03-10-2006A PHARMACEUTICAL FORMULATION FOR THETREATMENT OF HEPATITIS & VIRALINFECTIONS AND A PROCESS FOR ITSUNIVERSITY OF MADRASPREPARATION58 534/MAS/1996 202212 12-09-2006A PHARMACEUTICAL COMPOSITION FOR THEORAL ADMINISTRATION OF AN ACTIVE CIBA-GEIGY AGAGENT HAVING LOW WATER SOLUBILITY59 IN/PCT/2000/109/CHE 202273 21-09-2006COMPOSITION FOR TREATING RESPIRATORYAND SKIN DISEASESSCHERING CORPORATION60 IN/PCT/2002/00475/MUM 202295 11-09-2006PHARMACEUTICAL COMPOSITIONSPROVIDING ENHANCED DRUGPFIZER PRODUCTS INC.CONCENTRATIONS61 1119/MUM NP/2003 202297 04-08-2006 DOSAGE REGIMEN AND PHARMACEUTICAL RICHTER GEDEON VEGYESZETI GYAR RT,62 IN/PCT/2002/01658/MUM 202304 11-08-2006COMPOSITIONS CONTAININGPOLYCARBONATEBAYER AKTIENGESELLSCHAFT63 IN/PCT/2000/75/CHE 202344 31-10-2006A LIQUID NASAL PHARMACEUTICALCOMPOSITIONNOVARTIS CONSUMER HEALTH S.A64 IN/PCT/2001/1424/CHE 202354 11-10-2006CARBAMIC ACID DERIVATIVES AND THEIRUSE AS METABOTROPIC GLUTAMATERECEPTOR LIGANDSM/S. F. HOFFMANN-LA ROCHE AG

65 IN/PCT/2001/1516/CHE 202356 09-10-2006A PIPERIDINE DERIVATIVE AND APHARMACEUTICAL COMPOSITIONM/S. SCHERING CORPORATIONCOMPRISING THE SAME66 IN/PCT/2001/519/CHE 202372 03-10-2006 THE PHARMACEUTICAL COMPOSITION M/S. NOVARTIS AG67 IN/PCT/2001/819/CHE 202383 31-10-2006SUBTILASE SUBTILASE ENZYMES OF THE I S IAND IS2 SUB GROUPS HAVING ANADDITIONAL AMINO ACID AN ACTIVE NOVOZYMES A/SSITELOOP AND A METHOD OF PRODUCINGTHE SAME68 IN/PCT/2002/336/CHE 202425 13-04-2007 A VACCINE COMPOSITION SMITHKLINE BEECHAM BIOLOGICALS S.A.69 IN/PCT/2002/683/CHE 202441 04-10-2006 TRIPHENYLALKENE DERIVATIVES M/S. HORMOS MEDICAL CORPORATION70 587/CAL/1996 202521 23-02-2007 1,3-DIHYDRO-2H-IMIDAZOL-2-ONE JANSSEN PHARMACEUTICA N.V71 IN/PCT/2001/385/KOL 202523 02-03-2007DELTA TETRAHYDROCANNABINOL (DELTA THC) SOLUTION METERED DOSE VIRGINIA COMMONWEALTH UNIVERSITYINHALERS AND METHODS OF USECOMPOSITIONS FOR THE PREVENTION OF72 IN/PCT/2001/480/KOL 202527 02-03-2007 TOLERANCE TO MEDICATIONS AND METHODS BAKER NORTON PHARMACEUTICALS ,INC.OF PREPARATION THEREOF"73 425/KOLNP/2003 202530 02-03-2007"GROWTH HORMONE RELEASINGCOMPOUNDS AND THEIR ANTAGONISTS"ZENTARIS AG74 121/CAL/1996 202659 02-03-2007"4-(1H-INDOL-1-YL)-1-PIPERIDINYLDERIVATIVES"JANSSEN PHARMACEUTICAL N.V.75 605/KOLNP/2003 202663 02-03-2007 " L-HISTIDINE IN OPHTHALMIC SOLUTIONS " BIO CONCEPT LABOTORIES76 495/MUM/2002 202692 20/07/2006PHARMACEUTICAL COMPOSITION FORCONTROLLED DRUG DELIVERY SYSTEMJ B CHEMICAL & PHARMACEUTICALS LTD77 IN/PCT/2002/00589/MUM 202735 03-10-2006INDAZOLE COMPOUNDS, PHARMACEUTICALCOMPOSITIONS, AND METHODS FORMEDIATING OR INHIBITING CELLAGOURON PHARMACEUTICAL INCPROLIFERATION78 IN/PCT/2002/673/MUM 202748 07-09-2006 AN AMINOTHIAZOLE INHIBITOR COMPOUND BRISTOL- MAYERS SQUIBB CO,79 420/MAS/2002 202785 30-10-2006NOVEL TRANS-LUTEIN ENRICHEDM/S. OMINIACTIVE HEALTH TECHNOLOGIESXANTHOPHYLL ESTER CONCENTRATE AND APVT LTD.PROCESS FOR ITS PREPARATION80 848/MAS/2001 202806 13-11-2006NEW ALKOXYPROPIONIC ACID DERIVATIVESAS ANTIDIABETIC AGENTSDR. REDDY'S LABORATORIES LTD,NOVEL HYPOLIPIDEMIC, ANTIOBESITY,81 792/MAS/2002 202812 19-10-2006 HYPOCHOLESTEROLEMIC AND ANTIDIABETIC DR. REDDY'S LABORATORIES LTDCOMPOUNDS82 345/CHENP/2004 202813 19-10-2006 NOVEL-CYCLOHEXYL SULPHONES M/S. CORPORATE LAWGROUP83 1150/MAS/1996 202816 30-10-2006NOVEL HETEROCYCLIC COMPOUNDS,PROCESS FOR THEIR PREPARATION ANDPHARMACEUTICAL COMPOSITIONSCONTAINING THEMDR. REDDY’S LABORATORIES LTD

84 42/MAS/2002 202817 13-11-2006NOVEL ANTIBACTERIAL COMPOUNDS,PROCESS FOR THEIR PREPARATION ANDPHARMACEUTICAL COMPOSITIONDr. REDDY'S LABORATORIES LTDCONTAINING THEM85 736/MUM/2003 202870 20/07/2006NOVEL PHARMACEUTICAL COMBINATION….BIGUANIDE AN INSULINE ENHANCERIPCA LABORATORIES LIMITED86 972/MUM-NP/2003 202882 08-07-2006TRIPLE-TARGETING, CHIRAL, BROAD-SPECTRUM ANTIMICROBIAL 7-SUBSTITUTEDPIPERIDINO-QUINOLONE CARBOXYLIC ACID WOCKHARDT LIMITEDDERIVATIVES, THEIR PREPARATION,COMPOSITIONS AND USE AS MEDICAMENTS87 685/CHENP/2004 202974 08-11-2006 A CYANOACETYL COMP NOVARTIS AG88 1054/CHENP/2004 202989 03-11-2006COMPOUNDS OF FORMULA I AND A PROCESSFOR THEIR PREPARATIONM/S. NOVARTIS AG89 IN/PCT/2001/1151/MUM 203012 19/10/2006NOVEL MORPHOLINE DERIVATIVES, METHODFOR THE PRODUCTION THEREOF ANDPHARMACEUTICALS PREPARATIONSSANOFI SYNTHELABORATORYCONTAINING SAID DERIVATIVES90 IN/PCT/2001/00216/MUM 203050 20/10/2006CRYSTALLINE FORMS OF EtO2C-CH2-[R]Cg1-Aze-Pab-OHASTRAZENECA AB91 IN/PCT/2002/1601/MUM 203054 13/10/2006PHARMACEUTICAL COMPOSITION FORADMINISTRATION.SYMPHOGEN A/S92 IN/PCT/2002/776/MUM 203055 13/10/2006 COMPOUND FOR USE IN IMMUNOSUPPRESENT XCYTE THERAPIES INCA COMPOSITION COMPRISING AT LEAST93 IN/PCT/2002/1567/MUM 203056 20/10/2006PARTIALLY DEFATTED MEAL FROM PLANTSOURCE CONTAINING PROTEIN BOUNDSUSAN P HUDSON & CRAIG J HUDSONTRYPTOPHAN94 224/MUM NP/2005 203065 30/09/2006SUBSTITUTED N-PHENYL 2-HYDROXY-2-METHYL-3,3,3 TRIFLUOROPROPANAMIDE ASTRA ZENECA ABCOMPOUNDS95 IN/PCT/2002/690/MUM 203080 26/10/2006 A COMPOUND PIPERZINE DERV ASTRAZENECA ABAN ORAL PHARMACEUTICAL FORMULATION96 IN/PCT/2001/01216/MUM 203084 20/10/2006 COMPRISING AN IBAT INHIBITOR COMPOUND ASTRAZENECA ABAND A BILE ACID BINDER97 478/MUM/2002 203089 26/10/2006PHARMACEUTICAL FORMULATIONCOMPRISING LORATIDINE IN A SELF-STRIDES ARCOLAB LTDEMULSIFYING DRUG DELIVERY SYSTEM ANDPROCESS FOR PREPARING THE SAME98 IN/PCT/2002/452/MUM 203092 26/10/2006HEXAHYDROFURO [2,3-b] FURAN-3-YL-N-{3-[(1,3-BENZODIOXOL-5-TIBOTEC PHARMACEUTICA LS LT AND GOVTYLSUFONYL)(ISOBUTYL) AMINO]-1-BENZYL-2-OF USAHYDROXYPROPYL} CARBAMATE ASRETROVIRAL PROTEASE INHIBITOR

99 IN/PCT/2000/664/MUM 203095 27/10/2006A COMPOUND (S)-2-ETHOXY-3[4-(2-{4-METHANESULFONYLOXYPHENYL}ETHOXY)PHENYL]-PROPANOIC ACID HAVING THE ASTRAZENECA ABFORMULA (I) AND PROCESS FOR THEPREPARATION THEREOF100 386/MUM NP/2003 203117 07-12-2006ARYL OR HETROARYL FUSED IMIDAZOLECOMPPFIZER INCN-ALKOXYALKYL-SUBSTITUTED101 344/MUM NP/2003 203203 30/10/2006BENZIMIDAZOLES, THEIR PREPARATION ANDBAYER AKTIENGESELLSCHAFTTHEIR USE AS AGENTS AGAINST PARASITICPROTOZOA102 IN/PCT/2001/982/KOL 203208 09-02-2007"N0VEL LHRH ANTAGONISTS HAVINGIMPROVED SOLUBILITY PROPERTIES"ZENTARIS AG,103 IN/PCT/2001/794/KOL 203216 09-03-2007NOVEL NUCLEOSIDES ANDOLIGONUCLEOTIDE ANALOGUESSANKYO LIFETECH COMPANY LIMITED104 1351/KOL NP/2004 203333 13/04/2007 A VACCINE COMPOSITION GLAXO SMITH KLINE BIOLOGICAL SA105 IN/PCT/2002/01136/KOL 203371 09-03-2007NOVEL LHRH ANTAGONISTS AND THEIRPREPARATIONZENTARIS GMBH106 IN/PCT/2002/674/MUM 203415 13/10/2006 N- 5- KINASE OF FORMULA I BRISTOL- MAYERS SQUIBB CO,107 2990/CHENP/2004 203533 29-11-2006 NOVEL CONDENSED IMIDAZOLE EISAI R & D MANAGEMENT CO. LTD.108 47/MAS/1997 203534 27-11-2006 A PHARMACEUTICAL TABLET M/S. SMITHKLINE BEECHAM PLC109 IN/PCT/2002/1337/CHE 203540 24-11-20064-PYRIDYL-AND 2,4-PYRIMIDINYL-SUBSTITUTED PYRROLE DERIVATIVES AND M/S. MERCKLE GMBHTHEIR USE IN PHARMACY110 IN/PCT/2002/354/CHE 203558 21-11-2006A PHARMACEUTICAL COMPOSITIONCOMPRISING AT LEAST ONE LIPASEM/S. F. HOFFMANN-LA ROCHE AG111 1147/MAS/1998 203560 29-12-2006NEW HETEROCYCLIC COMPOUNDS, PROCESSFOR THEIR PREPARATION ANDPHARMACEUTICAL COMPOSITIONSM/S. DR. REDDY’S LABORATORIES LTDCONTAINING THEM112 124/MAS/1997 203561 04-12-2006A PHARMACEUTICAL COMBINATIONPRODUCT COMPRISING NUCLEOSIDE AND M/S. SMITHKLINE BEECHAM PLCIMMUNOSUPPRESSANT113 1610/CHENP/2003 203568 19-12-2006DIHYDRO-BENZO (B) (1,4) DIAZEPIN-2-ONEDERIVATIVES AS MGLUR2 ANTAGONISTS IIM/S. F. HOFFMANN-LA ROCHE AG114 968/CHENP/2004 203571 04-12-2006HETEROARYL DERIVATIVES WHICH ARELIGANDS FOR NOCICEPTIN RECEPTOR ORL-1SCHERING CORPORATION115 IN/PCT/2002/1417/CHE 203576 29-11-2006SUBSTITUTED 3-PHENYL-5-ALKOXI-1,3,4-OXDIAZOL-2-ONE AND USE THEREOF FOR M/S. SANOFI-AVENTIS DEUTSHLAND GMBHINHIBITING HORMONE-SENSITIVE LIPASE116 677/KOLNP/2003 203587 09-03-2007PIPERAZINE DERIVATIVES ANDPHARMACEUTICAL COMPOSITIONS THEREOFWYETH117 IN/PCT/2002/1328/KOL 203622 16-03-2007'PHARMACEUTICAL FORM ODADMINISTRATION FOR PEPTIDES METHODSFOR ITS PRODUCTION AND USE'ZENTARIS GMBH

118 IN/PCT/2001/760/KOL 203625 09-03-2007BENZOPYRAMS AND BENZOXEPINES,PHARMACEUTICAL COMPOSITIONSCOMPRISING THEM AND PREPARATIONMERCK PATENT GMBHPROCESS119 151/MUM NP/2004 203671 14/11/2006NOVEL PIPERIDINE 2, 6 DIONE BISULPHATESALTSPRESTWICK PHARMACEUTICALS INC,120 IN/PCT/2000/458/MUM 203706 08-11-2006GAMMA-AMINOBUTYRIC ACID DERIVATIVESCONTAINING, SOLID COMPOSITIONS AND WARNER LAMBERT COMPANYPROCESS FOR PREPARING THE SAME121 IN/PCT/2000/495/MUM 203725 08-11-2006STABILIZED PHARMACEUTICALPREPARATIONS OF GAMMA-AMINOBUTYRICACID DERIVATIVES AND PROCESS FORWARNER LAMBERT COMPANYPREPARING THE SAME122 303/CAL/2000 203790 09-03-2007"NOVEL BENZOFUROXAN DERIVATIVES ,ANDTORRENT PHARMACEUTICAL LTD.,THEIR PAHARMACEUTICAL COMPOSITIONS"123 1056/KOLNP/2004 203820 09-03-2007R-(-)-1-[2-(7-CHLOROBENZO[b] THIOPHEN-3-YL-METHOXY)-2-(2,4-DICHLOROPHENYL)-ETHYL]- FERRER INTERNACIONAL, S.A.1H-IMIDAZOLE"C2,5-DISTRIBUED AND N6,C2,5'-124 1131/KOLNP/2003 203843 16-03-2007TRISUBSTITUTED ADENOSINE DERIVATIVESAND A PHARMACEUTICAL COMPOSITIONUNIVERSITEIT LEIDENCONTAINING THE SAME"125 938/MUM/2004 203923 27/11/2006A SYNERGISTIC ANTISPASMODIC ANDANALGESIC FORMULATION AND TO A SANJEEV KHANDELWALMETHOD OF MAKING THE SAME126 IN/PCT/2001/1138/MUM 203937 16/11/2006A COMP 2- AMINO THIAZOLE5-CARBOXAMIDEBRISTOL- MAYERS SQUIBB CO,127 IN/PCT/2001/193/MUM 203959 05-02-2007AN AMIDE DERIVATIVE AND A PROCESS FORPREPARING THE SAMEASTRAZENECA AB128 1049/MUM/2003 203986 14/02/2007AYURVEDIC ANTIRETROVIRAL COMPOSITIONFOR TREATMENT OF ACQUIRED IMMUNO BAKUL JAINDEFICIENCY SYNDROME129 905/MUM NP/2003 203993 14/02/2007AN IMMEDIATE-RELEASE PHARMACEUTICAL3, 7-DIAZABICYCLO FORMULATIONASTRAZENECA ABA LIQUID PHARMACEUTICAL COMPOSITION130 315/MUM NP/2004 203998 27/07/2006 COMPRISING A GAMMA-AMINOBUTYRIC ACID WARNER LAMBERT COMPANY(GABA) ANALOG131 324/MUMNP 2005 203999 24/07/2006 ORALLY ADMINISTRABLE …. BASF AKTIENGESELLS CHAFT1-PHENYL-ALKYL AMIDE-2-PHENYL-4-132 366/MUM NP/2003 204006 29/09/2006 PIPERAZIN-1-YL-PIPERIDINE COMPOUND AND GLAXO GROUP LIMITEDPROCESS FOR THE PREPARATION THEREOF133 IN/PCT/2001/662/MUM 204012 08-11-2006 ORAL VACCINE COMPOSITION , DIARRHEA SBL VACCIN AB134 IN/PCT/2001/436/MUM 204028 19/09/2006 HIV REPLICATION INHIBITING PYRIMIDINES JANSSEN PHARMACEUTICA N.V.135 IN/PCT/2001/1294/MUM 204038 08-11-2006CYCLOTHIOCARBAMATE DERIVATIVES ASPROGESTERONE RECEPTOR MODULATORSWYETH, LIGAND PHARMACEUTICALS INC,

136 810/BOM/1999 204043 27/02/2007 ANTIPARASITIC FORMULATION PFIZER INC137 336/MUMNP/2004 204061 15/12/2006DEUTERATED SUBSTITUTED DIHYDR-OFURANONES AND PHARMACEUTICALS TORICUM DRUG DEVELOPMENT AGCONTAINING THESE COMPOUNDS138 143/CHENP/2003 204073 21-12-2006 SOMATOSTATIN PEPTIDOMIMETICS M/S. NOVARTIS AG139 IN/PCT/2002/605/MUM 204079 03-11-2006A PHARMACEUTICAL COMPOSITIONCOMPRISING (S)-(-)-a-ETHYL-2-OXO-1- UCB SAPYRROLIDINEACETAMIDE140 IN/PCT/2002/1246/MUM 204082 26/12/2006A COMPOUND O-ARYL GLUCOSIDE AND APHARMACEUTICAL COMPOSITION THEREOFBRISTOL- MAYERS SQUIBB CO,141 863/MUMNP/2003 204091 26/12/2006COMPOUND OF 5,8,14-TRIAZATRACYCLO[10.3.1.02.11.04.9]-HEXADECA-2(11),3,5,7,9-PENTAENE OF 5,8,14- PFIZER PRODUCT INCTRIAZATRACYCLO[10.3.1.02.11.04.9]-HEXADECA-2(11),3,5,7,9-PENTAENE142 913/MUM NP/2003 204094 26/12/2006 A COMPOUND PHENYL HETEROCYCLIC PFIZER INC143 IN/PCT/2002/890/MUM 204100 26/12/2006NOVEL 1,3-DIHYDRO-2H-INDOL-2-ONECOMPOUNDSSANOFI SYNTHELABORATORY144 IN/PCT/2002/01098/MUM 204124 05-01-2007RORALLY ADMINISTRABLE ACID STABLEANTIULCER BENZIMIDAZOLE DERVKOPRAN RESEARCH LABORATORIES LTD145 302/MUM/2002 204126 05-01-2007 4-DIARYLMETHYL 1-PIPERAZINYL DERV SUN PHARMACEUTICAL INDUSTRIES LTD146 885/MUM/1999 204132 05-01-2007 CCR5 MODULATOR COMPOUND PFIZER INC147 IN/PCT/2001/1539/MUM 204144 05-01-2007BENZIMIDAZOLES AND IMIDAZOPYRIDINESHAVING INHIBITORY ANTIVIRAL ACTIVITYJANSSEN PHARMACEUTICA N.V.148 IN/PCT/2002/583/MUM 204151 05-01-2007 SUBSTITUTED OXAZOLES AND THIAZOLES AS GLAXO GROUP LIMITED149 1164/MUM/2002 204153 05-01-2007AN INHIBITOR / FUNCTIONAL MODIFIERSYSTEM COMPRISING OF A KITHINDUSTAN LEVER LTD150 IN/PCT/2000/496/MUM 204158 08-01-2007IMIDAZOL PYRIDINE DERV WHICH INHIBITGASTRIC ACIDASTRAZENECA AB151 487/MAS/2001 204225 12-02-2007A NOVEL HERBAL DRUG COMPOSITION AND DR. POTHURAJU SURYA VENKATAPROCESS THE PREPARATION THEREOF SATYANARAYANA152 511/MAS/1998 204284 13-02-2007 CEPHALOSPORIN DERV THERAPEUTICS FOESCHUN GMBH153 IN/PCT/2001/226/CHE 204286 13-02-2007A SOLID ORAL PHARMACEUTICALCOMPOSITIONNOVARTIS AG154 46/CHE/2004 204302 13-02-2007NOVEL INTERMEDIATES AND IMPROVEDPROCESS FOR THE PREPARATION OFM/S. NATCO PHARMA LIMITEDGEFITINIB.155 IN/PCT/2002/1520/CHE 204303 13-02-2007AMIDINO COMPOUND AND SALTS THEREOFUSEFUL AS NITRIC OXIDE SYNTHASE PHARMACIA CORPORATIONINHIBITORS156 360/MUM/1996 204323 15/02/2007AN AYURVEDIC FORMULATION FORTREATMENT OF ACQUIRED IMMUNODEFICIENCY SYNDROME(AIDS)PREM CHAND JAIN

157 736/MUM/2002 204324 15/02/2007AN INCLUSION COMPLEX OF GLIPIZIDE ANDCYCLODEXTRIN AND ITS PHARMACEUTICAL USV LIMITEDCOMPOSITION158 841/MUM/1999 204325 15/02/2007AN ELETRIPTAN HYDROBROMIDEMONOHYDRATE AND A PROCESS FOR THE PFIZER INCPREPARATION OF THE SAMEPOLYMORPH OF (2R, 3S, 4R, 5R, 8R, 10R, 11R,12S, 13S, 14R)- 13- [[2,6-DIDEOXY-3-C-METHYL-3-0- METHYL-4-(-[(PROPYLAMINO)METHYL]-a-159 586/MUM/2000 204343 15/02/2007L- RIBO-HEXOPRYANOSYL]-2-ETHYL-3,4,10-TRIHYDROXY- 3,5,8,10,12,14- EXAMETHYL-11-PFIZER PRODUCT INC160 456/MUM/2000 204344 15/02/2007[[3,4,6-TRIDEOXY-3-(DIMETHYLAMINO)- B-D-XYLO-HEXOPYRANOSYL]OXA]-1-OXA-6-AZACYCOPENTADECAN-15-ONE1-THIFLUOROMETHYL-4-HYDROXY-7-PIPERIDINYLAMINOMETHYLCHROMAN PFIZER PRODUCT INCDERIVATIVES161 904/MUM/200 204386 19/02/2007COMPOSITION CONTAINING BIS-QUATERNARY SALTS OFGALAXY SURFACTANTS LIMITED162 IN/PCT/2000/476/MUM 204511 22/02/2007BENZAMIDE DERIVATIVES FOR THETREATMENT OF DISEASES MEDIATED BY ASTRAZENECA ABCYTOKINES163 IN/PCT/2000/426/MUM 204523 22/02/2007 A COMPOUND FORMULA I JANSSEN PHARMACEUTICA N.V.164 IN/PCT/2001/1472/MUM 204550 27/02/2007COMPOUND (35,5R)-3-AMINOMETHYL-5-METHYL-OCTANIOC ACID AND AWARNER LAMBERT COMPANYPHARMACEUTICALLY ACCEPTABLE SALT165 IN/PCT/2001/1295/MUM 204551 27/02/2007CYCLOCARBAMATE DERIVATIVES ASPROGESTERONE RECEPTOR MODULATORSWYETH166 IN/PCT/2001/1522/MUM 204567 27/02/2007COMPOSITIONS FOR THE TREATMENT OFAMYLOIDOGENIC DISEASENEURALAB LIMITED167 1210/MUM/2001 204579 27/02/2007CRYSTALLINE FORM I OF 2-METHYL-4-(4-METHYL-1-PIPERAZINYL)-10H-THIENO[2,3- SUN PHARMACEUTICAL INDUSTRIES LTDB][1,5]BENZODIAZEPINE168 IN/PCT/2001/548/MUM 204605 27/02/2007A SUSTAINED RELEASE PHARMACEUTICALCONTAINING 5-[4-[2-(N-METHYL-N-(2-PYRIDYL)AMINO)ETHOXY]BENZYL]THIAZOLISMITH KLINE BEECHAM PLCDINE-2,4-DIONE169 IN/PCT/2001/1540/MUM 204606 27/02/2007COMPOUND HAVING AN INHIBITORYACTIVITY ON THE REPLICATION OF THE JANSSEN PHARMACEUTICA N.V.RESPIRATORY SYNCYTIAL VIRUS170 940/MUM/2001 204612 28/02/2007DOSAGE FORM FOR TREATMENT OFDIABETES MELLITUSSUN PHARMACEUTICAL INDUSTRIES LTD171 IN/PCT/2001/83/MUM 204655 28/02/2007SUCCINOYLAMINO LACTAMS AS INHIBITORSOF AB PRODUCTIONBRISTOL- MAYERS SQUIBB CO,172 IN/PCT/2001/1108/MUM 204665 01-03-2007 SUSBSTITUTED BENZOYLPYRAZOLES BAYER AKTIENGESELLSCHAFT

173 IN/PCT/2001/503/MUM 204672 01-03-2007174 IN/PCT/2001/901/MUM 204695 02-03-2007SUCCINOYLAMINO BENZODIAZEPINES ASINHIBITORS OF A-BETA PROTEINAN IMPLANTABLE CARDIAC STIMULATORBRISTOL- MAYERS SQUIBB CO,THE MOWER FAMILY CHF TREATMENTIRREVOCABLE TRUST175 IN/PCT/2001/704/MUM 204696 02-03-2007COMPOSITIONS COMPRISNG 1,1,1,3-3-PENTAFLUORBUTANESOLVAY176 961/MUM/2000 204706 02-03-2007TRICYCLIC INHIBITOR OF POLY[ ADP- RIBOSE]AGOURON PHARMACEUTICAL INCPOLYMERS177 IN/PCT/2002/1441/MUM 204712 02-03-2007 SUBSTITUTED BENZOIC ACID SCHERING AKTIENGESELLSCHAFT178 IN/PCT/2002/1545/MUM 204725 02-03-2007FARNESYL TRANSFERASE INHIBITING 1,2-ANNELATED QUINOLINE ENANTIOMERJANSSEN PHARMACEUTICA N.V.179 IN/PCT/2002/1874/MUM 204729 05-03-2007ORAL PHARMACEUTICAL COMPOSITION WITHCONTROLLED RELEASE AND PROLONGEDABSORPTIONFLAMEL TECHNOLOGIES180 IN/PCT/2001/443/MUM 204758 06-03-2007181 IN/PCT/2001/979/MUM 204761 06-03-2007182 IN/PCT/2001/1600/MUM 204765 06-03-2007183 IN/PCT/2002/584/MUM 204783 09-03-2007184 IN/PCT/2002/1600/MUM 204952 12-03-2007185 496/MAS/1995 204982 13-03-2007186 1103/MAS/2000 204983 13-03-2007187 1312/MAS/1997 204984 13-03-2007188 1388/MAS/1998 204986 13-03-2007189 155/MAS/1999 204987 13-03-2007190 1955/MAS/1996 204989 13-03-2007191 2252/MAS/1998 204991 13-03-2007COMPOUNDS BENZISOXAZOLES ANDPHENONES OF FORMULA I AND PROCESS OFPREPARATION THEREOFINJECTION SOLUTION FOR THE TREATMENTOF ARTHROSESA GDF-8 ANALOGUE COMPRISING THENATURAL GDF-8 AMINO ACID SEQUENCE ANDA COMPOSITION THEREOFHETEROCYCLIC DIHYDROXYPYRIMIDINECOMPOUNDS OF FORMULA I*SUBSTITUTED BICYCLIC DERIVATIVES FORTHE TREATMENT OF ABNORMAL CELLACYLATED AMINOALKYLIMIDAZOLE AND-TRIAZOLE DERIVATIVESEXTENDED RELEASE ORAL DOSAGECOMPOSITIONCYCLOSPORIN-CONTAINING SOFT CAPSULEPREPARATIONSSOLID PHARMACEUTICAL COMPOSITIONCONTAINING BENZOFURAN DERIVATIVESA PHARMACEUTICAL COMPOSITIONCONTAINING NIMESULIDECONTROLLED RELEASE SOLID DOSAGEFORMULATION OF PHARMACEUTICALS FORORAL ADMINISTRATIONPARENTERAL FORMULATIONS COMPRISING10-HYDROXY-10,11-TETRAHYDROCARBAMAZEPINE,WATER AND GLUCOSEJANSSEN PHARMACEUTICA N.V.DR. MED.ADUSUMALLI CHAKRAVARTYPHARMEXA ASBRISTOL- MAYERS SQUIBB CO,PFIZER PRODUCT INCSANDOZ LTDM/S. SCHERING CORPORATIONNOVARTIS AGM/S. SANOFI-SYNTHELABONATCO PHARMA LIMITEDM/S. PENWEST PHARMACEUTICALSNOVARTIS AGDr. POTURAJU SURYA VENKATASATYANARAYANA192 486/MAS/2001 204994 13-03-2007AVALMIC-I HERBAL BASED DRUG CAPSULEPREPARATION193 802/MAS/1996 204998 13-03-2007 ANTIBACTERIAL CEPHALOSPORINS M/S. SANDOZ AG

194 IN/PCT/2002/692/MUM 205013 13/03/2007 A DIHYDRO BENZOFURAN COMPOUND ASTRAZENECA ABA SUBSTANTIALLY CRYSTALINE FORM OF195 IN/PCT/2001/1542/MUM 205032 13/03/2007ASTRAZENECA ABMELAGATRANA LIQUID NUTRITIONAL COMPOSITION FOR A196 IN/PCT/2000/619/CHE 205037 13-03-2007M/S. NOVARTIS AGPERSON HAVING RENAL FAILUREEPOTHILONE DERIVATIVES AND THEIR197 IN/PCT/2000/841/CHE 205038 13-03-2007NOVARTIS AGSYNTHESISAN ENANTIOMER-PURE 2,4-DISUBSTITUTED198 IN/PCT/2001/1290/CHE 205039 13-03-2007M/S. NOVARTIS AGOXAZOLINES OF FORMULA 11- ARYLSULPHONYL - 2- ARYL - PYRROLIDINE199 IN/PCT/2001/1291/CHE 205040 13-03-2007F. HOFFMANN-LA ROCHE AGAND PIPERIDINE COMPOUNDS200 IN/PCT/2001/1465/CHE 205042 13-03-2007 RENIN INHIBITOR F. HOFFMANN-LA ROCHE AG201 IN/PCT/2001/1711/CHE 205043 13-03-2007 ETHANESULFONYL PIPERIDINE DERV F. HOFFMANN-LA ROCHE AG202 759/MUM/1999 205063 13/03/2007 PHENYL-SUBSTITUTED CYCLIC ENAMINONES BAYER AKTIENGESELLSCHAFTNEW BENZAMIDE DERIVATIVES AND A203 IN/PCT/2001/638/CHE 205069 13-03-2007NOVARTIS AGPROCESS FOR PREPARING THE SAME204 IN/PCT/2001/593/MUM 205146 14/03/2007 VITRONECTIN RECEPTOR ANTAGONIST SMITH KLINE BEECHAM CORPORATION205 802/MUM/1999 205154 15/03/2007 NOVEL 13-MEMBERED AZALIDE COMPOUNDS PFIZER PRODUCT INCA MEDICAMENT FOR CONGESTIVE HEART206 IN/PCT/2002/1287/CHE 205173 22-03-2007 FAILURE COMPRISING PRETREATEDVASOGEN IRELAND LIMITEDAUTOLOGOUS BLOOD207 IN/PCT/2002/518/CHE 205174 22-03-2007 BENZODIAZEPINE DERV F. HOFFMANN-LA ROCHE AG208 IN/PCT/2002/58/CHE 205175 22-03-2007 VITAMINE D3 ANALOG F. HOFFMANN-LA ROCHE AG209 453/CHENP/2003 205180 22-03-2007 NEW RETINOIDS OF FORMULA I F. HOFFMANN LA - ROCHE AGA COMPOSITION COMPRISING A COMP OF210 1153/CHENP/2003 205182 22-03-2007M/S. SCHERING CORPORATIONFORMULA IINEW CAMPTOTHECIN DERIVATIVES211 948/CAL/1995 205321 30-03-2007 ,PREPARATIONS THEREOF AND ANTITUMOR KABUSHIKI KAISHA YAKULT HONSHAAGENTS"ANTI- V - INTEGRIN MONOCLONALMERCK PATENT GESELLSCHAFT MIT212 1646/CAL/1995 205485 05-04-2007ANTIBODY".BESCHRANKTERA COMPOSITION COMPRISINGA MIXTURE OF213 IN/PCT/2000/391/KOL 205534 05-04-2007GENENTECH INCANTI HER 2 ANTIBODYPLANT-DERIVED AND SYNTHETIC PHENOLICCOMPOUNDS AND PLANT EXTRACTS,214 153/KOLNP/2003 205543 05-04-2007CONTROL OX OYEFFECTIVE IN THE TREATMENT ANDPREVENTION OF CHLAMYDIAL INFECTIONSA PHARMACEUTICAL COMPOSITION FOR215 1538/CHENP/2003 205654 09-04-2007M/S. JAPAN TOBACCO, INCMODULATING THE ACTIVITY……DIHYDRO-BENZO(b)(1,4) DIAZEPIN-2-ONE216 1593/CHENP/2003 205655 09-04-2007M/S. F. HOFFMANN-LA ROCHE AGDERIVATIVES AS MGLUR2 ANTAGONISTS I"217 1770/CHENP/2003 205667 09-04-2007 CARBOXYLIC ACID SUBS OXAZOLE DERV M/S. F. HOFFMANN-LA ROCHE AGA COMPOUND FORMULA I WITH 5-HT6218 1913/CHENP/2003 205669 09-04-2007M/S. F. HOFFMANN-LA ROCHE AGRECEPTOR AFFINITY

219 1079/CHENP/2004 205676 09-04-2007NOCITIN OR ISONICOTIN BENZOTHIAZOLEDERVM/S. F. HOFFMANN-LA ROCHE AG220 1534/CHENP/2004 205681 09-04-2007 A THIADIAZOLE COMPOUND M/S. SUMITOMO CHEMICAL COMPANY,LIMITED221 1609/CHENP/2004 205687 09-04-2007 FLUOROSUBSTITUTED CYCLOALKANO M/S. MERCK FROSST CANADA & CO222 2007/CHENP/2004 205696 09-04-2007FLUORINATED 4-AZASTEROID DERIVATIVESAS ANDROGEN RECEPTOR MODULATORSM/S. MERCK & CO ., INC.223 IN/PCT/2002/840/MUM 205761 10-04-2007UNSATURATED 14, 15-CYCLOPROPANO-ANDROSTANESSCHERING AKTIENGESELLSCHAFT224 IN/PCT/2002/1884/MUM 205784 10-04-2007ANTIFUNGAL AND/OR ANTIBACTERIALPEPTIDES, PREPARATION METHODS AND ENTOMED S ACOMPOSITION CONTAINING SAME225 IN/PCT/2002/867/MUM 205788 10-04-2007 PHARMACEUTICAL COMPOSITION ASTRAZENECA AB226 IN/PCT/2002/1095/MUM 205807 10-04-2007 NEW IMIDAZOTRIAZINONES BAYER AKTIENGESELLSCHAFT227 IN/PCT/2001/1165/KOL 205853 13-04-2007A NOVEL ANTIOXIDATIVE VITAMIN B6ANALOGS.OBERTHUR, WALTER228 614/MUMNP/2004 205892 12-04-2007STABILISED PHARMACEUTICALCOMPOSITIONS ON THE BASIS OFPOLYOXYETHYLATED CASTOR OIL ANDPLIVALACHEMA A SMETHOD FOR MANUFACTURING THE SAME229 IN/PCT/2002/255/MUM 205893 12-04-2007NOVEL AMINODICARBOXYLIC ACIDDERIVATIVES HAVING PHARMACEUTICAL BAYER AKTIENGESELLSCHAFTPROPERTIES230 IN/PCT/2002/1609/CHE 205912 12-04-2007A COMPOSITION FOR TREATING FUNGALINFECTIONNEUTEC PHARMA PLC231 IN/PCT/2002/1670/CHE 205919 12-04-2007POLYAMIDE NUCLEIC ACID DERIVATIVES,AGENTS AND METHODS FOR PRODUCING SANOFI-AVENTIS DEUTSCHLAND GMBHTHEM232 IN/PCT/2002/1776/CHE 205926 12-04-2007A PHARMACEUTICAL COMPOSITIONCOMPRISING A CYCLODEXTRIN AND A THERAVANCE, INCLAPIDATED GLYCOPEPTIDE ANTIBIOTIC233 IN/PCT/2002/2115/CHE 205967 13-04-2007A HUMAN MONOCYTE CHEMOATTRACTANTPROTEIN (MCP)-1 BINDING MOLECULESNOVARTIS AG234 394/CHENP/2003 205993 13-04-2007 BICYCLIC HETEROAROMETIC COMP. N.V. ORGANON235 58/CHENP/2003 205996 13-04-2007A CONTROLLED RELEASE PHARMACEUTICALTABLET CONTAINING CROSS LINKEDAMYLOSE AND A PROCESS FOR PREPARINGM/S. LENAERTS VincentCROSS-LINKED AMYLOSE236 IN/PCT/2002/477/MUM 206033 16/04/2007 A NOVEL BENZIMIDAZOLE COMP, PFIZER PRODUCT INC237 396/MUMNP/2004 206034 16/04/2007DERIVATIVES OF COMPOUND 3-AMINO-1-MORPHOLINE-4-YL-PROPAN-1-ONEWARNER LAMBERT COMPANY238 76/MUMNP/2004 206036 16/04/2007NEW CARBOXYLIC ACID AMIDE DERIVATIVESWHICH ARE ANTAGONISTS OF NMDARECEPTOR OR ARE INTERMEDIATES FORPREPARING THEREOFRICHTER GEDEON VEGYESZETI GYAR RT,

239 IN/PCT/2001/1435/MUM 206050 16/04/2007A PHARMACEUTICAL COMPOSITION FOR THEPREVENTION AND TREATMENT OFELAN PHARMA INTERNATIONAL LIMITEDAMYLOIDOGENIC DISEASE240 121/MUMNP/2003 206069 17/04/2007IMIDAZOLO-5-YL-2-ANILINO-PYRIMIDINES ASAGENTS FOR THE INHIBITION OF THE CELL ASTRAZENECA ABPROLIFERATION241 210/MUMNP/2005 206080 17/04/2007PHARMACEUTICAL COMPOSITIONS ASINHIBITORS OF DIPEPTIDYL PEPTIDASE-IV ABBOTT LABORATORIES(DPP-IV)242 939/MUM/2004 206082 17/04/2007AN ANTISPASMODIC AND AN ANALGESICANTIPYRETIC WITH AN ANTI-INFLAMMATORY AND ANALGESICSANJEEV KHANDELWALCOMBINATION AND TO A METHOD OFMAKING THE SAME243 176/MUM/2004 206083 17/04/2007AN ANTISPASMODIC ORAL DROPFIORMULATIONSANJEEV KHANDELWAL244 1048/MUM/2003 206091 17/04/2007AYURVEDIC IMMUNO-MODULATORCOMPOSITION FOR TREATMENT OFBAKUL JAINACQUIRED IMMUNO DEFICIENCY SYNDROME245 75/MUMNP/2004 206098 17-04-2007DOSAGE REGIMEN AND PHARMACEUTICALCOMPOSITION FOR EMERGENCYRICHTER GEDEON VEGYESZETI GYAR RT.CONTRACEPTION246 130/MUM/2004 206100 17/04/2007STABLE ORAL ANTIDIABETIC FORMULATIONOF GLIPIZIDE AND METFORMINUSV LIMITEDHYDROCHLORIDE247 485/MUMNP/2005 206127 18/04/2007SUBSTITUTED PHENYL CYCLOHEXANECARBOXAMIDESBAYER AKTIENGESELLSCHAFT248 176/MUM/2004 206137 18/04/2007AN ANTISPASMODIC FORMULATION INSTABLE INJECTABLE FORM AND TO A SANJEEV KHANDELWALMETHOD OF MAKING THE SAME249 599/MUMNP/2004 206139 18/04/2007 PERINDORPRIL CIPLA LIMITED250 IN/PCT/2001/1376/KOL 206182 20-04-2007ORAL PHARMACEUTICAL COMPOSITIONSCONTAINING TAXANES AND METHODS OF IVAX RESEARCH, INC.PREPARATION THEREFOR.251 191/MUMNP/2003 206212 19/04/2007 BICYCLIC PYRROLYL AMIDE COMPOUND ASTRAZENECA AB252 IN/PCT/2002/1794/MUM 206214 19/04/2007A COMPOSITION CONSISTING ESSENTIALLYOF A CYCLOOXYGENASE-2 INHIBITORWYETH253 IN/PCT/2002/1125/MUM 206224 19/04/20071,5-DISUBSTITUTED-3M4-DIHYDRO-1H-PYRIMIDO[4,5-D] PYRIMIDIN-2-ONECOMPOUNDS AND THEIR USE IN TREATINGSMITH KLINE BEECHAM PLCCSBP/P38 KINASE MEDIATES DISEASES254 853/MUMNP/2003 206225 19/04/2007 A PYRAZOLE COMP PFIZER INC255 IN/PCT/2002/1457/MUM 206226 19/04/2007 A QUINAZOLINE DERV ASTRAZENECA AB256 IN/PCT/2002/1540/MUM 206227 19/04/2007 2-AMINO CARBONYL 9H PURIN COMP PFIZER INC257 990/MUMNP/2003 206231 19/04/2007 A COMPOUND BAYER CORPORATION

258 IN/PCT/2002/1868/MUM 206233 19/04/2007 PEPTIDE WITH WOUND HEALING CHANDA Zveri259 411/MUM/2004 206238 19/04/2007A SYNERGISTIC ANTISPASMODIC, ANALGESICFORMULATION AND A METHOD OF MAKING SANJEEV KHANDELWALTHE SAME260 293/MUMNP/2005 206252 20/04/2007 NOVEL TETRAHYDROPYRIDINES…. SANOFI SYNTHELABORATORIES261 924/CHENP/2003 206275 23-04-2007ISOINDOLIN-1-ONE GLUCOKINASEACTIVATORSF. HOFFMANN-LA ROCHE AG262 IN/PCT/2002/66/MUM 206328 24/04/2007SYNERGISTIC COMBINATION OFROFLUMILAST AND SALMETEROLALTANA PHARMA AG263 1077/MUM/2001 206337 24/04/2007AN OPTHALMIC PHARMACEUTICALPEPREPARATIONFDC LIMITED264 173/MUMNP/2004 206372 25/04/2007GLYCOCONJUGATE VACCINE COMPOSITIONFOR USE IN IMMUNE-COMPROMISEDPOPULATIONS FROM STAPHYLOCOCCALNABI BIOPHARMACEUTICALSINFECTION265 1999/CAL/1996 206383 27-04-2007"NOVEL N,N'-BRIDGEDBISINDOLYLMALEIMIDIES AND PROCESS OF ELI LILLY AND COMPANYPREPARING THEREOF"266 2230/CAL/1998 206386 27-04-2007"TOPICAL PHARMACEUTICAL COMPOSITIONS HEDONIST BIOCHEMICAL TECHNOLOGIESFOR HEALING WOUNDS."CO..,LTD.267 IN/PCT/2002/977/MUM 206388 25/04/2007A AZAINDOLE PIPERAZINE DIAMIDECOMPOUND OF FORMULA IBRISTOL- MAYERS SQUIBB CO,268 415/MUM/2005 206461 26/04/2007 A HOMEOPATHIC MEDICINE DR. SHAH RAJESH NAROTTAM DAS269 598/MUMNP/2005 206475 27/04/2007 PHARMACEUTICAL FORMULATION…. CIPLA LTD270 469/MUMNP/2003 206477 27/04/2007 A PIPERAZINE COMPOUND OF FORMULA (I) SCHERING AKTIENGESELLSCHAFT271 IN/PCT/2002/823/MUM 206479 27/04/2007NEW CRYSTALLINE AND AMORPHOUS FORMOF A TRIAZOLO(4,5-D)PYRIMIDINEASTRAZENECA AB272 483/MUMNP/2005 206509 27/04/2007IMPROVED PHARMACEUTICAL….BOTULINUM TOXIN RESEARCH ASSOCIATESINC273 IN/PCT/2002/888/MUM 206517 27/04/2007 NOVEL LIGAND FOR THYROID RECEPTOR BRISTOL- MAYERS SQUIBB CO,274 IN/PCT/2002/412/MUM 206527 27/04/2007 PIPERAZINE COMP GLAXO GROUP LIMITED275 IN/PCT/2002/1154/MUM 206543 30/04/2007A CYCLOPROPYL-FUSED PYRROLIDINE-BASEDBRISTOL- MAYERS SQUIBB CO,COMPOUND276 IN/PCT/2002/27/MUM 206545 30/04/2007IMIDAZO[1,2-A]PYRIDINE AND PYRAZOLO[2,3-A]PYRIDINE DERIVATIVESASTRAZENECA AB277 154/MUM/2003 206561 01-05-2007A NOVEL PHARMACEUTICAL COMPOSITIONOF STATIN WITH DISEASE MODIFYING ANTI- IPCA LABORATORIES LIMITEDRHEUMATIC DRUGPREPARATION FOR WOUND HEALING AND278 460/MUMNP/2004 206562 01-05-2007 PREVENTION OF BANDAGE ADHESION TO THE CPN SPOL SROWOUND((AMINOIMINOMETHYL) AMINO)279 IN/PCT/2001/792/KOL 206594 03-05-2007 ALKANECARBOXAMIDES AND THEIRAPPLICATIONS IN THERAPYMERCK PATENT GMBH

280 IN/PCT/2001/1284/KOL 206601 03-05-2007"BENZIMIDAZOLE DERIVATIVES OF FORMULAI AND THE PROCESS OF PREPARATION SANKYO COMPANY LIMITEDTHEREOF"281 IN/PCT/2002/675/MUM 206639 03-05-2007A PHARMACEUTICAL FORMULATIONADAPTED FOR INTRAMUSCLUAR INJECTIONASTRAZENECA AB282 502/MUM/2003 206652 04-05-2007A CELL FREE IMMUNOGEN PREPARATION / DR. MADHAO BHALCHANDRA SAHAPROPHYLACTIC VACCINESRABUDHE283 147/MUMNP/2005 206655 04-05-2007 8-CYCLO 1- CYCLOPROPYL…. BASF AKTIENGESELLS CHAFT284 1182/MAS/1998 206673 09-05-2007 5'- DEOXY CYTIDINE DERV F. HOFFMANN-LA ROCHE AG285 1735/MAS/1996 206674 09-05-2007 CARBOSTYRIL DERV M/S. D.WESTERN THERAPEUTICS INSTITUTE286 1908/MAS/1996 206676 09-05-2007PHARMACEUTICALLY ACCEPTABLELYOPHILIZED FORMULATIONSANOFI SYNTHELABO287 84/MAS/2001 206678 09-05-2007SYNTHESIS OF 3,6 - DIALKYL - 5,6 - DIHYDRO -4- HYDROXY-2H-PYRAN-2-ONEF. HOFFMANN-LA ROCHE AG288 IN/PCT/2000/740/CHE 206680 09-05-2007ORGANOPHOSPHORUS COMPOUNDS FORDENTAL POLYMERIZABLE COMPOSITIONSM/S. KURARAY MEDICAL INC.289 IN/PCT/2001/1842/CHE 206681 09-05-2007A CONJUGATE COMPRISING ANERYTHROPOIETIN GLYCOPROTEINF. HOFFMANN-LA ROCHE AG290 1234/CHENP/2003 206687 09-05-2007 6-SUBSTITUTED PYRIDO-PYRIMIDINES M/S. F. HOFFMANN-LA ROCHE AG291 1902/CHENP/2003 206746 11-05-2007PHARMACEUTICAL COMPOSITIONCOMPRISING A LIPASE INHIBITOR AND A M/S. F. HOFFMANN-LA ROCHE AGSUCROSE FATTY ACID ESTER292 2995/CHENP/2004 206750 11-05-2007 NOVEL BENZODIOXOLE DERIVATIVES M/S. F. HOFFMANN-LA ROCHE AG293 832/CHENP/2005 206753 11-05-2007 OROMUSCOSAL FORMULATION OY JUVANTIA PHARMA LTD.NOVEL ELONGASE GENE AND METHOD FOR294 IN/PCT/2002/1390/CHE 206888 15-05-2007 PRODUCING MULTIPLE-UNSATURATED FATTY BASF AKTIENGESELLSCHAFTACIDS295 IN/PCT/2002/1827/CHE 206891 15-05-2007A LIQUID PHARMACEUTICAL COMPOSITIONCOMPRISING AN ERYTHROPOIETIN PROTEINF. HOFFMANN-LA ROCHE AG296 1045/CAL/1995 206898 16-05-2007CRYSTALLINE FORM OF DIHYDRO- 2,3-BENZODIAZODIAZEPINE DERIVATIVE.ELI LILLY AND COMPANY297 766/CAL/1995 206911 16-05-2007 "THERAPEUTIC COMPOUNDS" THE WELLCOME FOUNDATION LIMITED298 IN/PCT/2002/1756/CHE 206931 16-05-2007 AN IMMINOREGULARTOR PEPTIDE BIOTEMPT B V299 IN/PCT/2002/1836/CHE 206936 16-05-2007PIPERAZINE AND PIPERIDINE DERIVATIVESOF FORMULA ISOLVAY PHARMACEUTICALS B.V.300 IN/PCT/2002/1966/CHE 206945 16-05-2007BIS-(N,N'-BIS-(2-HALOETHYL)AMINO)PHOSPHORAMIDATESTELIK INC.301 IN/PCT/2002/1986/CHE 206947 16-05-2007 GLYCOPEPTIDE PHOSPHONATE DERV THERAVANCE, INC302 IN/PCT/2002/2105/CHE 206949 16-05-2007PHARMACEUTICAL COMPOSITION FORTREATMENT OF VAGINAL DRYNESS ANDSEXUAL DYSFUNCTIONHORMOS MEDICAL CORPORATION

303 2609/MAS/1998 206960 16-05-20072-ARYL-8-OXODIHYDROPURINE DERIVATIVE,PROCESS FOR THE PREPARATION THEREOF,PHARMACEUTICAL COMPOSITIONDAINIPPON SUMITOMO PHARMA CO.,LTDCONTAINING THE SAME, AND INTERMEDIATETHEREFOR304 65/MAS/1998 206961 16-05-2007 TACHYKININ ANTAGONIST NOVARTIS AG,305 687/MAS/1996 206962 16-05-2007 PENTACYCLIC COPM M/S. DAIICHI PHARMACEUTICAL CO.,LTD306 IN/PCT/2001/1103/CHE 206965 16-05-2007 PHENYLALANINOL DERV F. HOFFMANN-LA ROCHE AG307 IN/PCT/2001/1308/CHE 206966 16-05-2007 GLUCOKINASE ACTIVATORS M/S. F. HOFFMANN-LA ROCHE AG308 136/CHENP/2003 206969 16-05-2007A PHARMACEUTICAL COMPOSITIONCOMPRISING LIPASE INHIBITOR AND BILE M/S. F. HOFFMANN-LA ROCHE AGACID SEQUESTRANT309 150/CHENP/2003 206971 16-05-2007QUINUCLIDYL N-PHENYL-N-ALKYLCARBAMATES HAVING ACTIVITY AS M/S. LABORATORIOS S.A.L.V.A.T., S.A.MUSCARINIC RECEPTOR ANTAGONISTS310 162/CHENP/2003 206972 16-05-2007 7-SUBSTITUTED TETRACYCLINE COMPOUNDS M/S. TRUSTEES OF TURTS COLLEGE311 24/CHENP/2003 206974 16-05-2007INDOLE DERIVATIVES USEFUL FOR THETREATMENT OF CNS DISORDERSH. LUNDBECK A/S312 77/CHENP/2003 206983 16-05-2007PHARMACEUTICAL COMPOSITIONSCOMPRISING ACRYLOYL DISTAMYCINDERIVATIVES AND TOPOISOMERASE I AND IIM/S. NERVIANO MEDICAL SCIENCES S R LINHIBITORS313 89/CHENP/2003 206985 16-05-2007NOVAL PEPTIDES AS NS3-SERINE PROTEASEINHIBITORS OF HEPATITIS C VIRUSM/S. SCHERING CORPORATION314 1145/CHENP/2003 207006 16-05-2007COMPOSITION COMPRISING STEROLABSORPTIONM/S. SCHERING CORPORATION315 1150/CHENP/2003 207007 16-05-2007A COMPOSITION OF STEROL ABSORPTIONINHIBITOR(S) WITH CARDIOVASCULARM/S. SCHERING CORPORATION316 1171/CHENP/2003 207008 16-05-20073,4-DI-SUBSTITUTED CYCLOBUTENE-1, 2-DIONES AS CXC CHEMOKINE RECEPTOR M/S. SCHERING CORPORATIONANTAGONISTS317 1594/CHENP/2003 207013 16-05-20077, 9-SUBSTITUTED TETRACYCLINECOMPOUNDSM/S. PARATEK PHARMACEUTICALS INC.318 1811/CHENP/2003 207017 16-05-2007IMIDAZO[1,5-A] PYRIMIDO[5,4-D]BENZAZEPINE DERIVATIVES AS GABA A M/S. F.HOFFMANN-LA ROCHE AGRECEPTOR MODULATORS319 1916/CAL/1996 207086 23-05-2007 "SUSTAINED RELEASE EXCIPIENT" PENWEST PHARMACEUTICALS CO.NUCLEIC ACID MOLECULES ENCODIN G ABRANCHING ENZYME FROM BACT ERIA OF PLANTTEC BIOTECHNOLOGIE GMBH320 IN/PCT/2001/299/MUM 207184 24/05/2007 THE GENUS NEISSERIA AS WELL AS METHODS F AND MAX PLANCK GESELLSCHAFT ZURFOR THE PRODUCTION OF A-1, 6-BRANCHED A- FORDERUNG DER WISSENSCHAFTEN1, 4-GLUCANS321 1108/MUM/2004 207193 30/04/2007METHOTREXATE TOPICAL SEMISOLIDDOSAGE FORM (GEL)SANJEEV KHANDELWAL

322 959/MAS/1995 207232 01-06-20072-(2-AMINO-1, 6-DIHYDRO-6-OXO-PURIN-9-YL)METHOXY-3-HYDROXY-1-PROPANYL-L- F. HOFFMANN-LA ROCHE AGVALINATE323 IN/PCT/2000/434/CHE 207233 01-06-2007A LYOPHILIZED POWDER PRODUCED BYLYOPHILIZATION OF AN AQUEOUSFORMULATION WHICH PROTECT THE PEG-M/S. SCHERING CORPORATIONINTERFERON ALPHA CONJUGATES324 39/CHENP/2003 207234 01-06-2007A NOVEL VACCINE FORMULATIONCONSISTING OF DNA VACCINE ANDM/S. INDIAN INSTITUTE OF SCIENCEINACTIVATED VIRUS325 1975/CHENP/2004 207245 01-06-2007 SUBSTITUTED INDAZOLE DERV M/S. AVENTIS PHARMA S.A.326 222/MUMNP/2004 207336 06-06-2007A COMPOSITION COMPRISING RECOMBINANT,ENGENEIC GENE THERAPY PTY LTDINTACT BACTERIAL MINICELLSNOVEL COMBINATION OF NON-SEDATING327 IN/PCT/2002/912/KOL 207505 14-06-2007ANTIHISTAMINES WITH SUBSTANCES WHICHINFLUENCE LEUKOTRIENE ACTION, FOR THEVIATRIS GMBH & CO. KGTREATMENT OF RHINITIS /CONJUNCTIVITIS328 2264/MAS/1996 207616 19-06-2007ALPHA-SUBSTITUTED ARYL SULPHONAMIDEACETOHYDROXAMIC ACIDM/S. NOVARTIS AGNOVEL HETEROCYCLIC COMPOUNDS AND329 2419/MAS/1997 207617 19-06-2007THEIR USE IN MEDICINE: PROCESS FOR THEIRDr.REDDY'S LABORATORIES LTDPREPARATION AND PHARMACEUTICALCOMPOSITIONS CONTAINING THEM330 IN/PCT/2001/1382/CHE 207622 19-06-2007 A STEROIDAL COMP NICOX S A331 IN/PCT/2002/187/CHE 207623 19-06-2007 PHARMACEUTICAL COMP NICOX S.A.332 IN/PCT/2002/826/CHE 207624 19-06-2007 4-PYRIMIDINYL-N-ACYL-L-PHENYLALANINES F. HOFFMANN-LA ROCHE AG333 140/CHENP/2003 207625 19-06-2007A PHARMACEUTICAL COMPOSITION FORDEMENTIAM/S. DAINIPPON PHARMA CO.,LTD334 250/CHENP/2003 207626 19-06-2007BICYCLO-PYRAZOLES ACTIVE AS KINASEINHIBITORS, PROCESS FOR THEIRPREPARATION AND PHARMACEUTICALPHARMACIA ITALIA S.P.ACOMPOSITIONS COMPRISING THEM335 254/CHENP/2003 207627 19-06-2007 SELECTIVE CYCLIC PEPTIDES OF FORMULA I M/S. F. HOFFMANN-LA ROCHE AG336 626/CHENP/2004 207636 19-06-2007PHARMACEUTICAL COMPOSITIONSCOMPRISING COLLOIDAL SILICON DIOXIDEM/S. NOVARTIS AG337 2798/CHENP/2004 207639 19-06-2007 MITOTIC KINESIN INHIBITOR M/S. MERCK & CO.,INCPEPTIDES EFFECTIVE IN THE TREATMENT OF338 177/KOLNP/2004 207745 21-06-2007TUMOURS AND OTHER CONDITIONSNYMOX CORPORATIONREQUIRING THE REMOVAL OR DESTRUCTIONOF CELLS.INTERMEDIATE COMPOUNDS FOR THE339 277/KOLNP/2004 207815 28-06-2007 PREPARATION OF MIRTAZAPINE ANDOBTENTION METHODS THEREOFMEDICHEM S.A.

340 333/MUMNP/2005 207881 29/06/2007CRYSTALS OF P1-(2'-DEOXYCYTIDINE 5'-) P4-(URIDINE 5'-) - TETRAPHOSPHATE OR A SALT YAMASA CORPORATIONTHEREOF341 IN/PCT/2000/218/MUM 207882 29/06/20072,3- DIDEOXY-3-FLURO-5-O-(2-(L-VALYLOXY)-PROPIONYL)GUANOSINEMEDIVIR AB342 IN/PCT/1999/14/MUM 207883 29/06/2007AN AQUEOUS PHARMACEUTICALCOMPOSITION FOR APPLICATION TO THE TEIJIN LIMITEDMUCOSA343 IN/PCT/2001/435/MUM 207884 29/06/2007 2,4-DISUBSTITUTED TRIAZINE DERIVATIVES JANSSEN PHARMACEUTICA N.V.344 134/MUMNP/2005 207886 29/06/2007 CRYSTAL MODIFICATION …. BASF AKTIENGESELLS CHAFT345 362/MUMNP/2004 207889 29/06/2007INTERMEDIATES FOR LHRH ANTAGONISTISTSYNTHESIS, PROCESS FOR THEIRPRODUCTION,AND PROCESS FOR LHRHPOLYPEPTIDE LABORATORIES ASANTAGONIST PRODUCTIONPURIFIED AND CHEMICALLY MODIFIED346 52/MUMNP/2005 207895 29/06/2007RECOMBINANT HUMAN ARGINASEI AND BIO CANCER TREATMENT INTERNATIONALPHARMACEUTICAL COMPOSITIONLTDCOMPRISING THE SAME347 IN/PCT/2000/135/KOL 207985 04-07-2007 "PHARMACEUTICAL DOSAGE FORM" AXCAN PHARMA INC348 IN/PCT/2000/187/KOL 208002 05-07-2007PHARMACEUTICAL COMPOSITIONCOMPRISING A COMBINATION OFMETFORMIN AND FIBRATE, AND ITS USE FOR MERCK PATENT GMBHTHE PREPARATION OF MEDICINES INTENDEDTO REDUCE HYPERGLYCAEMIA349 2509/MAS/1997 208018 06-07-2007A SUBTILASE ENZYME VARIANT ANDCOMPOSITIONS CONTAINING THE SAMENOVOZYMES A/S350 2508/MAS/1997 208087 09-07-2007SUBTILASE ENZYMES VARIANT ANDCOMPOSITIONM/S. NOVOZYMES A/S351 40/MUMNP/2005 208149 18/07/2007COMPOUND OF FORMULA VIIIA AND AMETHOD FOR PREPARING THE SAMEPFIZER PRODUCTS INC352 IN/PCT/2000/00074/MUM 208150 18-07-2007 WATER-SOLUBLE EYE DROP OTSUKA PHARMACEUTICAL353 322.MUM/2002 208157 18/07/2007KERNEL OIL FROM PLANT KERNEL ,PROCESSFOR EXTRACTING SAME, PHARMECEUTICAL DAPENG LI354 188/CAL/1995 208191 19-07-2007355 652/MUM/2002 208333 23/07/2007356 295/MUMNP/2004 208341 23/07/2007COMPOSITIONS AND USE THEREOFA PHARMACEUTICAL COMPOSITIONMODIFIED RELEASE PHARMACEUTICALCOMPOSITIONS OF CEFADROIXIL ANDCEPHALEXINPHARMACEUTICAL COMPOSITIONCONTAINING EPIDERMAL GROWTH FACTOR(EGF) FOR PREVENTING DIABETIC LIMBAMPUTATION1.JANSSEN PHARMACEUTICA N.V., &2.ALKERMES CONTROLLED THERAPEUTICSINC.,II.LYKA LABS LIMITEDCENTRO DE INGENEIRIA GENETICA YBIOTECHNOLOGIA

357 IN/PCT/2000/219/MUM 208346 24/07/2007A NEOCEOSIDE COMPOUND OF FORMULA IAND THE COMPOSITION OF THE SAID MEDIVIR ABNUCLEOSIDE COMPOUND358 233/MUMNP/2003 208347 24/07/20071, 4 DISUBSTITUTED BENZENE COMPOUND OFFMC CORPORATIONFORMULA I359 816/MUMNP/2005 208353 24/07/2007 CYCLOALKENE DICARBIXYLIC…. 4SC AG360 IN/PCT/2002/1325/MUM 208355 24/07/20072-HYDROXY-MUTILIN CARBAMATE OFFORMULA (I)SMITH KLINE BEECHAM PLC361 377/MUM/2003 208356 24/07/2007 BIPHENYLCARBOXAMIDES BAYER CROPSCIENCE362 512/MUMNP/2005 208357 25/07/2007 COMPOSITIONS FOR TRANSDERMAL WATSON PHARMACEUTICAL INC363 229/MUM/2000 208359 25/07/2007 2,4 DIHYDROXY PHENYL COMPOUNDS PFIZER INC364 346/MUM/2002 208367 25/07/2007 SUBSTITUTED ARYL KETONES BAYER AKTIENGESELLSCHAFT365 469/MUMNP/2004 208371 26/07/2007IMMORTALIZED HUMAN KERATINOCYTECELL LINEWISCONSIN ALUMNI RESEARCH FOUNDATION366 IN/PCT/2002/1291/KOL 208392 26-07-2007 MUSCARINIC AGONIST COMPOUNDS ACADIA PHARMACEUTICALS, INC.,367 311/KOLNP/2004 208399 26/07/2007TOPICAL COMPOSITION, TOPICALCOMPOSITION PRECURSOR, AND METHODS SKIN VISIBLE PHARMACEUTICALS INCFOR MANUFACTURING AND USING368 194/MUM/2001 208422 26/07/2007 SUBSTITUTED BENZOYLCYCLOHEXEN ONES BAYER AKTIENGESELLSCHAFT369 9/MUMNP/2003 208435 27/07/2007PRODRUGS OF PHOSPHONATE NUCLEOTIDEANALOGUES AND METHODS FOR SELECTING GILEAD SCIENCES INCAND MAKING SAME370 668/BOM/1997 208437 27/07/2007HERBAL AYURVEDIC COMPOSITION FORTREATMENT OF PSORIASISMAHENDRA KUMAR JHUNJHUNWALA371 667/BOM/1997 208438 27/07/2007ORAL HERBAL AYURVEDIC COMPOSITIONFOR TREATMENT OF PSORIASISMAHENDRA KUMAR JHUNJHUNWALA372 1504/MUM/2005 208484 01-08-2007 HRBAL HAVAN…. BHARAT MANHARLAL PARIKH373 500/BOM/1996 208498 01-08-2007AN ANTITUBERCULAR COMPOSITIONCOMPRISING RIFAMPICIN,ISONIAZIDE,PYRAZINAMIDE ANDLUPIN LABORATORIES LTDETHAMBUTOL HYDROCHLORIDE374 60/MUMNP/2003 208505 01-08-2007PHARMACEUTICAL COMPOSITIONS OFCHOLESTERYL ESTER TRANSFER PROTEIN PFIZER PRODUCT INCINHIBITORS375 1078/MUMNP/2003 208510 01-08-2007PIPERAZINO-DERIVATIVES AND THEIR USE ASALTANA PHARMA AGPDE4 INHIBITOR376 IN/PCT/2001/1062/MUM 208514 01-08-2007IMPROVED AQUOUS SOLUBILITYPHARMACEUTICAL FORMULATIONR P SCHERER TECHNOLOGIES INC377 IN/PCT/2002/428/MUM 208517 01-08-2007ORAL SOLUTION CONTAININGMILLIKEN & COMPANYGALANTHAMINE AND A SWEETENING AGENT378 IN/PCT/2002/645/KOL 208522 02-08-2007"A COMPOUND FOR PREVENTING ORTAKEDA PHARMACEUTICAL COMPANYTREATING DIABETES MELLITUS"LIMITED379 IN/PCT/2000/450/MUM 208573 02-08-2007BIOCIDAL BENZYLBIPHENYL DERIVATIVESAND A PROCESS OF PREPARATION THEREOFJANSSEN PHARMACEUTICA N.V.

380 782/MUM/2004 208592 02-08-2007A SYNERGISTIC ORAL SOLID FORMULATIONCONTAINING ETORICOXIB ANDSANJEEV KHANDELWALPARACETAMOL AND METHOD FOR MAKINGA PHARMACEUTICAL FORMULATION OF381 1120/MUM/2004 208600 02-08-2007 CHROMIUM INSULIN INJECTION (SUSPENSION L M COLLEGE OF PHARMACYANS ITS PREPARATION)382 IN/PCT/2002/1932/CHE 208630 06-08-2007 ADENOSINE A2A RECEPTOR ANTAGONISTS SCHERING CORPORATION383 IN/PCT/2002/1940/CHE 208631 06-08-2007HETEROCYCLIC COMPOUNDS SUCH ASSUBSTITUTED OXAZOLE DERIVATIVESNIPPON SHINYAKU CO., LTD384 1927/MAS/1998 208639 06-08-20075-ALKYL--2-(ARYLAMINOPHENYLACETICACIDS AND DERIVATIVESM/S. NOVARTIS AG385 940/CHENP/2003 208652 06-08-2007SUGAR-SUBSTITUTED 2-AZETIDINONESSCHERING CORPORATIONUSEFUL AS HYPOCHOLESTEROLEMIC AGENTSNOVEL INTERMEDIATE USEFUL FOR THE386 1028/CHE/2003 208656 06-08-2007PREPARATION OF TOLTERODINE, A PROCESSFOR THE PREPARATION OF THE SAIDM/S. NATCO PHARMA LTDINTERMEDIATE387 477/MAS/2002 208688 07-08-2007NOVEL TETRACYCLIC ARYLCARBONYLINDOLES HAVING SEROTONIN RECEPTORAFFINITY USEFUL AS THERAPEUTIC AGENTSM/S. SUVEN LIFE SCIENCES LIMITEDAND PROCESS FOR THEIR PREPARATION388 IN/PCT/2001/820/CHE 208697 07-08-2007SUBTILASE ENZYMES HAVING ANADDITIONAL AMINO ACID RESIDUENOVOZYMES A/S389 IN/PCT/2001/821/CHE 208698 07-08-2007SUBTILASE ENZYMES HAVING ANADDITIONAL AMINO ACID RESIDUENOVOZYMES A/S390 839/CHENP/2003 208706 07-08-2007PHENYLETHENYL OR PHENYLETHINYLDERIVATIVES AS GLUTAMATE RECEPTOR M/S. F. HOFFMANN-LA ROCHE AGANTAGONISTS391 478/MAS/2002 208714 07-08-2007NOVEL TETRACYCLIC ARYLSULFONYLINDOLES HAVING SEROTONIN RECEPTORAFFINITY USEFUL AS THERAPEUTIC AGENTSM/S. SUVEN LIFE SCIENCES LIMITEDAND PROCESS FOR THEIR PREPARATION392 IN/PCT/2001/484/CHE 208718 07-08-2007A PHARMACEUTICAL COMPOSITION IN SOLIDF HOFFMANN LA ROCHE AGUNIT DOSAGE FORM393 IN/PCT/2002/1841/CHE 208719 07-08-2007NOVEL PHENYL-PROPARGYLETHERDERIVATIVESSYNGENTA PARTICIPATIONS AG394 870/DEL/1997 208720 07-08-2007`"APHENYLETHANOLAMINOTETRALINCARBOXA KISSEI PHARMACEUTICAL CO., LTD.MIDE DERIVATIVE"395 IN/PCT/2002/94/MUM 208726 08-08-2007A COMPOUND OF GENERAL FORMULA I ORSALTS THEREOF.AVENTIS CROP SCIENCE GMBH396 228/DEL/2003 208732 08-08-2007WONDER HEALING AND VAT ROG HERBALDRUGDR. SHYAMJI TRIPATHI397 228/DEL/2003 208732 08-08-2007WONDER HEALING AND VAT ROG HERBALDRUGDr. Shyamji Tripathi

398 700/CAL/1999 208752 09-08-2007N-SUBSTITUATED INDOLE-3-GLYOXYLAMIDEASTA MEDICA AKATIENGESELLSCHAFTAND MEDICAMENTS USING THE SAMENOVEL COMPOUNDS FOR THE MANAGEMENT399 843/CAL/1999 208773 09-08-2007OF AGING RELATEDE AND DIABETICVASCULAR COMPLICATIONS,ANDTORRENT PHARAMACEUTICALS LTDTHERAPEUTIC USES THEREOF400 239/MUM/2004 208779 09-08-2007A PHARMACEUTICAL SYNERGISTICFORMULATION FOR TOPICAL APPLICATIONCONTAINING DICLOFENACSANJEEV KHANDELWALDIETHYLAMMONIUMAN ANTICHOLINERGIC (ANTIMUSCARINIC401 689/MUM/2004 208780 09-08-2007 COMPOSITION AND METHOD OF MAKING THE SANJEEV KHANDELWALSAME402 779/MUMNP/2005 208786 09-08-2007A COMPOSITION COMPRISING EPIDEMIUMEXTRACT FOR TREATMENT OF PROSTATIC BRIGHT FUTURE PHARMACEUTICALHYPERPLASIA AND METHOD OF EPIMEDIUM LABORATORIES LIMITEDHERB EXTRACTIONA TRANSMUCOSAL DRUG DELIVERY SYSTEM403 1027/MUM/2003 208788 09-08-2007 AND ITS PREPARATION FOR BENZIMIDAZOLE ASTRON RESEARCH PVT LTDCLASS OF PROTON PUMP INHIBITOR404 180/CAL/2002 208798 09-08-2007 RUTAPHOS PRASANTA BANERJI405 1111/CAL/1995 208799 09-08-2007 NOVEL PHARMACEUTICAL PRODUCT ELI LILLY AND COMPANY406 628/CAL/1998 208805 09-08-2007 LIQUID ANTACID COMPOSITIONS MCNEIL PPC-INC.407 203/MUM/2004 208818 10-08-2007 COMPOSITION FOR DELIVERY OF DITHRANOL USV LIMITED408 IN/PCT/2002/205/MUM 208841 13/08/2007NOVEL SPIROHETEROCYCLIC USEFUL AS BOEHRINGER INGELHEIM PHARMACEUTICALREVERSIBLE INHIBITORS CYSTEINEINC409 668/MUMNP/2003 208850 13/08/2007PHTHALAZINON PIPERIDINO DERIVATIVES ASALTANA PHARMA AGPDE4 INHIBITORS.410 422/MUMNP/2003 208865 14/08/2007PACLITAXEL LIPOSOME COMPOSITION FORNANJING ZHENZHONG BIOENGINEERINGTREATMENT OF CANCERAND PREPARATIONCOMPANY LTDTHEREOF411 313/MUMNP/2003 208866 14/08/2007A BILAYER TABLET CONSISTING OFPHARMACEUTICAL COMPOSITIONCONTAINING EPINASTINE ORPSEUDOEPHEDRINE412 IN/PCT/2001/1201/MUM 208867 14/08/2007 AN ADAMANTANE COMPOUND, ASTRAZENECA AB413 IN/PCT/2001/1137/MUM 208872 14/08/2007MACROCYCLIC PEPTIDASE ACTIVE AGAINSTHEPATITIS C VIRUSA PHARMACEUTICAL COMPOSITION414 IN/PCT/2002/1834/MUM 208874 14/08/2007CONTAINING DIPEPTIDYL PEPTIDASE IVINHIBITOR ISOLEUCINE THIAZOLIDIDE AND APROCESS FOR PREPARATION THEREOFBOEHRINGER INGELHEIM PHARMACEUTICALINCBOEHRINGER INGELHEIM PHARMACEUTICALINCSMITH KLINE BEECHAM PLCA PHARMACEUTICAL COMPOSITION FOR415 113/MUMNP/2004 208890 16/08/2007ALTANA PHARMA AGTREATMENT RESPIRATORY TRACT DISORDER416 1151/MUMNP/2003 208893 16/08/2007 TRICYCLIC IMIDAZOPYRIDINES ALTANA PHARMA AG

417 IN/PCT/2002/1605/CHE 208917 16-08-2007PERCYQUINNIN COMPM/S. SANOFI- AVENTIS DEUTSCHLAND GMBH418 IN/PCT/2002/1619/CHE 208918 16-08-2007INTRACORPOREAL MEDICAMENTS FOR HIGHENERGY PHOTOTHERAPEUTIC TREATMENT PHOTOGEN INC.OF DISEASE419 548/KOLNP/2005 208951 16-08-2007 A PHARMACEUTICAL COMPOSITION. THE UNIVERSITY OF BRITISH COLUMBIA.420 575/KOLNP/2004 208952 16-08-2007"W-CYCLOALKYL 17-HETEROARYLPROSTAGLANDIN E2 ANALOGS ANDALLERGAN, INC.OPHTHALMIC SOLUTION COMPRISING THEM".421 1772/CAL/1998 208958 16-08-2007"A5-AZAQUINOXALINE-BASED KINASECOMPOUND, ITS SYNTHESIS,PHARMACEUTICAL COMPOSITIONZENTARIS GMBHCOMPRISING IT AND IN VITRO METHOD OFUSING THE COMPOUND"422 1770/CAL/1997 208961 16-08-2007CONTROLLED RELEASE PHARMACEUTICALCOMPOSITIONS FOR THE ORALADMINISTRATION CONTAINING NIFEDIPINEVALPHARMA S.A.AS ACTIVE SUBSTANCE423 IN/PCT/2002/1975/CHE 208999 16-08-2007A PHARMACEUTICAL FORMULATIONCOMPRISING AN ALPHA-HALOGENOACRYLOYL DISTAMYCINNERVIANO MEDICAL SCIENCES SRLDERIVATIVE424 IN/PCT/2002/2111/CHE 209010 16-08-2007N-OXIDES AS NK1 RECEPTOR ANTAGONISTPRODRUGS OF 4-PHENYL-PYRIDINEF. HOFFMANN-LA ROCHE AGDERIVATIVES425 1029/MAS/2001 209016 16-08-2007ALKYL CARBOXYLIC ACID COMPOUND ANDPROCESS FOR THEIR PREPARATIONDR.REDDY'S RESEARCH FOUNDATION426 1124/MAS/2000 209017 16-08-2007NOVEL OXAZOLIDINONE COMPOUNDSHAVING ANTIBACTERIAL PROPERTY,PROCESS FOR THEIR PREPARATION ANDDr. REDDY'S LABORATORIES LTDPHARMACEUTICAL COMPOSITIONS427 2121/MAS/1998 209018 16-08-2007A BONE FRACTURE HEALING EXTRACT FROMTHE HERB ASYSTASIA GANGETICA AND A M/S. NATCO PHARMA LTDPROCESS FOR ITS PREPARATION428 2224/MAS/1997 209019 16-08-2007PHARMACEUTICAL MICROSPHERESCONTAINING VALPROIC ACID FOR ORAL SANOFI SYNTHELABOADMINISTRATION429 2420/MAS/1997 209020 16-08-2007 NOVEL PYRIMIDINE COMPOUNDS Dr.REDDY'S LABORATORIES LTD430 2645/MAS/1998 209021 16-08-2007 THROMBIN RECEPTOR ANTAGONISTS M/S. SCHERING CORPORATION431 266/MAS/2002 209022 16-08-2007NOVEL AMINO SUBSTITUTED PYRIMIDINONE M/S. ORCHID RESEARCH LABORATORIESDERIVATIVESLTD432 226/MUMNP/2005 209026 17/08/2007NOVEL COMPOUNDS WITH ANTIBACTERIAL MORPHOCHEM AKTIENGESELLSCH AFT FURACTIVITYKOMBINATODRISCHE CHEMIE433 1195/MUM/2001 209029 17/08/2007HETARYL SUBSTITUTED HOMOTETRAMICAND HOMOTETRONIC ACIDBAYER AKTIENGESELLSCHAFT

THE COMPOUND 4-(2-BUTYLAMINO )2,7-DIMETHYL -8-(2-METHYL-6-METHOXYPYRID-3-434 852/MUMNP/2003 209030 17/08/2007BRISTOL- MAYERS SQUIBB CO,YL)91,5 A)-PYRAZOLO -1,3,5TRIAZINE OFFORMULA (I)PHARMACEUTICAL PREPARATION IN435 513/MUMNP/2003 209043 17-08-2007 THE FORM OF A PASTE COMPRISING AN NYCOMED GMBHACID-LABILE ACTIVE INGREDIENT436 513/MUMNP/2003 209044 17/08/2007 PHARMACEUTICAL…. ALTANA PHARMA AG437 921/MUMNP/2003 209050 17/08/2007 PHARMACEUTICALLY ACTIVE URIDINE TROMMSDORFF GMBH AND CONOVEL ALKOXY PROPIONIC ACIDS AND438 569/MAS/2001 209072 20-08-2007DR. REDDY'S LABORATORIES LTDTHEIR DERIVATIVESOXIME COMPOUNDM/S. SUMITOMO CHEMICAL COMPANY439 715/MAS/1998 209075 20-08-2007LIMITEDORALLY DISINTEGRATING PHARMACEUTICAL440 759/MAS/2002 209077 20-08-2007 COMPOSITION CONTAINING SILDENAFIL NATCO PHARMA LTDCITRATEPHARMACEUTICAL SALTS OF 20 (S)441 798/MAS/2001 209079 20-08-2007DR. REDDY' S LABORATORIES LTDCAMPOTHESINS442 IN/PCT/2000/386/CHE 209085 20-08-2007 SUBSTITUTED PYRROLS F. HOFFMANN-LA ROCHE AGAMINOMETHYLCARBOXYLIC ACID443 IN/PCT/2001/109/CHE 209087 20-08-2007N.V. ORGANONDERIVATIVESSUBSTITUTED BENZIMIDAZOLES AND THEIR444 IN/PCT/2001/730/CHE 209089 20-08-2007BASF AKTIENGESELLSCHAFTPREPARATIONQUINOLINE AND QUINOXALINE COMPOUNDS445 IN/PCT/2001/878/CHE 209091 20-08-2007 OF FORMULA I AND A STENT DEVICE AVENTIS PHARMACEUTICALS, INCCOMPRISING THE SAMEA CHIMERIC CR3 GENE CONTAININGCENTRO DE INGENIERIA GENETICA Y446 1074/DELNP/2003 209104 20-08-2007FRAGMENTS FROM DIFFERNT HIV-1 GENES BIOTECHNOLOGIA447 IN/PCT/2002/132/MUM 209120 21/08/2007 STREPTOMYCES…. PFIZER PRODUCT INC448 IN/PCT/2001/442/MUM 209122 21/08/2007A 4-( AMINO METHYL) PIPERIDINEBENZAMIDE OF FORMULA (I) AND PROCESSFOR PREPARING THE SAMEAN AQUEOUS SINGLE FORMULATIONCOMPOSITION AND PROCESS THEREOFJASSEN PHARMACEUTICAL NV ANDALKERMES CONTROLLED PHERAPEUTIC INC449 IN/PCT/2002/957/MUM 209124 21/08/2007NEW PHARMA RESEARCH SWEEDEN AB450 IN/PCT/2002/1016/MUM 209125 21/08/2007 ALKYLATED.IIMIDAZOPYRIDINE ALTANA PHARMA AGPHARMACEUTICAL PREPARATION451 514/MUMNP/2003 209128 21/08/2007 COMPRISING PDE INHIBITOR AS AN ACTIVE ALTANA PHARMA AGAGENT DISPERSED ON A MATRIX452 750/MUMNP/2004 209130 21/08/2007453 IN/PCT/2002/1363/MUM 209138 21/08/2007NOVEL AZASUGAR DERIVATIVE AND DRUGCONTAINING THE SAME AS THE ACTIVEINGREDIENTOXAZOLIDINO DERIVATIVES WITHANTIBIOTIC ACTIVITY.CARNA BIOSCIENCES INCASTRAZENECA AB

454 195/MUMNP/2005 209147 21/08/2007455 IN/PCT/2002/1718/MUM 209150 22/08/2007456 560/MUMNP/2003 209158 22/08/2007457 999/MUMNP/2003 209165 22/08/2007458 514/MUM/2003 209166 22/08/2007459 IN/PCT/2001/558/MUM 209167 22/08/2007460 IN/PCT/2002/1274/MUM 209181 22/08/2007461 IN/PCT/2002/714/CHE 209183 22-08-2007462 100/CHENP/2003 209184 22-08-2007463 109/CHENP/2003 209185 22-08-2007464 220/CHENP/2003 209194 22-08-2007465 226/CHENP/2003 209195 22-08-2007466 246/CHENP/2003 209200 22-08-2007467 492/CHENP/2003 209213 22-08-2007468 631/CHENP/2003 209222 22-08-2007469 80/CAL/1995 209226 23-08-2007470 195/CAL/1995 209227 23-08-2007TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE AND ITS SEPRACOR INCFORMAMIDECOMPOUND AND COMPOSITIO OF THE SAIDASTRAZENECA ABCOMPOUND.COMPOUND BENZOTHIAZEPINE OF FORMULA(I)AND PROCESS FOR PREPARATIONASTRAZENECA ABTHEREOF….CRYSTALLINE AZITHROMYCINPFIZER PRODUCT INCSESQUITHYDRATELIQUID PHARMACEUTICAL FORMULATIONCOMPRISING PRADOFLOXACIN BOUND TO AN BAYER AKTIENGESELLSCHAFTION EXCHANGERA CONTROLLED RELEASE FORMULATIONCONTAINING GALANTAMINE AS THE ACTIVE JANSSEN PHARMACEUTICA N.V.INGREDIENTPHARMACEUTICAL COMPOSITION FOR THE BOEHRINGER INGELHEIM PHARMACEUTICALTREATMENT OF MYOCARDIAL DISEASE INCSPIRO(2H-1-BENZOPYRAN-2,4'-PIPERIDINE)DERIVATES AS GLYCINE TRANSPORT N.V. ORGANONINHIBITORS4-PHENYL-PYRIDINE DERIVATIVES ASF. HOFFMANN LA ROCHE AGNEUROKININ-1 RECEPTOR ANTAGONISTSA PHARMACEUTICAL COMPOSITIONCOMPRISING 5-HT2c RECEPTOR AGONIST AND BIOVITRUM AB5-HT6 RECEPTOR ANTOGONISTA VACCINATION AGAINST HOST CELL- M/S. LOHMANN ANIMAL HEALTH GMBH & COASSOCIATED HERPESVIRUSESKGINDOLE DERIVATIVES FOR THE TREATMENTM/S. H. LUNDBECK A/SOF CNS DISORDERSNEW MACROLIDES ANTIBIOTICS OF FORMULAM/S. BASILEA PHARMACEUTICA AGI WITH ANTIBACTERIAL ACTIVITYPYRAZOLE DERIVATIVES FOR THEM/S. F. HOFFMANN-LA ROCHE AGTREATMENT OF VIRAL DISEASESA PHARMACEUTICAL COMPOSITION FORM/S. SOLVAY PHARMACEUTICALS B.VPROLONGED RELEASE OF ACTIVE"STABILISED PHARMACEUTICALCOMPOSITION COMPRISING BUPROPIONTHE WELLCOME FOUNDATION LIMITEDHYDROCHLORIDE AND METHOD FORSTABILISING BUPROPION HYDROCHLORIDE"IONTOPHORETIC DELIVERY OF ANJANSSEN PHARMACEUTICA N.V.ANTIMIGRAINE DRUG

471 218/CAL/2001 209228 23-08-2007"A POLYNUCLEOTIDE THAT IS SUITABLE FORACCELERATING A BIOSYNTHESIS OF ML236BAND THE METHOD FOR PRODUCING ML236BSANKYO COMPANY, LIMITEDBY USING THE POLYNUCLEOTIDE"472 652/CAL/1998 209241 23-08-2007 FLUOXETINE ENTERIC PELLETS ELI LILLY AND COMPANYPHARMACEUTICAL COMBINATIONSCOMPRISING NONSEDATING473 1641/CAL/1998 209250 23-08-2007ANTIHISTAMINES AND A-ADRENERGIG DRUGASTA MEDICAL AKTIENGESELISCHAFTFOR THE TOPICAL TREATMENT OFRHINITIS/CONJNUCTIVITIS AND COLD, COLD-LIKE AND/OR FLU SYMPTOMS474 IN/PCT/2002/00785/DEL 209251 23-08-2007PYRROLE SUBSTITUTED 2-INDOLINONEPROTEIN KINASE INHIBITORSSUGEN INC., USA475 2000/CAL/1996 209253 23-08-2007 PROTEIN KINASE C INHIBITOR ELI LILLY AND COMPANY476 2225/CAL/1996 209255 23-08-2007"4-(BENZIMIDAZOLY-ANDIMIDAZOPYRIDINYL) PIPERIDINEDERIVATIVES AS SUBSTANCE PANTAGONISTJANSSEN PHARMACEUTICA N.V.477 327/MUM/2003 209289 23/08/2007 MICRO EMULSION IMMUNOSUPPRESENTS CIPLA LIMITED478 IN/PCT/2001/1152/MUM 209290 23/08/2007CILOSTAZOL PREPARATION479 IN/PCT/2002/1256/MUM 209291 23/08/2007480 127/MUMNP/2004 209309 24/08/2007481 IN/PCT/2002/344/MUM 209328 24/08/2007482 67/MUM/2003 209337 24/08/2007COMPOSITIONS CONTAININGPOLYCARBONATEA MONOLITHIC SUSTAINED RELEASECOMPOSITION OF METFORMINHYDROCHLORIDEQUINAZOLINE DERIVATIVES AS VEGFINHIBITORSDIFLUOROETHYLTHIAZOLYLCARBOXANILIDES OF THE FORMULA ( I ) AND THECOMPOSITION COMPRISING THEMOTSUKA PHARMACEUTIC AL COMPANYLIMITEDBAYER AKTIENGESELLSCHAFTUSV LIMITEDASTRAZENECA ABBAYER CROPSCIENCES GMBHA NEUROTROPHIC COMPOSITION COMPRISING483 1167/CHENP/2003 209347 27-08-2007M/S. ASTELLAS PHARMA INCA COMPOUND OF FORMULA IIMIDAZO PYRIMIDINE DERIVATIVES AS484 1473/CHENP/2003 209367 27-08-2007MERCK SHARP & DOHME LIMITEDLIGANDS FOR GABA RECEPTORSPYRIDO(2,1-A)ISOQUINOLINE DERIVATIVES AS485 1416/CHENP/2004 209390 28-08-2007F. HOFFMANN-LA ROCHE AGDPP-IV INHIBITORSA COMPOUND OR A TARGETABLE486 2815/CHENP/2004 209394 28-08-2007IMMUNOMEDICS, INCCONSTRUCT FOR THERAPEUTIC USE" ANA ORALLY ADMINISTRABLE TABLET" PENWEST PHARMACEUTICALS487 327/KOLNP/2003 209411 30-08-2007COMPANY488 752/KOLNP/2004 209420 30-08-2007 "A SULPHONAMIDE DERIVATIVE" LABORATORIOS DEL DR. ESTEVE, S.A.489 2167/CAL/1998 209431 30-08-2007 "IBUPROFEN COMPOSITION" MCNEIL-PPC,INC490 IN/PCT/2002/561/KOL 209442 30-08-2007SMALL PEPTIDES FOR TREATMENT OFERECTILE DYSFUNCTIONZENTARIS AG

491 574/DEL/2001 209451 30-08-2007HERBAL COMPOSITION FOR TREATMENT OFBONE METABELIC DISORDERSDABUR RESEARCH FOUNDATION492 2580/DEL/1998 209456 30-08-2007A PHARMACEUTICAL COMPOSITION AND KITCOMPRISING THE SAMEPFIZER INC.493 142/DEL/2004 209457 30-08-2007A HERBAL COMPOSITION USEFUL FOR THETREATMENT OF PILES.YOGENDRA SINGH494 IN/PCT/2002/1826/CHE 209514 04-09-2007A PHARMACEUTICAL COMPOSITION FORINTRAVENOUS ADMINISTRATIONNOVO NORDISK HEALTH CARE AG495 1336/MAS/1997 209528 04-09-2007AN AQUEOUS INSULIN PREPARATION HAVINGM/S. NOVO NORDISK A/SSUPERIOR PHYSICAL STABILITY496 1337/MAS/1997 209529 04-09-2007A CHEMICALLY STABLE AQUEOUS INSULINPREPARATIONM/S. NOVO NORDISK A/S497 2172/MAS/1998 209531 04-09-2007A VACCINE COMPOSITION COMPRISINGNOVEL HIV PROTEIN CONSTRUCTSMITHKLINE BEECHAM BIOLOGICALS SA498 2297/MAS/1997 209532 04-09-2007PHARMACEUTICAL COMPOSITIONCOMPRISING ENTRIC COATEDNAPO PHARMACEUTICALS, INCPROANTHOCYANIDIN POLYMER499 2437/MAS/1998 209533 04-09-2007 D-PROLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG500 2502/MAS/1997 209534 04-09-2007 N-SUBSTITUTED 2 -CYANOPYRROLIDINES NOVARTIS AG501 514/MAS/2000 209537 04-09-2007AN INGESTIBLE COMPOSITION AND METHODFOR PROLONGING THE USEFUL LIFE OF M/S. NOVARTIS AGENTERAL FEEDING TUBES502 622/MAS/1997 209538 05-09-2007ENTERIC COATED PHARMACEUTICALCOMPOSITION OF MYCOPHENOLATENOVARTIS AG503 IN/PCT/2001/1358/CHE 209544 05-09-2007 PHARMACEUTICAL COMPOUNDS NICOX S.A504 108/CHENP/2003 209556 05-09-2007 INTERFERON-LIKE PROTEIN ZCYTO21 ZYMOGENETICS INC505 110/CHENP/2003 209557 05-09-2007VACCINES FOR BROAD SPECTRUMM/S. CHILDREN'S HOSPITAL & RESEARCHPROTECTION AGAINST DISEASES CAUSED BYCENTER AT OAKLANDNEISSERIA MENINGITIDIS506 113/CHENP/2003 209559 05-09-2007SUBSTITUTEDSULFONYLAMINOMETHYLBENZOIC ACID AND BAYER CROPSCIENCE GMBHTHEIR PREPARATION507 138/CHENP/2003 209561 05-09-2007 9-SUBSTITUTED MINOCYCLINE COMPOUNDS M/S. TRUSTEES OF TUFTS COLLEGE508 147/CHENP/2003 209603 05-09-2007 PHENYLPIPERAZINE DERIVATIVES M/S. SOLVAY PHARMACEUTICALS B.V509 171/CHENP/2003 209604 05-09-2007 4-PHENYL-PYRIDINE DERIVATIVES M/S. F. HOFFMANN-LA ROCHE AG510 223/CHENP/2003 209614 05-09-2007NOVEL COMPOUNDS OF GENERAL FORMULA IAND THEIR USE AS GLYCINE TRANSPORT M/S. H. LUNDBECK A/SINHIBITORS511 33/CHENP/2003 209620 05-09-2007 PHENETHYLACRYLAMIDES M/S. BASF AKTIENGESELLSCHAFT512 76/CHENP/2003 209628 05-09-2007A PHARMACEUTICAL COMPRISINGSUBSTITUTED ACRYLOYL DISTAMYCIN M/S. NERVIANO MEDICAL SCIENCES S R LDERIVATIVES AND ALKYLATING AGENTS513 480/CHENP/2003 209636 05-09-2007BENZOYL BENZOFURANE DERIVATIVES FORTREATMENT OF CARDIAC ARRHYTHMIAM/S. ARYX THERAPEUTICS514 679/CHENP/2003 209645 05-09-2007 CYANOPYRROLIDINE DERIVATIVES M/S. TAISHO PHARMACEUTICAL CO., LTD

515 759/CHENP/2003 209648 05-09-2007PIPERAZINYLPYRAZINES COMPOUNDS ASANTAGONISTS OF SEROTONIN 5-HT2M/S.. BIOVITRUM ABRECEPTOR516 847/CHENP/2003 209653 05-09-2007LACTAM COMPOUNDS ANDPHARMACEUTICAL USE THEREOFAJINOMOTO CO.,INC517 879/CHENP/2003 209654 05-09-2007ORTHO-SUBSTITUTED NITROGEN-CONTAINING BISARYL COMPOUNDSM/S. SANOFI-AVENTIS DEUTSCHLAND GMBH518 1280/CHENP/2003 209668 05-09-2007RECOMBINANT MICROORGANISMS ANDPROCESSES FOR ENHANCED PRODUCTION OF M/S. BASF AKTIENGESELLSCHAFTPANTOTHENATE519 1289/CHENP/2003 209669 05-09-20072-THIO-SUBSTITUTED IMIDAZOLEDERIVATIVESM/S. MERCKLE GMBH520 181/MUMNP/2005 209696 06-09-2007 HELICASE DEPENDENT…. NEW ENGLAND BIO LABS INC521 7/MUMNP/2003 209697 06-09-2007A PHARMACEUTICAL COMPOSITIONCOMPRISING GABAPENTINTEVA PHARMACEUTICAL INDUSTRIES LTD522 805/MUMNP/2003 209701 06-09-2007 METALLOPROTEINASE INHIBITORS ASTRAZENECA AB523 408/MUMNP/2004 209724 06-09-2007TETRAHYDROQUINOLINE ANALOGUES ASMUSCARINIC AGONISTSACADIA PHARMACEUTICALS INC524 419/CAL/1996 209754 06-09-2007"BICYCLIC COMPOUNDS, PREPARATION A. MENARINI INDUSTRIE FARMACEUTICHETHEREOF "RIUNITE S.R.L.525 00917/KOLNP/2003 209757 06-09-2007A PHARMACEUTICAL COMPOSITIONLYCORED NATURAL PRODUCTS INDUSTRIESLTD.526 589/CAL/1996 209765 06-09-20071,3-DIHYDRO-1-(PHENYLALKENYL)-2H-IMIDAZOL-2-ONE DERIVATIVES.JANSSEN PHARMACEUTICA N.V527 IN/PCT/2001/631/KOL 209771 06-09-2007 A TRIPHASIC ORAL CONTRACEPTIVE UNIT ORTHO-MCNEIL PHARMACEUTICAL, INC.528 IN/PCT/2002/241/KOL 209775 06-09-2007"PHARMACEUTICAL COMPOSITION FOR ORALIVAX PHARMACEUTICALS S.R.O.AND TOPICAL ADMINISTRATION.""VACCINE FOR THE PROPHYLACTIC OR529 IN/PCT/2002/930/KOL 209777 06-09-2007 THERAPEUTIC IMMUNIZATION AGAINST HIV SMITHKLINE BEECHAM BIOLOGICALS S.A.AND PROCESS FOR ITS PREPARATION"530 1471/CHENP/2003 209780 06-09-2007VACCINE COMPOSITION COMPRISING HPVANTIGENS, ADJUVANT AND 3DMPLM/S. SMITHKLINE BEECHAM BIOLOGICALS S.A531 1981/CHENP/2003 209789 06-09-2007AROMATIC DICARBOXYLIC ACIDDERIVATIVESM/S. F. HOFFMAN-LA ROCHE AG532 IN/PCT/2001/557/MUM 209803 06-09-2007 1,2-ANNELATED QUINOLINE COMPOUND JANSSEN PHARMACEUTICA N.V.533 3125/CHENP/2004 209814 06-09-2007POLYETHYLENE GLYCOL ALDEHYDEDERIVATIVESF.HOFFMANN-LA ROCHE AG534 3127/CHENP/2004 209815 06-09-2007 PEGYLATED T1249 POLYPEPTIDE COMPOUNDS F. HOFFMANN-LA ROCHE AGA THERAPEUTICALLY ACTIVE COMPOSITION535 738/MUM/2001 209839 06-09-2007 FOR THE TREATMENT OF SKIN DISORDERS DILIP SUKHLAL MEHTAAND A PROCESS FOR MAKING THE SAME536 66/MUM/2003 209842 06-09-2007THIAZOLYLCARBOXANILIDES OF THEFORMULA IBAYER CROPSCIENCES GMBH537 195/DEL/2004 209853 07-09-2007A NOVEL DENTAL AND GUM CARE HERBALCOMPOSITIONYOGENDRA SINGH

538 194/DEL/2004 209857 07-09-2007AN ANTIPOISON, ANTIVIRAL & ANTI HIVHERBAL COMPOSITION AND PROCESS FOR YOGENDRA SINGHPREPARATION THEREOF539 196/DEL/2004 209859 07-09-2007A HERBAL COMPOSITION USEFUL FOR THETREATMENT OF WHOOPING COUGH,YOGENDRA SINGHREDUCING CHOLESTROL & BODY FAT540 380/DEL/1997 209863 07-09-20073,4- DISUBSTITUTEDPHENYLETHANOLAMINOTETRALIN-KISSEI PHARMACEUTICAL CO., LTD.CARBOXAMIDE DERIVATIVES541 1294/DELNP/2004 209865 07-09-2007A FILM-COATED PHARMACEUTICALCOMPOSITION COMPRISING SUMATRIPTANGLAXO GROUP LIMITED.,542 IN/PCT/2002/1195/MUM 209871 10-09-2007HYDROCHLORIDE SALTS OF 5-[4-[2-(N-METHYL-N-(2-SMITH KLINE BEECHAM PLCPYRIDYL)AMINO)ETHOXY]BENZYL]543 1045/MUM/2003 209877 10-09-2007 pharmaceautical composition TORRENT PHARMACEUTICAL LTD,544 226/MUMNP/2003 209888 10-09-2007 MESTRIONE FORMULATION SYNGENTA PARTICIPATION AG545 IN/PCT/2001/577/MUM 209907 10-09-2007A TRIAZOLO [4,5-D] PYRIMIDINE COMPOUNDOF FORMULA ( I )ASTRAZENECA AB546 IN/PCT/2002/1065/MUM 209908 10-09-2007 NOVEL ARYLPYRAZINES NEUROGEN CORPORATION547 889/MUM/2003 209947 10-09-2007A NOVEL PHARMACEUTICAL COMPOSITIONOF A PROTON PUMP INHIBITOR WITH A ARISTO PHARMACEUTICAL LTDPROLINETIC AGENT548 1249/MUM/2003 209964 10-09-2007HMG C0A REDUCTASE INHIBITINGCOMPOSITIONCADILA HEALTHCARE LIMITED549 IN/PCT/2000/665/MUM 209967 10-09-2007 A NOVEL 3- ARYL PROPIONIC ACID ASTRAZENECA AB550 IN/PCT/2001/1466/MUM 209973 10-09-2007BENZENE DERIVATIVES AND PROCESS FORPREPARATION THEREOFSANOFI SYNTHELABORATORY551 254/MUMNP/2005 209975 10-09-2007 STABILIZATION OF…. ION BEAMS APPLICATIONS SA552 1024/KOLNP/2003 209996 13-09-2007AN ISOLATED NUCLEIC ACID MOLECULETEMASEK LIFE SCIENCES LABORATORYCONTAINING AN ANTHER-SPECIFICLIMITEDPROMOTER.BENZIMIDAZOLE DERIVATIVES AND A553 1187/CAL/1996 209998 13-09-2007 PROCESS FOR PREPARING BENZIMIDAZOLE OTSUKA PHARMACEUTICAL CO. LTD.DERIVATIVE554 1241/KOLNP/2004 209999 13-09-2007 "KINASE INHIBITORS" ALLERGAN, INC.555 IN/PCT/2000/633/KOL 210010 13-09-2007556 IN/PCT/2001/01233/KOL 210029 13-09-2007"NOVELPOLYOXYPROPYLENEPOLYOXYETHYLENEVITAMIN E AND PREPARATION THEREOF"COMBINATION OF LACTIC ACIDBACTERIA AND USE FOR THEPREVENTION AND/OR TREATMENT OFINFECTIONS AND INFLAMMATORYCONDITIONS.KIM YOUNG DAE,PARK KEUN JA,KIM JUNGSOO AND KIM JI SOO ALLACTIAL FARMACEUTICA LDA.,

DIHYDROBENZODIAZEPIN-2-ONE557 1700/CHENP/2004 210045 17-09-2007 DERIVATIVES FOR THE TREATMENT OF F. HOFFMANN-LA ROCHE AGNEUROLOGICAL DISORDERSTREATMENT AND MANAGEMENT OF OBESITYAND OBESITY RELATED558 384/CHE/2004 210052 17-09-2007RAMASWAMY RAJENDRANDISORDERS/SYMPTOMS USING CARALLUMAEXTRACTS559 757/KOLNP/2003 210099 18-09-2007 THIAZOLE DERIVATIVES GLAXO GROUP LIMITEDTRANSDERMAL BOTULINUM TOXIN560 1927/KOLNP/2004 210106 18-09-2007 ALLERGAN INC.COMPOSITIONS"SODIUM SALT OF 3-(4-CINNAMYL-1-561 IN/PCT/2001/523/KOL 210110 18-09-2007 PIPERAZINYL)IMINO-METHYL RIFAMYCIN SV KONSTANTINOVA ROUMIANA GUEORGUIEVAAND PROCESS OF PREPARATION THEREOF".INDOLIN OSPIROPYRAN COMPOUNDS AND ESSILOR INTERNATIONAL (COMPAGNIE562 IN/PCT/2002/1452/KOL 210119 18-09-2007METHODS FOR THEIR MANUFACTURE. GENERALE D'OPTIQUE)NOVEL (S)-2-AMINO-3-(4-AMINOPHENYL)563 28/CHE/2003 210215 25-09-2007NATCO PHARMA LTDPROPANOL, PROCESS FOR ITS PREPARATION564 28/MAS/2003 210215 25-09-2007 A QUINAZOLINONE COMPOUND NATCO PHARMA LTDA DOSAGE FORM FOR CONTROLLED565 00300/KOLNP/2005 210282 26-09-2007ALZA CORPORATIONDELIVERY OF PALIPERIDONE"ADJUVANT COMPOSITION COMPRISING AN566 428/KOLNP/2003 210283 26-09-2007 IMMUNOSTIMULATORY OLIGONUCLEOTIDE GLAXOSMITHKLINE BIOLOGICAL S.A.,AND A TOCOL'PYRIMIDINEAMINES AS ANGIOGENESIS567 818/KOLNP/2003 210284 26-09-2007GLAXO GROUP LIMITEDMODULATORSPIPERAZINYLCARBONYLQUINOLINES AND568 1021/KOLNP/2003 210285 26-09-2007MERCK PATENT GMBH,ISOQUINOLINES"3-HETEROARYL-3,5-DIHYDRO-4-OXO-4H-569 1448/KOLNP/2004 210286 26-09-2007 PYRIDAZINO[4,5-B]INDOLE-1-ACETAMIDE SANOFI-AVENTISDERIVATIVES,AMINOGUANIDINES AND3-DIMENSIONAL PHARMACEUTICALS, INC., ACORPORATION ORGANISED AND EXISTING570 2234/CAL/1997 210290 26-09-2007 ALKOXYGUANIDINES AS PROTEASEUNDER THE LAWS OF THE STATE OFINHIBITORSDELAWARECOMPOSITION COMPRISING A TRAMADOL571 IN/PCT/2002/193/KOL 210300 26-09-2007ORTHO MCNEIL PHARMACEUTICAL,INC.MATERIAL AND AN ANTICONVULSANT DRUG"COMPOSITION COMPRISING A TRAMADOL572 IN/PCT/2002/193/KOL 210300 26/09/2007ORTHO MCNEIL PHARMACEUTICAL INCMATERIAL AND AN ANTICONVULSANT DRUG"PHARMACEUTICAL COMPOSITION OF A PDE4573 404/MUMNP/2004 210307 24/09/2007 OR A PDE3/4 INHIBITOR AND A HISTAMINE ALTANA PHARMA AGRECEPTOR ANTAGONISTAQUEOUS CYCLODEXTRINE-FREE SOLUTION BOEHRINGER INGELHEIM PHARMACEUTICAL574 IN/PCT/2002/1776/MUM 210315 24/09/2007OF MELOXICAMINC575 1135/DEL/1999 210324 27-09-2007 A COMPOUND OF FORMULA III SYNGENTA LIMITED576 3859/DEL/1998 210325 27-09-2007 ARYL FUSED AZAPOLYCYCLIC COMPOUNDS PFIZER PRODUCTS INC.

577 3207/DEL/2005 210329 28-09-2007AN AYURVEDIC COMPOSITION FOR JOININGFRACTURED BONE & AS ANTI-INFLAMMATORY AND PROCESS FORANIT KUMAR YADAVPREPARATION THEREOF578 IN/PCT/2002/00609/MUM 210338 01-10-2007PHARMACEUTICAL FORMULATIONSCONTAINING ZOLMITRIPTANASTRAZENECA AB579 420/KOLNP/2003 210349 03-10-2007PYRIDINONE DERIVATIVES FOR TREATMENTSMITHKLINE BEECHAM P. L. C.OF ATHEROSCLEROSIS580 1372/KOLNP/2004 210350 03-10-2007ANDROGEN HYDROALCOHOLIC GEL FORTREATING DEPRESSIONUNIMED PHARMACEUTICALS, INC.581 15/CAL/1996 210351 03-10-2007AN EXCIPIENT COMPOSITION AND METHODOF PREPARATION OF SOLID DOSAGE FORM.J. RETTENMAIER & SOEHNE GMBH + CO. KG.582 IN/PCT/2001/32/KOL 210357 03-10-2007THIOSUBSTITUTED QUINOLINE-3-CARBOXAMIDES, METHODS FOR THEIRPREPARATION AND PHARMACEUTICALACTIVE BIOTECH AB.,COMPOSITIONS CONTAINING THEM583 IN/PCT/2001/399/KOL 210359 03-10-2007PHARMACEUTICAL PREPARATIONCONTAINING A CYCLOPEPTIDE AND ACHEMOTHERAPEUTIC AGENT OR ANMERCK PATENT GMBHANGIOGENESIS INHIBITOR584 IN/PCT/2001/479/KOL 210362 03-10-2007 DRY POWER FORMULATION FOR INHALATION JAGO RESEARCH AG.585 IN/PCT/2001/1296/KOL 210367 03-10-2007"N-ALKOXYALKYL-N,N-DIALKYLAMINECOMPOUNDTOYAMA CHEMICAL CO. LTD.586 83/KOLNP/2005 210369 03-10-2007 ISOQUINOLINONE CASPASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED587 IN/PCT/2002/276/KOL 210371 03-10-2007COMPOSITION FOR STIMULANTING CYTOKINESERCRETION AND IMMUNOSTIMULATION INEX PHARMACEUTICALS CORP,RESPONSE TO TARGET ANTIGEN.588 607/KOLNP/2003 210400 03-10-2007A PHARMACEUTICAL COMPOSITIONCONTAINING AN ANGIOTENSIN II RECEPTOR DAIICHI SANKYO COMPANY LIMITEDANTAGONISTAN ISOLATED NUCLEIC ACID MOLECULE589 IN/PCT/2001/117/MUM 210408 03-10-2007 ENCODING A HUMAN NEROTROPHIC GROWTH JANSSEN PHARMACEUTICA N.V.FACTOR590 IN/PCT/2002/362/MUM 210415 03-10-2007INDOLINONES OF GENERAL FORMULA I BOEHRINGER INGELHEIM PHARMACEUTICALINCA PHARMACEUTICAL COMPOSITION FOR591 250/MUMNP/2004 210476 05-10-2007 CONTROLLED RELEASE OF BETA-LACTAM LUPIN LABORATORIES LTDANTIBIOTIC592 667/MUMNP/2005 210490 05-10-2007 A PHARMACEUTICAL COMPOSITION…. THE UNIVERSITY OF CHICAGO593 IN/PCT/2001/1052/MUM 210514 05-10-2007ANTI-INFLAMMATORY AGENTS AND METHOD BOEHRINGER INGELHEIM PHARMACEUTICALINC594 IN/PCT/2001/1541/MUM 210519 05-10-2007BICYCLIC HETEROCYCLES AND PROCESS FOR BOEHRINGER INGELHEIM PHARMACEUTICALTHE PREPARATION THEREOFINC595 911/DEL/2002 210537 05-10-2007IMMUNOMODULATORY COMPOUND FORTREATING CANCERNATIONAL INSTITUTE OF IMMUNOLOGY

596 29/MUMNP/2003 210738 08-10-2007 A PYRIMIDINE COMPOUND OF FORMULA ( I ) ASTRAZENECA AB597 IN/PCT/2002/00902/DEL 210799 08-10-2007A GLUCOPYRANOSYLOXYBENZYLBENZENECOMPOUNDKISSEI PHARMACEUTICAL CO. LTD. Japan598 IN/PCT/2002/00868/DEL 210805 08-10-2007A COMPOUND SELECTED FROM DERIVATIVESFERRING BV, a corporation organized and existingOF FORMULA 1 THAT ARE INHIBITORS OF THEudner the laws of NetherlandsENZYME OF DIPEPTIDYL PEPTIDASE IV599 517/CAL/1996 210816 10-10-2007ORAL 2-METHYL-THIENO-BENZODIAZEPINEFORMULATIONELI LILLY AND COMPANY600 577/KOL/2004 210817 10-10-20071-ALPHA-FLUORO-25-HYDROXY-16,23E-DIENE-26,27-BISHOMO-20-EPI-CHOLECALCIFEROLFOR PREVENTION AND /OR TREATMENT OF BIOXELL SPABENIGN PROSTATIC HYPERPLASIA ANDASSOCIATED SYMPTOMS.601 79/CAL/2001 210818 10-10-2007SUSTAINED-RELEASE PHARMACEUTICALFORMULATIONS CONTAINING MIZOLASTINESANOFI-AVENTIS602 IN/PCT/2001/276/KOL 210826 10-10-2007 "IMIDAZOLE COMPOUNDS" ALLERGAN SALES,INC.603 IN/PCT/2002/511/KOL 210830 10-10-2007 A BENZAMIDINE DERIVATIVE SANKYO COMPANY LIMITED604 IN/PCT/2002/1297/KOL 210833 10-10-2007COMPOUND, COMPOSITION AND METHOD FORTHE TREATMENT OF INFLAMMATORY AND BIOCELL LABORATORIESINFLAMMATORY-RELATED DISORDERS605 IN/PCT/2002/1556/KOL 210840 10-10-2007 "A QUINAZOLINONE COMPOUND" CYTOKINETICS, INC."AN INVITRO PRODUCED POLYPEPTIDE OF606 IN/PCT/2002/1363/KOL 210841 10-10-2007NOT MORE THAN 80 AMINO ACIDS IN LENGTHUNIVERSITY OF ROCHESTERCOMPRISING AT LEAST ONE C35 PEPTIDEEPITOPE"607 IN/PCT/2002/1364/KOL 210842 10-10-2007 "NOVEL NON-PSYCHOTROPIC PHARMOS CORPORATION608 3668/DEL/1998 210866 15/10/2007 THE ECHINOCANDIN COMPOUND" NOVEXEL609 156/MUMNP/2003 210885 15/10/2007NOVEL COMPOUNDS THAT INHIBIT FACTORXA ACTIVITYMORPHOCHEN AG610 173/MUMNP/2005 210892 15/10/2007OXAZOLIDINONE DERIVATIVES, PROCESS FORTHEIR PREPARATION AND THEIR USE AS LUPIN LIMITEDANTIMYCOBACTERIAL AGENTS611 IN/PCT/113/2002/MUM 210898 15/10/2007CALCIUM COMPLEX OF PHOSPHORUSCONTAINING ETHYLENEDIAMINESCHERING CORPORATIONDERIVATIVES612 603/MUM/2000 210899 15/10/2007THIEN - 3 - YL - SULPHONYLAMINO(THIO)CARBONYL-TRIAZOLIN(ETHI)ONES OF THE BAYER AKTIENGESELLSCHAFTGENERAL FORMULA( I )613 IN/PCT/2002/1494/MUM 210902 15/10/2007NOVEL FORMULATIONS OF A-2, 4-DISULFOPHENYL-N-TERT-BUTYLNITRONEASTRAZENECA AB614 255/MUMNP/2004 210910 15/10/2007HEPTA-OCTA- AND NONAPEPTIDES HAVINGANTIANGIOGENIC ACTIVITYABBOTT LABORATORIES

A PHARMACEUTICAL PRODUCT FORCOUNTERACTING DAMAGE TO THE HEART615 IN/PCT/2002/00153/MUM 210919 15/10/2007SOLVAY PHARMACEUTICALS B.VAND A PROCESS FOR MANUFACTURING THESAMEACTIVE AND PASSIVE IMMUNISINGSUBSTANCES AS A VACCINE AGAINST616 40/BOM/1995 210931 15/10/2007 SYPHILIS, HEPATITIS B AND AIDS AND MADHAV PANDHARINATH KAMATKARPROCESS TO MANUFACTURE THE SAME FROMPARTS OF COCONUT PALM (COCOSANTITUBERCULAR PHARMACEUTICAL617 220/MUMNP/2004 210943 16/10/2007 COMPOSITION IN FIXED DOSE COMBINATION SYNGENTA LIMITEDCOMPRISING FOUR DRUGSQUINOLINECARBOXYLIC ACID DERIVATIVE618 339/MUMNP/2005 210956 16/10/2007WAKUNAGA PHARMACEUTICAL CO LIMITEDOR SALTS THEREOFFORMULATION AND DOSAGE FORM FOR619 229/MUMNP/2004 210957 16/10/2007 INCREASING ORAL BIOAVAILABILITY OF ALZA CORPORATIONHYDROPHILIC MACROMOLECULESNOVEL GALENIC FORMULATIONS OF BOEHRINGER INGELHEIM PHARMACEUTICAL620 1019/MUMNP/2003 210964 16/10/2007MELOXICAM FOR ORAL ADMINISTRATION INC621 IN/PCT/2002/1689/MUM 210984 16/10/2007BENZIMIDAZOLES THAT ARE USEFUL IN622 826/MUMNP/2003 210986 16/10/2007ABBOTT LABORATORIESTREATING SEXUAL DYSFUNCTION623 IN/PCT/2000/777/MUM 210996 16/10/2007 A HUMAN THROMBOPOIETIN MUTANT DAEWOONG PHARACEUTICAL CO LTDA BIPHENYLBENZAMIDE DERIVATIVES OF624 165/MUM/2003 211085 17/10/2007BAYER AKTIENGESELLSCHAFTFORMULA ( IA ) AND COMPOSITION THEREOFA STABLE INJECTABLE ANTISPASMODIC AND625 209/MUM/2004 211089 17/10/2007 ANALGESIC FORMULATION AND PROCESS SANJEEV KHANDELWALFOR PREPARING THE SAME626 462/MUMNP/2004 211092 17/10/2007 NOVEL ALKOXYPYRIDINE - DERIVATIVES ALTANA PHARMA AGPIPERIDINE DERIVATIVES USEFUL AS627 1142/MUMNP/2003 211107 17/10/2007 MODULATORS OF CHEMOKINE RECEPTOR ASTRAZENECA ABACTIVITYSTABILIZED PHARMACEUTICAL ORAL SOLID628 384/MUM/2003 211143 17/10/2007IPCA LABORATORIES LIMITEDDOSAGE COMPOSITIONSN-ALKYL-4-METHYLENEAMINO-3-HYDROXY-2-629 1663/DELNP/2005 211210 19-10-2007THE PROCTER & GAMBLE COMPANYPYRIDONES AS ANTIMICROBIALS630 IN/PCT/2002/00923/DEL 211212 19-10-2007PHARMACEUTICAL COMPOSITION631 805/DEL/2000 211213 19-10-2007PANACEA BIOTEC LIMITEDCOMPRISING CYCLOSPORINNOVEL INHIBITORS OF DIPEPTIDYL632 IN/PCT/2002/00992/DEL 211218 19-10-2007FERRING BVPEPTIDASE IVIMMUNOSTIMULATORY DEOXYINOSINE-TROPANE DERIVATIVES AS CCR5INTERCELL BIOMEDIZINISCHE FORSCHUNGSPFIZER INC., a corporation organized under the lawsCONTAINING OLIGONUCLEOTIDEMODULATORSAND ENTWICKLUNGS AGof the State of Delaware

633 IN/PCT/2002/880/MUM 211238 19/10/2007THE SUBSTANCE 5-CHLORO-N-[2-[4-[[[(CYCLOHEXYLAMINO)-BRISTOL- MAYERS SQUIBB CO,CARBONY1)AMINO]SULFONY1]PHENY1]ETHY1]-2-METHOXYBENZAMIDE (GLYBURIDE)634 212/DEL/2000 211244 23-10-2007NOVEL ETHER DERIVATIVES OFCOUNCIL OF SCIENTIFIC AND INDUSTRIALDIHYDROARTEMISNIN AS ANTIMALARIALSRESEARCHAND THE PROCESS THEREOF635 237/DEL/2002 211246 23-10-2007 A THERAPEUTIC COMPOSITION IMMUNOMEDICS, INC.636 1095/DEL/2000 211247 23-10-2007A FORMULATION USEFUL FOR THECOUNCIL OF SCIENTIFIC AND INDUSTRIALTREATMENT OF COMATOSE AND CEREBRALRESEARCHMALARIA637 1038/MUMNP/2003 211290 24/10/2007 A PHARMACEUTICAL COMPOSITION PFIZER PRODUCT INC638 IN/PCT/2002/1198/MUM 211297 24/10/2007 2-SUBSTITUTED 4- HETEROARYL- CYCLACEL LIMITED639 IN/PCT/2002/992/MUM 211298 24/10/2007 TRICYCLIC IMIDAZOPYRIDINES ALTANA PHARMA AG640 IN/PCT/2002/763/MUM 211300 24/10/2007 OXAZOLIDINONES AND THEIR USE BAYER AKTIENGESELLSCHAFT641 313/MUMNP/2004 211302 24/10/2007COMPOSITIONS OF MONOCLONALANTIBODIES SPECIFIC FOR BETA-AMYLOIDPROTEINS642 765/MUMNP/2004 211304 24/10/2007A LOW DOSAGE PHARMACEUTICALCOMPOSITIONPFIZER PRODUCT INCA COMPOUND OF FORMULA IA AND A643 149/MUMNP/2005 211310 24/10/2007 PHARMACEUTICAL COMPOSITIONAAIPHARMA INCCOMPRISING COMPOUND THEREOF644 742/MUMNP/2003 211328 25/10/2007 NOVEL CAROTENIOD ESTERS BARLOVENTO INTERNATONAL….A METASTABLE POLYMORPH (CRYSTAL645 IN/PCT/2001/01478/MUM 211338 25-10-2007A ) OF 2-(3-CYANO-4-ISOBUTYLOXYPHENYL)-4-METHYL-5-TEIJIN LIMITEDTHIAZOLECARBOXYLIC ACID646 856/DEL/2001 211342 26-10-2007647 997/MUM/2000 211345 26/10/2007648 761/DEL/2001 211351 26-10-2007649 1022/DEL/2002 211356 26-10-2007650 720/DEL/2000 211361 26-10-2007651 30/DEL/2002 211366 26-10-2007652 636/MUMNP/2005 211369 26/10/2007DIAGENICS INTERNATIONAL CORPORATIONRESEARCH AND DEVELOPMENT CENTERA PHARMACEUTICAL COMPOSITIONCOUNCIL OF SCIENTIFIC AND INDUSTRIALESSENTIALLY COMPRISING (-)-OLIVIL USEFULRESEARCHAS AN ANTIOXIDANT.ARYL-SUBSITUTED HETEROCYCLICBAYER AKTIENGESELLSCHAFTENAMINONES OF THE GENERAL FORMULAA FORMULATION FROM EXTRACT OF INDIANGREEN MUSSEL (PERNA VIRIDIS) USEFUL FORINHIBITING OSTEOCLAST FORMATION ANDBONE RESORPTION.A POLYPEPTIDE FOR USE IN THE TREATMENTOF CANCERORAL PHARMACEUTICAL COMPOSITIONSCOMPRISING RIFAMPCIN AND ISONIAZAIDCOMPOSITION USEFUL FOR TREATMENT OFCANCERSYNERGISTIC COMBINATION COMPRISINGROFLUMILAS AND (R.R) - FORMOTEROLCOUNCIL OF SCIENTIFIC AND INDUSTRIALRESEARCHDABUR RESEARCH FOUNDATIONPANACEA BIOTEC LIMITEDDABUR RESEARCH FOUNDATIONALTANA PHARMA AG

653 382/MUMNP/2005 211375 26/10/2007654 1115/DELNP/2004 211378 26-10-2007655 IN/PCT/2002/326/MUM 211406 29/10/2007656 IN/PCT/2001/806/MUM 211409 29/10/2007657 99/MUM/2004 211413 29/10/2007658 594/MUMNP/2004 211414 29/10/2007659 1260/MUMNP/2005 211421 29/10/2007660 IN/PCT/2002/384/MUM 211422 29/10/2007661 IN/PCT/2002/217/MUM 211424 29/10/2007662 IN/PCT/2002/218/MUM 211430 29/10/2007663 1711/CAL/1997 211433 29-10-2007664 1722/CAL/1998 211434 29-10-2007A PHARMACEUTICAL COMPOSITIONA CONTROLLED RELEASE PHARMACEUTICALCOMPOSITION COMPRISING ABOUT 0.01% TOABOUT 10.0% OF 5,7,14-TRIAZATETRACYCLO[10.3.1.02,11. 04.9]-HEXADECA-2(11), 3,5,7,9-PENTAENEAN ACRYLAMIDE BASED COMPOUND OFFORMULA I, PROCESS FOR PREPARATION ANDPHARMCEUTICAL COMPOSITION THEREOFNOVEL ARALKYL AMINES OFSPIROFUROPYRIDINES USEFUL IN THERAPYTHE COMPOUND PH (3-CI) (5-OCHF2) -(R) CH(OH)C (O)-(S)AZE-PAB(2,6-DIF)(OH) OR APHARMACEUTICALLY ACCEPTABLE SALTTHEREOFTOPICALLY APPLICABLE PRARMACEUTICALPREPARATIONPYRROLOPYRIDINE-2-CARBOXYLIC ACIDAMIDE INHIBITORS OF GLYCOGENPHOSHORYLASENOVEL PESTICIDE AND/OR GROWTHREGULATING COMPOSITIONS WITHPARTICULAR NON-IONIC SURFCTANTA 4 -PHENYLBUTANOIC ACID COMPOUND OFFORMULA ( I )A PHARMACEUTICAL COMPOSITIONCOMPRISING BENZIMIDAZOLETETANUS TOXIN FUNCTIONAL FRAGMENTANTIGEN AND TETANUS VACCINE.AZABENZIMIDAZOLE COMPOUNDS, METHODSOF MODULATING THE FUNCTION OFSERINE/THREONINE PROTEIN KINASES ANDMETHOD OF SYNTHESIS THEREOFBOEHRINGER INGELHEIM PHARMACEUTICALINCPFIZER PRODUCTS INC.AFFINIUM PHARMACEUTICALS INCASTRAZENECA ABASTRAZENECA ABALTANA PHARMA AGPROSIDION LIMITEDAVENTIS CROP SCIENCE GMBHSMITH KLINE BEECHAM CORPORATIONAAIPHARMA INCTHE RESEARCH FOUNDATION FOR MICROBIALDISEASES OF OSAKA UNIVERSITY.ZENTARIS GMBH665 195/CAL/1999 211435 29-10-2007ALPHA-LIPOIC ACID HAVING A NOVEL ASTA MEDICA HEALTH PRODUCTS GMBH &MODIFICATION.CO. KG.,666 IN/PCT/2001/538/MUM 211460 31/10/2007 A PHARMACEUTICAL COMPOSITION SMITH KLINE BEECHAM CORPORATION667 522/DEL/2000 211476 01-11-2007NOVEL PACLITAXEL DERIVATIVES FOR THETREATMENT OF CANCERDABUR RESEARCH FOUNDATION668 147/DEL/2000 211479 01-11-2007BOMBESIN ANALOGS USEFUL IN THETREATMENT OF CANCERDABUR RESEARCH FOUNDATION669 1125/DEL/2000 211482 01-11-2007NOVEL SUBSTITUTED ARYL ALKENOIC ACID COUNCIL OF SCIENTIFIC AND INDUSTRIALHETEROCYCLIC AMIDESRESEARCH670 1/DEL/2001 211483 01-11-2007NOVEL CARVIDELOL DERIVATIVES, USEFULIN THE TREATMENT OF CANCERDABUR RESEARCH FOUNDATION

671 IN/PCT/2002/00911/DEL 211484 01-11-2007672 861/DEL/2001 211486 01-11-2007673 338/DELNP/2004 211490 01-11-2007674 IN/PCT/2001/127/MUM 211493 01-11-2007675 800/BOM/1999 211519 01-11-2007676 258/MUM/2000 211522 01-11-2007677 IN/PCT/2001/684/MUM 211527 01-11-2007PERMEABLE COMPOSITION, CONTROLLEDRELEASE PRODUCT AND METHODS FOR THEPRODUCTION THEREOFA PHARMACEUTICAL COMPOSITIONESSENTIALLY COMPRISING (-)-SECOISOLARICIRESINOL OBTAINED FROMSTEREOSPERMUM PERSONATUM USEFUL ASAN ANTIOXIDANTNOVEL SUBSTITUTED 2-AMINO-PYRAN-4-ONECOMPOUNDSA COMPOUND OF FORMULA I4-SUBSTITUTED PIPERIDINES(-)-ENANTIOMER OF 2-[2-(1-CHLORO-CYCLOPROPYL)-3-(2-CHLOROPHENYL)-2-HYDROXY-PROPYL]-2,4-DIHYDRO-[1,2,4]-TRIAZOLE-3-THIONEA COMPOSITION IN FORM OF A SOLUTION FORUSE IN AN AEROSOL INHALER AND ANAEROSOL INHALER THEREOFBEACHPOINT HOLDINGS INC.,COUNCIL OF SCIENTIFIC AND INDUSTRIALRESEARCHCANCER RESEARCH TECHNOLOGY LIMITED,BOEHRINGER INGELHEIM PHARMACEUTICALINCFAES FABRICA ESPANOLA DE PRODUCTOSQUIMICOS FARMACEUTICOS SABAYER AKTIENGESELLSCHAFTCHIESI FARMACEUTICI S.P.A.678 263/MUMNP/2003 211531 01-11-2007 VACCINE COMPOSITION INTERCELL AG679 IN/PCT/2000/84/CHE 211539 05-11-2007 A PHARMACEUTICAL FORMULATION PFIZER HEALTH AB680 IN/PCT/2002/1699/CHE 211544 05-11-2007 FORMULATION FOR AN INHALER DEVICE VECTURA LIMITED681 1460/MAS/1995 211556 05-11-2007 SULFONAMIDE COMPOUNDS F. HOFFMANN-LA ROCHE AGSUBSTITUTED BENZENESULFONYLUREASAND -THIOUREAS, PROCESSES FOR THEIR682 141/MAS/1996 211558 05-11-2007PREPARATION, THEIR USE FOR THEPRODUCTION OF PHARMACEUTICALHOECHST AKTIENGESELLSCHAFTPREPARATIONS, AND PHARMACEUTICALPREPARATIONS CONTAINING THEMSUBSTITUTED BENZENESULFONY-LUREASAND -THIOUREAS, PROCESSES FOR THEIR683 242/MAS/1996 211560 05-11-2007PREPARATION, THEIR USE FOR THEPRODUCTION OF PHARMACEUTICALM/S. HOECHST AKTIENGESELLSCHAFTPREPARATIONS AND MEDICAMENTSCONTAINING THEM684 929/MAS/1999 211561 05-11-2007STABLE COMPLEXES OF POORLY SOLUBLECOMPOUNDSF. HOFFMANN-LA ROCHE AG685 991/MAS/1996 211562 05-11-2007TERPENES FOR REDUCING THE PHEROMONEACTION ON LEPIDOPTERABASF AKTIENGESELLSCHAFT686 185/CHENP/2003 211566 05-11-2007 NOVEL SUBTILASE ENZYMES NOVOZYMES A/S687 401/CHENP/2003 211577 05-11-20074-, 5-, 6- AND 7-INDOLE DERIVATIVES USEFULFOR THE TREATMENT OF CNS DISORDERSH. LUNDBECK A/S

688 452/CHENP/2003 211580 05-11-2007EUCARYOTIC MICROBIAL HOST CELLS AND ANOVEL METHOD FOR PREPARING VITAMIN K- NOVO NORDISK HEALTH CARE AGDEPENDENT PROTEINS689 743/CHENP/2003 211599 05-11-2007AN ISOLATED POLYNUCLEOTIDE ASPROMOTER IN EUKARYOTIC CELLSVASCULAR BIOGENICS LTD690 786/CHENP/2003 211603 05-11-2007 PYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG691 1379/CHENP/2003 211624 05-11-2007CALOPOROSIDE DERIVATIVES PROCESS FORTHEIR PREPARATIONSANOFI-AVENTIS DEUTSCHLAND GMBH692 485/CHE/2005 211626 05-11-2007EUKARYOTIC BASED SYNERGISTICFORMULATIONBHARAT BIOTECH INTERNATIONAL LIMITED693 IN/PCT/2002/1435/MUM 211629 11-05-20078B-HYDROCARBYL-SUBSTITUTEDESTRATRIENES FOR USE AS SELECTIVE SCHERING AKTIENGESELLSCHAFTESTROGENS694 IN/PCT/2002/434/MUM 211644 06-11-2007PHENYL- AND PYRIDYL-TETRAHYDROPYRIDINES HAVING TNF- SANOFI SYNTHELABORATORYINHIBITING ACTIVITY695 307/MUM/2004 211646 06-11-2007CONTROLLED RELEASE GASTRO-RETENTIVEBUOYANT MATRIX TABLETSCADILA HEALTHCARE LIMITED696 IN/PCT/2002/1539/MUM 211650 06-11-2007 ANTHRANILAMIDE COMPOUND SCHERING AKTIENGESELLSCHAFTMEDICINE BASED ON ANTI-HYPERGLYCEMIC697 442/MUMNP/2003 211653 06-11-2007 MICROCAPSULES WITH PROLONGED RELEASE FLAMEL TECHNOLOGIESAND METHOD FOR PREPARING SAME698 IN/PCT/2000/543/MUM 211663 06-11-2007OCTAHYDRO-6,10-DIOXO-6H-PYRIDAZINO-1,2-A -1,2-DIAZEPIN-1-CARBOXYLIC ACIDAVENTIS PHARMACEUTICALS INC699 IN/PCT/2000/374/MUM 211667 06-11-2007A PHARMACEUTICAL COMPOSITIONCOMPRISING EPROSARTANSMITH KLINE BEECHAM CORPORATION700 939/MUM/2001 211669 07-11-2007A CONTROLLED RELEASE ANTIDIABETICCOMPOSITIONSUN PHARMACEUTICAL INDUSTRIES LTD701 in/pct/2002/01015/mum 211678 07-11-2007pyrano 2,3-C; imidazo;-1,2-A; pyridine derivatives forALTANA PHARMA AGthe treatment of gastrointestinal disorders702 IN/PCT/2001/00451/MUM 211681 07-11-2007 A STABILIZED SOLID COMPOSITION WARNER-LAMBERT COMPANYMEDICINAL COMPOSITION COMPRISING703 1505/CAL/1997 211685 07-11-2007 OXIDIZED AND REDUCED FORM OFKANEKA CORPORATIONCOENZYME Q10.704 1668/CAL/1996 211686 07-11-2007 AN ANTHELMINTIC COMPOSITION. ASHMONT HOLDINGS LIMITED705 IN/PCT/2001/830/KOL 211718 07-11-2007COMPOUNDS USEFUL AS GROWTH HORMONEELI LILLY AND COMPANYSECRETAGOGUES706 573/MUMNP/2005 211720 07-11-2007 THERAPEUTIC POLYPEPTIDE…. ANLYNX NV707 IN/PCT/2002/927/CHE 211746 09-11-2007A PHARMACEUTICAL COMPOSITIONCOMPRISING ORALLY DELIVERABLE PHARMACIA CORPORATIONDOSE UNITS OF CELECOXIB708 1425/MAS/1995 211748 09-11-2007 NOVEL SULFONAMIDES F HOFFMANN LA ROCHE AGBILAYER SUSTAINED RELEASE ORAL DOSAGE709 1104/MAS/2000 211749 09-11-2007 COMPOSITION COMPRISING DESLORATADINE SCHERING CORPORATIONAND A NASAL DECONGESTANT

710 1833/MAS/1998 211752 09-11-2007A PHARMACEUTICALLY ACCEPTABLE RECKITT BENCKISER HEALTHCARE (UK)POLYMER COMPOSITIONLIMITED711 1847/MAS/1997 211753 09-11-2007ACYLAMINOALKENYLENE-AMIDENOVARTIS AGDERIVATIVES AS NK1 AND NK2 ANTAGONISTS712 1875/MAS/1997 211754 09-11-2007CHLOROFLUOROCARBON-FREEMOMETASONE FUROATE AEROSOLSCHERING CORPORATION713 2414/MAS/1997 211755 09-11-2007NOVEL HETEROCYCLES AS INHIBITORS OFLEUCOCYTE ADHESION AND AS VLA-4 HOECHST AKTIENGESELLSCHAFTANTAGONISTS714 2417/MAS/1997 211756 09-11-2007NOVEL BICYCLIC COMPOUNDS AND THEIRUSE IN MEDICINE; PROCESS FOR THEIRPREPARATION AND PHARMACEUTICALDR. REDDY'S LABORATORIES LTDCOMPOSITIONS CONTAINING THEM715 2858/MAS/1998 211758 09-11-2007 DRINKABLE PHARMACEUTICAL SANOFI SYNTHELABO716 199/CHENP/2003 211764 09-11-2007A PHARMACEUTICAL COMPOSITION FORTREATING SYMPTOMS OF COMMON COLD,ALLERGIC RHINITIS AND INFECTIONSIMMUPHARM APSRELATING TO RESPIRATORY TRACT717 40/CHENP/2003 211767 09-11-2007NOVEL 4-PHENYL SUBSTITUTEDTETRAHYDROISOQUINOLINES ANDAMR TECHNOLOGY INCTHERAPEUTIC USE THEREOF718 59/CHENP/2003 211768 09-11-2007 PIPERIDINE COMPOUNDS AS CCR-3 NOVARTIS AG719 528/CHENP/2003 211772 09-11-2007 NOVEL NON-IMIDAZOLE COMPOUNDS SCHERING CORPORATIONA NATEGLINIDE-CONTAINING HYDROPHILIC720 612/CHENP/2003 211774 09-11-2007 PHARMACEUTICAL PRODUCT AND A METHOD M/S. AJINOMOTO CO.,INCFOR PREPARING THE SAME721 624/CHENP/2003 211775 09-11-2007 ANTACID AND LAXATIVE TABLET M/S. KYOWA CHEMICAL INDUSTRY CO., LTD722 663/CHENP/2003 211778 09-11-2007INDOLYLMALEIMIDE DERIVATIVES ASPROTEIN KINASE C INHIBITORSM/S. NOVARTIS AG723 730/CHENP/2003 211783 09-11-2007COMPOUNDS OF GENERAL FORMULA I FORSEROTONIN RELATED DISEASEBIOVITRUM AB724 830/CHENP/2003 211795 09-11-2007ORTHO-SUBSTITUTED AND META-SUBSTITUTED BIS-ARYL COMPOUNDS AND SANOFI-AVENTIS DEUTSCHLAND GMBHMETHOD FOR THE PRODUCTION THEREOF725 877/CHENP/2003 211803 09-11-2007COMPOUNDS OF GLYCEROPHOSPHOINOSITOL I.R.B. ISTITUTO DI RICERCHEAND COMPOSITIONS THEREOFBIOTECNOLOGICHE S.R.L726 952/CHENP/2003 211807 09-11-2007PHARMACEUTICAL COMPOSITIONCOMPRISING BENAZEPRIL AND AMLODIPINENOVARTIS AG727 IN/PCT/2002/01014/MU 211820 12-11-2007Prodrugs of imidazopyridine derivatives forinfibition of gastric acid secretionALTANA PHARMA AG728 61/MAS/2002 211823 12-11-2007NOVEL SUBSTITUTED THIAZOLYL ACETIC ORCHID CHEMICALS ANDACIDPHARMACEUTICALS LIMITEDA PHYSICALLY STABLE, THIXOTROPIC,729 244/CHENP/2004 211834 13-11-2007 ORALLY DELIVERABLE PHARMACEUTICALCOMPOSITIONPHARMACIA CORPORATION

730 99/CHENP/2004 211840 13-11-2007 DOLASTATIN 10 DERIVATIVES F. HOFFMANN-LA ROCHE AG731 482/CHENP/2004 211842 13-11-2007A NOVEL 17 BETA -HYDROXYSTEROIDDEHYDROGENASE TYPE 3 INHIBITORS OF M/S. SCHERING CORPORATIONFORMULA (1)732 528/CHENP/2004 211844 13-11-2007A COMBINATION COMPRISING 4-PYRIDYLMETHYL-PHTHALAZINEANTIANGIOGENIC AGENT AND PLATINUMM/S. NOVARTIS AGCOMPOUND733 1994/CHENP/2003 211852 13-11-2007 ACETYLATION OF GP41 FRAGMENTS F. HOFFMANN-LA ROCHE AG734 602/CHENP/2004 211856 13-11-2007ALKYNE-ARYL PHOSPHODIESTERASE -4INHIBITORSM/S. MERCK FROSST CANADA & CO735 628/CHENP/2004 211857 13-11-2007 QUINOLINE DERIVATIVES OF FORMULA I M/S. F. HOFFMANN-LA ROCHE AG736 2694/CHENP/2004 211863 13-11-20071,3,5-TRIAZINE DERIVATIVES AS LIGANDS FORM/S. SOLVAY PHARMACEUTICALS B.VHUMAN ADENOSINE-A3 RECEPTORSARYL 5-THIO-BETA-D-GLUCOPYRANOSIDE737 2004/CHENP/2004 211872 13-11-2007 DERIVATIVES AND PHARMACEUTICAL TAISHO PHARMACEUTICAL CO., LTDCOMPOSITION CONTAINING THE SAME738 594/CHENP/2003 211917 13-11-2007A PHARMACEUTICAL COMPOSITIONCOMPRISING CAMPTOTHECIN OR ADERIVATIVE THEREOF AND A STILBENEPFIZER ENTERPRISES SARLDERIVATIVE739 553/mum/2001 211937 13/11/2007composition comprising mixtures of compoundsof the formula having insecticidal and acaricidal BAYER AKTIENGESELLSCHAFTproperties740 IN/PCT/2001/441/MUM 212018 13/11/2007 A SPIRO COMPOUND OF FORMULA (I) JANSSEN PHARMACEUTICA N.V.741 112/mumnp/2004 212021 13/11/2007Pharmaceutical composition of pde4-inhibitor andNYCOMED GMBHconventional nsaidCOMPOSITION COMPRISING COMPOUND OF742 251/MUM/2001 212023 13/11/2007 FORMULA (1-B-1) AND PROCESS FORBAYER AKTIENGESELLSCHAFTPREPARATION THEREOF743 111/MUM/2000 212024 13/11/2007A PHARMACEUTICAL COMBINATIONCOMPRISING THE HMG COA REDUCTASEINHIBITOR AND THE ALL ANTAGONISTASTRAZENECA ABCANDESARTAN744 754/MUMNP/2004 212036 13/11/2007TRIAMIDE SUBSTITUTED INDOLES,BENZOFURANES AND BENZOTHIOPHENES AS PFIZER PRODUCT INCINHIBITORS OF MICROSOMAL TRIGLYCERIDE2-MERCAPTO-5-PHENYL-1, 3, 4-OXADIAZOLYL-745 1766/CHENP/2003 212050 13-11-2007(Z)-4-BROMO-2-METHOXYIMINO BUTYRIC ORCHID CHEMICALS & PHARMACEUTICALSACID DERIVATIVE AND PROCESS OFLTDPREPARATION THEREOF746 236/CHENP/2005 212052 13-11-2007 AN ISOLATED NUCEIC ACID…. M/S. TEXAS TECH UNIVERSITY747 136/DEL/2000 212057 14-11-2007 VASOACTIVE INTESTINAL PEPTIDE ANALOGS DABUR RESEARCH FOUNDATION

748 791/DEL/1996 212060 14-11-2007ORAL ANTI-SPASMODIC ANTI-INFLAMMATORY COMPOSITION COMPRISINGPITOFENONE, FENPERINIUM AND NSAIDNOVEL PYRROLO[2,1-C] [1,4]BENZODIAZEPINES USEFUL AS ANTITUMOURNOVEL SUBSTITUTED 1H-PANACEA BIOTEC LIMITED749 210/DEL/2000 212061 14-11-2007COUNCIL OF SCIENTIFIC AND INDUSTRIALRESEARCH750 1163/DEL/2000 212064 14-11-2007COUNCIL OF SCIENTIFIC AND INDUSTRIALBENZ[DE]ISOQUINOLINE-1,3-DIONESRESEARCHA PHARMACEUTICAL COMPOSITION FOR THE751 317/DEL/1997 212067 14-11-2007 CONTROL AND PREVENTION OF ANORECTAL PANACEA BIOTEC LIMITEDAND COLONIC DISEASESA PHARMACEUTICAL COMPOSITION BASED752 641/DEL/2000 212068 14-11-2007 ON NANOPARTICLES OF POLYMERIC DABUR INDIA LIMITEDMICHELLES CONTAINING PACLITAXEL753 936/KOLNP/2005 212088 15-11-2007 CEPHEM COMPOUNDS ASTELLAS PHARMA INC.754 180/CAL/1996 212119 20-11-2007VASOCONSTRICTIVE SUBSTITUTED 2,3-DIHYDRO-1,4-DIOXINOPYRIDINES.JANSSEN PHARMACEUTICA N.V.755 2224/CAL/1996 212127 20-11-2007A 1-(1,2-DISUBSTITUTED PIPERIDINYL)-4-(FUSED IMIDAZOLE)-PIPERIDINEJANSSEN PHARMACEUTICA N.V.,756 460/CAL/2002 212137 20-11-2007A HERBAL PHARMACEUTICAL PREPARATIONFOR THE TREATMENT OF LEUCODERMADR. SWAPAN KUMAR CHATTERJEE757 480/CAL/1998 212139 20-11-2007NOVEL COMPLEXES OF LHRH ANTAGONISTSWITH POLYAMINO ACIDZENTARIS GMBH758 343/CHENP/2004 212164 26-11-2007759 1172/MAS/1997 212174 26-11-2007760 1182/MAS/1996 212175 26-11-2007761 128/MAS/2000 212176 26-11-2007762 1877/MAS/1996 212179 26-11-2007763 8/CHENP/2003 212191 26-11-2007764 647/CHENP/2003 212197 26-11-2007765 724/CHENP/2003 212199 26-11-2007766 1097/CHENP/2003 212205 26-11-2007A PHARMACEUTICAL DERIVATIVE FORINHIBITING THE METASTASIS ORPREVENTING THE RECURRENCE OFPIPERIDINE DERIVATIVE AND PROCESS FORPREPARING THE SAMEPYRROLOPYRIMIDINES AND PROCESSES FORTHE PREPARATION THEREOFNUCLEIC ACID MOLECULE CODING FORPROTEIN HAVING ENZYMATIC ACTIVITY INTHE CLEAVAGE OF BETA-CAROTENESUBSTITUTED CHROMANYLSULFONYL (THIO)UREAS, PROCESSES FOR THEIR PREPARTIONAND PHARMACEUTICAL PREPARATIONSCOMPRISING THEMPLEUROMUTILIN DERIVATIVES HAVINGANTIBACTERIAL ACTIVITYA MEDICAMENT CONTAINING ENZYMESFROM CILIATESPHARMACEUTICAL COMPOSITIONCOMPRISING THE RENIN INHIBITOR AND AKIT COMPRISING THE SAMEAN ORALLY DELIVERABLEPHARMACEUTICAL COMPOSITIONM/S. TANABE SEIYAKU CO., LTDSUMITOMO CHEMICAL COMPANY LIMITEDCIBA- GEIGY AGDSM IP ASSETS B.VHOECHST AKTIENGESELLSCHAFTM/S. SANDOZ AGCILIAN AGM/S. NOVARTIS AGPHARMACIA CORPORATION

767 1151/CHENP/2003 212206 26-11-2007GENETICALLY MODIFIED YEAST STRAINAUTONOMOUSLY PRODUCING STEROIDSAVENTIS PHARMA S.A768 978/CHENP/2003 212218 26-11-2007SUBSTITUTED CYCLOHEXENES AND THEIRMETHOD OF PREPARATIONGIVAUDAN SA769 175/CHENP/2005 212235 26-11-2007 A QUINUCLIDINE MOLECULE OF FOREMULA I NEUROSEARCH A/SA MEDICAMENT FOR INHIBITING THE770 1638/CHENP/2004 212237 26-11-2007 PRODUCTION OF BETA-LACTAMASES BY M/S. AVENTIS PHARMA S.APATHOGENIC BACTERIAN-BIPHENYLMETHYLAMINOCYCLOALKANECARBOXAMIDE771 1753/CHENP/2004 212241 26-11-2007 DERIVATIVES WITH A SUBSTIUTUENT ON THE MERCK & CO., INCMETHYL USEFUL AS BRADYKININANTAGONISTSAN ORAL IMMEDIATE RELEASE772 1769/CHENP/2004 212242 26-11-2007 FORMULATION AND A METHOD OFSOLVAY PHARMACEUTICALS B.VPREPARING THE SAME773 3228/CHENP/2004 212244 26-11-2007 TRIAZOLE-3-CARBOXAMIDE DERIVATIVES SOLVAY PHARMACEUTICALS B.V774 1164/CHENP/2004 212246 26-11-2007A COMPOSITION COMPRISING RIBOFLAVIN,AN EFFECTOR OF THE UREA CYCLE AND BURZYNSKI Stanislaw RAMINO ACIDS775 IN/PCT/2001/128/MUM 212256 26/11/2007A COMPOUND OF FORMULA (I) FOR THEBOEHRINGER INGELHEIM PHARMACEUTICALTREATMENT OF HEPATITIS C VIRUS (HCV)INCINFECTION776 2223/CAL/1996 212264 28-11-20071-(1,2-DISUBSTITUTED PIPERIDINYL)-4-SUBSTITUTED PIPERIDINE DERIVATIVESJANSSEN PHARMACEUTICA N.V.777 943/KOLNP/2005 212279 28-11-2007A QUINOLINYL-PYRROLOPYRAZOLECOMPOUND AND PHARMACEUTICAL ELI LILLY AND COMPANYCOMPOSITION THEREOF778 IN/PCT/2000/235/KOL 212280 28-11-2007E-2-[4-(4-CHLORO-1,2-DIPHENYL-BUT -1-ENYL)PHENOXY] ETHANOL ANDORION CORPORATIONPHARMACEUTICAL COMPOSITIONS THEREOF779 IN/PCT/2001/1232/KOL 212282 28-11-2007 THIAZOLE AD OXAZOLE DERIVATIVES GLAXCO GROUP LIMITED780 1740/CAL/1997 212288 28-11-2007A PHARMACEUTICAL COMPOSITIONCONSISTING OF OLANZAPINE ANDFLUOXETINE FOR THE TREATMENT OFELI LILLY AND COMPANYPYSCHOSES.781 1880/CAL/1996 212296 28-11-20071-(1,2-DISUBSTITUTED PIPERIDINYL)-4-SUBSTITUTED PIPERAZINE DERIVATIVESJANSSEN PHARMACEUTICA N.V.782 IN/PCT/2001/460/MUM 212307 30/11/20073-SUBSTITUTED-4-ARYLQUINOLIN-2-ONEDERIVATIVES AS POTASSIUM CHANNEL BRISTOL- MAYERS SQUIBB CO,MODULATORS783 113/MUM/2000 212310 30-11-2007A NON-INTERACTING DRUG-COMBINATION FOR TREATINGHYPERLIPIDAEMIA IN MAMMALSSYNGENTA LIMITED

784 306/MUM/2001 212313 30-11-2007NOVEL COMPOUND NAMELY METHYLSUBSTITUTED DIOXA-TETRACYCLOSAURASHTRA UNIVERSITYHEPTADECA-2,4,6,11,13,15- HEXAENE785 1156/mumnp/2003 212314 30/11/2007alkyl-substituted imidazopyridines for the treatment ofALTANA PHARMA AGgastrointestinal disorders786 868/CHENP/2004 212400 03-12-2007N-SUBSTITUTED HYDROXYPYRIMIDINONEM/S. ISTITUTO DI RICERCHE DI BIOLOGIACARBOXAMIDE INHIBITORS OF HIVMOLECOLARE P. ANGELETTI, SPAINTEGRASE787 1095/MAS/1998 212412 03-12-2007HYDRATES OF TRIAZINYLAMINOSTILBENECOMPOUNDS AND OBTAINING THE SAMECIBA SPECIALTY CHEMICALS HOLDING INC788 55/DEL/2003 212533 04-12-2007FORMULATION COMPRISING A PROTEINENRICHED FRACTION OBTAINED FROM A NATIONAL INSTITUTE OF IMMUNOLOGYPLANT OF TINOSPORA SPECIES789 2854/DEL/1996 212535 04-12-2007 AN AQUEOUS PHARMACEUTICAL SOLUTION. PFIZER INC.790 1156/DEL/1997 212536 04-12-2007MESYLATE DIHYDRATE SALTS OF 5-(2-(4-(1,2-BENZISOTHIAZOL-3-YL)-1-PIPERAZINYL)-ETHYL)-6-CHLORO-1,3-DIHYDRO-2H-INDOL-2-PFIZER INC.ONE791 2698/DEL/1997 212567 04-12-2007RECOMBINANT MVA VIRUS EXPRESSINGDENGUE VIRUS ANTIGENS, AND THE USE BAVARIAN NORDIC A/STHEREOF IN VACCINES792 182/DEL/1996 212568 04-12-2007A COMPOUND-1(2,5,6-TRISUBSTITUTEDPYRIDINE)-3-YI]AMINOCARBONYL]-4-(SUBSTITUTEDSAMJIN PHARMACEUTICAL CO., LTD.PHENYL) PIPERAZINE793 385/KOLNP/2004 212573 04-12-2007ARALKYL-TETRAHYDRO-PYRIDINES, THEIRPREPARATION AND PHARMACEUTICAL SANOFI-AVENTISCOMPOSTIONS CONTAINING SAME794 1396/KOLNP/2003 212576 04-12-2007ORO DISPERSIBLE SOLID PHARMACEUTICALFORMULATION AND PREPARATIONROQUETTE FRERES795 1270/CAL/1998 212583 04-12-2007DERIVATIVES OF ACYL-PIPERAZINYL-PYRIMIDINE AND A PHARMACEUTICAL LABORATORIOS DEL DR. ESTEVE S.A.COMPOSITION THEREOF796 187/KOLNP/2005 212588 04-12-2007FORMULATION FOR INWARDLYTRANSFERRING NUCLEIC ACIDS INTO A VONTEC GMBHEUKARYOTIC CELLS797 351/KOLNP/2004 212596 04-12-2007A PHARMACEUTICAL COMPOSITION FOR THEPROPHYLAXIS AND/OR THERAPY OFBROMHIDROSIS AND IMPROVEMENT OFALLERGAN INC.GENERAL BODY ODOUR798 58/CAL/1999 212601 04-12-2007A PHARMACEUTICAL EXCIPIENT SUITABLEMERCK PATENT GESELLSCHAFT MITAS A SOLUBILITY ENHANCER FOR ABESCHRANKTER HAFTUNGPHARMACEUTICAL COMPOSITION799 IN/PCT/2000/00621/KOL 212614 04-12-2007TABLET COMPRISING LEVOTHYROXINESODIUM, GELATINE AND FILLERSMERCK PATENT GMBH

800 IN/PCT/2001/33/KOL 212615 04-12-2007 "NEW ANTIMICROBIAL COMPOUNDS" SANKYO COMPANY LIMITED801 443/CHENP/2004 212623 05-12-2007CYSTEINE PROTEASE INHIBITORS WITH 2-CYANO-4-AMINO-PYRIMIDINE STRUCTURE NOVARTIS AGAND CATHEPSIN K INHIBITORY ACTIIVITY802 1743/CHENP/2003 212625 05-12-2007 MALONONITRILE COMPOUNDS SUMITOMO CHEMICAL COMPANY, LIMITED803 3775/DELNP/2004 212655 10-12-2007 STABLE ORAL SOLID DRUG COMPOSITION ASTELLAS PHARMA INC.804 IN/PCT/2001/00914/DEL 212664 10-12-2007ORAL PHARMACEUTICAL IBUPROFEN LABORATOIRES DES PRODUITS ETHIQUESSUSPENSIONETHYPHARM805 370/KOLNP/2004 212684 12-12-2007A PHARMCEUTICAL COMPOSITION FORTHE RESEARCH FOUNDATION OF STATETREATING HYPERTENSION AND HEARTUNIVERSITY OF NEW YORKFAILURE.806 397/KOLNP/2004 212685 12-12-2007AN AQUEOUS SOLUTION CONTAINING AREDUCED COENZYME QKANEKA CORPORATION807 982/KOLNP/2004 212687 12-12-2007PHARMACEUTICAL COMPOSITION FOR ORALUSE WITH IMPROVED ABSORPTION.ASTELLAS PHARMA INC.HYPOTENSIVE LIPID (PROSTAGLANDIN808 1346/KOLNP/2003 212695 12-12-2007 DERIVATIVES ) AND TIMOLOL COMPOSITIONS ALLERGAN INC.AND METHODS OF USING SAME809 242/KOLNP/2003 212710 12-12-2007PEPTIDOMIMETIC COMPOUNDS ANDPHARMACEUTICAL COMPOSITIONSVERTEX PHARMACEUTICALS INCORPORATED810 346/KOLNP/2004 212714 12-12-2007PHENETHANOLAMINE DERIVATIVES FORTREATMENT OF RESPIRATORY DISEASES.GLAXO GROUP LIMITED811 470/KOLNP/2005 212721 12-12-2007A PHARMACEUTICAL KIT FOR TREATMENT OFAMMANNATI, PAOLARETINITIS PIGMENTOSA812 633/KOLNP/2005 212727 12-12-2007NOVEL PHARMACEUTICAL FORMULATIONSOF MODAFINILCEPHALON, INC.813 IN/PCT/2000/94/KOL 212733 12-12-2007A PHARMACEUTICAL COMPOSITIONCOMPRISING ALKYL HYDROGEN FUMERATEFUMAPHARM AG814 IN/PCT/2000/193/KOL 212734 12-12-2007 PHARMACEUTICAL COMPOSITIONS GLAXO GROUP LIMITED815 IN/PCT/2001/1225/KOL 212737 12-12-2007NOVEL DERIVATIVES AND ANALOGUES OFGALANTHAMINPHARMACEUTICAL COMPOSITION816 IN/PCT/2002/1252/KOL 212743 12-12-2007 COMPRISING (R)-(-)-2-[5-(4-FLUOROPHENY)-3- MERCK PATENT GMBHPYRIDYLMETHYLAMINOMETHYL]-817 IN/PCT/2002/1302/KOL 212745 12-12-2007818 IN/PCT/2001/879/CHE 212755 14-12-2007819 78/CHENP/2003 212756 14-12-2007820 IN/PCT/2001/1140/CHE 212764 14-12-2007A FORMULATION USEFUL TO IMPROVECIRCULATION OF STEM CELLS ANDPROGENITOR CELLS IN MAMMAL.QUINOLINE AND QUINOXALINECOMPOUNDSA PHARMACEUTICAL COMPOSITIONCOMPRISING A PHARMACEUTICAL CARRIEROR EXCIPIENT AND AS ACTIVE INGREDIENTAN ACRYLOYL DISTAMYCIN DERIVATIVENOVEL 3-PHENYLPYRIDINEDERIVATIVESSANOCHEMIA PHARMAZEUTIKAAKTIENGESELLSCHAFTGENTIUM SPAAVENTIS PHARMACEUTICALS INCNERVIANO MEDICAL SCIENCES SRLF. HOFFMANN-LA ROCHE AG

821 IN/PCT/2001/779/CHE 212815 17-12-2007N-SUBSTITUTED 2-CYANOPYRROLIDINESNOVARTIS AG822 IN/PCT/2002/98/CHE 212945 17-12-2007 a pharmaceutical composition PHARMACIA & UPJOHN COMPANY823 168/CHENP/2005 212953 17-12-2007 3,10 and 12A substituted tetracycline compounds PARATEK PHARMACEUTICALS INCCOMPOSITION FOR USE IN THE TREATMENT824 183/MUM/20002 212955 19/12/2007INTER ALIA, OF ASTHMA AND OTHERCADILA HEALTHCARE LIMITEDBRONCHIAL CONDITIONS AND PREPARATIONTHEREOF825 306/MUM/2004 212956 19/12/2007A PHARMACEUTICAL GASTRO RETENTIVEDELIVERY SYSTEMCADILA HEALTHCARE LIMITED826 1034/KOLNP/2004 212961 19-12-2007A PHARMACEUTICAL COMPOSITION FORPROMOTING HAIR GROWTH.GOVERNMENT OF THE UNITED STATES OFAMERICA AS REPRESENTED BY THESECRETARY OF THE DEPARTMENT OF HEAL"4-'7-HALO-2-QUINO (XA-) LINYLOXY !827 1569/KOLNP/2004 212965 19-12-2007 PHENOXY- PROPIONIC ACID DERIVATIVES AS WAYNE STATE UNIVERSITYANTINEOPLASTIC AGENTS828 IN/PCT/2001/920/KOL 212984 19-12-2007 NOVEL COMPOUNDS AS ANTIVIRLA AGENT. BIOTA SCIENTIFIC MANAGEMENT PTY LTD829 IN/PCT/2002/782/KOL 212990 19-12-2007SUBSTITUTED PIPERAZINE AND PIPERIDINECALCIUM CHANNEL BLOCKERS.NEUROMED TECHNOLOGOES INC.830 2663/DEL/1996 213003 19-12-2007THIAZOLYL OXADIAZINE COMPOUNDS OFFORMULA IISYNGENTA PARTICIPATIONS AG831 18/DEL/2003 213005 19-12-2007HERBAL COMPOSITION FOR TREATINGDISORDERS ASSOCIATED WITH MENOPAUSESYEDA AAMENA NAAZ832 IN/PCT/2000/543/CHE 213020 19-12-2007composition to enhance cognitive function inhuman or non-human animalPHYTOPHARM PLC833 IN/PCT/2000/643/CHE 213022 19-12-2007 compounds from moraxella catarrhalis SMITHKLINE BEECHAM BIOLOGICALS S. A834 IN/PCT/2000/782/CHE 213024 19-12-2007substituted benzo (B) theipine derivatives andmethod of production thereofSANOFI-AVENTIS DEUTSCHLAND GMBH835 1619/DEL/1998 213027 19-12-2007A NOVEL ORAL DOSAGE FORM TO BEDELIVERED TO THE STOMACHTHE PROCTER & GAMBLE COMPANY836 IN/PCT/2001/460/CHE 213044 19-12-2007 controlled release pharmaceutical composition ROHM GMBH837 IN/PCT/2001/610/CHE 213049 19-12-2007n-arylsulfonyl amino acid omega amides and theprocess for their separationSANOFI-AVENTIS DEUTSCHLAND GMBH838 IN/PCT/2001/991/CHE 213051 19-12-2007 macrolides with anti inflammatory activity ZAMBON GROUP S.P.A839 IN/PCT/2002/1073/CHE 213054 19-12-2007SUBSTITUTED BENZOYLGUANIDINES,METHOD FOR THEIR PRODUCTION, THEIRPRODUCTION, THEIR USE AS MEDICAMENT SANOFI-AVENTIS DEUTSCHLAND GMBHOR DIAGNOSTIC AGENT AND A MEDICAMENTCONTAINING THE SAME840 IN/PCT/2002/231/CHE 213056 19-12-2007A PHARMACEUTICAL COMPOSITION ADAPTEDPHOTOGEN, INCFOR TOPICAL APPLICATION841 1592/CHENP/2004 213062 19-12-2007NOVEL INTERMEDIATES FOR LINEZOLID ANDSYMED LABS LIMITEDRELATED COMPOUNDS

842 1329/CHENP/2003 213069 19-12-2007combination comprising a signal transduction inhibitorNOVARTIS AGand an lipothilone derivative843 364/CHENP/2004 213075 19-12-2007 c-14 oxidation of morphone derivatives N.V. ORGANON844 444/CHENP/2004 213077 19-12-2007 pyrrolopyrimidine enitrile NOVARTIS AG845 467/CHENP/2004 213078 19-12-2007THIENO[2,3-D]PYRIMIDINES WITH COMBINEDLH AND FSH AGONISTIC ACTIVITYN.V. ORGANONGLYCINE-SUBSTITUTED THIENO [2,3-846 468/CHENP/2004 213079 19-12-2007 d]PYRIMIDINES WITH COMBINED LH AND FSH N.V. ORGANONAGONISTIC ACTIVITY847 1997/CHENP/2003 213083 19-12-2007AMINOACETONITRILE COMPOUNDS FORCONTROLLING ENDOPARASITESNOVARTIS AG848 2846/CHENP/2004 213088 19-12-2007a lipid compound and a pharmaceuticalcomposition comprising the sameIC VEC LIMITED849 3133/CHENP/2004 213091 19-12-2007pyridyl-triazine derivatives as microbicidal activeCIBA SPECIALTY CHEMICALS HOLDING INCsubstances850 1978/CHENP/2004 213095 20-12-2007composition comprising anti infective agents andCHARITE UNIVERSITATSMEDIZIN BERLINimmunomodulators851 2029/CHENP/2004 213096 20-12-2007neurotensin active 2,3 diaryl pyrazolidinederivativesSOLVAY PHARMACEUTICALS B.V852 1152/CHENP/2005 213098 20-12-2007TRANS-9,10-DEHYDROEPOTHILONE CAND D, ANALOGS THEREOF AND KOSAN BIOSCIENCES INCORPORATEDMETHODS OF MAKING THE SAME853 201/CHENP/2005 213104 20-12-2007 novel indoline compound KYOTO PHARMACEUTICAL INDUSTRIES, LTD854 IN/PCT/2002/1892/CHE 213115 20-12-2007arylmethylamine derivatives of formula 1 astryptase inhibitorsAVENTIS PHARMACEUTICALS INC855 1273/MAS/1998 213117 20-12-2007composition containing an inhibitor of factor Xand an anti-platelet aggregation agentSANOFI-SYNTHELABO856 1426/MAS/1996 213119 20-12-2007 novel piperidines F.HOFFMANN-LA ROCHE AG857 1648/MAS/1997 213121 20-12-2007a pharmaceutical composition intended to preventSANOFI-SYNTHELABOthe proliferation of tumour cells858 1724/MAS/1997 213122 20-12-2007vaccine composition comprising malaria derivedantigens and an adjuvantSMITHKLINE BEECHAM BIOLOGICALS S A859 1829/MAS/1996 213123 20-12-2007 a phenylacetic acid derivative BASF AKTIENGESELLSCHAFT860 2294/MAS/1996 213125 20-12-2007 matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG861 352/MAS/1999 213127 20-12-2007 calcium complex and food fortified therewith SOCIETE DES PRODUITS NESTLE SAA NOVEL AND NON-INVASIVEPHARMACEUTICAL COMPOSITION USEFUL862 605/MAS/2002 213128 20-12-2007 FOR THE TREATMENT IN SEXUAL IMPOTENCE, NATCO PHARMA LIMITEDAND A PROCESS FOR PREPARING THE SAIDCOMPOSITION863 821/MAS/1996 213129 20-12-2007 MODIFIED CELLULOSE ETHERS HOECHST AKTIENGESELLSCHAFT

864 IN/PCT/2000/710/CHE 213131 20-12-2007SUBSTITUTED (4-BROMPYRAZOLE-3-YL)BENZAZOLESBASF AKTIENGESELLSCHAFT865 IN/PCT/2001/1400/CHE 213132 20-12-2007DI-ARYL ACID DERIVATIVES AS PPARRECEPTOR LIGANDS AND APHARMACEUTICAL COMPOSITIONAVENTIS PHARMA DEUTSCHLAND GMBHCOMPRISING THE SAME866 IN/PCT/2001/1520/CHE 213133 20-12-2007 CCR5 ANTAGONISTS OF FORMULA H SCHERING CORPORATION867 IN/PCT/2001/1583/CHE 213134 20-12-2007CINNAMOLYAMINO ALKYL-SUBSTITUTEDBENZENESULFONAMIDE DERIVATIVES AND SANOFI-AVENTIS DEUTSCHLAND GMBHPROCESSES FOR THEIR PREPARATION868 IN/PCT/2001/978/CHE 213139 20-12-2007CLARATHATES OFDEHYDROEPIANDROSTERONE ANDCORRESPONDING PHARMACEITICALEUPHAR GROUP S.R.LCOMPOSITIONSS869 IN/PCT/2002/1026/CHE 213140 20-12-2007A PHARMACEUTICAL COMPOSITIONCOMPRISING A SEROTONIN REUPTAKE H. LUNDBECK A/SINHIBITOR AND DERAMCICLANE870 869/MUM/2004 213142 20/12/2007A HERBAL COMPOSITION FOR THETREATMENT OF DAMAGED AND FRACTURED AJAY BHAGWANDAS BAROTBONE871 IN/PCT/2002/1666/MUM 213176 24/12/2007A COMPOUND AND A PHARMACEUTICALCOMPOSITION FOR USE IN ENHANCING SMITH KLINE BEECHAM CORPORATIONPLATELET PRODUCTION872 IN/PCT/2002/603/MUM 213186 24/12/2007 A PHARMACEUTICAL COMPOSITION SMITH KLINE BEECHAM PLCHYDRATE OF 5-[4-[2-(N-METHYL-N-(2-873 IN/PCT/2000/00076/MUM 213203 24-12-2007PYRIDIL)AMINO) ETHOXY] BENZYL]THIAZOLIDINE-2, 4-DIONE MALEIC ACIDSMITHKLINE BEECHAM PLCSALT874 179/MUM/2003 213206 24/12/2007 TOPICAL PHARMACEUTICAL PREPARATIONS CIPLA LIMITED875 374/CHENP/2005 213247 26-12-2007A RECOMBINANTLY PRODUCED IGGANTIBODY SPECIFIC FOR FcGAMMARIIBMACROGENICS INC876 137/KOLNP/2005 213254 26-12-2007ACYLOXYPYRROLIDINE DERIVATIVES ANDUSE THEREOF AS LIGANDS OF V 1B OR BOTH SANOFI-AVENTISV 1B AND V 1A RECEPTORS877 1631/KOLNP/2003 213257 26-12-2007SUSTAINED RELEASE FORMULATIONS OFOXYMORPHONE.PENWEST PHARMACEUTICALS COMPANY.878 in/pct/2002/00319/mum 213266 26/12/2007ciclesonide containing aqueous pharmaceuticalcompositionNYCOMED GMBH879 IN/PCT/2001/68/MUM 213295 26/12/2007BENZOCYCLOHEPTENES OF GENERALFORMULA ISCHERING AKTIENGESELLSCHAFT880 321/MUMNP/2005 213304 26/12/2007 CRYSTAL MODIFICATION OF CYANO…. BASF AKTIENGESELLS CHAFT

881 119/MUMNP/2005 213311 27-12-2007FORMULATION AND DOSAGE FORM FORINCREASING ORALBIO AVAILABILITY OFALZA CORPORATIONHYDROPHILIC MACROMOLECULESAN ANTISPASMODIC AND AN ANALGESIC882 175/MUM/2004 213319 27/12/2007 COMBINATION AND TO A METHOD OF SANJEEV KHANDELWALMAKING THE SAME883 72/MUM/2004 213330 27/12/2007A NOVEL CAPSULE OF ACTIVEPHARMACEUTICAL INGREDIENTSL M COLLEGE OF PHARMACY884 15/MUMNP/2004 213332 27/12/2007 ARTHROPODICIDAL ANTHRANILAMIDES E I DU PONT DE NEMOURS AND CO,A NOVEL HERBAL COMPOSITION FOR885 478/DEL/2000 213348 27-12-2007 DIABETIC PATIENTS AND A PROCESS FOR DABUR RESEARCH FOUNDATIONPRODUCING THE SAME886 671/MUM/2001 213392 01-01-2008 PYRAZOLYLBIPHENYLCARBOXAMIDES BAYER AKTIENGESELLSCHAFT887 1333/MUM/2003 213402 01-01-2008HERBAL PHARMACEUTICAL COMPOSITIONSIN JELLY FORMULATIONSLYKA LABS LIMITEDN - TRIAZOLYLMETHYL-PIPERAZINE888 909/MUM/2002 213405 01-01-2008 COMPOUNDS WITH NEUROKININ - RECEPTOR SOLVAY PHARMACEUTICALS B.VANTAGONIST ACTIVITY889 387/KOLNP/2005 213425 02-01-2008NUCLEOSIDE DERIVATIVES FOR TREATINGHEPATITIS C VIRUS INFECTIONGENELABS TECHNOLOGIES INC.890 476/KOLNP/2005 213428 02-01-2008 A PYRAZOLE CARBOXYLIC ACID CIMPOUND ARENA PHARMACEUTICALS, INC891 IN/PCT/2000/162/KOL 213436 02-01-2008ALPHA-KETOAMIDE INHIBITORS OF 20SPROTEASOME.CV THERAPEUTICS, INC.892 IN/PCT/2000/585/KOL 213439 02-01-20084-SUBSTITUTED-2-CARBOXYTETRAHYDROQUINOLINE COMPOUNDSGLAXO WELLCOME SPA893 IN/PCT/2001/45/KOL 213441 02-01-2008 MEDICINAL AEROSOL FORMULATIONS JAGO RESEARCH AGPHARMACEUTICAL FORMULATIONS894 IN/PCT/2001/636/KOL 213442 02-01-2008 CONTAINING FLOUROALKANES AND IVAX RESEARCH, INC.BUDESONIDE.895 IN/PCT/2002/1019/KOL 213446 02-01-2008 AZACYCLIC COMPOUNDS ACADIA PHARMACEUTICALS, INC.896 IN/PCT/2002/1342/KOL 213447 02-01-20082-ACYL INDOLE DERIVATIVES AND THEIR USEBAXTER HEALTHCARE SA.AS ANTITUM OR AGENTS897 IN/PCT/2002/1415/KOL 213450 02-01-2008 B-CARBOLINE COMPOUNDS ORTHO - MCNEIL PHARMACEUTICAL, INC.898 IN/PCT/2002/891/MUM 213457 02-01-2008A PHARMACEUTICAL COMPOSITION FORTREATING HEPATITIS B INFECTIONBRISTOL- MAYERS SQUIBB CO,899 1045/DEL/2003 213480 02-01-20084-ARYL-2,6 DIMETHYL-3-CARBOETHOXY-5-COUNCIL OF SCIENTIFIC AND INDUSTRIALCARBOMETHOXY-1,4-DIHYDROPYRIDINESRESEARCHUSEFUL AS THERAPEUTIC AGENTS"A PHARMACEUTICAL COMPOSITION900 628/MUMNP/2004 213512 07-01-2008COMPRISING AS ACTIVE INGREDIENT aCRYSTALLINE FORM OF THE COMPOUND OFLES LABORATORIES SERVIERFORMULA ( I )901 1304/MUM/2003 213541 08-01-2008 STABLE ORAL COMPOSITION SUN PHARMACEUTICAL INDUSTRIES LTD902 72/MUM/2005 213545 08-01-2008 NOVEL SATUIRATED… MILLIKEN & COMPANY

903 248/MUMNP/2004 213546 08-01-2008904 IN/PCT/2001/816/MUM 213551 08-01-2008905 445/MUMNP/2003 213576 09-01-2008PEPTIDES FOR TREATMENT OF THE HUMANPAPILLOMAVIRUS (HIV)- ASSOCIATEDCANCER AND OTHER EPITHELIAL TUMORSCENTRO DE INGENEIRIA GENETICA YBIOTECHNOLOGIAPOTASSIUM SALT OF (S) - OMEPRAZOLE FORMASTRAZENECA ABBA COMPOSITION COMPRISING 11B-(4-ACETYLPHENYL)-17B-HYDROXY-17a-(1,1,2,2,2,-PENTAFLUOROETHYL) ESTRA-4,9-DIEN-3-ONEOR A PHARMACEUTICALLY ACCEPATBLEDERIVATIVE OR ANALOGUE THEREOFSCHERING AKTIENGESELLSCHAFT906 IN/PCT/2001/598/MUM 213578 09-01-2008SUSTAINED RELEASE MATRIX SYSTEMS FORHIGHLY SOLUBLE DRUGSPENWEST PHARMACEUTICALS CO,907 4/MUMNP/2003 213581 09-01-2008A COMPOUND OF FORMULA I AS A PROTEINKINASE INHIBITORBRISTOL- MAYERS SQUIBB CO,908 IN/PCT/2001/00815/MUM 213593 09-01-2008 NOVEL 6 - PHENYLPHENANTHRIDINES NYCOMED GMBH.909 1831/KOLNP/2004 213638 09-01-2008ANTIMYELIN ASSOCIATED GLYCOPROTEIN(MAG) ANTIBODIESGLAXO GROUP LIMITED910 1021/KOLNP/2004 213640 09-01-2008BICYCLIC CB2 CANNABINOID RECEPTORLIGANDSPHARMOS CORPORATION911 78/KOLNP/2005 213659 09-01-2008LIQUID PREPARATION COMPRISINGOLIGOPEPTIDES AND ETHERIFIEDCYCLODEXTRINMERCK PATENT GMBH912 IN/PCT/2000/285/KOL 213669 09-01-2008 QUINOLINE DERIVATIVES ACTIVE BIOTECH AB913 IN/PCT/2000/316/KOL 213670 09-01-2008SOLID, RAPIDLY DISINTEGRATINGCETIRIZINE FORMULATIONSVIATRIS GMBH & CO. KG.914 IN/PCT/2001/725/KOL 213675 09-01-2008TRICYCLIC BENZODIAZEPINES ASVASOPRESSIN RECEPTOR ANTAGONISTSORTHO-MCNEIL PHARMACEUTICAL, INC.915 1621/mum/2005 213685 10-01-2008 novel aerosol compositions of sodium fusidate salgoacar dilip ramcrisna916 1368/mumnp/2005 213693 10-01-2008novel intermediate for the preparation oftherapeutically active imidazopyridines andprocess for preparing the samealtana pharma ag917 319/MUMNP/2005 213697 10-01-2008918 1132/mumnp/2006 213701 10-01-2008919 IN/PCT/2002/00313/MUM 213717 10-01-2008920 IN/PCT/2001/00123/DEL 213748 11-01-2008921 470/MUMNP/2005 213840 18/01/2008A SUSTAINED RELEASE ORAL SOLIDDOSAGE FORMnovel indole derivative for alkylating specific basesequence of DNA and alkylating agent and drugeach comprising the sameNOVEL THIAZOLO[4,5-D]PYRIMIDINECOMPOUNDSNON-CYTOLYTIC RECOMBINANT HUMANIMMUNODEFICIENCY VIRUS-1 AND VACCINEINCORPORATING SAID VIRUSCOMPOUNDS OF AMIDINE OF GENERALFORMULA (I') AND PHARMACEUTICALCOMPOSITION THEREOF.PENWEST PHARMACEUTICAL COtmrc co. ltd.ASTRAZENECA UK LIMITEDUNIVERSITY OF WESTERN ONTARIOSOCIETE DE CONSEILS DE RECHERCHES ETD'APPLICATIONS SCIENTIFIQUES S.A.S.

922 IN/PCT/2002/1444/MUM 213842 21/01/2008DIAZABICYCLIC CENTRAL NERVOUS SYSTEMABBOTT LABORATORIESACTIVE AGENTS923 255/MUMNP/2003 213854 21/01/2008A PHARMACEUTICAL PRODUCT COMPRISINGA HALOGENATED INHALATION ANESTHETICBAXTER INTERNATIONAL INC924 139/MUM/2002 213857 22/01/2008NEW HETEROCYCLIC COMPOUNDS FORTHERAPEUTIC USEJ B CHEMICAL & PHARMACEUTICALS LTDNOVEL 1,2,3-SUBSTITUTED INDOLIZINE925 1212/KOLNP/2004 213959 23-01-2008DERIVATIVES, INHIBITORS OF FGFS, METHODSANOFI-AVENTISFOR MAKING SAME AND PHARMACEUTICALCOMPOSITIONS CONTAINING SAME.926 424/KOLNP/2005 213985 23-01-2008 A SUBSTITUTED 4-(INDAZOL-3-YL) PHENOL WYETH927 855/KOLNP/2003 213993 23-01-2008PHARMACEUTIC AL OR NUTRITIONALCOMPOSITION FOR THE TREATMENT ORPROPHYLAXIS OF ANY OR ALL OFBIOTIE THERAPIES CORPCONDITIONS DUE TO PRESENCE OF928 IN/PCT/2001/484/KOL 213997 23-01-2008A PHARMACEUTICAL COMPOSITIONCOMPRISING AN ANGIOTENSIN CONVERTING G. D. SEARLE & CO.ENZYME INHIBITOR929 231/MUMNP/2005 214011 23-01-2008AQUEOUS FORMULATION COMPRISINGMOXIFLOXACIN HYDROCHLORIDE AND BAYER HEALTHCARE AGSODIUM CHLORIDE930 646/mum/2003 214041 24/01/2008a phenylbenzamide of formula and process forpreparing the sameBAYER CORPORATION931 75/mum/2005 214054 25/01/2008pharmaceutical compositions comprising misprostolfor vaginal suppository dosage form and process for lincoln pharmaceuticals limitedpreparation thereof932 603/mum/2002 214056 25/01/2008PYRAZOLINE DERIVATIVES OF THE FORMULABAYER AKTIENGESELLSCHAFT( I )933 1056/MUM/2002 214064 25/01/2008NOVEL HAIR GROWTH RETARDANT ORINHIBITORCADILA HEALTHCARE LIMITED934 1463/KOLNP/2003 214076 30-01-2008PYRIMIDINE DERIVATIVES USEFUL ASSELECTIVE COX-2-INHIBITORSGLAXO GROUP LIMITED.935 1627/KOLNP/2005 214078 30-01-2008LIQUID INTRANASAL PHARMACEUTICALFORMULATIONSCHWARZ PHARMA AG936 1528/KOLNP/2003 214080 30-01-2008 OXAZOL/THIAZOL COMPOUNDS GLAXO GROUP LIMITED937 1743/KOLNP/2004 214081 30-01-2008 KINASE INHIBITOR COMPOUNDS CYTOPIA PTY LTD.938 440/KOLNP/2005 214090 30-01-2008ANTIDEPRESSANT PIPERIDINE DERIVATIVESOF HETEROCYCLE-FUSED BENZODIOXANSWYETH939 274/mumnp/2004 214093 30/01/2008TRIPLE-TARGETING, CHIRAL, BROAD-SPECTRUM ANTIMICROBIAL 7-SUBSTITUTEDPIPERIDINO-QUINOLONE CARBOXYLIC ACID WOCKHARDT LIMITEDDERIVATIVES , THEIR PREPARATION,COMPOSITIONS AND USE AS MEDICAMENTS940 746/KOLNP/2005 214098 30-01-2008COMPOUNDS CAPABLE OF ACTIVATINGCHOLINERGIC RECEPTORSTARGACEPT, INC.

941 777/KOLNP/2003 214103 30/01/2008943 19/DEL/2000 214108 30-01-2008PHARMACEUTICAL COMPOSITION FOR THETREATMENT OF DISEASES CAUSED BYTHROMBUS OR EMBOLUS.SANKYO COMPANY LIMITED, UBE INDUSTRIESLTD942 in/pct/2001/00576/mum 214104 30/01/2008 vitronectine receptor antagonist pharmaceuticals BRISTOL- MAYERS SQUIBB CO,NOVEL COMPOSITION FOR STABILIZATION OFPHARMACEUTICALLY ACTIVEPANACEA BIOTEC LIMITEDCHEMICAL/BIOLOGICAL AGENTS944 367/DEL/1996 214115 30-01-2008 VACCINE COMPOSITIONS SMITHKLINE BEECHAM BIOLOGICALS S.A.945 1316/DEL/1997 214116 30-01-2008A PHARMACEUTICAL PREPARATIONCONSISTING OF A SOLID DISPERSION.JANSSEN PHARMACEUTICA N.V.946 2490/DELNP/2005 214118 30-01-2008N-(SUBSTITUTED ARYLMETHYL) -4-(DISUBSTITUTED METHYL)PIPERIDINES ANDPYRIDINESBAYER CROPSCIENCE AG.947 815/mum/2002 214127 04-02-2008soirocyclic 3-phenyl-3-substituted-4-ketolactams andlatonesBAYER AKTIENGESELLSCHAFT948 in/pct/2001/00940/mum 214128 04-02-2008epothilone compounds of general formula and apharmaceutival composition thereofSCHERING AKTIENGESELLSCHAFT949 992/MUM/2002 214134 04-02-2008NOVEL SUBSTITUTED ARALKYLDERIVATIVES HAVING ANTIDIABETICHYPOLIPIDEMIC HYPOCHOLESTEREMICACTIVITIES PROCESS FOR THEIRCADILA HEALTHCARE LIMITEDPREPARATION AND PHARMACEUTICALCOMPOSITIONS CONTAINING THEM ANDTHEIR USE IN MEDICINE950 222/mumnp/2003 214135 04-02-2008 A 4-aminoquinazoline compound BOEHRINGER INGELHEIM PHARMA GMBH &CO. KG.951 IN/PCT/2002/1151/CHE 214145 05-02-20081,3-DISUBSTITUTED PYRROLIDINES AS ALPHA -NOVARTIS AG2-ADRENORECEPTOR ANTAGONISTS952 IN/PCT/2002/1156/CHE 214146 05-02-2008A HALOGEN SUBSTITUTED 4-PHENYL-1-PIPERANZINYL DERIVATIVEH. LUNDBECK A/S953 IN/PCT/2002/264/CHE 214148 05-02-2008A VACCINE COMPOSITION AND METHOD OFPRODUCING SAMEIMMUNOBIOLOGY LIMITED954 IN/PCT/2002/526/CHE 214150 05-02-2008 PENTACYCLIC TAXANE COMPOUND DAIICHI SANKYO COMPANY LIMITED955 IN/PCT/2002/838/CHE 214152 05-02-2008PHARMACEUTICAL COMBINATIONS FORTREATING GASTRO-INTESTINAL DISORDERSNOVARTIS AG956 858/BOM/1999 214162 05-02-2008SUBSTITUTED BICYCLIC COMPOUNDS OFFORMULA IPFIZER PRODUCTS, INC.957 680/MUMNP/2003 214166 05-02-2008HERBAL COMPOSITION FOR ANGINAPECTORIS,METHOD TO PREPARE SAME ANDUSES THEREOFTIANJIN TASLY PHARMACEUTICAL CO.,LTD958 315/mumnp/2003 214177 05-02-2008 phenoxyphenyl alkanesulphonates BAYER AKTIENGESELLSCHAFT959 282/mum/2002 214189 07-02-2008 hetaryl substituted carbocyclic 1,3 diones BAYER AKTIENGESELLSCHAFT960 1087/mumnp/2003 214195 07-02-2008 an oral pharmaceutical formulation ASTRAZENECA AB

961 614/MUMNP/2003 214197 07-02-2008A COMPOUND 5-4-[2-(N-METHYL-N-(2-PYRIDYL)AMINO)ETHOXY]BENZYL]-THIAZOLIDINEDIONE-2,4-DIONE MESYLATESMITH KLINE BEECHAM PLCSALT,OR SOLVATE THEREOF962 327/mum/2002 214206 07-02-2008NOVEL 4- -(HETEROCYCLYL)-BENZENESULFOXIMINE COMPOUNDS AND CADILA HEALTHCARE LIMITEDPROCESS OF THEIR PREPARATION THEREOF963 in/pct/2002/01774/mum 214214 07-02-2008A pharmaceutical composition for the treatment ofrheumatoid arthritisBRISTOL- MAYERS SQUIBB CO,964 393/mumnp/2004 214218 07-02-2008 controlled release formulation of lamotrigine TORRENT PHARMACEUTICAL LTD,965 706/KOLNP/2004 214237 07-02-2008PHARMACEUTICAL COMPOSITION OFARGININE AND IBUPROFENCUMBERLAND PHARMACEUTICALS INC966 874/KOLNP/2003 214242 07-02-2008NOVEL COMPOUNDS AS BETA-3-ADRENORECEPTOR AGONISTGLAXO GROUP LIMITED967 604/CAL/2001 214276 07-02-2008NOVEL COMPOUNDS FOR THE MANAGEMENTOF AGING-RELATED AND DIABETICVASCULAR COMPLICATIONS, PROCESS FOR TORRENT PHARMACEUTICALS LTDTHEIR PREPARATION AND COMPOSITIONCOMPRISING THEM968 IN/PCT/2002/1212/KOL 214281 07-02-2008STABILIZED PHARMACEUTICALCOMPOSITIONS CONTAINING CALCIUM SANKYO COMPANY, LIMITEDCHANNEL BLOCKERS969 697/CHENP/2003 214298 07-02-2008NOVEL SERINE PROTEASE GENES RELATEDFERRING BV970 1176/CHENP/2003 214318 11-02-2008971 856/CHENP/2003 214320 11-02-2008972 391/MAS/2003 214329 11-02-2008973 1559/CHENP/2003 214337 11-02-2008974 1631/CHENP/2003 214339 11-02-2008975 47/CHENP/2004 214343 11-02-2008976 138/CHENP/2004 214344 11-02-2008977 260/CHENP/2004 214346 11-02-2008978 313/CHENP/2004 214347 11-02-2008TO DPPIVCONJUGATES OF IMMUNE CELL SPECIFICMACROLIDE COMPOUNDS AND A PROCESSFOR PREPARING THE SAMEA PHARMACEUTICAL COMPOSITION FORTREATMENT OF INFLAMMATORY ANDOBSTRUCTIVE AIRWAYS DISEASESGLAXOSMITHKLINE ISTRAZIVACKI CENTARZAGREB D.O.ONOVARTIS AGA MONOMER PYROMELLITIC DIANHYDRIDE SREE CHITRA TIRUNAL INSTITUTE FORGLYCEROL DIMETHACRYLATE (PMGDM) MEDICAL SCIENCES & TECHNOLOGYA PHARMACEUTICAL COMPOSITION ANDPHARMACIA CORPORATIONPROCESS FOR PREPARING THE SAME3,4-DISUBSTITUTED CYCLOBUTENE-1,2-SCHERING CORPORATIONDIONES AS CXC-CHEMOKINE RECEPTORPIPERAZINE OXIME DERIVATIVES HAVING NK-SOLVAY PHARMACEUTICALS B.V1 RECEPTOR ANTAGONISTS ACTIVITYA NOVEL COMPOUND OF FORMULA I ANDSCHERING CORPORATIONPHARMACEUTICAL COMPOSITION THEREOFSTABILIZED BIVALENT HEPATITIS A/TYPHOIDAVENTIS PASTEURFEVER IMMUNIZATION COMPOSITION6-(2,6-DIFLUORO-PHENYL)-TRIAZOLOPYRIMIDINES AND A PROCESS FOR BASF AKTIENGESELLSCHAFTTHEIR PREPARATION

979 872/CHENP/2004 214356 11-02-2008A PHARMACEUTICAL COMPOSITIONCOMPRISING A LYSIS DEFECTIVEGANGAGEN, INCBACTERIOPHAGE980 889/CHENP/2004 214358 11-02-2008DIBENZYLAMINE COMPOUNDS ,APHARMACEUTICAL COMPOSITIONJAPAN TOBACCO INCCOMPRISING THE SAME981 1344/CHENP/2004 214361 11-02-20085-PHENYLPYRIMIDINES,THEIR PREPARATION,COMPOSITIONS COMPRISING THEM AND BASF AKTIENGESELLSCHAFTTHEIR USE982 1386/CHENP/2004 214362 11-02-2008A MEDICAMENT AND A METHOD OFMANUFACTURING THE SAMENEUTEC PHARMA PLC983 1168/CHENP/2004 214363 11-02-2008PHARMACEUTICAL FORMULATIONSCOMPRISING AN IMMUNE RESPONSE 3M INNOVATIVE PROPERTIES COMPANYMODIFIER984 2756/CHENP/2004 214368 11-02-2008a pharmaceutical composition for treatment of woundsMEDIGENEScontaining blood plasma or serum985 2865/CHENP/2004 214369 11-02-2008 A DIBENZOAZULENE COMPOUND PLIVA - ISTRAZIVACKI INSTITUT D.O.O986 2880/CHENP/2004 214370 11-02-20081-[(INDOL-2-YL)CARBONYL]PIPERAZINEDERIVATIVESN. V. ORGANONA COMBINATION OF AN NMDA ANTAGONIST987 2954/CHENP/2004 214371 11-02-2008AND ACETYLCHOLINE ESTERASE INHIBITORSH. LUNDBECK A/SFOR THE TREATMENT OF ALZHEIMER'SDISEASE988 3122/CHENP/2004 214374 11-02-2008 PEGYLATED T20 POLYPEPTIDE COMPOUND F. HOFFMANN-LA ROCHE AG989 2175/CHENP/2004 214380 11-02-2008DIAZABICYCLO ALKANE DERIVATIVESWITH NKI ANTAGONISTIC ACTIVITYSOLVAY PHARMACEUTICALS B.V990 3689/DEL/1997 214398 11-02-2008 NOVEL COMPOUND NIHON NOHYAKU CO., LTD.991 1414/DEL/1999 214515 12-02-2008COMPOUND R-(-)-(E)-[4-(,4- DICHLOROPHENYL)-1,3- DITHIOLAN-2-YLIDENE]-1-IMIDAZOLYLACETONITRILA COMPOSITION COMPRISING A MIXTURE OF992 01265/DELNP/2003 214517 12-02-2008 TRITERPENES AND PROCESS FORBSP PHARMAPREPARATION THEREOF993 72/KOLNP/2004 214645 13-02-200817 ALFA , 21-DIHYDROXYPREGNENE ESTERSAS ANTIANDROGENIC AGENTSCOSMO S.P.A.994 708/DEL/1995 214653 13-02-2008 AN AZITHROMYCIN COMPOSITION PFIZER INC.995 650/CAL/2000 214665 15-02-2008MONOCLONAL ANTIBODY REACTIVE TOHUMAN CHOLESTROL ESTER TRANSFER JAPAN TOBACCO INCPROTEIN996 IN/PCT/2002/01077/DEL 214740 15-02-2008SUBSTITUTED STYRYL BENZYLSULFONES TEMPLE UNIVERSITY- OF THECOMMONWEALTH SYSTEM OF HIGHERFOR TREATING PROLIFERATIVE DISORDERS. EDUCATION.

HERBAL COMPOSITION FOR THE TREATMENTOF ANIMAL BITES ESPECIALLY SNAKE BITE997 672/DEL/2003 214744 15-02-2008PRASAD VAIDYA BANKE,AND EARLY STAGES OF HYDROPHOBIA, ANDA PROCESS OF PREPARING THE SAME998 1159/DEL/1996 214837 18-02-2008 A TRIAZOLO PYRIDINE COMPOUND PFIZER INC.ARALKYL AND ARALKYLIDENE999 2639/DEL/1997 214875 18-02-2008PFIZER INC.HETEROCYCLIC LACTAMS AND IMIDESANTIFUNGAL ORAL COMPOSITION1000 IN/PCT/2001/01141/DEL 214886 18-02-2008 CONTAINING ITRACONAZOLE AND PROCESS HANMI PHARM CO LTDFOR PREPARING SAMEA BITA-L(2'-AZIDO)-2',3'-DIDEOXY-5-CENTRE NATIONAL DE LA RECHERCHE1001 IN/PCT/2001/00467/DEL 214915 18-02-2008FLUOROCYTOSINE COMPOUNDSCIENTIFIQUE,ORAL CONTROLLED RELEASE1002 1050/MUM/2001 214918 18/02/2008SUN PHARMACEUTICAL INDUSTRIES LTDPHARMACEUTICAL COMPOSITIONCOMPOSITIONS COMPRISING MIXTURES OF1003 122/MUM/2001 214922 18/02/2008BAYER AKTIENGESELLSCHAFTCOMPOUNDS OF THE FORMULA ( I - b - 1 )1004 80/MUMNP/2005 214932 18/02/2008 pyrazolo pyramidine compound PFIZER INC.4,4-DIFLUORO-1,2,3,4-TETRAHYDRO-5H-1-BENZAZEPINE DERIVATIVE OR A1005 615/KOLNP/2004 214989 20-02-2008ASTELLAS PHARMA INCPHARMACEUTICALLY ACCEPTABLE SALT1006 1082/KOLNP/2004 214992 20-02-20081007 IN/PCT/2001/00576/DEL 215104 21-02-20081008 2838/DELNP/2005 215143 19-02-20081009 362/MUMNP/2005 215154 21/02/20081010 3133/DEL/1997 215210 21-02-20081011 2318/DELNP/2005 215211 24-01-20081012 437/MUMNP/2005 215218 22/02/20081013 IN/PCT/2000/00351/MUM 215225 22/02/20081014 1364/MUM/2004 215228 22/02/2008THEROF1-[ALKYL], 1-[HETEROARYL)ALKYL] AND 1-[ARYL)ALKYL]-7- (PYRIMIDIN-4-YL)-IMADAZO[1,2-a] PYRIMIDIN-5(1H)- ONEDERIVATIVESA PHARMACEUTICAL COMPOSITION FORTREATMENT OF HELPATITIS B VIRUSINFECTIONINDOTRICARBOCYANINE DYE OF GENERALFORMULA (I)y CRYSTALLINE FORM OF PERINDOPRILTERTBUTYLAMINE COMPOUND OF FORMULA(I)A COMPOUND OR A PHARMACEUTICALLYACCEPTABLE SALT AND A METHOD THEROFA SUBSTITUTED PYRROLO-PYRAZOLEDERIVATIVES AND ITS PROCESS FORPREPARATIONSANOFI- AVENTIS AND MITSUBISHI PHARMACORPORATIONCENTRE NATIONAL DE LA RECHERCHESCIENTIFIQUESCHERING AKTIENGESELLSCHAFTLES LABORATORIES SERVIERWARJNER-LAMBERT COMPANYPHARMACIA ITALIA S.P.A.,Substituted dihydro 3 halo 1 h pyrazole 5 carboxylateseldu pont denemours and companytheir preparation and useNOVEL INDOLINONE COMPOUNDS HAVINGAN INHIBITING EFFECT ON KINASES ANDCYCLINE/CDK COMPLEXESOral pharmaceutical tablet composition and process ofmaking the sameBOEHRINGER INGELHEIM PHARMA GMBH &CO. KG.J B CHEMICAL & PHARMACEUTICALS LTD

1015 IN/PCT/2001/00934/MUM 215231 22/02/20081016 IN/PCT/2001/00579/DEL 215252 22-02-2008c-21 modified epothilones 1) bristol-mayers squibb compnay 2) gesellschaft furbiotechnologies che forschung mbh(gbf), gesellsch aftfur biotechnologies che forchung mbh [gbf]A PHARMACEUTICAL COMPOSITIONCENTRE NATIONAL DE LA RECHERCHESCIENTIFIQUE1017 26/CHENP/2005 215364 26-02-2008NOVEL PIPERAZINYL-PYRAZINONEDERIVATIVES FOR THE TREATMENT OF 5- M/S. BIOVITRUM AB (publ)HT2A RECEPTOR RELATED DISORDERS1018 463/CHENP/2005 215387 26-02-2008BENZENESULFONATE SALTS OF 4-FLUORO-2-CYANOPYRROLIDINE DERIVATIVESTAISHO PHARMACEUTICAL CO., LTD1019 1055/CHENP/2005 215400 26-02-2008BIFUNCTIONAL PHENYLISO(THIO) CYANATES,METHOD AND INTERMEDIATE PRODUCTS BASF AKTIENGESELLSCHAFTFOR THE PRODUCTION THEREOF1020 1003/MAS/2000 215440 26-02-20082-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-N-METHYL-N-(6-MORPHOLIN-4-YL-4-O-TOLYL- F HOFFMANN-LA ROCHE AGPYRIDIN-3-YL)-ISOBUTYRAMIDE1021 144/MAS/2000 215447 26-02-2008 4-PHENYL-PYRIDINE DERIVATIVES HOFFMANN-LA ROCHE AG1022 IN/PCT/2001/1276/CHE 215457 26-02-2008PHARMACEUTICAL COMPOSITIONCONTAINING TOPO II CATALYTIC INHIBITORAND USE OF SAID INHIBITOR FORPREVENTION OR TREATMENT TISSUEDAMAGE BY EXTRAVASATIONTOPO TARGET A/S1023 836/DEL/1998 215477 27-02-20081024 777/DEL/2003 215478 27-02-20081026 660/KOLNP/2005 215519 27-02-2008SUSTAINED RELEASE COMPOSITION OFDRUGS ENCAPSULATED IN MICROPARTICLESOF HYALURONIC ACIDA PHARMACEUTICAL COMPOSITION FORTREATING SOLID TUMORS AND A METHOD OFPREPARING SAME THEREOF1025 97/KOLNP/2004 215514 27-02-2008 AN ANTINEOPLASTIC COMPOSITION WYETHIMMUNOGENIC COMPOSITION, VACCINEMADE THEREFROM, AND KIT CONTAININGSAID COMPOSITION1027 882/KOLNP/2004 215521 27-02-20081028 892/KOLNP/2004 215522 27-02-20081029 1386/KOLNP/2004 215527 27-02-2008AQUEOUS COMPOSITITIONS CONTAININGMETRONIDAZOLEPROTEIN HYDROLYSATE AND PLANT STEROLCONTAINING COMPOSITITION FORIMPROVING SERUM LIPID PROFILE ANDPREVENTING ATHEROSCLEROSISORAL PHARMACEUTICAL FORMULATION INTHE FORM OF AN AQUEOUS SUSPENSION OFMICROCAPSULES FOR THE MODIFIEDRELEASE OF ACTIVE PRINCIPLE(S)LG CHEMICAL LIMITEDNATIONAL INSTITUTE OF PHARMACEUTICALEDUCATION AND RESEARCH (NIPER)GLAXOSMITHKLINE BIOLOGICALS S.A.,DOW PHARMACEUTICAL SCIENCESRAISIO BENECOL OYFLAMEL TECHNOLOGIES1030 1415/KOLNP/2004 215528 27-02-2008 5HT 2C RECEPTOR MODULATORS ARENA PHARMACEUTICALS, INC.

1031 1535/KOLNP/2004 215531 27-02-2008HETEROCYCLIC COMPOUNDS WHICH INHIBITLEUKOCYTE ADHESION MEDIATED BY ELAN PHARMACEUTICALS, INC.ALPHA 4 INTEGRINS1032 1614/KOLNP/2004 215533 27-02-2008A COMPOSITION OF MATTERCOMPRISED OF A MISXTURE OF ATLEAST ONE FREE B RING FLAVONOIDUNIGEN PHARMACEUTICALS INC.AND AT LEAST ONE FLAVAN1033 1775/KOLNP/2004 215535 27-02-2008 AN AZULENE DERIVATIVE AND SALT ASTELLAS PHARMA INC1034 321/KOLNP/2005 215541 27-02-2008 THIOPHENE COMPOUNDS` SMITHKLINE BEECHAM CORPORATION1035 471/KOLNP/2005 215544 27-02-2008PYRROLE BASED INHIBITORS OF GLYCOGENSYNTHASE KINASE 3CHIRON CORPORATION1036 IN/PCT/2001/351/KOL 215552 27-02-2008STABILIZED PHARMACEUTICALCOMPOSITION IN LYOPHILIZED FORMFUJISAWA PHARMACEUTICAL CO. LTD1037 IN/PCT/2001/820/KOL 215554 27-02-2008 A PHARMACEUTICAL COMPOSITION ZENTARIS GMBH1038 2134/DEL/1998 215587 27-02-2008AMINOETHYLPHENOXYACETIC ACIDCOMPOUND AND PHARMACEUTICAL KISSEI PHARMACEUTICAL CO. LTD.COMPOSITION THEREOF1039 in/pct/2001/00026/mum 215599 28/02/2008a pharmaceutical composition for the treatment of BOEHRINGER INGELHEIM PHARMA GMBH &depressionCO. KG.1040 372/MUMNP/2005 215602 28/02/2008POLYMORPHIC CRYSTAL MODIFICATION B(FORM B) OF TELMISARTAN1041 IN/PCT/2002/00420/MUM 215611 28/02/2008A COMPOUND OF FORMULA I AND PROCESSOF PREPARATION THEREOFASTRAZENECA AB1042 in/pct/2000/00635/mum 215613 28/02/2008 peptide antiangiogenic drugs ABBOTT LABORATORIES1043 in/pct/2001/00799/mum 215758 03-03-2008 carboxyaryl substituted diphenyl ureas BAYER CORPORATION1044 227/DEL/1998 215761 03-03-2008A PHARMACEUTICAL COMPOSITION FOR THETREATMENT OF APPETENCY DISORDERSSANOFI SYNTHELABO1045 IN/PCT/2001/00360/DEL 215814 04-03-2008A BIAROMATIC VITAMIN D ANALOGUE AND APHARMACEUTICAL COMPOSITION THEREOFPHARMACEUTICAL COMPOSITIONS FOR THE1046 00070/DELNP/2003 215817 04-03-2008 TREATMENT OF MUCOSITIS, STOMATITIS ANDBEHCET'S SYNDROMEBOEHRINGER INGELHEIM PHARMA GMBH &CO. KG.GALDERMA RESEARCH & DEVELOPMENTS.N.C.SINCLAIR PHARMACEUTICALS LIMITED1047 IN/PCT/2002/00962/DEL 215830 04-03-2008 ECTEINASCIDIN COMPOUND PHARMA MAR, S.A.1048 2527/DELNP/2005 215848 04-03-2008A CONTRAST AGENT OF THE GENERALFORMULA IAMERSHAM HEALTH AS,1049 IN/PCT/2001/1579/CHE 215956 05-03-2008SUBTILASE ENZYMES HAVING AT LEAST ONEADDITIONAL AMINO ACID DIPEPTIDE ESTERDERIVATIVES AND SWEETENING AGENTNOVOZYMES A/S1050 IN/PCT/2001/448/CHE 215995 05-03-2008 THERAPEUTICAL MEDICAMENT LEUVEN RESEARCH & DEVELOPMENT VZW1051 562/mumnp/2005 215998 05-03-2008 pharmaceutical moxifloxacin preparation bayer healthcare ag1052 in/pct/2002/00663/mum 216013 05-03-2008 a compound of formula 1 HINDUSTAN LEVER LTD1053 777/DEL/1999 216033 05-03-2008 A NOVEL CYCLOSPORIN COMPOSITION PANACEA BIOTEC LIMITED1054 724/KOLNP/2005 216043 06-03-2008 A POLYNUCLEOTIDE VACCINE GLAXO GROUP LIMITED1055 1402/KOLNP/2005 216055 06-03-2008 GYRASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED

1056 IN/PCT/2000/136/CHE 216233 10-03-20081057 8/DEL/2000 216268 11-03-20081058 376/DEL/2000 216274 11-03-20081059 880/KOL/2005 216300 12-03-20081060 1077/KOLNP/2004 216304 12-03-20081061 1884/CAL/1997 216315 12-03-20081062 1292/CAL/1997 216316 12-03-20081063 1408/CAL/1998 216317 12-03-20081064 1832/CAL/1996 216318 12-03-2008AN ORALLY ADMINISTRABLE SOLID DOSAGEFORM COMPRISING A RIBAVIRINCOMPACTED COMPOSITION AND A METHODOF PRODUCING THE SAMESUBSTITUTED OXOBUTYRIC ACIDS ASMATRIX METALLOPROTEASE INHIBITORSA NOVEL COMPOUND 4-(P-METHOXYPHENYL)-2-AMINOBUTANE EXHIBITING GROWTHINHIBITION AND ANTIFEEDANT AVTIVITYAGAINST LARVAEA MEDICINAL COMPOSITION FOR CURINGPILES AND HARIS AND A METHOD FORPREPARING THE SAMESUSTAINED RELEASE PHARMACEUTICALCOMPOSITION1H-PYRIDO (3,4-B) INDOLE-4-CARBOXAMIDEDERI-VATIVES"SUSTAINED RELEASE MATRIX FOR HIGH-DOSE INSOLUBLE DRUGS"SYNERGISTIC RED BLOOD CORPUSCLE (RBC)AGGREGATING TONIC SOLUTIONS WITH ALONG SHELF FOR DETERMINING OSMOTICFRAGILITY OF RED CELLS IN MICROTITREPLATE WELLS.A MEDICAMENT SUITABLE FOR THEPREVENTION OF SEQUELAE OF CHROMICREDUCED CEREBRAL BLOOD SUPPLY.SCHERING CORPORATIONBAYER CORPORATIONCOUNCIL OF SCIENTIFIC AND INDUSTRIALRESEARCHHAKIM MAKHANLAL MALLICKSOCIETE DE CONSEILS DE RECHERCHES ETD'APPLICATIONS SCIENTIFIQUES, S.A.S.SANOFI-AVENTISPENWEST PHARMACEUTICALS CO.DR. MANJIT KAUR SHARMA.VIATRIS GMBH & CO. KG.1065 249/bom/1999 216339 03-12-2008a composition for the treatment of burns, cufs and likeCIPLA LIMITEDwounds1066 528/KOLNP/2005 216350 12-03-2008 GLYCOPEPTIDE ANTIBIOTIC DERIVATIVES CHIRON CORPORATION1067 593/CAL/1999 216362 12-03-2008HOMEOPATHIC COMPOSITION FOR THETREATMENT OF CANCER.DR. ALAKH MOHAN MATHUR1068 2177/DELNP/2005 216379 12-03-2008A 4-ANILINO QUINAZOLINE COMPOUND OFFORMULA 1PFIZER PRODUCTS INC.1069 904/mum/2002 216381 12-03-2008SUBSTITUTED THIENE-3-YLSULPHONYLAMINO[THIO]CARBONYLTRIAZOLIN[ETHI] ONESBAYER AKTIENGESELLSCHAFT1070 344/mum/2004 216384 12-03-20081071 182/mum/2002 216386 12-03-20081072 484/MUMNP/2005 216396 12-03-2008ifosfamide compositions for parenteral administrationsustained release pharmaceutical compositions andprocess for the preparation thereofNOVEL ECHINOCANDIN COMPOUND OFFORMULA IIBHARAT SERUMS & VACCINES LTD.CADILA HEALTHCARE LIMITEDNOVEXEL

1073 37/DEL/2000 216398 12-03-2008LIPOPHILIC MICROPARTICLES CONTAINING APROTEIN DRUG OR ANTIGEN ANDLG CHEMICAL LIMITEDFORMULATION COMPRISING SAME1074 1281/DEL/2004 216402 12-03-2008 AN ISOLATED PROTEIN DAIICHI FINE CHEMICAL CO. LTD.,1075 IN/PCT/2001/817/CHE 216443 13-03-2008ENZYMES HAVING AN ADDITIONAL AMINOACID RESIDUE IN AN ACTIVE SITE LOOP NOVOZYMES A/SREGION1076 IN/PCT/2002/17/CHE 216453 13-03-2008A PHARMACEUTICAL COMPOSITION FORREGULATING, INDUCING OR ENHANCING NOVO NORDISK HEALTH CARE AGCELL MIGRATION1077 108/MAS/2003 216471 13-03-2008NEW ANTICANCER COMPOUNDS,PROCESSFOR THEIR PREPARATION ANDOPHARMACEUTICAL COMPOSITIONDR. REDDY`S LABORATORIES LTD.CONTAINING SAME1078 2567/CHENP/2004 216506 13-03-2008(IMIDAZOL-1-YL-METHYL)-PYRIDAZINE ASNMDA RECEPTOR BLOCKERF. HOFFMANN-LA ROCHE AG1079 1223/DELNP/2005 216507 13-03-2008POLYSACCHARIDE VACCINE FORSTAPHYLOCOCCAL INFECTIONSTHE BRIGHAM AND WOMEN'S HOSPITAL, INC.,1080 2952/DELNP/2005 216508 13-03-2008A THIENOPYRIMIDINONE COMPOUND OFFORMULA (I)ASTRAZENECA AB,1081 1615/DELNP/2005 216510 13-03-2008PIPERIDINE COMPOUNDS USEFUL AS PPARACTIVATORSPFIZER PRODUCTS, INC.,1082 505/DEL/2000 216518 14-03-2008PHARMACEUTICAL COMPOSITIONSCOMPRISING BETULINIC ACID ANDDERVATIVES AND A METHOD FOR THEDABUR RESEARCH FOUNDATION,PREPARATION THEREOF1083 1211/DEL/2002 216519 14-03-2008 A NOVEL BETULINIC ACID DERIVATIVE DABUR RESEARCH FOUNDATION1084 728/DEL/1998 216531 14-03-2008 NOVEL PYRIMIDINE DERIVATIVES YUHAN CORPORATION1085 00856/DELNP/2004 216563 17-03-2008VACCINE COMPOSITION COMPRISING GRAM-BOEHRINGER INGELHEIM VETMEDICA S.A. DENEGATIVE, PLEOMORPHIC ROD-SHAPEDC.V.BACTERIUMCOMPOSITIONS CONTAIN THE COMPOUND OF1086 0821/DEL/1999 216564 17-03-2008 THE MITROGMANDINE COMPOUND MIXTURE BAYER AKTIENGESELLSCHAFT ,WITH FUNGICIDAL ACTIVE COMPOUNDS1087 1952/DELNP/2005 216565 17-03-20085-(3-[4-(4- HALO- PHENYL) 4- HYDROXY-3, 3-DIMETHYL- PIPERIDIN-1-YL]- PROPYLIDENE) -5, 11- DIHYDRO -10- OXA- 1- AZA- DIBENZO MILLENNIUM PHARMACEUTICALS, INC.,[A,D] CYCLOHEPTENE -7 - CARBOXYLIC ACIDCOMPOUND1088 667/MUM/2002 216575 17/03/2008A PYRROLINE COMPOUNDS AND PROCESSFOR PREPARING THE SAMEBAYER AKTIENGESELLSCHAFT1089 1039/mum/2004 216577 17/03/2008 herbal composition for angina pectoris TIANJIN TASLY PHARMACEUTICAL CO.,LTD1090 3/MUMNP/2004 216584 17/03/2008PHARMACEUTICAL FORMULATION IN THE BOEHRINGER INGELHEIM PHARMA GMBH &FORM OF A TABLETCO. KG.

1091 IN/PCT/2000/00490/MUM 216597 17/03/2008A COMPOUND HAVING FORMULA(XV) OR ASOLVATE OR PHARMACEUTICALLYCARDIOME PHARMA CORP.ACCEPTABVLE SALT THEREOF1092 833/MAS/2000 216605 17-03-2008A CONTROLLED RELEASE DOSAGE FORM FORPENWEST PHARMACEUTICALS COORAL ADMINISTRATION1093 2580/CHENP/2004 216612 17-03-2008A COMPOSITION FOR TREATING METASTATICAVENTIS PHARMA S.A.CANCER BY ADJUVANT THERAPY1094 1638/DELNP/2005 216701 18-03-20082-PYRIDONE DERIVATIVES AS INHIBITORS ORASTRAZENECA AB,NEUTROPHILE ELASTASE1095 3779/DELNP/2004 216703 18-03-2008 A PHARMACEUTICAL COMPOSITION TIBOTEC PHARMACEUTICALS LTD.,1096 310/mum/2002 216730 18/03/2008novel antiinfective compounds, process for theirpreparation and pharmaceutical compositionsCADILA HEALTHCARE LIMITED1097 1998/DELNP/2005 216737 19-03-2008A QUIONOLINYL-SUBSTITUTED COMPOUNDALMIRALL PRODESPHARMA, S.A.,OF FORMULA (I) AND COMPOSITION THEREOF1098 01020/DELNP/2003 216753 19-03-2008A PYRIMIDINE COMPOUND HAVING FORMULAASTRAZENECA ABI1099 IN/PCT/2001/01162/DEL 216756 19-03-2008 INDOLE DERIVATIVES NEURIM PHARMACEUTICALS (1991) LTD.1100 507/DEL/2001 216759 19-03-2008MICROPARTICULATE FORM OF 1-(2-(NAPHTH-2-YL)ETHYL)-4-(3-TRIFLUOROMETHYLPHENYL)-SANOFI-SYNTHELABO.1,2,3,6-TETRAHYDROPYRIDINEHYDROCHLORIDE1101 475/DEL/2000 216784 19-03-2008 AN HERBAL THERAPEUTIC PRODUCT INDIAN COUNCIL OF MEDICAL RESEARCH1102 221/KOLNP/2004 216832 19-03-20081103 719/KOLNP/2003 216840 19-03-20081104 1013/KOLNP/2005 216857 19-03-20081105 1330/KOLNP/2004 216859 19-03-20081106 1587/CAL/1997 216866 19-03-20081107 1046/CAL/1995 216867 19-03-20081108 778/KOLNP/2003 216889 19-03-20081109 946/CAL/1995 216897 19-03-2008A PHARMACEUTICAL COMPOSITION FORENHANCING THE MOBILIZATION OFRMULTILINEAGE HEMATOPOIETIC STEM CELSTO THE PERI;HERL BLOOD(2S) -2-AMINO-4-([2-(ETHANIMIDOYLAMINO)ETHYL] THIO) BUTANOIC ACID AND THEPROCESS FOR PREPARATION THEREOFFORMULATION CONTAINING MELATONINGINKGO BILOBA AND BIOTIN.A PHARMACEUTICAL COMPOSITION FORTREATING GLIOBLASTOMAN-SUBSTITUTED INDOL-3-GLYOXYLAMIDE, AYISSUM RESEARCH DEVELOPMENT COMPANYOF THE HEBREW UNIVERSITY OF JERUSALEMGLAXO GROUP LIMITEDASAT AG APPLIED SCIENCE & TECHNOLOGYASTELLAS PHARMA INC.ASTA MEDICA AKTIENGESELLSCHAFTMEDICAMENT AND PROCESS THEREOFA FORM III OF (R)-7-ACETYL-5-(4-AMINOPHENYL) -8, 9-DIHYDRO-8-METHYL-7H-ELI LILLY AND COMPANY1, 3-DIOXOLO [4,5-H] [2,3]-BENZODIAZEPINEAND PROCESS FOR PREPARATION THEREOF.NOVEL USE OF COMBINED 5-HT 1A AGONISTSAND SELECTIVE SEROTONIN REUPTAKE MERCK PATENT GMBHINHIBITORS.NOVEL PYRIMIDINE DERIVATIVES ANDPROCESS FOR THE PREPARATION THEREOF.YUHAN CORPORATION

1110 IN/PCT/2000/668/KOL 216904 19-03-2008PYRAZOLINE DERIVATIVES, THEIRPREPARATION AND APPLICATION AS LABORATORIOS DEL DR. ESTEVE S.A.MEDICAMENTS1111 730/CHE/2003 216990 24-03-2008NOVEL BIOFILM VACCINES AGAINSTBACTERIAL DISEASES OF BIRDS AND DR. B. M. VEEREGOWDADOMESTIC ANIMALS1112 318/mum/2001 217007 24/03/2008PHENYL-SUBSTITUTED 4-HYDROXYTETRAHYDROPYRIDONES AND THEIR BAYER AKTIENGESELLSCHAFTPROCESS OF PREPARATION1113 1128/CHENP/2005 217043 24-03-2008 CYCLIC KETONE PEROXIDE FORMULATIONS AKZO NOBEL N.V1114 1153/MAS/1997 217044 24-03-2008NOVEL AZOLIDINEDIONE COMPOUNDS,PROCESS FOR THEIR PREPARATION ANDPHARMACEUTICAL COMPOSITIONSDR. REDDY'S LABORATORIES LTDCONTAINING THEM1115 476/MAS/2002 217067 24-03-2008NOVEL ARYLALKYL INDOLES HAVINGSEROTONIN RECEPTOR AFFINITY AND SUVEN LIFE SCIENCES LIMITEDPROCESS FOR THEIR PREPARATION1116 627/CHENP/2005 217076 24-03-20084-PIPERIZINYL BENZENESULFONYL INDOLESWITH 5-HT6 RECEPTOR AFFINITYF. HOFFMANN-LA ROCHE AG1117 718/mumnp/2005 217098 24/03/2008 a pharmaceutical composition containing… pharmacia corporation1118 1109/DEL/2001 217147 25-03-2008A PHARMACEUTICAL COMPOSITION USEFUL COUNCIL OF SCIENTIFIC AND INDUSTRIALAS AN ANTIOXIDANTRESEARCH1119 IN/PCT/2001/1331/CHE 217196 26-03-2008ANTI-IDIOTYPIC ANTIBODIESS AGAINSTANTIBODIES WHICH INHIBIT THE BINDING OFNOVARTIS AGIMMUNOGLOBBULINE TO ITS HIGH AFFINITYRECEPTORNOVEL HETEROCYCLIC COMPOUNDS1120 771/MAS/1997 217289 26-03-2008PROCESS FOR THEIR PREPARATION ANDPHARMACEUTICAL COMPOSITIONSDR. REDDY'S LABORATORIES LTDCONTAINING THEM1121 900/KOLNP/2004 217408 26-03-2008NICOTINAMIDE DERIVATIVES USEFUL AS P38INHIBITORSSMITHKLINE BEECHAM CORPORATION1122 1046/KOLNP/2005 217414 26-03-2008SUBSTITUTEDDIHYDROPHENANTHRIDINESULFONAMIDESWYETH1123 1195/KOLNP/2004 217424 26-03-2008A PHENYL OXAZOLIDINONE COMPOUNDHAVING ANTI-BACTORIAL ACTIVITYORTHO-MCNEIL PHARMACEUTICAL INC.1124 1323/KOLNP/2004 217428 26-03-2008EYE DROPS CONTAINING TETRAZOLEDERIVATIVESANKYO COMPANY LIMITED.1125 1548/KOLNP/2004 217438 26-03-2008POLYCYCLIC COMPOUNDS AS POTENTALPHA2-ADRENOCEPTOR ANTAGONISTSORION CORPORATION1126 484/KOLNP/2005 217454 26-03-2008BENZIMIDAZOLE QUINOLINONES AND USESTHEREOF.CHIRON CORPORATION1127 28/KOLNP/2003 217463 26-03-2008 A SUBSTITUTED AMINE. ELAN PHARMACEUTICALS, INC.1128 51/KOLNP/2004 217464 26-03-2008METHYL-THIENO-BENZODIAZEPINELYOPHILIZED FORMULATIONELI LILLY AND COMPANY

1129 116/KOLNP/2004 217466 26-03-20081130 379/KOLNP/2004 217468 26-03-20081131 432/KOLNP/2004 217469 26-03-2008NOVEL AMINO-FUNCTIONAL POLYSILOXANEAND PROCESS FOR PREPARATION THEREOFPROAEROLYSIN CONTAINING PROTEASEACTIVATION SEQUENCES AND METHODS OFUSE FOR TREATMENT OF PROSTATE CANCERPHARMACEUTICAL COMPOSITIONCOMPRISING GABAPENTIN OR AN ANALOGUETHEREOF AND AN (ALFA)-AMINOAMIDE ANDITS ANALGESIC USEDOW CORNING CORPORATIONUNIVERSITY OF VICTORIA INNOVATION ANDDEVELOPMENT CORPORATIONNEWRON PHARMACEUTICALS SPA1132 2784/DEL/1996 217511 26-03-2008A FUSED TETRAHYDROPYRIDAZINE ANDDIHYDROPYRAZOLE DERIVATIVESPFIZER INC.1133 703/DEL/2000 217581 27-03-2008 PEPTIDES FOR THE TREATMENT OF CANCER DABUR RESEARCH FOUNDATION1134 IN/PCT/2002/01292/DEL 217584 27-03-2008LIPOSOMAL FORMULATION FOR USE ASANTITUMOR AGENTS AND PROCESS FORPREPARATION THEREOFOSI PHARMACEUTICALS, INC.1135 IN/PCT/2002/01075/DEL 217588 27-03-20081136 856/DEL/2003 217597 27-03-20081137 1039/DEL/2003 217600 27-03-20081138 656/DEL/2001 217659 28-03-20081139 305/DELNP/2005 217699 28-03-2008PYRROLO [2,3-D] PYRIMIDINE COMPOUNDSUSEFUL AS IMMUNOSUPPRESSIVE AGENTSAN INHIBITOR COMPOSITION FOR SOLIDPROPELLANTS AND A PROCESS FORPREPARATION THEREOFINTERMEDIATES FOR USEIN THE PREPRATIONOF ANTICANCER COMPOUNDS AND POCESSFOR THE PREPRATION THEREOFA COMPOSITION FOR USE FOR TREATINGVITILIGO''A NUTRITIONAL OR PHARMACEUTICALCOMPOSITION DESIGNED TO STIMULATEBONE FORMATION AND/OR INHIBIT BONERESORPTION IN MAN OR ANIMALS"PFIZER PRODUCTS, INC.DIRECTOR GENERAL, DEFENCE RESEARCH &DEVELOPMENT ORGANISATIONPFIZER PRODUCTS, INC.ABBURI RAMAIAHINSTITUT NATIONAL DE LA RECHERCHEAGRONOMIQUE (INRA)1140 1509/MAS/1998 217725 28-03-2008 TRIAZOLE COMPOUNDS ABBOTTGMBH & CO KG1141 848/DELNP/2004 217753 28-03-2008 NOVEL 1, 2, 4- TRIAZOLE COMPOUNDS FUJI YAKUHIN CO. LTD1142 1676/DELNP/2003 217830 28-03-2008 ISOQUINOLINONE COMPOUND KuDOS PHARMACEUTICALS LIMITED1143 3008/DELNP/2004 217832 28-03-20081144 418/DEL/2002 217878 29-03-20081145 1185/DEL/2000 217896 29-03-20081146 650/MUM/2003 217915 31/03/20081147 1746/DELNP/2003 217926 31-03-20089-AMINOACRIDINE DERIVATIVES ANDSAMJIN PHARMACEUTICAL CO., LTD.PROCESS FOR THE PREPARATION THEREOFA HERBAL OPHTHALMIC FORMULATION OFOCIMUM SANCTUM FOR DELAYING THE ALL INDIA INSTITUTE OF MEDICAL SCIENCESONSET AND PROGRESSION OF CATARACTA COMPLEX OF CARRIER ENZYME ANDNICHIREI BIOSCIENCES INC.,PROTIENPHARMACEUTICAL PREPARATIONSKHANDELWAL LABORATORIES PVT LTDCOMPRISING CEFIXIME TRIHYDRATEANHYDROUS CRYSTAL OF β-LACTAMCOMPOUND AND METHOD FOR PREPARATION OTSUKA CHEMICAL CO., LTD.THEREOF

1148 2521/DELNP/2004 217950 31-03-2008SULFONYLAMINO-DERIVATIVES AS NOVELINHIBITORS OF HISTONE DEACETYLASEJANSSEN PHARMACEUTICA N.V1149 1819/DEL/2004 217960 31-03-2008ENZYMES HAVING ALPHA AMYLASEACTIVITY AND METHODS OF USE THEREOFDIVERSA CORPORATION1150 IN/PCT/2002/00482/DEL 218028 31-03-2008'CONDENSED AZEPINES AS VASOPRESSINAGONISTS.''FERRING BV,1151 1130/DELNP/2004 218040 31-03-2008 PYRIMIDINE COMPOUNDS EISAI R&D MANAGEMENT CO., LTD.,1152 990/DELNP/2004 218047 31-03-2008A COMPOUND [(1RS, 2RS, 4aSR, 8aSR)-2-HYDROXY-2,5,5,8a-TETRAMETHYLDECAHYDRONAPHTHALEN-1-FIRMENICH SA,y1] ACETATE OF FORMULA (I) OR (I')1153 181/DELNP/2004 218075 31-03-2008 A PHARMACEUTICAL PRODUCT TAS SINAN1154 1366/DELNP/2004 218080 31-03-2008A CONJUGATE COMPRISING APOLY(ETHYLENE GLYCOL)MOLECULEPHARMACIA CORPORATION1155 1074/DELNP/2004 218083 31-03-2008'SUCCINAATE SALT OF E-2-METHOXY-N-[3-[4-[3- METHYL-PYRIDIN-3-YLOXYL]-PHENYLAMINO]-QUINAZOLIN-6-YL]-ALLYL]-PFIZER PRODUCTS INC.,ACETAMIDE AND PREPARATION THEREOF''1156 54/DELNP/2005 218097 31-03-2008AN ANTIALLERGIC FORMULATIONCOMPRISING AS AN ACTIVE INGREDIENT, CALPIS CO. LTD.LACTIC ACID BACTERIA1157 3774/DELNP/2004 218140 31-03-2008A PHARMACEUTICAL COMPOSITION OF ACETP INHIBITORPFIZER PRODUCTS INC.,1158 819/DEL/2003 218161 31-03-2008AN ANTIDOTE S-(w-AMINOALKYLAMINO) THE CHIEF CONTROLLER, RESEARCH &ALKYL ARYL SULPHIDE DIHYDROCHLORIDES DEVELOPMENTCRYSTALLINE 3-{(3R,4R)-4-METHYL-3-[METHYL-[7H-PYRROLO[2,3- D]PYRIMIDIN-4-1159 1095/DELNP/2004 218212 31-03-2008 YL)-AMINO]-PIPERIDIN-L-YL}-3-OXO- PFIZER PRODUCTS INC.PROPINITRILE MONO CITRATE SALT AND ITSMETHOD OF PREPARATION1160 627/DELNP/2004 218216 31-03-2008OILY PACLITAXEL COMPOSITION ANDFORMULATION FOR CHEMOEMBOLIZATION DAEHWA PHARM. CO. LTD.AND PREPARATION METHOD THEREOFTHE CITRATE SALT OF 4-(3,4-1161 1401/DELNP/2004 218230 31-03-2008 DICHLOROPHENYL)-2[2-(4-METHYLPIPERAZIN- PFIZER PRODUCTS INC.1-YL)-BENZYLIDENE]-THIOMORPHOLIN-3-ONE1162 1186/DELNP/2004 218231 31-03-2008 A PHARMACEUTICAL COMPOSITION. THE PROCTER & GAMBLE COMPANY1163 271/CHENP/2004 218257 31-03-2008ARYLSULFONYL DERIVATIVES WITH 5-HT6RECEPTOR ANTAGONISTS OF FORMULA-IF. HOFFMANN-LA ROCHE AG1164 793/CHENP/2004 218259 31-03-2008A THROMBIN RECEPTOR ANTAGONISTS OFFORMULA ISCHERING CORPORATION1165 821/CHENP/2004 218263 31-03-2008 3-SUBSTITUTED-4-PYRIMIDONE DERIVATIVES MITSUBISHI PHARMA CORPORATION1166 863/CHENP/2004 218264 31-03-2008N-SUBSTITUTED PYRROLIDIN DERIVATIVESAS DIPEPTIDYL PEPTIDASE IV INHIBITORSF. HOFFMANN-LA ROCHE AG1167 1377/DELNP/2004 218276 31-03-2008 A SUBSTITUTED PYRIMIDINE COMPOUND ASTRAZENECA AB.,

NICOTINAMIDE DERIVATIVES USEFUL AS1168 2070/DELNP/2004 218281 31-03-2008PFIZER INC.,PDE4 INHIBITORSDRY GRANULATED FORMULATIONS OF1169 2107/DELNP/2004 218289 31-03-2008PFIZER PRODUCTS INC.AZITHROMYCIN2-(PYRIDIN-2-YLAMINO)-PYRIDO(2,3-1170 1733/DELNP/2004 218291 31-03-2008WARNER-LAMBERT COMPANY LLC,d)PYRIMIDIN-7-ONESA PHARMACEUTICAL COMPOSITION USEFUL COUNCIL OF SCIENTIFIC AND INDUSTRIAL1171 1096/DEL/2000 218307 31-03-2008AS AN ANTIOXIDENTRESEARCH3,4-DIFLUORO-2-ALKYLAROMATICS AND 2,4-DIFLUORO-3-ALKYLAROMATICS OF THE1172 1511/DEL/2004 218326 31-03-2008BAYER CHEMICALS AGFORMULA (1) AND THEIR PROCESS OFPREPARATIONNAPHTHOQUINONES AS ANTIDIABETIC National Institute of Pharmaceutical Education and1173 669/DEL/2004 218363 31-03-2008AGENTSResearch (NIPER)A COMPOSITION USEFUL AS A1174 2005/DEL/2004 218373 31-03-2008INDIAN COUNCIL OF MEDICAL RESEARCHCONTRACEPTIVENOVEL AMPIPHILIC DERIVATIVES OF ALPHA-1175 2260/DELNP/2005 218395 01-04-2008TS PHARMAC-PHENYL-N-TERT-BUTYL NITRONE1176 IN/PCT/2001/00731/DEL 218396 01-04-2008 AN ANTIBACTERIAL PROTEIN BLIS TECHNOLOGIES LIMITED3,4-DI-SUBSTITUTED CYCLOBUTENE -1-21177 263/CHENP/2005 218420 01-04-2008SCHERING CORPORATIONDIONES OF FORMULA ICONJUGATES COMPRISED OF POLYMER AND1178 470/CHENP/2005 218425 01-04-2008TRIMERIS, INC.HIV GP41-DERIVED PEPTIDESA NOVEL NASAL ADMINISTRATION1179 1128/MAS/1999 218429 01-04-2008 CONTAINING SILDENAFIL SALT FORNATCO PHARMA LIMITEDTREATING MALE ERECTILE DYSFUNCTIONNOVEL N-ARYLSULFONYL-3- SUBSTITUTEDINDOLES HAVING SEROTONIN RECEPTOR1180 884/MAS/2002 218438 01-04-2008AFFINITY USEFUL AS THERAPEUTIC AGENTSSUVEN LIFE SCIENCES LIMITED,PROCESS FOR THEIR PREPARATION ANDPHARMACEUTICAL COMPOSITIONSCONTAINING THEMNOVEL ALKOXY PROPIONIC ACIDCOMPOUNDS AND THEIR DERIVATIVES1181 971/MAS/2001 218448 01-04-2008DR. REDDY'S LABORATORIES LTD.,PROCESS FOR THEIR PREPARATION ANDPHARMACEUTICAL COMPOSITIONS1182 1681/DELNP/2003 218460 01-04-2008 A POLYPEPTIDE USED FOR ANTI-OBESITY YONSEI UNIVERSITYAN ANTITUSSIVE COMPOSITION AND METHOD1183 425/MUM/2004 218463 02-04-2008SANJEEV KHANDELWALOF MAKING THE SAMEAN ANTISPASMODIC ANALGESIC1184 277/MUM/2004 218464 02-04-2008 SYNERGISTIC FORMULATION FOR THE RELIEF SANJEEV KHANDELWALOF PAIN IN AN ORAL SYRUP FORMAROMETIC COMPOUNDS AS ANTI1185 815/MUMNP/2005 218476 02-04-20084SC AGINFLAMMATORY….

1186 119/MUM/2004 218479 02-04-2008FENOFIBRATE -CYCLODEXTRIN INCLUSIONCOMPLEXES AND THEIR PHARMACEUTICAL USV LIMITEDCOMPOSITION1187 90/MUMNP/2004 218482 02-04-2008ANTHRANILLAMIDE ARTHROPODICIDETREATMENTE I DU PONT DE NEMOURS AND CO,1188 791/MUM/2002 218490 02-04-2008PHARMACEUTICAL COMPOSITION OFMETAXALONE WITH ENHANCEDSUN PHARMACEUTICAL INDUSTRIES LTDBIOAVAILABILITY1189 388/MAS/2003 218508 02-04-2008A PHARMACEUTICAL COMPOSITIONCONTAINING BENZIMIDAZOLE DERIVATIVESNATCO PHARMA LIMITED1190 IN/PCT/2001/1223/CHE 218509 02-04-2008 BIPHENYL COMPOUNDS F. HOFFMANN-LA ROCHE AG1191 702/CHENP/2004 218511 02-04-2008ACYLSULFONAMIDES AS INHIBITORS OFSTEROID SULFATASENOVARTIS AG1192 726/CHENP/2004 218514 02-04-20081H-INDOLE DERIVATIVES AS HIGHLYSELECTIVE CYCLOOXYGENASE-2 INHIBITORCHEIL JEDANG CORPORATION1193 735/CHENP/2004 218515 02-04-20084-METHANESULFONYL-BIPHENYLDERIVATIVES OF FORMULA ICHEIL JEDANG CORPORATION1194 740/CHENP/2004 218516 02-04-2008HEPATITIS C VIRUS VACCINEISTITUTO DI RICERCHI DI BIOLOGIAMOLECOLARE P. ANGELETTI SPA1195 1011/CHENP/2005 218522 02-04-2008 INDOLYL DERIVATIVES F. HOFFMANN-LA ROCHE AG1196 1298/CHENP/2004 218525 02-04-2008 PRODRUGS TO D-PROLINES F. HOFFMANN-LA ROCHE AG1197 1960/KOLNP/2004 218541 02-04-2008A THERAPEUTIC COMPOSITIONCOMPRISING PATHOGEN INHIBITING GLYKOS FINLAND OYOLIGOSACCHARIDES1198 1533/KOLNP/2004 218545 02-04-2008HETEROARYL COMPOUNDS WHICH INHIBITLEUKOCYTE ADHESION MEDIATED BY ELAN PHARMACEUTICALS, INC.ALPHA-4 INTEGRINS1199 1414/CAL/1996 218548 02-04-20084-SULFONYL- OR 4-MERCK PATENT GESELLSCHAFT MITSULFINYLBENZOYLGUANIDINE DERIVATIVESBESCHRANKTER HAFTUNGOF THE FORMULA I1200 226/CAL/1998 218556 02-04-2008 PHENYL XANTHINE ESTERS AND AMIDES GLAXO GROUP LIMITED1201 224/KOLNP/2004 218571 02-04-2008INJECTABLE COMPOSITIONS FOR THECONTROLLED DELIVERY OFPHARMACOLOGICALLY ACTIVEIDEXX LABORATORIES, INC.COMPOUND1202 245/KOLNP/2004 218576 02-04-2008 GLUCAGON-LIKE PEPTIDE-1 ANALOGS ELI LILLY AND COMPANY1203 33/DELNP/2004 218588 03-04-2008THIENOPYRIMIDINEDIONES AND USE IN THEMODULATION OF AUTOIMMUNE DISEASEAstraZeneca AB1204 22/MUMNP/2004 218603 03-04-2008ORTHO - HETEROCYCLIC SUBSTITUTED ARYLAMIDES FOR CONTROLLING INVERTEBRATE E I DU PONT DE NEMOURS AND CO,PESTS1205 200/MUMNP/2003 218615 03-04-2008NOVEL DIHYDROPYRIMIDINE COMPOUNDS OFBAYER AKTIENGESELLSCHAFT1206 IN/PCT/2002/00999/DEL 218620 03-04-2008THE GENERAL FORMULA (I)NOVEL COMPOUNDS USEFUL FOR TREATNGCELL PROLIFERATIVE DISORDERSHSC RESEARCH AND DEVELOPMENT LIMITEDPARTNERSHIP

1207 IN/PCT/2002/00990/DEL 218621 03-04-2008 HERPES SIMPLEX VIRUS VACCINE BIOVEX LIMITED1208 00606/DELNP/2003 218624 03-04-2008A PHARMACEUTICAL COMPOSITION FORTREATMENT OF PROLIFERATIVE DISORDERSTEMPLE UNIVERSITY -OF THECOMMONWEALTH SYSTEM OF HIGHEREDUCATION1209 2094/DELNP/2005 218625 03-04-2008 MORPHOLINE DOPAMINE AGONISTS PFIZER INC1210 97/MUMNP/2005 218635 04-04-2008COMBINATION OF CICLESONIDE ANDANTIHISTAMINES FOR THE TREATMENT OF NYCOMED GMBHALLERGIC RHINITIS1211 407/MUMNP/2004 218642 04-04-2008SPIROAZACYCLIC COMPOUNDS ASMONOAMINE RECEPTOR MODULATORSACADIA PHARAMACEUTICALS INC1212 IN/PCT/2001/00160/MUM 218643 04-04-2008 TETRAHYDROPYRIDO ETHERS ALTANA PHARMA AG1213 2723/DELNP/2005 218671 09-04-2008AQUEOUS-ALCOHOLIC DEPIGMENTING GELGALDERMA RESEARCH & DEVELOPMENT,COMPOSITION CONTAINING A PHENOLICS.N.C.DERIVATIVE AND A RETINOID1214 3693/DEL/1997 218673 09-04-2008 A COMPOUND HAVING THE FORMULA I PFIZER, INC.1215 731/KOL/2005 218675 09-04-2008A HERBAL COMPOSITION FOR CONTROLLINGBLOOD SUGAR LEVEL,AND PROCESS FOR CHOUDHARY, GIRISH PRASADPREPARING THE SAME1216 270/KOLNP/2005 218694 09-04-2008PROTEIN KINASE INHIBITORS AND USESTHEREOFVERTEX PHARMACEUTICALS INCORPORATED1217 IN/PCT/2001/421/KOL 218713 09-04-2008PHARMACEUTICAL COMPOSITIONCOMPRISING ENTACAPONE OR NITECAPONEAS WELL AS CROSS-LINKED CELLULOSEORION CORPORATIONDERIVATIVE1218 IN/PCT/2001/453/KOL 218715 09-04-2008PARICLES COATED WITH GRANULATEDETHYPHARMCRYSTALLINE IBUPROFEN1219 IN/PCT/2001/742/KOL 218716 09-04-2008S-NITROSOTHIOLS AS AGENTS FOR THETREATMENT OF CIRCULATORYLACER S.A.DYSFUNCTIONS1220 IN/PCT/2002/128/KOL 218719 09-04-2008 A PHARMACEUTICAL COMPOSITION CEPHALON INC.1221 IN/PCT/2002/341/KOL 218720 09-04-2008REPLICATION DEFICIENT ADENOVIRALVECTOR FOR BOOSTING CD8 + T CELL ISIS INNOVATION LIMITEDIMMUNE RESPONSE TO ANTIGEN1222 IN/PCT/2002/82/KOL 218721 09-04-2008A PEPTIDE CONJUGATE OF AN EXEN DIN-4(1-39) VARIANTZEALAND PHARMA A/S1223 981/KOLNP/2004 218723 09-04-2008COMPOSITION OF AMMONIA OXIDIZINGBACTERIAWHITLOCK DAVID R.1224 1912/DELNP/2004 218727 09-04-2008ANTICHOLINERGIC COMPOUND AND BOEHRINGER INGELHEIM PHARMA GMBH &PHARMACEUTICAL PREPARATIONS THEREOF CO. KG.1225 52/DEL/2004 218729 10-04-2008A NOVEL THROMBOLYTIC ENZYMENATIONAL RESEARCH DEVELOPMENTCORPORATION1226 2939/DELNP/2005 218730 10-04-2008A THIENOPYRIDAZINONE COMPOUND OFFORMULA (I)ASTRAZENECA AB1227 2585/DELNP/2005 218732 10-04-2008 A CAPSULE COMPOSITION KISSEI PHARMACEUTICAL CO., LTD

1228 IN/PCT/2001/01235/MUM 218742 11-04-2008AN ISOLATED POLYPEPTIDE, A FUSIONPROTEIN AND A PHARMACEUTICALCORIXA CORPORATIONCOMPOSITION COMPRISING THE SAME1229 979/MUMNP/2005 218745 11-04-2008 6-SUBSTITUTED IMIDAZOPYRAZINES ALTANA PHARMA AG1-PHENYL ALKYL AMIDE-2-PHENYL-4-(6-OXO-1230 1738/DELNP/2004 218756 15-04-2008HEXAHYDRO-PYRROLO[1,2-A]-PYRAZIN-2-YL)GLAXO GROUP LIMITED,COMPOUND OF FORMULA (I) AND PROCESSTHEREOFNOVEL CRYSTALS OF (-)-N-{2-[(R)-3-(6, 7-DIMETHOXY-1, 2, 3, 4-1231 4378/DELNP/2005 218761 15-04-2008 TETRAHYDROISOQUINOLINE-2-ASTELLAS PHARMA INCCARBONYL)PIPERIDINO] ETHYL}-4-FLUROBENZAMIDE MONOPHOSPHATE1232 160/CHENP/2005 218768 16-04-2008A PHARMACEUTICAL COMPOSITION FORTREATING NEOPLASMCOMBINATORX, INCORPORATED1233 198/CHENP/2005 218776 16-04-2008COMPOUNDS OF FORMULA 1 FORMODULATING IKB KINASESANOFI-AVENTIS DEUTSCHLAND GMBH1234 2291/CHENP/2004 218783 16-04-2008TRICYCLIC THROMBIN RECEPTORANTAGONISTS OF FORMULA 1SCHERING CORPORATION1235 2654/CHENP/2004 218788 16-04-2008N-ACYLAMINOBENZENE DERIVATIVES ASSELECTIVE MONOAMINE OXIDASE BF. HOFFMANN-LA ROCHE AGINHIBITORS1236 30/CHENP/2005 218791 16-04-2008PHARMACEUTICAL COMPOSITIONSCOMPRISING 3-AZA BICYCLO (3.2.1) OCTANE MIMETECH S.R.LDERIVATIVES1237 301/CHENP/2005 218792 16-04-2008A COMPOSITION COMPRISING A LIPOSOME ORLIPID COMPLEX AND AN ENTRAPPED ACTIVEPLATINUM COMPOUND AND A PROCESS FORTRANSAVE, INCPRODFUCING THE SAME1238 311/CHENP/2005 218794 16-04-2008 AZA-BICYCLOALKYL ETHERS NOVARTIS AG1239 325/CHENP/2005 218796 16-04-2008NOVEL AMINOINDAZOLE ANDPHARMACEUTICAL COMPOSITIONS AVENTIS PHARMA S.ACONTAINING SAME1240 1329/CHENP/2004 218814 16-04-2008PYRROLIDINE AND PIPERIDINE DERIVATIVESOF GENERAL FORMULA ISCHERING CORPORATION1241 57/CHENP/2005 218816 16-04-2008 NEW ANTI-CANCER COMPOUNDS PSIMEI PHARMACEUTICALS PLC1242 711/CHENP/2005 218826 16-04-2008 COMBINATION DRUG EISAI R & D MANAGEMENT CO. LTD1243 455/CHENP/2005 218855 16-04-2008NON-NUCLEOSIDE REVERSE TRANSCRIPTASEINHIBITORSARDEA BIOSCIENCES, INC1244 IN/PCT/2002/1096/CHE 218867 16-04-2008A PHARMACEUTICAL COMPOSITION IN THEFORM OF AN ORAL DOSAGESCHERING AKTIENGESELLSCHAFT1245 IN/PCT/2002/1263/CHE 218875 16-04-2008RECEPTACLE FOR THE ANALYTICS OFNUCLEIC ACIDSPREANALYTIX GMBH1246 IN/PCT/2002/1288/CHE 218879 16-04-2008A PLURAFLAVINS OF FORMULA I AND ITSPREPARATION THEREOFSANOFI-AVENTIS DEUTSCHLAND GMBH

A TROPICAL COMPOSITION COMPRISING1247 439/CHENP/2005 218897 16-04-2008SLA PHARMA AGMETRONIDAZOLEAN IMPROVED PHARMACEUTICAL1248 968/MAS/1999 218901 16-04-2008 COMPOSITION AND A PROCESS FOR ITS NATCO PHARMA LIMITEDPREPARATIONINFANT FORMULATION COMPRISING A1249 IN/PCT/2002/891/CHE 218912 16-04-2008N.V. NUTRICIAPROTEIN COMPONENT AND LIPIDSUBTILASE VARIANTS HAVING AN IMPROVED1250 IN/PCT/2002/893/CHE 218913 16-04-2008NOVOZYMES A/SWASH PERFORMANCE OF EFF STAINSNOVEL SEMISYNTHETIC MACROLIDE1251 1551/CHENP/2005 218922 16-04-2008PLIVA-ISTRAZIVACKI INSTITUT D.O.OANTIBODIES OF THE AZALIDE SERIESENANTIOMERS OF THIOPHENE HYDROXAMIC1252 1553/CHENP/2005 218923 16-04-2008F. HOFFMANN-LA ROCHE AGACID DERIVATIVESA PHARMACEUTICAL COMPOSITION FOR1253 2323/CHENP/2004 218926 16-04-2008BENTLEY PHARMACEUTICALS, INCTRANDERMAL DELIVERY OF ANDROGEN1254 2409/CHENP/2004 218928 16-04-2008 ISOQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AGA FUSION PROTEIN CAPABLE OF ACTIVATING1255 559/CHENP/2005 218936 16-04-2008NATIMMUNE A/STHE COMPLEMENT SYSTEMN-BISARYL-AND N-ARYL-1256 59/CHENP/2005 218938 16-04-2008 CYCLOALKYLIDENYL-ALPHA-HYDROXY-AND SYNGENTA PARTICIPATIONS AGALPHA-ALKOXY ACID AMIDESC7 CARBONATE SUBSTITUTED TAXANES AS FLORIDA STATE UNIVERSITY RESEARCH1257 IN/PCT/2001/1336/CHE 218945 16-04-2008ANTITUMOR AGENTSFOUNDATION, INCORAL PHARMACEUTICAL FORMULATION INTHE FORM OF A PLURALITY OF1258 69/KOLNP/2005 218972 16-04-2008 MICROCAPSULES FOR PROLONGED RELEASE FLAMEL TECHNOLOGIESOF ACTIVE PRINCIPLE (S) WITH LOWSOLUBILITYSUBSTITUTED 2-PYRIDINYL-6,7,8,9-TETRAHYDROPYRIMIDO[1,2-A] PYRIMIDIN-4-1259 203/KOLNP/2004 218973 16-04-2008SANOFI-AVENTISONE AND 7-PYRIDINYL-2, 3-DIHYDROIMIDAZO[1, 2-A] PYRIMIDIN-5(1H) ONE DERIVATIVES3-HETEROARYL-3,5-DIHYDRO-4-OXO-4H-1260 726/KOLNP/2004 218974 16-04-2008 PYRIDAZINO[4,5-B] INDOLE-1-CARBOXAMIDE SANOFI-AVENTISDERIVATIVE, COMPOUNDSPIPERAZINYL AND DIAZAPANYL1261 952/KOLNP/2005 218978 16-04-2008JANSSEN PHARMACEUTICA, N.V.BENZAMIDES AND BENZTHIOAMIDES1262 1580/KOLNP/2004 218986 16-04-2008 THIAZOLIDINE-4-CARBONITRILE COMPOUNDS TORRENT PHARMACEUTICALS LTD.A PHARMACEUTICAL COMPOSITIONCOMPRISING AN ERYTHROPOIETIN AND1263 9/MUMNP/2005 219011 16/04/2008 OTHER ACTIVE INGREDIENTS FOREPOPLUS GMBH & CO. KG.STIMULATING ENDOTHELIAL PROGENITALCELLS

1264 811/MUM/2004 219014 16/04/2008NEBIVOLOL AND ITS PHARMACEUTICALLYACCEPTABLE SALTS, PROCESS FORPREPARATION AND PHARMACEUTICALTORRENT PHARMACEUTICAL LTD,COMPOSITIONS OF NEBIVOLOL1265 226/MUMNP/2004 219022 21/04/2008ALENDRONATE MONOSODIUM SALT ANDPROCESS OF PREPARING THEREOFCIPLA LIMITED1266 1180/MUMNP/2003 219034 21/04/2008S-OMEPRAZOLE (ESOMEPRAZOLE) INCLUSIONCIPLA LIMITEDCOMPLEX WITH CYCLODEXTRINS1267 406/BOM/1999 219037 21/04/2008A NOVEL FORMULATION OF N-(4-NITRO-2- 1) DR. DINESH SHANTILAL PATEL 2)PHENOXYPHENYL) METHANESULFONAMI DE SHASHIKANT PRABHUDAS KURANI1268 138/MUMNP/2003 219038 21/04/2008BENZOFURAN COMPOUNDS AND PROCESSFOR THE PREPARATION OF THE SAMESANOFI SYNTHELABORATORY1269 1025/MUM/2002 219042 21/04/2008MODIFIED RELEASE PHARMACEUTICALCOMPOSITIONS AND PROCESS FOR THE CADILA HEALTHCARE LIMITEDPREPARATION THEREOF1270 2725/DELNP/2005 219049 21-04-2008SUBSTITUTED 1-PIPERIDIN-4-YL-4-PYRROLIDIN-3-YL-PIPERRAZINE COMPOUND JANSSEN PHARMACEUTICA N.V.OF FORMULA (I) AND PROCESS THEREOF1271 00952/DELNP/2004 219054 22-04-2008CONCENTRATED PROTEIN-CONTAININGPHARMACEUTICAL AND METHOD FOR RxKinetix, INC.PREPARATION THEREOF1272 20/DEL/2004 219055 22-04-2008N-PIPERIDINO-5-(4-BROMOPHENYL)-1-(2,4-DICHLOROPHENYL)-4- ETHYLPYRAZOLE-3-CARBOXAMIDE OF FORMULA (I) ANDSANOFI-SYNTHELABO,COMPOSITION THEREOF1273 00913/DELNP/2003 219056 22-04-2008A HUMANIZED ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOFELAN PHARMA INTERNATIONAL LIMITED1274 02079/DELNP/2003 219057 22-04-2008N-{1-[2-(4-MORPHOLINYL)-2-OXOETHYL]-2-OXO-3-GLAXO GROUP LIMITEDPYRROLIDINYL}METHANESULFONAMIDE1275 00970/DELNP/2004 219058 22-04-2008 A BICYCLIC OXOPYRIDINE COMPOUND UCB PHARMA S.A.1276 327/KOLNP/2004 219060 23-04-2008ANTIOXIDANT COMPOSITION AND USETHEREOFACTIAL FARMACEUTICA, LDA1277 795/KOLNP/2003 219078 23-04-2008 PYRAZOLE COMPOUNDS VERTEX PHARMACEUTICALS INCORPORATED1278 IN/PCT/2001/01051/DEL 219088 23-04-2008PURINE DERIVATIVES USED ASMEDICAMENTS OF FORMULA (I)ARATIONMETHOD AND PHARMACEUTICALAVENTIS PHARMA S.A.COMPOSITIONS CONTAINING SAME"1279 IN/PCT/2001/00400/DEL 219093 24-04-2008THE COMPOUND OF FORMULA (I) ANDPROCESS FOR PREPARING THE SAMEAVENTIS PHARMA S.A.,1280 IN/PCT/2001/348/CHE 219102 25-04-2008 NOVEL FACTOR VIIa INHIBITORS SANOFI-AVENTIS DEUTSCHLAND GMBH1281 1654/CHENP/2005 219106 25-04-2008DIAZEPANES DERIVATIVES USEFUL AS LFAINHIBITORSNOVARTIS AG1282 1169/CHENP/2005 219116 25-04-20085-SUBSTITUTED-PYRAZINE OR PYRIDINEGLUCOKINASE ACTIVATORSF. HOFFMANN-LA ROCHE AG

1283 1517/CHENP/2005 219125 25-04-2008 CONDENSED FURAN COMPOUNDS TANABE SEIYAKU CO. LTD1284 1574/MAS/1997 219126 25-04-2008A PHARMACEUTICAL COMPOSITIONCONTAINING THIENOPYRIDINE DERIVATIVE SANOFI-SYNTHELABOAND HMG-COA REDUCTASE INHIBITOR1285 222/CHENP/2005 219132 25-04-2008COMPOSITION FOR PROMOTING THEPROLIFERATION OF LACTOBACILLUS CASEI MEITO SANGYO CO., LTD.SUBSP.CASEI1286 316/CHENP/2004 219134 25-04-2008A PHARMACEUTICAL COMPOSITION FORORAL DELIVERY COMPRISING A PTH NOVARTIS AGFRAGMENT AND 5-CNAC1287 553/CHENP/2005 219135 25-04-2008CHIRALE OXAZOLE-ARYLPROPIONIC ACIDDERIVATIVES OF FORMULA IF. HOFFMANN-LA ROCHE AG1288 638/CHENP/2005 219138 25-04-2008 NOVEL TRICYCLIC AMINE DERIVATIVES SYNGENTA PARTICIPATIONS AG1289 884/MAS/1996 219147 25-04-2008PYRIMIDINEDIONE, PYRIMIDINETRIONE,TRIAZINEDIONE, DERIVATIVES AS ALPHA 1 F. HOFFMANN-LA ROCHE AGADRENERIGIC RECEPTOR1290 963/CHENP/2005 219148 25-04-2008BETA-AMINO HETEROCYCLIC DIPEPTIDYLPEPTIDASE FOR THE TREATMENT OF MERCK & CO., INCPREVENTION OF DIABETES1291 994/CHENP/2005 219149 25-04-2008 BIS-ALKYLBENZYLAMINES CIBA SPECIALTY CHEMICALS HOLDING INC1292 1204/CHENP/2005 219155 25-04-2008 NOVEL AMINOINDAZOLE DERIVATIVES AVENTIS PHARMA S.A1293 1402/CHENP/2005 219163 25-04-2008BUTENE-1 COPOLYMERS AND PROCESS FORTHEIR PREPARATIONBASELL POLIOLEFINE ITALIA S.P.A1294 213/CHENP/2005 219167 25-04-2008 2-THIO-SUBSTITUTED IMIDAZOLE MERCKLE GMBH1295 983/CHENP/2005 219193 25-04-2008SUSTAINED RELEASE L-ARGININEFORMULATIONS AND METHODS OFPALMETTO PHARMACEUTICALS LLCMANUFACTURE AND USE1296 1005/MAS/2000 219198 28-04-2008CEPHALOSPORIN COMPOUND AND A PROCESSAUROBINDO PHARMA LIMITEDFOR ITS PREPARATION1297 2455/CHENP/2004 219200 28-04-2008THAIZOLYL ACETIC ACID DERIVATIVES AND ORCHID CHEMICALS & PHARMACEUTICALSTHE PROCESS OF PREPARATION THEREOF LIMITED1298 1755/CHENP/2003 219205 28-04-2008STABLE SALTS OF SADENOSYL-L-ORCHID CHEMICALS & PHARMACEUTICALSMETHIONINE AND THE PROCESS FOR THEIR LIMITEDNOVEL STRAIN OF BIFIDOBACTERIUM1299 2453/CHENP/2005 219206 28-04-2008 BIFIDUM AND A GALACTOOLIGOSACCHA CLASADO INCRIDES PRODUCED THEREBY1300 755/CHENP/2005 219209 28-04-2008 BASIC MEDICINE CONTAINING PREPARATION KYOWA PHARMACEUTICAL IND. CO., LTD1301 1897/MAS/1998 219257 28-04-2008 ALKANOYLPHENYLALA NINE DERIVATIVES F. HOFFMANN-LA ROCHE AG1302 257/CHENP/2005 219259 28-04-2008 INDOLES HAVING ANTI-DIABETIC ACTIVITY MERCK & CO., INC1303 320/CHENP/2005 219260 28-04-2008AN IMMUNE MODULATOR COMPOSITIONCOMPRISING A WHOLE CELL OF AUNIVERSITY COLLEGE LONDON1304 410/CHENP/2005 219261 28-04-2008PYRROLIDONE DERIVATIVES AND PROCESSFOR THEIR PREPARATIONF. HOFFMANN-LA ROCHE AG1305 419/CHENP/2005 219262 28-04-20084-PYRROLIDINO-PHENYL-BENZYL ETHERDERIVATIVESF. HOFFMANN-LA ROCHE AG

1306 721/MAS/1996 219271 28-04-20081307 1160/CHENP/2005 219282 28-04-20081308 2121/MAS/1996 219287 28-04-2008HETEROCYCLIC COMPOUNDS AND PROCESSFOR THEIR PREPARATION THEREOFA FORMULATION FOR GASTROINTESTINALADMINISTRATIONBENZAZEPINE DERIVATIVESDR. REDDY’S LABORATORIES LTDFRESENIUS KABI DEUTSCHLAND GMBHOTSUKA PHARMACEUTICAL COMPANYLIMITED1309 3276/DEL/1997 219309 30-04-2008CYCLIC IMINES AND PROCESS OFPREPARATION THEREOFBAYER AKTIENGESELLSCHAFT1310 00985/DELNP/2003 219311 30-04-2008A COMPOSITION COMPRISING MICRONIZEDDROSPIRENONE AND A COMPLEX BETWEENETHINYL ESTRADIOL AND BETA-SCHERING AKTIENGESELLSCHAFTCYCLODEXTRIN1311 462/KOLNP/2004 219317 30-04-2008MEDICINAL COMPOSITIONS FOR NASALABSORPTIONDAIICHI ASUNBIO PHARMA CO. LTD.1312 1417/KOLNP/2005 219324 30-04-200810,10-DIALKYL PROSTANOIC ACIDDERIVATIVES AS AGENTS FOR LOWERING ALLERGAN, INC.INTRAOCULAR PRESSURE1313 1510/KOLNP/2003 219327 30-04-2008 INFLUENZA VACCINE COMPOSITION SAECHSISCHES SERUMWERK DRESDEN1314 1677/KOLNP/2003 219330 30-04-2008PHARMACEUTICAL COMPOSITION FORTHERAPY OF INTERSTITIAL CYSTITISYAMANOUCHI PHARMACEUTICAL CO. LTD.1315 182/KOLNP/2003 219346 30-04-2008CHEMOKINE RECEPTOR BINDINGHETEROCYCLIC COMPOUNDSANORMED INC.1316 740/KOLNP/2003 219366 30-04-2008BENZIMIDAZOLE AND PYRIDYLIMIDAZOLEDERIVATIVES AS LIGANDS FOR GABARECEPTORSNEUROGEN CORPORATION1317 IN/PCT/2001/165/KOL 219370 30-04-2008A STABLE READY TO USE LIQUIDPHARMACEUTICAL BOTULINUM TOXINFORMULATIONELAN PHARMACEUTICALS, INC.1318 IN/PCT/2002/1087/KOL 219372 30-04-2008EXPRESSION OF AN ANTIMICROBIAL PEPTIDEVIA THE PLASTID GENOME TO CONTROL AUBURN UNIVERSITYPHYTOPATHOGENIC BACTERIA1319 2669/DEL/1996 219377 30-04-2008NEW PHENYLAMIDINE DERIVATIVES,PROCESSES FOR THEIR PREPARATION AND BOEHRINGER INGELHEIM KG.THEIR USE AS PHARMACEUTICALS1320 2025/DELNP/2005 219378 30-04-2008AN ISOLATED NUCLEIC ACID THAT ENCODESTHE PROTEIN TCDB2, USEFUL TO EXPRESS A UNIVERSITY OF BATHPOTENTIATOR FOR INSECTIDICAL TCDA11321 3633/DEL/1998 219382 01-05-2008PREVENTION OF AND TREATMENT OFAMYLOIDOGENIC DISEASEELAN PHARMA INTERNATIONAL LIMITED1322 2662/DELNP/2005 219386 02-05-2008 A PEPTIDE ENKAM PHARMACEUTICALS A/S1323 1582/DELNP/2005 219394 05-05-2008A 2-SUBSTITUTED-4-HETEROARYL-PYRIMIDINE OF FORMULA IBCYCLACEL LIMITED1324 01589/DELNP/2003 219395 05-05-2008A 2-(SUBSTITUTED-AMINO)-BENZOXAZOLESULFONAMIDETIBOTEC PHARMACEUTICALS LTD.

1344 IN/PCT/2000/233/KOL 219534 07-05-2008AN ORALLY ADMINISTERABLE GALENICFORMULATION ALLOWING IMPROVEDABSORPTION BY THE TRANSMEMBRANE INMERCK PATENT GMBHTHE GASTROINTESTINAL TRACT1345 IN/PCT/2002/1476/KOL 219547 07-05-2008 A PYRAZINE DERIVATIVE TOYOMA CHEMICAL CO. LTD.1346 4034/DELNP/2005 219558 07-05-2008SUBSTITUTED AMINO HETEROCYCLES AS VR-1 ANTAGONISTS FOR TREATING PAINMERCK SHARP & DOHME LIMITED1347 2002/DELNP/2005 219563 07-05-2008 THIAZOLIDIN COMPOUND SMITHKLINE BEECHAM CORPORATION1348 5748/DELNP/2005 219566 07-05-2008NUTRACEUTICAL FOR THE PREVENTION ANDTREATMENT OF CANCERS AND DISEASES BUI, CAN, V.AFFECTING THE LIVER1349 00939/DELNP/2003 219567 07-05-2008A QUINUCLIDINE CARBAMATE OF FORMULA(I), A COMPOSITION AND A METHOD THEREOF ALMIRALL AG.,1350 2404/DELNP/2004 219571 07-05-2008 PHARMACEUTICAL COMPOSITION BRISTOL - MYERS SQUIBB COMPANY1351 2718/DELNP/2005 219577 08-05-2008DERIVATIVES OF PHOSPHONOOXYQUINAZOLINEASTRAZENECA ABA PHARMACEUTICAL PREPARATION1352 3165/DELNP/2004 219578 08-05-2008 COMPRISING SYNERGISTIC COMBINATION OF MEDIVIR ABABACAVIR & ALOVUDINE1353 IN/PCT/2001/00072/DEL 219619 12-05-2008A COMPOSITION FOR STIMULATINGSYNTHESIS OF MELANIC PIGMENTCENTRO DE HISTOTERAPIA PLACENTARIA1354 2122/DELNP/2004 219622 12-05-2008 PHARMACEUTICAL TABLET PHARMACIA CORPORATION1355 2385/DELNP/2005 219639 12-05-2008A PHARMACEUTICAL COMPOSITION FOR THEPREVENTION OR TREATMENT OF A DIESEASE KISSEI PHARMACEUTICAL CO., LTDASSOCIATED WITH HYPERGLYCEMIA1356 780/CHENP/2005 219660 13-05-2008 NOVEL PIPERIDINE DERIVATIVE OF FORMULA NEUROSEARCH A/S1357 865/CHENP/2005 219662 13-05-2008AN AQUEOUS TOPICALLY APPLIED MICELLARFORMULATION FOR CONTROLLING INTERNAL SCHERING-PLOUGH LTDPARASITES1358 2315/CHENP/2004 219679 13-05-2008 2-(2,6-DICHLOROPHENYL)- F. HOFFMANN-LA ROCHE AG1359 2648/CHENP/2004 219683 13-05-2008COMPOUNDS USEFUL IN THE TREATMENT OFANTHRAX AND INHIBITING LETHAL FACTORMERCK & CO. INC1360 1265/CHENP/2004 219691 13-05-2008PHARMACEUTICAL NANOPARTICULATECOMPOSITION OF A TACHYKININ RECEPTOR MERCK & CO., INCANTAGONIST1361 1091/CHENP/2005 219696 13-05-20085 SUBSTITUTED SULFONYLAMINOPYR AZOLEBAYER CROPSCIENCE S.ADERIVATIVESTETRAHYDROPYRANYL CYCLOPENTYL1362 2443/CHENP/2004 219704 13-05-2008 TETRAHYDROPYRIDO PYRIDINEMERCK & CO., INCMODULATORS OF CHEMOKINE RECEPTOR1363 703/CHENP/2005 219706 13-05-2008 CONTROLLED RELEASE COMPOSITIONS LABOPHARM INCBENZOXAZINE DERIVATIVES AS 5-HT61364 2541/CHENP/2004 219724 13-05-2008 MODULATORS AND PROCESS FOR PREPARING F. HOFFMANN-LA ROCHE AGTHE SAME

RECOMBINANT NUCLEIC ACID MOLECULES1365 737/CHENP/2005 219742 13-05-2008 WHICH ARE IL-1 RECEPTOR BASEDREGENERON PHARMACEUTICALS, INC.ANTAGONISTS1366 919/CHE/2003 219745 13-05-2008 A NOVEL ENZYME PREPARATION NOVOZYMES A/SCRYSTALLINE CEPHEM ADDITION SALTS,1367 1372/MAS/1995 219754 13-05-2008 PROCESSES FOR THEIR PREPARATION AND A SANOFI-AVENTIS DEUTSCHLAND GMBHPHARMACEUTICAL COMPRISING THE SAMEA NOVEL COMPOUND OF THE PRESENT1368 2313/CHENP/2004 219761 13-05-2008SCHERING CORPORATIONINVENTIONIMIDAZOLINYLMETHYL COAXIAL1369 2383/CHENP/2004 219762 13-05-2008 ELECTRICAL PLUGIN CONNECTOR AND AN F. HOFFMANN-LA ROCHE AGELECTRICAL CONNECTOR PLUGNOVEL SEMISYNTHETIC MACROLIDE1370 1192/CHENP/2005 219841 13-05-2008PLIVA - ISTRAZIVACKI INSTITUT D.O.O.ANTIBIOTICS OF THE AZALIDE SERIESAN ANTISENSE COMPOUND AND A1371 1218/CHENP/2005 219847 13-05-2008ISIS PHARMACEUTICALS, INC.COMPOSITION THEREOFRILOZOLE AND ALPHA-TOCOPHEROL1372 IN/PCT/2000/00402/DEL 219855 13-05-2008ALFA LAVAL MOATTI SNCCOMBINATIONA COMPOSITION FOR ORAL ADMINISTRATION1373 2513/DELNP/2005 219872 13-05-2008 CONTAINING A PHARMACEUTICALLY ACTIVE R.P. SCHERER CORPORATIONINGREDIENTA PHARMACEUTICAL COMPOSITION AND A1374 956/DEL/1996 219873 13-05-2008PANACEA BIOTEC LIMITEDPROCESS FOR THE MANUFACTURE THEREOFA COMPOSITION USEFUL FOR THE1375 298/DEL/2001 219874 13-05-2008 TREATMENT OF VIRAL INFECTIONS IN AN SAGE R & DANIMALAN ANTI-OSTEOPONTIN ANTIBODY OR AN IMMUNO-BIOLOGICAL LABORATORIES CO.1376 359/KOLNP/2004 219898 14-05-2008ANTIBODY FRAGMENT DERIVED THEREFROM LTD.A PHOSPHONIC ACID COMPOUND AND A1377 625/KOLNP/2004 219900 14-05-2008ORTHO-MCNEIL PHARMACEUTICAL, INC.PROCESS FOR PREPARING THE SAMEA PHARMACEUTICAL COMPOSITIONSUITABLE FOR THE TREATMENT OF1378 975/KOLNP/2005 219910 14-05-2008 OPHTHALMIC DISEASES OF THE POSTERIOR GASCO MARIA ROSASEGMENT OF THE EYE BY INTRAVENOUS ORTOPICAL OCULAR ADMINISTRATIONCRYSTALLINE FORMS OF PYRIMIDINE1379 991/KOLNP/2003 219911 14-05-2008SANKYO COMPANY, LIMITEDNUCLEOSIDE DERIVATIVE1380 1051/KOLNP/2005 219919 14-05-2008 3-AMINOPYRROLIDINE COMPOUNDS INCYTE CORPORATIONHETEROCYCLIC COMPOUNDS, PROCESS FORTHEIR PREPARATION AND PHARMACEUTICAL1381 1174/KOLNP/2003 219920 14-05-2008TORRENT PHARMACEUTICALS LTD.AND COSMETIC COMPOSITIONS COMPRISINGTHEMINHIBITORS OF SERINE PROTEASES,1382 1504/KOLNP/2004 219924 14-05-2008 PARTICULARLY HEPATITIS C VIRUS NS3-NS4 VERTEX PHARMACEUTICAL INCORPORATEDPROTEASE

1383 1790/KOLNP/2005 219932 14-05-2008NOVEL 8-SUBSTITUTED-6,7,8,9-TETRAHYDROPYRIMIDO[1,2-a]PYRIMIDIN-4-ONE DERIVATIVES AND MEDICAMENTSANOFI-AVENTISCONTAINING THE SAME1384 210/KOLNP/2005 219935 14-05-2008 MOTILIDE COMPOUNDS PFIZER INC.1385 2351/KOLNP/2005 219939 14-05-2008COMPOSITIONS AND METHODS FOR THEPREPARATION OF HUMAN GROWTHNEOSE TECHNOLOGIES, INCHORMONE GLYCOSYLATION MUTANTS1386 785/KOLNP/2005 219945 14-05-2008 NEUROLOGICALLY- ACTIVE COMPOUNDS PRANA BIOTECHNOLOGY LIMITED1387 849/KOLNP/2003 219949 14-05-2008LACTAM COMPOUNDS, PROCESS FORREPRODUCING THE SAME AND SERUMCHOLESTROL-LOWERING AGENTSKOTOBUKI PHARMACEUTICAL CO. LTD.CONTAINING THE SAMEA COMPOSITION COMPRISING METHYL N-(2,6-1388 0542/DEL/1998 219955 14-05-2008DIMETHYLPHENYL)-N-(METHOXYACETYL)-DL-SYNGENTA PARTICIPATIONS AG.ALANINATE AND 4-[3-(4-CHLOROPHENYL)-3-(3,4-1389 1248/CHENP/2005 219996 15-05-2008HUMAN MONOCLONAL ANTIBODIES AGAINSTGENMAB A/SCD25COMPOSITION OF ESTROGEN AND OTHER1390 1299/CHENP/2004 220005 15-05-2008 HORMONES WITH ASCORBATE, LYSINE DR. MATTHIAS RATHPROLINE AND OTHER SUBSTANCES1391 1412/CHENP/2005 220009 15-05-2008A PHARMACEUTICAL FORMULATIONCOMPRISING HIGH CONCENTRATION OF DURECT CORPORATIONOPIOIDS1392 1519/CHENP/2005 220014 15-05-2008ARYLENE-CARBOXYLIC ACID (2-AMINO-PHENYL)-AMIDE AS PHARMACEUTICAL F. HOFFMANN-LA ROCHE AGAGENTS1393 2604/CHENP/2004 220040 15-05-2008A COMPOSITION CONTAINING FLUNIXIN ANDAN ANTIBIOTIC OF FORMULA ISCHERING-PLOUGH LTD1394 7/CHENP/2005 220067 15-05-2008STABLE PHARMACEUTICAL COMPOSITIONCOMPRISING ERYTHROPOIETINLEK PHARMACEUTICALS D.D1395 841/CHENP/2005 220076 15-05-2008SUBSTITUTED 4-ALKOXYOXAZOLDERIVATIVES AS PPARAGONISTSF. HOFFMANN-LA ROCHE AG1396 857/CHENP/2005 220078 15-05-2008 1,2,4-THIADIAZOLE COMPOUNDS SUMITOMO CHEMICAL COMPANY LIMITED1397 877/CHENP/2005 220080 15-05-2008SUNFONYLAMINO-ACETIC DERIVATIVES ANDTHEIR USE AS OREXIN RECEPTORACTELION PHARMACEUTICALS LTDANTAGONISTS1398 2474/CHENP/2004 220159 16-05-2008A PHARMACEUTICAL COMPOSITIONCOMPRISING IBANDRONATE FORMULATION F. HOFFMANN-LA ROCHE AGAND PROCESS FOR PREPARING THE SAME1399 1971/DELNP/2005 220216 19-05-2008AN ISOLATED N-(1- OXY- PYRIDYLMETHYL)PHENYLAMINE COMPOUNDMEMORY PHARMACEUTICALS CORPORATION1400 2716/DELNP/2005 220217 19-05-2008A DIARYLMETHYLIDENE PIPERIDINECOMPOUND OF FORMULA IAstraZeneca AB

1401 2945/DELNP/2005 220218 19-05-20081402 IN/PCT/2002/00130/MUM 220229 21-05-2008A THIENOPYRIMIDINDIONE COMPOUND OFFORMULA (1)PHARMACEUTICAL COMPOSITION FORAstraZeneca ABBOEHRINGER INGELHEIM PHARMA GMBH& CO. KG.TREATING MENOPAUSAL HOT FLUSHES1403 329/KOLNP/2004 220251 21-05-2008 MUSCARINIC AGONISTS ELI LILLY AND COMPANY1404 931/KOLNP/2005 220260 21-05-2008 SUBSTITUTED TETRALINS AND INDANES JANSSEN PHARMACEUTICA N.V.1405 1627/KOLNP/2003 220265 21-05-2008 AN ENKEPHALIN PEPTIDE COMPOSITION PLOTNIKOFF NICHOLAS P.1406 1973/KOLNP/2004 220273 21-05-20081407 IN/PCT/2001/338/KOL 220287 21-05-20081408 IN/PCT/2002/1229/KOL 220289 21-05-20081410 1685/DEL/1996 220334 23-05-2008PEPTIDYL ANALOGS ACTIVE AT THEGROWTH HORMONE SECRETAGOGUEAN OLANZAPINE PAMOATE SALT ANDPHARMACEUTICALLY ACCEPTABLE SOLVATETHEREOFA PHARMACEUTICAL COMPOSITION WITHIMMEDIATE AND SUSTAINED RELEASE PHASEOF PARACETAMOLSOCIETE DE CONSEIL DE RECHERCHES ETD'APPLICATIONS SCIENTIFIQUES S.A.S.ELI LILLY AND COMPANYSMITHKLINE BEECHAM P.L.C.1409 IN/PCT/2002/399/KOL 220290 21-05-2008 PHARMACEUTICAL COMPOSITION BAXTER HEALTHCARE S.A.INHALABLE PHARMACEUTICALCOMPOSITIONS CONTAINING (ENDO, SYN)-(-)-3-(3-HYDROXY-1-OXO-2-PHENYLPROPOXY)-8- BOEHRINGER INGELHEIM KGMETHYL-8-(1-METHYLETHYL)-8-AZONIABICYCLO [3.2.1] OCTANE SALT1411 00971/DELNP/2004 220335 23-05-20081412 2197/DELNP/2004 220357 26-05-20081413 3186/DELNP/2004 220358 26-05-20081414 1636/DELNP/2005 220374 27-05-20081415 429/DEL/2002 220375 27-05-20081416 865/DEL/1996 220376 27-05-2008A PYRROLIDONE COMPOUND OF FORMULA I,USEFUL IN INHIBITING PDE4 ENZYMEHEPATITIS C INHIBITOR TRIPEPTIDECOMPOUND OF FORMULA (I)17ALPHA-ALKYL- 17BETA- OXY -ESTRATRIENES WITH GENERAL FORMULA IPYRIDOPYRIMIDINONE COMPOUNDS OFFORMULA (I) AND PHARMACEUTICALCOMPOSITION THEREOFA COMPOSITION FOR USE IN AN AEROSOLINHALERALKYL-DIHALOGENTED PHENYLSUBSTITUTED KETOENOLS OF THE FORMULA(I) AND PROCESS FOR PREPARATION THEREOFMEMORY PHARMACEUTICALS CORPORATIONBOEHRINGER INGELHEIM INTERNATIONALGMBHSCHERING AKTIENGESELLSCHAFTLES LABORTOIRES SERVIERCHIESI FARMACEUTICI S.P.A.BAYER AKTIENGESELLSCHAFT1417 IN/PCT/2002/00239/DEL 220377 27-05-2008BENZAMIDE DERIVATIVE-CONTAININGPHARMACEUTICAL FORMULATIONSCHERING AKTIENGESELLSCHAFT1418 930/CHENP/2005 220415 28-05-2008 DIAZINOPYRIMIDINES F. HOFFMANN-LA ROCHE AG1419 954/CHENP/2005 220421 28-05-2008A MIDICAMENT COMPRISINGERYTHROPOIETIN PROTEIN FOR TREATINGDISTURBANCES OF IRON DISTRIBUTION INHEART DISEASESF. HOFFMANN-LA ROCHE AG1420 959/CHENP/2005 220424 28-05-2008PYRAZOLOQUINOLINE DERIVATIVES WITHIMMUNOMODULATING ACTIVITYACTIVE BIOTECH AB

1421 1222/CHENP/2005 220431 28-05-2008 3H-QUINAZOLIN-4-ONE-DERIVATIVES F. HOFFMANN-LA ROCHE AG1422 2471/CHENP/2004 220446 28-05-2008MEDICAMENTS COMPRISING LIPOSOMES OFPARTICULAR SIZESESPERION LUV DEVELOPMENT, INC.1423 297/CHENP/2005 220447 28-05-2008A HUMANIZED OR CHIMERIC MONOCLONALANTIBODY OR FRAGMENTS THEREOF IMMUNOMEDICS, INC.SPECIFIC FOR ALPHAFETO PROTEINPYRIMIDINE-4,6-DICARBOXYLIC ACID1424 781/CHENP/2005 220456 28-05-2008 DIAMIDES FOR THE SELECTIVE INHIBITION OF SANOFI-AVENTIS DEUTSCHLAND GMBHCOLLAGENASES1425 673/KOLNP/2005 220472 28-05-2008A PHARMACEUTICAL COMPOSITION OF ABOTULINUM TOXIN FOR ORALALLERGAN, INC.1426 609/KOLNP/2003 220487 28-05-2008A SUBSTITUTED LACTAM COMPOUND ANDPHARMACEUTICAL COMPOSITION THEREOFELI LILLY AND COMPANY1427 2588/KOLNP/2005 220494 28-05-2008DIARYL AND ARYLHETEROARYL UREADERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR ARENA PHARMACEUTICALS INCTHE PROPHYLAXIS AND TREATMENT OFDISORDERS RELATED THERETO1428 2731/DELNP/2005 220513 28-05-2008 A DIAMINE DERIVATIVES DAIICHI PHARMACEUTICAL CO. LTD.1429 1154/CHENP/2005 220538 29-05-20086-(2-HALOGENPHENYL)-TRIAZOLOPYRIMIDINES DERIVATIVES AND BASF AKTIENGESELLSCHAFTPROCESS FOR PREPARING THE SAME1430 1346/CHENP/2005 220550 29-05-2008 TETRAHYDROQUINOLINE DERIVATIVES N.V ORGANON1431 1492/MAS/1998 220553 29-05-2008 INDOLE-2,3-DIONE-3-OXIME DERIVATIVES NEUROSEARCH A/S1432 2368/CHENP/2004 220559 29-05-2008A TRIAZOLOPYRIMIDINE AND A PROCESS FORBASF AKTIENGESELLSCHAFTTHE PREPARATION OF THE SAME1433 587/CHENP/2005 220575 29-05-2008 BENZOTRIAZOLE COMPOUND SANOFI-AVENTIS DEUTSCHLAND GMBH1434 763/CHENP/2005 220595 29-05-2008A RECOMBINANT FACTOR VII OR VIIAPOLYPEPTIDE VARIANT HAVING INCREASED MAXYGEN HOLDINGS LTDCLOTTING ACTIVITY1435 777/CHENP/2005 220596 29-05-2008SPIRO COMPOUNDS, MEDICINALCOMPOSITIONS CONTAINING THE SAME AND DAINIPPON PHARMACEUTICAL CO. LTDINTERMEDIATES OF THE COMPOUNDS1436 784/CHENP/2005 220597 29-05-2008ORTHO CYCLOPROPYL-THIENYL-CARBOXAMIDE AS FUNGICIDES HAVING SYNGENTA PARTICIPATIONS AGMICROBIOCIDAL ACTIVITY1437 790/CHENP/2005 220599 29-05-2008ISOQUINOLINE COMPOUNDS AND PROCESSFOR PREPARING THE SAMEMITSUBISHI TANABE PHARMA CORPORATIONBENZOTHIEPINE-1, 1-DIOXIDE DERIVATIVES,1438 IN/PCT/2000/781/CHE 220615 29-05-2008THEIR PHYSIOLOGICALLY TOLERABLE SALTS,SANOFI-AVENTIS DEUTSCHLAND GMBHFUNCTIONAL DERIVATIVES AND THEMETHOD FOR PRODUCING THE SAME1439 2809/DELNP/2004 220674 30-05-2008SUBSTITUTED AMINO ISOXAZOLINECOMPOUNDSJANSSEN PHARMACEUTICA N.V.

1440 713/DEL/2002 220683 02-06-20081441 665/DEL/2002 220688 02-06-20081442 0309/DEL/1998 220704 02-06-20081443 1524/DEL/2003 220708 03-06-20081444 2580/DELNP/2004 220709 03-06-20081445 1008/DEL/2001 220711 03-06-2008A HERBAL FORMULATION FOR THEMANAGEMENT OF OSTEO-ARTHRITIS AND APROCESS FOR THE PREPARATION THEREOFA HERBAL COMPOSITION HAVING ANTI-STRESS AND ADAPTOGENIC PROPERTIES ANDA PROCESS FOR THE PREPARATION THEREOFAN AZOLE COMPOUND OF FORMULA (I) ANDPROCESS FOR PREPARATION THEREOFA HERBO-MINERAL FORMULATIONA 5,11-DIHYDRO-6H-DIPYRIDO[3,2-B:2',3-E][1,4]DIAZEPIN-6-ONE COMPOUNDREPRESENTED BY FORMULA IA NOVEL ANTI-FUNGAL MOLECULE 2-(3,4-DIMETHYL-2, 5-DIHYDRO-1H-PYRROL-2-YL)-1-METHYLETHYL PENTANOATERAVI PATODIARAVI PATODIAJANSSEN PHARMACEUTICA N.V.NATIONAL RESEARCH DEVELOPMENTCORPORATIONBOEHRINGER INGELHEIM INTERNATIONALGMBHCOUNCIL OF SCIENTIFIC AND INDUSTRIALRESEARCH1446 2773/DELNP/2005 220713 03-06-2008 A COMPOUND HAVING THE FORMULA (I) JANSSEN PHARMACEUTICA N.V.,1447 IN/PCT/2002/00039/DEL 220723 03-06-2008A COMPOSITION1448 664/DEL/2002 220749 04-06-20081449 666/DEL/2002 220786 05-06-20081450 663/DEL/2002 220806 05-06-20081451 IN/PCT/2001/00899/DEL 220809 05-06-2008A HERBAL COMPOSITION FOR THEPREVENTION AND MANAGEMENT OFPOTENTIAL DIABETES AND A PROCESS FORTHE PREPARATION THEREOFA HERBAL FORMULATION FOR PREVENTIONAND MANAGEMENT OF CORYZA AND APROCESS THEREOFA HERBAL PREPARATION AND A PROCESSFOR THE PREVENTION OF LIVER CIRRHOSISOF VARYING ETIOLOGYZ-STYRYL SULFONE COMPOUNDSINSTITUT NATIONAL DE LA SANTE ET DE LARECHERCHE MEDICALE (INSERM)RAVI PATODIARAVI PATODIARAVI PATODIA.TEMPLE UNIVERSITY OF THECOMMONWEALTH SYSTEM OF HIGHEREDUCATION1452 486/DELNP/2005 220812 05-06-2008 NOVEL TRIAZOLE COMPOUNDS ASTRAZENECA AB1453 497/KOLNP/2005 220846 06-06-2008A MEDICAMENT TO FACILITATEPHAGOCYTIC ACTIVITY OFMACROPHAGESHIROSHI TERADA1454 00806/DELNP/2004 220861 09-06-2008A SUSPENSION OF NANOPARTICULATES OFAN ANTIMITOTIC DRUGCRITITECH, INC.,N-PHENY1-TRIFLUOROPROPANAMIDE1455 0817/DEL/1999 220862 09-06-2008 COMPOUNDS AND PROCESS OF PREPARATION ASTRAZENECA UK LIMITEDTHEREOF1456 4140/DELNP/2004 220864 09-06-2008 A QUINUCLIDINE AMIDE COMPOUND ALMIRALL AG

1457 IN/PCT/2000/00062/DEL 220865 09-06-2008A PHARMACEUTICAL COMPOSITION FOR THEMANAGEMENT OF ATTENTION DIFICITDISORDER (ADD) AND ATTENTION DEFICITNOVEN PHARMACEUTICALS, INC.HYPERACTIVITY DISORDER (ADHD)1458 1557/DEL/1996 220866 09-06-2008N,N-DIETHY-8, 8-DIPROPYL-2-AZASPIRO[4,5]DECANE-2-PROPANAMINE DIMALEATEANORMED INC.1459 955/DEL/2002 220868 09-06-2008A PHARMACEUTICAL PREPARATION FORREDUCTION OF THE FIBRINOGEN LEVEL AND PROBI ABCHOLESTEROL LEVEL IN BLOOD1460 318/MAS/1995 220879 10-06-2008 ACYLATED INSULIN NOVO NORDISK A/S1461 1996/CHENP/2005 220885 10-06-2008 CHOLESTERIC LIQUID CRYSTAL 3M INNOVATIVE PROPERTIES COMPANY1462 3157/DELNP/2004 220898 10-06-2008 3-CARBONYLOXY-1-ALKYL PYRROLIDINIUMS ALMIRALL AG1463 840/MUMNP/2005 220901 06-10-2008 TRI(CYCLO)SUBSTITUTED AMIDEORAL DOSAGE FORM CONTAINING A PDE 41464 369/MUMNP/2004 220907 06-10-2008 INHIBITOR AS AN ACTIVE INGREDIENT AND NYCOMED GMBHPOLYVINYLYPYRROL IDON AS EXCIPIENT1465 2137/DELNP/2005 220911 10-06-2008A BENZAMIDE COMPOUND OF THE FORMULA(I)PFIZER PRODUCTS INC.1466 114/CHENP/2005 220938 11-06-2008NOVEL PYRAZOLE DERIVATIVES ANDPROCESS FOR THE PRODUCTION THEREOFIHARA CHEMICAL INDUSTRY CO. LTD1467 1516/CHENP/2005 220956 11-06-2008 PYRROLOPYRIDAZINE DERIVATIVES ASTELLAS PHARMA INC1468 155/CHENP/2005 220961 11-06-2008BENZOTHIAZOLE DERIVATIVES HAVING BETA-NOVARTIS AG2-ADRENORECEPTOR AGONIST ACTIVITY1469 1556/CHENP/2005 220963 11-06-2008 3-SUBSTITUTED-4-PYRIMIDONE DERIVATIVES MITSUBISHI PHARMA CORPORATION1470 181/CHENP/2005 220973 11-06-2008 SALT OF MORPHINE-6-GLUCURONIDE CENES LIMITED1471 223/CHENP/2005 220990 11-06-2008A PAMOATE SALT OF 3-PHENYL-3-DIMETHYLAMINOAL KYL-4-4-PRESTWICK PHARMACEUTICALS, INCDIMETHYLPIPERIDIN-2,6-DIONE OF FORMULA1472 1193/KOLNP/2004 220994 11-06-2008A STABLE CONTROLLED RELEASEMONOLITHIC COATING COMPOSITIONBIOVAIL LABORATORIES INC1473 858/KOLNP/2005 221016 11-06-2008A COMPOUND OF FORMULA 1 FOR INHIBITINGALCHEMIA LIMITEDTHE ACTIVITY OF GPCR1474 IN/PCT/2000/130/KOL 221017 11-06-2008 BICYCLIC HETEROAROMATIC COMPOUNDS GLAXO GROUP LIMITED1475 1833/DELNP/2004 221037 12-06-2008FLUOREN-9-CARBON ACID ESTERSBOEHRINGER INGELHEIM PHARMA GMBH &CO. KG.1476 1020/MUMNP/2005 221040 12-06-2008 A PHARMACEUTICAL COMPOSITION1477 48/MUM/2002 221042 12-06-2008 A HERBAL COMPOSITION GUFIC HEALTHCARE LIMITED1478 915/MUM/2003 221047 12-06-2008BENZOQUINOLIZINE-2-CARBOXYLIC ACIDARGININE SALT TETRAHYDRATE AND WOCKHARDT LIMITEDPROCESS FOR PREPARATION THEREOF1479 1798/DELNP/2004 221048 12-06-2008A MALAYAMYCIN COMPOUND AND APROCESS THEREOFSYNGENTA LIMITED1480 146/DEL/2003 221050 13-06-2008A PHARMACEUTICAL COMPOSITION USEFUL COUNCIL OF SCIENTIFIC AND INDUSTRIALAS CONTRACEPTIVERESEARCH

1481 305/DEL/2002 221053 13-06-20081482 00916/DELNP/2004 221054 13-06-2008A SYNERGISTIC PHARMACEUTICALCOMPOSITION FOR DIABETIC NEPHROPATHYCRYSTALLINE SODIUM SALT OF 4'-[2-N-PROPYL-4-METHYL-6-(1-METHYLBENZIMIDAZOL-2YL)BENZIMIDAZOL-1-YLMETHYL]BIPHENYL-2-CARBOXYLIC ACID1483 658/MUM/2003 221064 13/06/2008 PHARMACEUTICAL DISPENSING AID CIPLA LIMITEDA PHARMACEUTICAL COMPOSITION FOR1484 02209/DELNP/2003 221070 16-06-2008 ALTERING THE AFFINITY OF A NUCLEIC ACID DUKE UNIVERSITYLIGAND1485 00802/DELNP/2003 221071 16-06-20081486 1500/DELNP/2005 221075 16-06-20081487 629/MUMNP/2006 221076 16/06/2008A N-6 SUBSTITUTED 7-DEAZAPURINECOMPOUNDSUBSTITUTED INDOLEPYRIDINIUM AS ANTI-INFECTIVE COMPOUNDSINTACT MINICELLS AS VECTORS FOR DNATRANSFER AND GENE THERAPY IN VITROAND IN VIVO1488 129/DEL/2003 221082 16-06-2008A COMPOSITION USEFUL FORHEPATOPROTECTION1489 793/MUMNP/2005 221090 17/06/2008 PYRIDOPYRANOAZEPINE DERIVATIVESENTERIC COATED FORMULATION FOR1490 709/BOM/1999 221092 17/06/2008 BISPHOSPHONIC ACID(S) FOR SALT(S)THEREOF1491 1777/DELNP/2005 221093 17-06-20081492 1169/KOLNP/2005 221111 18-06-20081493 1180/KOLNP/2005 221119 18-06-2008CORTICOTROPIN RELEASING FACTORRECEPTOR 2 AGONISTSGASTRIN COMPOUND CAPABLE OF BEINGUSED AS MEDICAMENT FOR TREATMENT OFDIABETESCOMBINATION OF ANTIDIABETIC DRUGSCOUNCIL OF SCIENTIFIC AND INDUSTRIALRESEARCHBOEHRINGER INGELHEIM PHARMA GMBH &CO., KG,OSI PHARMACEUTICALS, INC.TIBOTEC PHARMACEUTICALS LTDCOUNCIL OF SCIENTIFIC AND INDUSTRIALRESEARCHCIPLA LIMITEDTHE PROCTER & GAMBLE COMPANYWARATAH PHARMA CEUTICALS, INC.SIGMA-TAU INDUSTRIE FARMACEUTICHERIUNITE S.P.A.1494 1481/KOLNP/2005 221125 18-06-2008 AMINO ACID PHENOXY ETHERS BEXEL PHARMACEUTICALS INC.1495 1495/KOLNP/2003 221126 18-06-2008ANTI-INFLAMMATORY 17, BETA-CARBOTHIOATE ESTER DERIVATIVES OFANDROSTANE WITH A CYCLIC ESTER GROUPIN POSITION 17. ALPHAGLAXO GROUP LIMITED1496 1848/KOLNP/2004 221138 18-06-20081497 1670/KOLNP/2004 221140 18-06-20081498 2357/KOLNP/2005 221146 18-06-2008BENZIMIDAZOLE COMPOUNDS USEFUL FORTHE INHIBITION OF MACROPHAGEMIGRATION INHIBITORY FACTOR (MIF) ANDPHARMACEUTICAL COMPOSITIONCOMPRISING THEMAEROSOL CONTAINING A PARTICULATEACTIVE SUBSTANCEANTI-INFLAMMATORY ANALGESIC ADHESIVEPATCHCORTICAL PTY LTD.NEKTAR THERAPEUTICS UK LTD.TEIKOKU SEIYAKU CO., LTD.

1499 1599/KOLNP/2004 221152 18-06-2008SUSTAINED RELEASE OF GUAIFENESINCOMBINATION DRUGSADAMS LABORATORIES, INC.1500 IN/PCT/2002/1457/KOL 221171 18-06-2008QUINAZOLINE DITOSYLATE SALTCOMPOUNDSGLAXO GROUP LIMITED1501 IN/PCT/2001/00087/DEL 221176 18-06-2008TOPICAL PATCH CONTAINING AS ACTIVESUBSTANCE A NON-STEROID ANTIREUMATIC LTS LOHMANN THERAPIE-SYSTEME AGAGENT HAVING A FREE CARBOXYL GROUP1502 974/BOM/1999 221180 18/06/2008A PHARMACEUTICAL OR COSMETICCOMPOSITION IN THE FORM OFMICRODROPLETS OF WATER INSOLUBLELAMAR INTERNATIONAL PVT LTDLIQUID FOR TOPICAL APPLICATION1503 1114/MUMNP/2005 221181 18/06/2008NOVEL FUNCTIONAL PEPTIDE NUCLEIC ACIDAND PROCESS FOR PRODUCING THE SAME1504 IN/PCT/2002/01546/MUM 221184 18/06/20083-NITROGEN-6,7-DIOXYGEN STERIODCOMPOUNDSINFLAZYME PHARMACEUTICALS LIMITED1505 1230/MUMNP/2005 221186 18/06/2008ORAL PHARMACEUTICAL PREPARATIONCOMPRISING A PROTON PUMP ANTAGONISTS1506 3570/DELNP/2004 221213 19-06-2008 A PYRIDAZIN-3 (2H)-ONE ALMIRALL PRODESFARMA, S.A.1507 1217/DEL/2002 221214 19-06-2008 A SUBSTITUTED N-ACYL GLYCINE MITSUBISHI TANABE PHARMA CORPORATION1508 2302/CHENP/2004 221220 20-06-2008LIQUID PREPARATION COMPRISINGCAMPTOTHECIN DERIVATIVE ANDPHARMACEUTICAL COMPOSITIONMITSUBISHI TANABE PHARMA CORPORATIONPRODUCIBLE BY LYOPHILIZING THEPREPARATION1509 2410/CHENP/2004 221222 20-06-2008SUBSTITUTED-CYCLOALKYL ANDOXYGENATED-CYCLOALKYLF. HOFFMANN-LA ROCHE AGPHENYLACETAMIDE DERIVATIVES1510 2521/CHENP/2004 221224 20-06-2008 2-THIA-DIBENZOAZULENES OF FORMULA I PLIVA-ISTRAZIVACKI INSTITUT D.O.O.1511 276/CHENP/2005 221229 20-06-2008NOVEL-2 ARYLTHIAZOLE COMPOUNDS ASPPARALPHA AND PPARGAMA AGONISTSF. HOFFMANN-LA ROCHE AG1512 348/CHENP/2005 221240 20-06-2008N-SUBSTITUTED INDOLPROPIONIC ACIDDERIVATIVESF. HOFFMANN-LA ROCHE AG1513 54/CHENP/2005 221266 20-06-2008A GALLOTANNIN VARIANT COMPOSITION FOROHIO UNIVERSITYTREATING DIABETES MELLITIS1514 545/CHENP/2005 221267 20-06-2008 ARYL SULFONAMIDE COMPOUNDS CHEMOCENTRYX INC.1515 IN/PCT/2001/141/CHE 221277 20-06-2008A PHARMACEUTICAL FORMULATION FORTHE REGENTS OF THE UNIVERSITY OFTREATMENT OF AIRWAY MUCUSCALIFORNIAHYPERSECRETION1516 1646/CHENP/2005 221296 20-06-2008 CaSR ANTAGONIST JAPAN TOBACCO, INC1517 997/CHE/2004 221311 20-06-2008 HERBAL ANT REPELLENT COMPOSITION PSG COLLEGE OF PHARMACY1518 2639/CHENP/2004 221341 23-06-2008A PHARMACEUTICAL COMPOSITIONCOMPRISING A PLANT THYMIDINE KINASESKNECHT, Wolfgang1519 1943/CHENP/2004 221356 23-06-2008 NOVEL VIP3 TOXINS SYNGENTA PARTICIPATION AG1520 IN/PCT/2002/1062/CHE 221380 23-06-2008PHARMACEUTICAL AND COSMETIC CARRIERFOAMIX LTDOR COMPOSITION FOR TOPICAL APPLICATION

1521 IN/PCT/2002/162/CHE 221395 23-06-2008ARYLSULFONAMIDO-SUBSTITUTEDHYDROXAMIC ACID DERIVATIVESNOVARTIS AG1522 2739/DELNP/2005 221400 23-06-2008BIGUANIDE OF FORMULA 1 OR APHARMACEUTICALLY ACCEPTABLE SALT JACOBUS PHARMACEUTICAL COMPANY, INC.,THEREOF1523 1940/CHENP/2004 221417 23-06-2008 CATHEPSIN CYSTEINE PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC1524 968/CHE/2004 221428 23-06-2008MUCOADHESIVE BUCCAL COMPOSITIONCONTAINING NICOTINE USEFUL FORTHE MANIPAL COLLEGE OFSMOKING CESSATION AND A PROCESS FOR PHARMACEUTICAL SCIENCESITS PREPARATION1525 IN/PCT/2002/1651/CHE 221437 23-06-2008 PHARMACEUTICAL COMPOSITION NOVARTIS AG1526 188/MAS/1995 221440 23-06-2008A SYNERGESTIC GROWTH PROMOTINGCOMPOSITIONTABLETS (INDIA) LIMITED1527 509/MAS/1995 221441 23-06-2008PROPIOPHENONE DERIVATIVE AND APROCESS FOR PREPARING THE SAMEMITSUBISHI TANABE PHARMA CORPORATION1528 1020/MAS/1996 221442 23-06-2008A VALINE P-ISOPROPYLBENZENESULFONATECRYSTAL AND PROCESS FOR PURIFYING THE AJINOMOTO CO. INCSAME1529 1785/DELNP/2005 221465 23-06-2008A PHARMACEUTICAL COMPOSITIONPHARMACIA & UPJOHN COMPANY1530 IN/PCT/2002/00025/MUM 221507 24/06/2008COMPRISING A VEHICLEPHARMACEUTICAL COMPOSITIONCONTAINING FENOFIBRATE AND METHODFOR THE PREPARATION THEREOFLABORATORIES DES PRODUCTS ETHIQUESETHYPHARM1531 1120/MUM/2003 221514 24/06/2008 A NOVEL PHARMACEUTICAL COMBINATION CIPLA LIMITED1532 627/KOLNP/2004 221531 25-06-2008SUBSTITUTED DIAMINO-HYDROXYPROPANECOMPOUNDELAN PHARMACEUTICALS, INC.1533 935/KOLNP/2003 221535 25-06-2008ANTI-ALLERGIC AGENT OF A COMPLEXMOLECULE AND PHARMACEUTICALCOMPOSITION COMPRISING IT.RAMOT AT TEL AVIV UNIVERSITY LTD.1534 1491/KOLNP/2003 221544 25-06-20081535 1913/KOLNP/2004 221550 25-06-2008SOMATOSTATIN-DOPAMINE CHIMERICANALOGSA NOVEL ARYL-OR HETERDARYL -SUBSTITUTED PIPERAZINYL CARBONYLCOMPOUNDSOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES S.A.S.ZENTARIS GMBH1536 237/CAL/2001 221562 25-06-2008PENTAPEPTIDES AND COMPOSITIONCOMPRISING THEMTETRAGENEX PHARMACEUTICALS INC.1537 51/CAL/1995 221574 25-06-2008 BISINDOLEMALEIMIDE COMPOUNDS ELI LILLY AND COMPANYMETHOD AND COMPOSITIONSEMPLOYING FORMULATIONS OF1538 739/KOLNP/2003 221578 25-06-2008TRACT AND PROVIDING ENHANCEDTHERAPEUTIC ACTIVITY.LECITHIN OILS AND NSAIDS FOR THE BOARD OF REGENTS OF THEPROTECTING THE GASTROINTESTINAL UNIVERSITY OF TEXAS SYSTEM

SUBSTITUTED ARYLALCANOIC ACIDDERIVATIVES AS PPAR PAN AGONISTS WITH1539 792/KOLNP/2005 221582 25-06-2008SHENZHEN CHIPSCREEN BIOSCIENCES LTD.POTENTANTIHYPERGLYCEMIC ANDANTIHYPERLIPIDEMIC ACTIVITYAN ISOLATED POLYPEPTIDE OF NEISSERIA1540 IN/PCT/2000/101/KOL 221583 25-06-2008THE UNIVERSITY OF QUEENSLANDMENINGITIDISA PHARMACEUTICAL COMPOSITION1541 IN/PCT/2000/106/KOL 221584 25-06-2008 COMPRISING ONE OR MORE DISCRETE SOLID G. D. SEARLE & CO.,ORALLY DELIVERABLE DOSE UNITSPHARMACEUTICAL COMPOSITIONCOMPRISING 5-[4-[2-(N-METHYL-N-(2-1542 845/DEL/2002 221597 26-06-2008PYRIDYL)AMINO)ETHOXY]BENZYL]THIAZOLISMITHKLINE BEECHAM PLCDINE-2,4-DIONE AND METFORMIN ORMETFORMIN HYDROCHLORIDE SUITABLE FORTHE TREATMENT OF DIABETESNOVEL HERBAL COMPOSITION FOR THE COUNCIL OF SCIENTIFIC AND INDUSTRIAL1543 1340/DEL/2003 221610 27-06-2008TREATMENT OF GASTRIC ULCERRESEARCHA HERBAL INJECTION AND A METHOD TO1544 592/MUMNP/2004 221614 27/06/2008MAOXIANG WANGPRODUCE THE SAME1545 50/MUMNP/2005 221618 27/06/2008 PRODRUGS OF PROTON PUMP INHIBITORSCRYSTALLINE POLYMORPHIC FORMS OF1546 146/MUMNP/2006 221621 27/06/2008ATOVAQUONE AND PROCESS THEREOFA CRYSTAL OF 1-(2-METHOXYETHYL)-2-METHYL-4, 9-DIOXO-3- (PYRAZIN-2-1547 4719/DELNP/2005 221624 27-06-2008ASTELLAS PHARMA INCYLMETHYL)-4, 9-DIHYDRO-1 H-NAPHTHO [2,3-D] IMIDAZOL-3- IUM BROMIDE4-[4-(2-PYRROLYLCARBONYL)-1-PIPERAZINYL]BOEHRINGER INGELHEIM PHARMA GMBH &1548 01168/DELNP/2003 221648 30-06-2008 3-TRIFLUOROMETHYL-BENZOYLGUANIDINECO. KG.,HYDROCHLORIDE 1CYCLOHEXYL (ALKYL)-PROPANOLAMINES,PREPARATION METHOD AND1549 00811/DELNP/2003 221670 30-06-2008SANOFI-SYNTHELABOPHARMACEUTICAL COMPOSITIONSCONTAINING SAMEENTERIC COATED SOLID PHARMACEUTICAL1550 772/CHENP/2004 221674 01-07-2008 COMPOSITIONS CONTAINING MYCOPHENOLIC NOVARTIS AGACID OR ITS SALTSNOVEL ANTIINFECTIVE COMPOUNDS AND1551 448/CHE/2003 221690 01-07-2008DR. REDDY'S LABORATORIES LTD.THEIR PHARMACEUTICAL COMPOSITIONSAN EDIBLE, HARDENABLE, PROMPT RELEASE,1552 IN/PCT/2001/00886/MUM 221715 02-07-2008 PHARMACEUTICAL AND VETERINARY FMC CORPORATIONCOATING COMPOSITIONA PHARMACEUTICAL COMPOSITION FOR1553 IN/PCT/2002/01101/MUM 221718 02-07-2008NICOX S.AORAL ADMINISTRATIONLIMPID PARENTERAL FORMULATION OF 2,61554 65/BOM/1999 221768 03-07-2008THEMIS CHEMICALS LIMITEDDIISOPROPHYLPHENOL

AN AYURVEDIC COMPOSITION FOR ORAL1555 1623/MUM/2006 221770 03-07-2008 CONSUMPTION IN TREATMENT OF HEARTDISEASES AND HYPERTENSION1556 294/MUMNP/2003 221792 04-07-2008 POLYSUBSTITUTED IMIDAZOPYRIDINES ALTANA PHARMA AGIMIDAZOPYRIDINE- DERIVATIVES AS1557 362/MUMNP/2006 221798 07-07-2008ALTANA PHARMA AGINDUCTIBLE NO-SYNTHASE INHIBITORSSUBTILASE ENZYMES OF THE I-S 1 AND I-S21558 IN/PCT/2001/814/CHE 221847 08-07-2008 SUB-GROUPS HAVING AN ADDITIONAL AMINO NOVOZYMES A/SACID RESIDUESUBTILASE ENZYMES HAVING AN1559 IN/PCT/2001/822/CHE 221848 08-07-2008NOVOZYMES A/SADDITIONAL AMINO ACID RESIDUE1560 719/KOLNP/2005 221897 09-07-2008 AN HCV VACCINE GLAXO GROUP LIMITED1561 00083/DELNP/2004 221905 10-07-2008 A BIS(THIOHYDRAZIDE AMIDE COMPOUND SYNTA PHARMACEUTICALS CORP.A QUINAZOLINE DERIVATIVE OF THE1562 0354/DEL/1997 221906 10-07-2008ASTRAZENECA UK LIMITEDFORMULA IA MUSCLE RELAXANT CUM ANALGESIC1563 206/MUM/2004 221923 10-07-2008 FORMULATION AND TO A METHOD OF SANJEEV KHANDELWALMAKING THE SAMEPHARMACEUTICAL DRONEDARONE1564 00718/DELNP/2003 221937 11-07-2008 COMPOSITION FOR PARENTERALSANOFI-SYNTHELABOADMINISTRATIONA VACCINE MODIFIED NON-PATHOGENICPESTIVIRUS, NUCLEIC ACID AND1565 413/MUMNP/2004 221943 11-07-2008BOEHRINGER INGELHEIM VETMEDICA GMBHPHARMACEUTICAL COMPOSITIONCOMPRISING THE SAMEA COMPOSITION FOR REVERSING MALARIA1566 IN/PCT/2002/00624/DEL 221957 12-07-2008KEVIN C. KAINDRUG RESISTANCETRICYCLIC HIV-INTEGRASE INHIBITING1567 1969/DELNP/2005 221962 12-07-2008GILEAD SCIENCES, INC.COMPOUNDBENZOPYRAN DERIVATIVES SUBSTITUTEDWITH SECONDARY AMINES INCLUDING1568 3100/DELNP/2004 221964 12-07-2008 TETRAZOLE, METHOD FOR THE PREPARATION DONGBU HANNONG CHEMICAL CO.THEREOF AND PHARMACEUTICALCOMPOSITIONS CONTAINING THEM.TRIPEPTIDE COMPOUNDS AS HEPATITIS C BOEHRINGER INGELHEIM INTERNATIONAL1569 2200/DELNP/2004 221979 14-07-2008INHIBITORGMBH(-) 3-((2S, 5R)-4-ALLYL-2, 5-DIMETHYL-1-PIPERAZINYL) (3-THIENYL) METHYL) PHENOL1570 00710/DELNP/2004 221984 14-07-2008MOUNT COOK BIOSCIENCES, INC.OR A PHARMACEUTICALLY ACCEPTABLEESTER OR SALT THEREOF OF FORMULA I1571 795/MUM/2002 222008 15/07/2008 1- PYRROLINES BAYER AKTIENGESELLSCHAFTA NEEM OIL BASED WOUND HEALING1572 261/MUM/2005 222010 15/07/2008GODREJ AGROVET LIMITEDOINTMENT OR CREAM

1573 1014/MUMNP/2005 222019 16-07-2008IMIDAZO [4,5-B]QUINOLINE-DERIVATIVES FORTHE TREATMENT OF INFLAMMATORY ALTANA PHARMA AGDISEASES1574 576/KOLNP/2004 222022 16-07-2008CAROTENOID COMPOSITIONLYCORED NATURAL PRODUCTS INDUSTRIESLTD.1575 1229/KOLNP/2005 222024 16-07-2008A PHARMACEUTICAL COMPOSITIONCOMPRISING ARIPIPRAZOLE IN COMBINATIONOTSUKA PHARMACEUTICAL CO. LTD.WITH AT LEAST ONE SEROTONIN REUPTAKEINHIBITOR1576 IN/PCT/2002/1341/KOL 222054 16-07-2008ISOLATION AND CHARACTERIZATION OF THEcsa OPERON (ETEC-CS4 PILI) AND METHODS OF UNIVERSITY OF MARYLAND, BALTIMOREUSING THE SAMEA COMPOSITION FOR INHIBITING B-SA MAJESTE LA REINE DU CHEF DU CANADA1577 IN/PCT/2002/850/KOL 222058 16-07-2008AGRICULTURE ET AGROALIMENTAIRELACTAMASE IN A MICROORGRANISM CANADA1578 IN/PCT/2002/1066/KOL 222059 16-07-2008CATALYTIC COMPOSITION FORCARBONYLATION INCLUDING IRIDIUM AND CELANESE INTERNATIONAL CORPORATIONPYRIDINE POLYMERS1579 1568/DELNP/2004 222070 16-07-2008STABLE OXALIPLATIN SOLUTIONFORMULATIONNERVIANO MEDICAL SCIENCES S.R.L.1580 1167/DEL/1995 222077 17-07-2008NEW ERYTHROMYCIN COMPOUNDS, THEIRPREPARATION PROCESS AND THEIR USE AS AVENTIS PHARMA S.A.MEDICAMENTS1581 0407/DEL/1998 222078 17-07-2008 AN THIADIAZINE COMPOUND OF FORMULA (I) UNIROYAL CHEMICAL COMPANY, INC.1582 01829/DELNP/2003 222079 17-07-2008 PYRAZOLOPYRIMIDINONE COMPOUNDS DONG A PHARM. CO., LTD.1583 3722/DELNP/2004 222080 17-07-20082,5-DISUBSTITUTED 3-MERCAPTOPENTANOICACIDAstraZeneca AB,1584 485/MUMNP/2006 222088 18/07/2008A CONTROLLED RELEASE PHARMACEUTICALCOMPOSITION AND A PROCESS FORLUPIN LIMITEDPREPARING THE SAME1585 416/MUMNP/2004 222091 18/07/20082-METHYLTHIAZOLIDINE-2, 4-DICARBOXYLICACID AND THE SALTS THEREOF USED FORTHE TREATMENT OF NEURODEGENERATIVESUSILO, RUDYDISEASES1586 4014/DELNP/2004 222108 21-07-2008TRICYCLIC SPIROPIPERIDINE ORSPIROPYRROLIDINES AND PROCESS FOR ASTRAZENECA ABPREPARATION THEREOF1587 00078/DELNP/2004 222109 21-07-2008A BIS(THIOHYDRAZIDE AMIDE) COMPOUNDAND PHARMACEUTICAL COMPOSITION SYNTA PHARMACEUTICALS CORPORATIONTHEREOF1588 115/DEL/2000 222112 22-07-2008A QUINAZOLINE DERIVATIVE OF THEFORMULA IIASTRAZENECA UK LIMITED.

1,2,3-TRISUBSTITUTED ARYL ANDHETEROARYL DERIVATIVES AS1589 1150/KOLNP/2005 222137 23-07-2008MODULATORS OF METABOLISM AND THEPROPHYLAXIS AND TREATMENT OFARENA PHARMACEUTICALS INC.DISORDERS RELATED THERETO SUCH ASDIABETES AND HYPERGLYCEMIA1590 1338/KOLNP/2004 222139 23-07-2008CHIRAL 1,4-DISUBSTITUTED PIPERAZINESPROCESS FOR THEIR PREPARATION AND WYETHINTERMEDIATES1591 1487/KOLNP/2004 222144 23-07-2008A PHARMACEUTICAL COMPOSITIONCOMPRISING A PANEL OF BACTERIOPHAGESUNIVERSITY OF WARWICK1592 1727/KOLNP/2004 222148 23-07-2008 A NOVEL OPIOID RECEPTOR MODULATORS JANSSEN PHARMACEUTICA N.V.1593 392/KOLNP/2005 222157 23-07-2008CHEMICAL COMPOUNDS CONTAININGTOCOPHEROL AND AT LEAST ONEADDITIONAL PHARMACEUTICAL ACTIVEJSW-RESEARCH FORSCHUNGSLABOR GMBHSUBSTANCE1594 1461/KOLNP/2003 222158 23-07-2008SUBSTANTIALLY PURIFIED POLYPEPTIDECOMMONWEALTH SCIENTIFIC ANDFROM AGAROBACTERIUM RADIOBACTERINDUSTRIAL RESEARCH ORGANISATIONP230DIETETIC, NUTRIENT ORPHARMACEUTICAL COMPOSITION1595 IN/PCT/2001/1234/KOL 222166 23-07-2008 COMPRISING ALKALINEACTIAL FARMACEUTICA LDA.SPHINGOMYELINASE OF BACTERIALORIGIN1596 0108/DEL/1996 222173 28-07-2008A PHARMACEUTICAL COMPOSITION FORDERMAL OR MUCOSAL ADMINISTRATIONASTRA AKTIEBOLAG1597 IN/PCT/2001/588/KOL 222233 30-07-2008 A PHARMACEUTICAL COMPOSITION PHARMASOLUTIONS, INC.1598 810/DELNP/2005 222240 31-07-2008 A PYRIDINYLPYRAZOLE COMPOUND BIOGEN IDEC MA INC.1599 1086/CHENP/2005 222316 05-08-2008INDAZOLE DERIVATIVES AS CRFANTAGONISTSF. HOFFMANN-LA ROCHE AG1600 1453/CHENP/2005 222326 05-08-2008PYRAZOLE DERIVATIVES USEFUL AS COX-IINHIBITORSASTELLAS PHARMA INC1601 1466/CHENP/2005 222328 05-08-2008 NOVEL CB 1 RECEPTOR INVERSE AGONISTS F. HOFFMANN-LA ROCHE AG1602 1510/CHENP/2005 222331 05-08-2008A DISCRETE TUBULAR OR DISCRETESPHERICAL PEPTIDE NANOSTRUCTURE AND RAMOT AT TEL AVIV UNIVERSITY LTDTHE METHOD OF PREPARING THEREOF1603 666/CHENP/2005 222342 05-08-2008SEQUESTERING SUBUNIT AND RELATEDCOMPOSITIONS AND METHODSALPHARMA, INC1604 IN/PCT/2001/1673/CHE 222346 05-08-2008 BETA 2-ADRENOCEPTOR AGONISTS NOVARTIS AG1605 IN/PCT/2002/631/CHE 222348 05-08-2008ARYL-AND HETEROARYL-SUBSTITUTEDAMR TECHNOLOGY INCTETRAHYDROISOQUINO LINES OF FURMULA I1606 723/CHENP/2005 222356 05-08-2008SUSTAINED-RELEASE TRAMADOLFORMULATIONS WITH 24 HOUR EFFICACYLABOPHARM INC1607 794/CHENP/2005 222358 05-08-2008MONOCLONAL ANTIBODY SPECIFIC FOR NCA90IMMUNOMEDICS, INC

1608 834/CHENP/2005 222360 05-08-2008 BENZOXAZINONE DERIVATIVES F. HOFFMANN-LA ROCHE AG1609 01031/DELNP/2003 222406 08-08-2008 ANTI-MICROBIAL COMPOSITION BYOTROL LLCNOVEL ARYL AND HETEROARYL PROPENE TEMPLE UNIVERSITY-OF THE1610 1093/DELNP/2005 222436 08-08-2008COMMONWEALTH SYSTEM OF HIGHERAMIDE THIOAMIDE COMPOUNDSEDUCATIONA PYRIMIDINEDIONE HOMOCARBOCYCLIC1611 412/DEL/1997 222437 08-08-2008SAMJIN PHARMACEUTICAL CO., LTD,COMPOUNDAN IMMEDIATE-RELEASE FENOFIBRATE1612 0085/DEL/1998 222441 11-08-2008LABORATOIRES FOURNIER S.A.COMPOSITIONA MEDICAL COMPOSITION FOR PREVENTING KANSAI TECHNOLOGY LICENSING1613 01757/DELNP/2003 222458 12-08-2008HUMAN LIVER CANCERORGANIZATION CO., LTD.A FUSED TRICYCLIC HETEROCYCLIC1614 2065/DELNP/2004 222465 13-08-2008 COMPOUND FOR TREATING HYPER-BAYER PHARMACEUTICALS CORPORATIONPROLIFERATIVE DISORDERSORAL DELAYED IMMEDIATE RELEASE1615 2181/MAS/1997 222532 14-08-2008 FORMULATION AND METHOD FOR PREPARING DUPHAR INTERNATIONAL RESEARCH BVTHE SAMEAN AQUEOUS, TOPICAL, ANTISEPTICRECKITT BENCKISER HEALTHCARE (UK)1616 2386/MAS/1996 222533 14-08-2008COMPOSITIONLIMITED1617 2467/MAS/1998 222534 14-08-2008 AZOLINE DERIVATIVES SYNGENTA PARTICIPATIONS AGA PHARMACEUTICAL COMPOSITIONRECKITT BENCKISER HEALTHCARE (UK)1618 282/MAS/1996 222536 14-08-2008LIMITED1619 IN/PCT/2000/822/CHE 222541 14-08-2008 A COMPOUND OF THE FORMULA-I N.V. ORGANONPOLYPEPTIDE VARIANTS WITH INCREASED1620 IN/PCT/2001/1139/CHE 222543 14-08-2008OSTEOPHARMA INC.HEPARIN BINDING ABILITYSUBSTANTIALLY OILFREE CYCLOSPORIN1621 IN/PCT/2001/1636/CHE 222545 14-08-2008NOVARTIS AGCOMPOSITIONS1622 IN/PCT/2001/1648/CHE 222546 14-08-2008 4-PHENYL-PYRIMIDINE DERIVATIVES F. HOFFMANN - LA ROCHE AGFACTOR VIIa INHIBITORS AND PROCESS FOR1623 IN/PCT/2001/1700/CHE 222547 14-08-2008SANOFI-AVENTIS DEUTSCHLAND GMBHPREPARATION THEREOFBENZIMIDAZOLE COMPOUNDS AND1624 IN/PCT/2001/1773/CHE 222548 14-08-2008 PHARMACEUTICAL COMPOSITIONSNEUROSEARCH A/SCOMPRISING THESE COMPOUNDSPHENYLSULFONYLAMI NO PHOSPHONIC ACID1625 IN/PCT/2001/49/CHE 222551 14-08-2008SANOFI-AVENTIS DEUTSCHLAND GMBHDERIVATIVES1626 IN/PCT/2001/517/CHE 222552 14-08-2008 A VACCINE COMPOSITION SMITHKLINE BEECHAM BIOLOGICALS S.A.VANCORESMYCIN, A PROCESS FOR ITS1627 IN/PCT/2001/609/CHE 222553 14-08-2008 PRODUCTION AND ITS USE AS ASANOFI AVENTIS DEUTSCHLAND GMBHPHARMACEUTICALHYDROXAMIC ACID AND N-FORMYL1628 IN/PCT/2002/209/CHE 222557 14-08-2008VERNALIS (R & D) LIMITEDHYDROXYLAMINE DERIVATIVESVACCINE AGAINST INTRA-CELLULAR1629 IN/PCT/2002/265/CHE 222558 14-08-2008IMMUNOBIOLOGY LIMITEDPATHOGENS1630 IN/PCT/2002/335/CHE 222559 14-08-2008 A NOVEL VACCINE COMPOSITION SMITHKLINE BEECHAM BIOLOGICALS S A

1631 IN/PCT/2002/345/CHE 222560 14-08-2008DISPERSION FORMULATIONSCONTAINING LIPASE INHIBITORSF. HOFFMANN - LA ROCHE AG1632 IN/PCT/2002/666/CHE 222561 14-08-2008COMPOUND WITH GROWTH HORMONERELEASING PROPERTIESNOVO NORDISK A/S1633 IN/PCT/2002/781/CHE 222562 14-08-2008 A NOVEL QUINAZOLINE DERIVATIVE SHIONOGI & CO., LTD1634 IN/PCT/2002/815/CHE 222563 14-08-2008 NOVEL ANDROGENS N.V. ORGANON1635 IN/PCT/2002/921/CHE 222564 14-08-2008AN ANALGESIC COMPOSITIONRECKITT BENCKISER HEALTHCARE (UK)LIMITED(1R,2S,4R)-(-)-2(2'-{N,N-DIMETHYLAMINO}]-2-1636 IN/PCT/2001/01018/DEL 222569 18-08-2008[PHENYL]- 1,7,7-TRI-[METHYL]-BICYCLO[2.2.1]HEPTANE AND PHARMACEUTICALLYEGIS GYOGYSZERGYAR RT.ACCEPTABLE ACID ADDITION SALTS1637 IN/PCT/2002/00411/DEL 222588 19-08-2008AN OLIGOSACCHARIDE OF FORMULA (I) ANDPROCESS FOR PREPARING THE SAMEAVENTIS PHARMA S.A.1638 1402/DEL/1996 222589 19-08-20082,4,5-TRISUBSTITUTED PHENYLKETOENOLSCOMPOUNDS OF THE FORMULA (I) AND BAYER AKTIENGESELLSCHAFT.PROCESS THEREOF1639 3189/DELNP/2004 222590 19-08-2008 PYRROLO-TRIAZENE ANILINE COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY1640 00478/DELNP/2004 222591 19-08-2008THE INDENO [1,2-c] ISOQUINOLINECOMPOUND OF FORMULA (III) AND METHOD INOTEK PHARMACEUTICALS CORPORATIONFOR MAKING THE SAME1641 636/CHENP/2003 222609 20-08-2008DERIVATIVES OF TRYPTAMINE ANDANALOGOUS COMPOUNDS, ANDPHARMACEUTICAL FORMULATIONSNEURIM PHARMACEUTICALS (1991) LTDCONTAINING THEM1642 781/CHENP/2003 222611 20-08-2008NAPHTHALENE DERIVATIVES OF FORMULA IAND PROCESS FOR THEIR PRODUCTIONNOVARTIS AG1643 1281/CHENP/2003 222625 20-08-2008PHENYLPIPERAZINE DERIVATIVE & APHARMACEUTICAL COMPOSITIONSOLVAY PHARMACEUTICALS B.V.COMPRISING THE SAME1644 1705/CHENP/2003 222626 20-08-2008PHARMACEUTICAL DOSAGE FORM OFAMORPHOUS NELFINAVIR MESYLATEF. HOFFMANN-LA ROCHE AG1645 1336/CHENP/2003 222628 20-08-20084,5-DIHYDRO-1H-PYRAZOLE DERIVATIVESHAVING CB1-ANTAGONISTIC ACTIVITYSOLVAY PHARMACEUTICALS B.V.1646 1342/CHENP/2003 222629 20-08-2008ACYLATED PIPERIDINE DERIVATIVES ASMELANOCARTIN-4 RECEPTOR AGONISTSMERCK & CO. INC.1647 1644/CHENP/2003 222633 20-08-2008FINELY SELF-EMULSIFIABLEPHARMACEUTICAL COMPOSITIONPHARMACIA CORPORATION1648 575/CHENP/2004 222640 20-08-2008PYROZOLE DERIVATIVES AND PROCESS FORPREPARING THE SAMESOLVAY PHARMACEUTICALS B.V.1649 831/CHENP/2004 222642 20-08-2008MACROLIDES CONTAININGPHARMACEUTICAL COMPOSITIONSNOVARTIS AG1650 1546/CHENP/2004 222647 20-08-20083,4-DIHYDRO-1H-ISOQUINOLOIN-2-YL-DERIVATIVESH. LUNDBECK A/S

1651 2835/CHENP/2004 222649 20-08-2008PHARMACEUTICAL COMPOSITIONS WITHIMPROVED DISSOLUTIONTRANSFORM PHARMACEUTICALS, INC.1652 3081/CHENP/2004 222651 20-08-2008 NOVEL POLYSILOXANE COMPOUNDS DSM IP ASSETS B.V.1653 1416/CHENP/2005 222667 20-08-2008PHARMACEUTICAL COMPOSITIONSCOMPRISING DEXANABINOLPHARMOS CORPORATIONPHARMACEUTICAL COMPOSITION USEFUL1654 634/MAS/2002 222692 20-08-2008FOR THE TREATMENT OF DISEASES CAUSED THE COLLEGE OF PHARMACEUTICALBY VIRUSES AND A PROCESS FOR ITS SCIENCESPREPARATIONA THERAPEUTIC COMPOSITION AND A BEN GURION UNIVERSITY OF THE NEGEV1655 3262/CHENP/2005 222700 20-08-2008RESEARCH OF AND DEVELOPMENTPROCESS FOR PREPARING THE SAME AUTHORITY1656 476/KOLNP/2004 222735 21-08-2008" B-LACTAMYL VASOPRESSIN V1AANTAGONISTS"AZEVAN PHARMACEUTICALS, INC.1657 IN/PCT/2002/286/KOL 222753 21-08-20082-PYRIDYLCARBOXALDEHYDEISOMCOTINOYL HYDRAZONE AS IRON THE UNIVERSITY OF QUEENSLANDCHELATORS.1658 2056/DELNP/2005 222758 21-08-2008A CONTROLLED-RELEASE DELIVERYCOMPOSITIONPFIZER PRODUCTS INC.1659 IN/PCT/2002/00743/DEL 222767 22-08-2008A NOVEL SUSTAINED RELEASE SOLID ORALGALENICAL COMPOSITION OF MOLSIDOMINETHERABEL PHARMACEUTICALS LIMITED1660 5961/DELNP/2005 222768 22-08-2008 A SUBSTITUTED DEPSIPEPTIDE COMPOUND INSTITUTO BIOMAR S.A.1661 712/DEL/1998 222769 22-08-2008PHARMACEUTICAL COMPOSITION FOR THEORAL ADMINISTRATION OF AN N-PIPERIDINOPYRAZOLE-3-CARBOXAMIDE SANOFI-SYNTHELABODERIVATIVES, ITS SALTS AND THEIRSOLVATES1662 0922/DEL/2000 222771 22-08-2008A COMPOSITION CONTAINING ATLEAST ONEBOEHRINGER INGELHEIM INTERNATIONALPEPTIDE, PROTEIN OR PROTEIN FRAGMENTGMBHWITH AN IMMEDIATELY ACTIVITYAMINOTHIAZOLE COMPOUNDS IN RACEMIC1663 1046/MUMNP/2005 222775 25/08/2008 FORM OR IN THE FORM OF A PURESANOFI SYNTHELABORATORIESENANTIOMER AS CRF RECEPTOR LIGANDS1664 83/MUMNP/2006 222777 25/08/2008PYRROLODIHYDROIS OQUINOLINES AS PDE10ALTANA PHARMA AGINHIBITORS1665 237/MUM/2003 222805 25/08/2008 A NOVEL BENZIMIDIAZOLE FORMULATION CADILA HEALTHCARE LIMITED1666 00774/DELNP/2004 222813 25-08-2008A POLYPEPTIDE AND METHOD OFPRODUCTION THEREOFBAYER PHARMACEUTICALS CORPORATION1667 44/MUMNP/2006 222817 25/08/2008PHARMACEUTICAL FORMULATIONSCOMPRISING A PROTON PUMP INHIBITORCIPLA LTD1668 1229/MUMNP/2005 222818 25/08/2008 CYCLIC BENZIMIDAZOLES ALTANA PHARMA AG1669 515/MUM/2003 222821 25/082008A PHARMACEUTICALLY HERBAL SEEDEXTRACT WITH BROAD-SPECTRUMMEDICINAL APPLICATIONGOVIND MARUTI WAGLE

1670 773/MUMNP/2003 222823 25/08/20081671 538/DELNP/2003 222828 25-08-20081672 1579/DELNP/2005 222833 26-08-2008CRYSTALLINE FORM OF ANHYDROUS 1S-[1ALPHA(2S*,3R*)9ALPHA] 6,10-DIOXO-N-(2-ETHOXY-5-OXO-TETRAHYDRO-3-FURANY1)-9[[(1-ISOQUINOL Y1)CARBONY1]AMINO]OCTAHYDRO-6H-PIRIDAZINO [1,2-A][1 2] DIAZEPIN-1-CARBOXAMIDE (FORM A)DIPHENYLCARBON ACID ESTERSA 4-(3-CARBOXYAMINOPHENYL) (PIPERAZIN-1-YL) METHYL)-N,N-DIETHYLBENZAMIDECOMPOUNDHOECHEST MARION ROUSSELBOEHRINGER INGELHEIM PHARMA GMBH &CO. KG.ASTRAZENECA AB1673 1533/DEL/2003 222834 26-08-2008N-ARYLOXYPROPANOLYL-N' -PHENETHYL- COUNCIL OF SCIENTIFIC AND INDUSTRIALUREA COMPOUND AND PROCESS THEREOF RESEARCH1674 194/MUMNP/2006 222846 26/08/2008ORAL COMPOSITIONS FOR THE TREATMENTOF DISEASESWOCKHARDT LIMITED1675 02218/DELNP/2003 222862 26-08-2008PEPTIDE BASED COMPOUNDS OF GENERALFORMULA (I)GE HEALTHCARE AS1676 00419/DELNP/2003 222863 27-08-2008 A VACCINE GLAXO GROUP LIMITED1677 3634/DEL/1997 222864 27-08-2008AQUEOUS PHARMACEUTICAL PREPARATIONIN THE FORM OF A SOLUTIONBOEHRINGER INGELHEIM KG.1678 1738/KOLNP/2004 222897 27-08-2008A 6-AMINO-2-PHENYL SUBSTITUTEDPYRAZINE COMPOUND.CYTOPIA PTY LTD.1679 200/KOLNP/2003 222899 27-08-2008A PHARMACEUTICAL COMPOSITION FORTOPICAL ADMINISTRATION.S.I.S. SHULOV INSTITUTE FOR SCIENCE LTD.,1680 704/KOLNP/2004 222926 27-08-2008NOVEL ISOFORMS OF VASCULARENDOTHELIAL CELL GROWTH INHIBITORGEORGETOWN UNIVERSITY1681 764/KOLNP/2005 222927 27-08-2008PEPTIDES MODULATING CASPASEOTKRYTOE AKTSIONERNOE OBSCHESTVOACTIVATION"BIOSISTEMA"1682 902/KOLNP/2005 222931 27-08-2008PLASMA PRODUCT OR SERUM PRODUCT ANDMETHOD FOR PRODUCING THE SAMEASAHI KASEI MEDICAL CO. LTD1683 972/KOLNP/2005 222934 27-08-2008 PYRAZINE-BASED TUBULIN INHIBITORS CYTOPIA RESEARCH PTY LTDSUBSTITUTED 3-AMINO-THIENO[2,3-1684 3224/DELNP/2004 222956 27-08-2008PREPARING AND THEIR USESb]PYRIDINE-2-CARBOXYLIC ACID AMIDE BOEHRINGER INGELHEIMCOMPOUNDS AND PROCESSES FORPHARMACEUTICALS, INC.1685 3357/DELNP/2005 222958 28-08-20081686 1176/MUM/2006 222965 28/08/20081687 1034/MUMNP/2006 222966 28/08/2008FURAN COMPOUNDSHERBAL COMPOSITION FOR PREVENTINGHAIRFALL & DANDRUFF AND PROCESS FORPRODUCING THE SAMEIMIDAZOLO-5-YL-2-ANILINOPYRIMIDINECOMPOUNDSASTERAND UK LIMITED formely known asPHARMAGENE LABORATORIES LIMITED.SAXENA ASHISH KUMARASTRA ZENECA AB

1688 1324/MUM/2004 222973 29/08/2008A PHARMACEUTICAL ORAL DOSAGE FORMCOMPRISING OF A NOVEL COMBINATION OFACECLOFENAC, PARACETAMOL ANDJ B CHEMICAL & PHARMACEUTICALS LTDSERRATIOPEPTIDASE1689 584/MUM/2001 222977 29/08/2008 NOVEL TETRAZOLE COMPOUNDS NIHON BAYER AGROCHEM K.K.1690 2649/DEL/1997 222986 29-08-2008A CYANOIMINOIMIDAZOLE COMPOUNDHAVING THE FORMULA IJANSSEN PHARMACEUTICA N.V.1691 00265/DELNP/2004 222987 29-08-2008 A PYRIMIDINE COMPOUND OF FORMULA (I) JANSSEN PHARMACEUTICA N.V.1692 3177/DELNP/2005 222991 29-08-2008MHC CLASS I-RESTRICTED EPITOPE PEPTIDESURVAC ApSDERIVED FROM SURVIVIN AND USE THEREOFA TARGET BINDING PROTEIN FOR1693 00086/DELNP/2003 222992 29-08-2008 TREATMENT AND DETECTION OF TUMORS IMMUNOMEDICS INC.AND INFECTIOUS LESIONS1694 00288/DELNP/2003 222993 29-08-2008 RECOMBINATION VECTOR THERAPEUTIC HUMAN POLYCLONALS INC.PHARMACEUTICAL COMPOSITION FOR ORAL1695 3370/DELNP/2004 223014 03-09-2008ADMINISTRATION COMPRISING A TABLET BOEHRINGER INGELHEIM PHARMA GMBH &CORE, CONTAINING FLIBANSERINCO. KG.POLYMORPH ACOMBINATION MOTIF IMMUNE1696 162/KOLNP/2004 223023 03-09-2008 STIMULATORY OLIGONUCLEOTIDES WITH COLEY PHARMACEUTICAL GMBHIMPROVED ACTIVITY1697 833/KOLNP/2004 223024 03-09-2008TETRACYCLIC HETEROCOMPOUND AND APROCESS FOR PREPARING THE SAMEORTHO MCNEIL PHARMACEUTICAL INC.1698 10/KOLNP/2003 223035 03-09-2008POLYPEPTIDE ENCODING ANTIGENIC HIVTYPE C POLYPEPTIDE POLYPEPTIDES AND CHIRON CORPORATIONUSES THEREOF1699 1433/KOLNP/2004 223046 03-09-2008 BENZAZOLE COMPOUNDS CHIRON CORPORATION1700 257/KOLNP/2004 223053 03-09-2008 A HISTONE DEACETYLASE INHIBITOR METHYLGENE INC1701 604/KOLNP/2005 223061 03-09-2008A CAPSULE COMPRISING A TABLET GRANULE TAKEDA PHARMACEUTICAL COMPANYOF FINE GRANULELIMITED1702 614/KOL/2005 223062 03-09-2008 COMPOSITION FOR REDUCING BLOOD LIPIDS MAXLUCK BIOTECHNOLOGY CORP.1703 667/KOLNP/2004 223067 03-09-2008INJECTION SOLUTION OF AN LHRHANTAGONISTZENTARIS GMBH1704 698/KOLNP/2004 223068 03-09-2008INHIBITORS OF CYTOSOLIC PHOSPHOLIPASEA2WYETH1705 834/KOLNP/2004 223075 03-09-2008 ISOCHROMAN COMPOUNDS ELI LILLY AND COMPANY1706 0988/DEL/1998 223083 03-09-2008SUSTAINED RELEASE COMPOSITIONS ANDTHE PROCESS FOR THEIR PREPARATIONIPSEN PHARMA BIOTECH1707 902/DEL/1998 223084 03-09-2008COMPOSITIONS AND METHODS FOR THETREATMENT AND DIAGNOSIS OF BREAST CORIXA CORPORATIONCANCER1708 1298/DEL/1999 223093 04-09-2008NOVEL EFFERVESCENT PHARMACEUTICALCOMPOSITIONSPANACEA BIOTEC LIMITED

1709 IN/PCT/2002/00850/DEL 223094 04-09-2008AN AZETIDINE COMPOUND USEFUL IN THETREATMENT AND / OR PREVENTION OF AVENTIS PHARMA S.A.PSYCHOSES1710 185/MAS/1995 223111 04-09-2008A SYNERGISTIC REJUVENATING ANDREVITALIZING PHARMACEUTICALTABLETS (INDIA) LIMITEDCOMPOSITION1711 186/MAS/1995 223112 04-09-2008A PHARMACEUTICAL COMPOSITION FORENHANCING IRON ASSIMILATION AND TABLETS (INDIA) LIMITEDHAEMOGLOBIN SYNTHESIS1712 1209/MAS/1998 223117 04-09-2008 SUBSTITUTED 2-AMINO PHENYL JAPAN TOBACCO INC1713 1383/MAS/1996 223119 04-09-200811 SUBSTITUTED PHENYL ESTRA-4, 9-DIENEDERIVATIVESN.V. ORGANON1714 185/MAS/2002 223121 04-09-2008ANTI-SNAKE VENOM IMMUNOGLORULINES SREE CHITRA TIRUNAL INSTITUTE FOROBTAINED FROM CHICKEN EGG-YOLK MEDICAL SCIENCES & TECHNOLOGYSUBSTITUTED BENZENESULFONYL UREAS1715 215/MAS/1996 223122 04-09-2008AND THIOUREAS, PROCESS FOR THEIRPREPARATION AND A MEDICAMENTHOECHST GmbHCOMPRISING THE SAME1716 IN/PCT/2000/135/CHE 223128 04-09-2008INDOLE DERIVATIVES AS INHIBITORS OFFACTOR XA, PROCESS FOR THEIRPREPARATION AND A COMPOSITIONSANOFI-AVENTIS DEUTSCHLAND GmbHCOMPRISING THE SAME1717 IN/PCT/2000/595/CHE 223132 04-09-2008 A NOVEL VACCINE COMPOSITION SMITHKLINE BEECHAM BIOLOGICALS S A1718 IN/PCT/2001/1649/CHE 223133 04-09-2008 5-PHENYL-PYRIMIDINE DERIVATIVES F HOFFMANN-LA ROCHE AG1719 IN/PCT/2001/1784/CHE 223135 04-09-2008 VLA-4 INHIBITOR COMPOUND OF FORMULA I DAIICHI PHARMACEUTICAL CO LTD1720 IN/PCT/2001/29/CHE 223136 04-09-2008SULFUR SUBSTITUTEDSULFONYLAMINOCARB OXYLIC ACID N-ARYLAMIDES, A PROCESS FOR ITSSANOFI-AVENTIS DEUTSCHLAND GMBHPREPARATION AND A PHARMACEUTICAL1721 IN/PCT/2001/48/CHE 223137 04-09-20082,5-SUBSTITUTED BENZOLSULFONYLURE ASAND THIOUREAS OF FORMULA I AND A SANOFI-AVENTIS DEUTSCHLAND GMBHPROCESS FOR PREPARING THE SAME1722 IN/PCT/2002/109/CHE 223139 04-09-2008PURINE DERIVATIVES INHIBITORS OFTYROSINE PROTEIN KINASE SYKNOVARTIS AG1723 463/CHENP/2003 223148 04-09-2008VACCINE COMPOSITION AND STABILISATIONMETHODAVENTIS PASTEUR1724 589/CHENP/2003 223154 05-09-2008COMBINATION OF SIBUTRAMINE WITHCANNABINOID 1 RECEPTOR ANTAGONISTAVENTIS PHARMA S.A.1725 1316/CHENP/2003 223179 05-09-2008N-SUBSTITUTED NONARYL-HETEROCYCLICNMDA/NR2B ANTAGONISTSMERCK & CO., INC.1726 1618/CHENP/2003 223189 05-09-20085-PHENYLPYRIMIDINES, THEIR PREPARATION,INTERMEDIATES FOR THEIR PREPARATIONAND A COMPOSITION COMPRISING THE SAMEBASF AKTIENGESELLSCHAFT

1727 1957/CHENP/2003 223196 05-09-20081728 573/CHENP/2004 223197 05-09-20081729 574/CHENP/2004 223198 05-09-20081730 983/CHENP/2004 223200 05-09-20081731 1434/CHENP/2004 223201 05-09-20081732 01894/DELNP/2003 223212 05-09-20081733 00506/DELNP/2003 223213 05-09-20081734 308/MUMNP/2005 223217 08-09-20081735 1367/DEL/2003 223231 08-09-20081736 713/MUM/2006 223238 09-09-20081737 615/DELNP/2005 223239 09-09-20081738 2735/CHENP/2004 223241 09-09-20081739 2767/CHENP/2004 223242 09-09-20081740 2861/CHENP/2004 223243 09-09-20081741 1599/CHENP/2004 223244 09-09-20081742 1634/CHENP/2004 223245 09-09-2008SUBSTITUTED SULFONAMIDE COMPOUNDS,PROCESS FOR THEIR USE AS MEDICAMENTBIOVITRUM AB (publ)FOR THE TREATMENT OF CNS DISORDERS,OBESITY AND TYPE II DISBETESNOVEL 4,5-DIHYDRO-1H-PYRAZOLEDERIVATIVES HAVING CB1-ANTAGONISTIC SOLVAY PHARMACEUTICALS B.VACTIVITY1H-IMIDAZOLE DERIVATIVES HAVING CB1AGONISTIC, CB1 PARTIAL AGONISTIC OF CB1- SOLVAY PHARMACEUTICALS B.VANTAGONISTIC ACTIVITY2-AMINO-4-PYRIDYLMETHYL-THIAZOLINEDERIVATIVES AS INHIBITORS OF INDUCIBLE AVENTIS PHARMA S.ANO-SYNTHASEA COMPOUND OF FORMULA I AND APHARMACEUTICALLY ACCEPTABLE SALT CJ CHEILJEDANG CORPORATIONTHEREOFA PEPTIDE IMMUNOGEN FOR THEPREVENTION AND TREATMENT OFUNITED BIOMEDICAL, INC.ALZHEIMER'S DISEASE AND COMPOSITIONSA PHARMACEUTICAL COMPOSITIONSUBSTANTIALLY ALCOHOL AND PROPYLENE BOEHRINGER INGELHEIMFREE AND COMPRISING OF 5,6-DIHYDRO-4- PHARMACEUTICALS, INC.HYDROXY-2-PYRONES COMPOUNDSSTEREOSPECIFIC SYNTHESIS OF 3-HYDROXY-5B-H STEROIDAL SAPOGENINS AND THEIR PHYTOPHARM PLCDERIVATIVES[3R,4R] - TRANS-3,4-DIARYLCHROMANCOUNCIL OF SCIENTIFIC AND INDUSTRIALDERIVATIVES AND A PROCESS FOR THERESEARCHPREPARATION THEREOFCOMPOUNDS WITH ANTIFUNGAL PROPERTIES COUNCIL OF SCIENTIFIC & INDUSTRIALAND PROCESS THEREOFRESEARCH, FDC LIMITEDSTROMAL CELL-DERIVED FACTOR-1(SDF-1)THE CLEVELAND CLINIC FOUNDATIONMEDICAMENTAMIDOACETONITRILE COMPOUNDS ANDNOVARTIS AGPROCESS FOR THE PREPARATION THEREOFFLUORINATED CYCLOALKYL DERIVATEDSANOFI-AVENTIS DEUTSCHLAND GmbHBENZOYLGUANIDINES1-AZA-DIBENZOAZULENES AS INHIBITORS OFTUMOUR NECROSIS FACTOR PRODUCTIONPLIVA-ISTRAZIVACKI INSTITUT d.o.oAND INTERMEDIATES FOR THE PREPARATIONTHEREOFN-OXYDE OF N-PHENYL-2-PYRIMIDINE-AMINENOVARTIS AGDERIVATIVESA PEPTIDE FOR INHIBITING MELANOMAANTISENSE PHARMA GmbHINHIBITORY ACTIVITY MIA

1743 1811/CHENP/2004 223246 09-09-2008 ANTIBIOTIC CONJUGATES MERCKLE GmbH1744 2017/CHENP/2004 223247 09-09-2008 A CHIMERIC MONOCLONAL ANTIBODY IMMUNOMEDICS, INC1745 2172/CHENP/2004 223250 09-09-2008INDOLYLMALEIMIDE DERIVATIVES ANDPROCESS FOR THEIR PRODUCTIONNOVARTIS AG1746 2176/CHENP/2004 223251 09-09-2008STABILIZED NATURAL CANNABINOIDFORMULATIONSOLVAY PHARMACEUTICALS B.V1747 1250/CHENP/2005 223280 09-09-2008 AN ISOLATED POLYPEPTIDE MAXYGEN, INC1748 IN/PCT/2001/00747/MUM 223304 09-09-2008A COMPOUND OF FORMULA I HAVING ANACTIVITY TO INHIBIT MATRIXABBOTT LABORATORIESMETALLOPROTEINASES1749 IN/PCT/2001/01369/MUM 223311 09-09-2008ANTIBACTERIAL OPTICALLY PUREBENZOQUINOLIZINE CARBOXYLIC ACIDS, WOCKHARDT LIMITEDDERIVATIVES1750 2587/CHENP/2004 223313 09-09-2008A PHARMACEUTICAL COMPOSITIONCOMPRISING VALSARTAN, AMLODIPINE, NOVARTIS AGHYDROCHLOTHIAZIDE1751 1257/CHENP/2005 223345 09-09-20084-TETRAZOLYL-4PHENYLPIPERIDINECOMPOUNDSEURO-CELTIQUE S.A.1752 IN/PCT/2000/224/CHE 223357 09-09-2008NOVEL FUSION PROTEINS OF MAGE FAMILYAND ENCODIING NUCLEIC ACID SEQUENCES SMITHKLINE BEECHAM BIOLOGICALS SATHEREOF1753 1419/CHENP/2003 223358 09-09-2008A NUCLEIC ACID OR FUNCTIONAL FRAGMENTTHEREOF ENCODING PROTEINACEOUSMOLECULE AND A METHOD FOR PRODUCINGDE RUITER SEEDS R&D B VA FLAVOUR EMPLOYING THE SAME4-(2-PHNYLOXYPHENYL)-PIPERIDINE OR-1754 2519/CHENP/2005 223359 09-09-2008 1,2,3,6-TETRAHYDROPHYRIDINE DERIVATIVES H. LUNDBECK A/SAS SEROTONIN REUPTAKE INHIBITORS1755 2173/DEL/1998 223364 09-09-2008A NEW 1,2,4-TRIAZOLO [4,3-b] PYRIDO [3,2-d]PYRIDAZINESALMIRALL PRODESFARMA, S.A.1756 2033/KOLNP/2005 223381 10-09-2008 A TOPICAL PHARMACEUTICAL COMPOSITION. BERLIN-CHEMIE AKTIENGESELISCHAFT1757 156/KOLNP/2003 223388 10-09-2008A NON-IMIDAZOLE ARYLOXYPIPERIDINESCOMPOUNDORTHO MCNEIL PHARMACEUTICAL, INC.1758 1730/KOLNP/2004 223389 10-09-2008 THIOPHENE AMIDINES 3-DIMENSIONAL PHARMACEUTICALS, INC.1759 431/CAL/2000 223396 10-09-2008A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3-(4-[2-(PIPERIDIN-1-YL) ETHOXY] PHENOXY)-2-ELI LILLY AND COMPANY(4-METHANOXYPHENYL) BENZO [B]THIOPHENE HYDROCHLORIDE1760 IN/PCT/2000/600/KOL 223402 10-09-2008BENZIMIDAZOLE DERIVATIVES ASMODULATORS OF IgE.AVANIR PHARMACEUTICALS

DERIVATIVES OF ISOSORBIDE MONONITRATEAND PHARMACEUTICAL COMPOSITION1761 IN/PCT/2001/395/KOL 223406 10-09-2008CONTAINING THE SAME FOR TREATMENT OFCARDIOVASCULAR OR CORONARYLACER S.A.DYSFUNCTIONS, OR FOR TREATMENT OFDYSFUNCTIONS OF CIRCULATORY SYSTEM1762 IN/PCT/2001/1236/KOL 223408 10-09-2008SUBSTITUTED 3-PYRIDYL-4-ARYLPYRROLES,AND RELATED THERAPEUTIC ANDORTHO-MCNEIL PHARMACEUTICAL, INC.PROPHYLACTIC METHODS1763 IN/PCT/2002/280/KOL 223421 10-09-2008BENZOPHENONES AS INHIBITORS OFREVERSE TRANSCRIPTASEGLAXO GROUP LIMITED1764 IN/PCT/2002/1385/KOL 223425 10-09-2008 A THIOACETAMIDE COMPOUND CEPHALON INC.1765 3814/DELNP/2004 223438 11-09-2008AN INDAZOLE OR INDAZOLYL COMPOUND ASANTAGONISTS OF CALCITONIN GENE BRISTOL-MYERS SQUIBB COMPANYRELATED PEPTIDE RECEPTOR1766 344/MUM/2002 223444 11-09-2008SUBSTITUTED BENZOPYRAZOLES OFGENERAL FORMULA (I)BAYER AKTIENGESELLSCHAFT1767 3241/DELNP/2004 223450 11-09-2008A 3-HYDRAZINO-3-OXOPROPYLHYDROXYFORMAMIDE COMPOUND OF SMITHKLINE BEECHAM CORPORATIONFORMULA (1)1768 2173/CHENP/2005 223463 11-09-2008COMPOSITION COMPRISING THERAPEUTICAJINOMOTO CO., INC1769 IN/PCT/2001/1706/CHE 223483 11-09-20081770 IN/PCT/2001/1770/CHE 223501 11-09-2008AGENTS FOR TREATING DIABETESA MYCOADHESIVE PHARMACEUTICALCOMPOSITION FOR THE TREATMENT OFDISORDERS OF OESOPHAGUSSUBSTITUTED BENZIMIDAZOIE AND APHARMACEUTICAL COMPOSITIONCOMPRISING THE SAMERECKITT BENCKISER HEALTHCARE (UK)LIMITEDSANOFI-AVENTIS DEUTSCHLAND GmbH1771 IN/PCT/2002/1136/CHE 223512 12-09-2008NOVEL BACILLUS THURINGIENSIS CRYSTALPROTEIN NAMED Cry1Bf, Cry 9Fa AND Cry1JdBAYER BIOSCIENCE N.V1772 251/MAS/1995 223521 12-09-2008NOVEL GENE DERIVED FROM CORYNEFORMBACTERIAAJINOMOTO CO., INC1773 1175/MAS/1998 223525 12-09-2008SUBSTITUTED CYCLOBUTYLAMINEDERIVATIVEDAIICHI PHARMACEUTICAL CO., LTD.1774 1176/MAS/1997 223526 12-09-2008THEPHYLLINE DERIVATIVES AND PROCESSESHOECHST AKTIENGESELLSCHAFTFOR THEIR PREPARATION1775 1346/MAS/1998 223529 12-09-2008 AN INSULIN DERIVATIVE OF FORMULA I SANOFI-AVENTIS DEUTSCHLAND GMBH1776 154/MAS/1998 223530 12-09-2008ISOXAZOLE AND CROTONAMIDEDERIVATIVES, A PROCES FOR THEIRPREPARATION AND A PHARMACEUTICALCOMPOSITION COMPRISING THE SAMESANOFI-AVENTIS DEUTSCHLAND GMBH1777 1799/MAS/1997 223531 12-09-2008 NOVEL THROMBIN INHIBITORS ABBOTT GMBH & CO. KG1778 IN/PCT/2000/604/CHE 223542 12-09-2008AN ISOLATED POLYNUCLEOTIDE THATENCODES A PESTICIDALLY ACTIVE PROTEINAND THE PROTEINMYCOGEN CORPORATION

1779 IN/PCT/2001/1002/CHE 223544 12-09-2008PROTEINS EXHIBITING ACTIVITY AGAINSTLEISHMANIOSISC.B.F. LETI S.A.1780 IN/PCT/2001/1195/CHE 223546 12-09-2008A COMPOSITION CONTAINING LACTIC ACIDBACTERIA STRAINS CAPABLE OFSOCIETE DES PRODUITS NESTLE S.A.PREVENTING DIARRHOEA1781 IN/PCT/2001/1443/CHE 223548 12-09-2008 AN IMMUNOGENIC COMPOSITION SMITHKLINE BEECHAM BIOLOGICALS S A1782 IN/PCT/2001/1521/CHE 223549 12-09-2008A COMPOSITION FOR NON-INVASIVELYINDUCING AN IMMUNE RESPONSETHE UAB RESEARCH FOUNDATION1783 IN/PCT/2001/459/CHE 223550 12-09-2008SUBSTITUTED 1,3-DIARYL-2-PYRIDINE-YL-3-(PYRIDINE -2-YLAMINO)-PROPANOLDERIVATIVES, METHODS FOR THEIRSANOFI-AVENTIS DEUTSCHLAND GMBHPRODUCTION PHARMACEUTICALCOMPOSITION CONTAINING THE SAME1784 IN/PCT/2002/1189/CHE 223552 12-09-2008CONTROLLED RELEASE PHARMACEUTICALCOMPOSITION COMPRISING MELATONINNEURIM PHARMACEUTICALS (1991) LTD.1785 IN/PCT/2002/01089/DEL 223555 12-09-2008AN UNSATURATED SULFONE COMPOUND TEMPLE UNIVERSITY OF THECOMMONWEALTH SYSTEM OF HIGHEREDUCATION1786 00915/DELNP/2004 223560 12-09-2008A SUBSTITUTED 4-PHENYL-4 [1H-IMIDAZOL-2-JANSSEN PHARMACEUTICA N.V.YL]-PIPERIDINE COMPOUND OF FORMULA (I)1787 2162/MUM/2006 223571 15/09/2008A COMPOSITION FOR CONTROLOF FERTILITYIN FEMALESMS. VAISHALI VASANT POTNIS1788 683/MUMNP/2006 223576 15/09/2008 PEPTIDES HAVING AN ACE INHIBITING HINDUSTAN UNILEVER LIMITED1789 189/MUM/2005 223582 15/09/2008STABLE CONTROLLED RELEASEPHARMACEUTICALCOMPOSITIONIPCA LABORATORIES LIMITEDCOMPRISING ACECLOFENAC1790 89/MUMNP/2003 223589 16/09/2008A CRYSTALLINE POLYMORPH OF ANEPOTHILONE ANALOG OF FORMULA IBRISTOL- MAYERS SQUIBB CO,1791 3844/DELNP/2004 223597 16-09-2008BENZOIC ACID COMPOUND AS MODULATORSAstraZeneca ABOF PPAR ALPHA AND GAMMA1792 1271/DEL/2003 223598 16-09-2008LABORATORY PIPETTE AND A METHOD OFIDENTIFYING CHARACTERISTIC THEREOFARTICLES DE LABORATOIRE DE PRECISION1793 2389/DELNP/2004 223601 17-09-2008A HETEROCYCLIC AMIDE SUBSTITUTEDTHEINOPYRROLE COMPOUND AND PROCESS ASTRAZENECA ABTHEREOF1-(4-SULFAMYLARYL)-3-TRIFLUOROMETHYL-5 TEMPLE UNIVERSITY- OF THE1794 IN/PCT/2002/0001/DEL 223608 17-09-2008 ARYL-2-PYRAZOLINES AS INHIBITORS OFCYCLOOXYGENASE-2COMMONWEALTH SYSTEM OF HIGHEREDUCATION1795 IN/PCT/2002/463/CHE 223624 19-09-20082'-SUBSTITUTED1, 1'-BIPHENYL-2-CARBOXAMIDES AND PHARMACEUTICAL SANOFI-AVENTIS DEUTSCHLAND GmbHPREPARATIONS COMPRISING THEM1796 IN/PCT/2002/595/CHE 223625 19-09-2008SUBSTITUTED INDOLES OF FORMULA I FORMODULATING NFKB ACTIVITYSANOFI-AVENTIS DEUTSCHLAND GmbH

1797 IN/PCT/2002/634/CHE 223626 19-09-2008N-GUANIDINOALKYLAMIDES OF FORMULA I,THEIR PREPARATION, ANDSANOFI-AVENTIS DEUTSCHLAND GmbHPHARMACEUTICAL PREPARATIONS1798 IN/PCT/2002/760/CHE 223627 19-09-2008COMPOSITION FOR CONTROLLING ANDENDOPARASITES ON PRODUCTIVENOVARTIS AGLIVESTOCK, DOMESTIC ANIMALS AND PETS1799 1044/CHENP/2003 223640 19-09-2008A PHARMACEUTICAL COMPOSITION FORPREVENTING AND/OR TREATMENT OFATHEROSCLEROSIS IN A SUBJECT IN NEEDVASCULAR BIOGENICS LTDTHEREOFARYLATED FURANCE AND THIOPHENE1800 904/CHENP/2003 223647 19-09-2008 CARBOXYLIC ACID AMIDES WITH POTASSIUM SANOFI-AVENTIS DEUTSCHLAND GmbHCHANNEL BLOCKING EFFECT1801 449/DEL/2000 223653 19-09-2008A VACCINE COMPRISING A SALMONELLATYPHI Ty800 CELLTHE GENERAL HOSPITAL CORPORATION1802 301/CHENP/2004 223668 19-09-2008A PEPTIDE CAPABLE OF INHIBITING MATRIXMETALLOPROTEINASEKIMBERLY-CLARK WORLDWIDE, INC1803 1965/CHENP/2003 223672 19-09-2008ANTHRANILIC ACID AMIDES WITH AHETEROARYLSULFONYL SIDE CHAIN ANDPHARMACEUTICAL COMPOSITIONSANOFI-AVENTIS DEUTSCHLAND GmbHCOMPRISING THE SAME1804 1401/CHENP/2004 223682 19-09-2008PHARMACEUTICAL COMPOSITIONS BASED ONAVENTIS PHARMA S.AAZETIDINE DERIVATIVES1805 2807/CHENP/2004 223683 19-09-2008A PHARMACEUTICAL FORMULATIONCOMPRISING ACIDIC INSULINSANOFI-AVENTIS DEUTSCHLAND GmbH1806 3075/CHENP/2004 223686 19-09-2008CEPHALOSPORINSNABRIVA THERAPEUTICS FORSCHUNGSGMBH1807 3147/CHENP/2004 223690 19-09-2008A NOVEL 1,2,3-TRIAZOLE DERIVATIVES OFFORMULA ISYNGENTA PARTICIPATIONS AG1808 1994/CHENP/2004 223693 19-09-2008A NON-HUMAN ANIMAL MEDICINE AND APROCESS FOR PREPARING THE SAMENOVARTIS AG1809 01054/DELNP/2003 223705 19-09-2008COMPOUND USEFUL AS INHIBITORS OFCRUZIPAIN AND OTHER CYSTEINEAMURA THERAPEUTICS LIMITED1810 464/CHENP/2005 223713 19-09-2008 NOVEL PYRIMIDINEAMIDE DERIVATIVES NOVARTIS AG1811 1749/DELNP/2005 223731 22-09-2008A 4-AMINO, 6-PIPERIDINYL PYRIMIDINECOMPOUND AND A PROCESS FOR PREPARING GALAPAGOS SASTHE SAME1812 2390/DELNP/2004 223749 22-09-2008A HETEROCYCLYLAMINOMETHYLSUBSTITUTED OXAZOLIDINONE COMPOUND ASTRAZENECA AB,OF THE FORMULA (I)1813 1375/DEL/1996 223753 22-09-2008A COMBINATION VACCINE COMPRISING ACAPSULAR POLYSACCCHARIDE ANTIGEN OFHAEMOPHILUS INFLUENZA B AND METHODFOR PREPARING THE SAMESMITHKLINE BEECHAM BIOLOGICALS S.A.

1814 2844/DEL/1996 223754 23-09-2008A QUINAZOLINE DERIVATIVE OF THEFORMULA I AND PROCESS FOR PREPARATION ASTRAZENECA UK LIMITEDTHEREOF1815 210/KOLNP/2004 223757 23-09-2008 AN ANTI-HTNFSF13B HUMAN ANTIBODY ELI LILLY AND COMPANYA THERAPEUTIC HERBAL COMPOSITION1816 441/KOL/2005 223765 23-09-2008 EFFECTIVE AGAINST TUMOURS AND PROCESS SARKAR NEAMATULLAHFOR PREPARING THE SAME1817 869/KOLNP/2004 223767 23-09-2008 INDOLYLAKYLAMINE DERIVATIVES WYETH1818 1090/KOLNP/2004 223771 23-09-2008A COMPOSITION CONTAININGSUBSTANTIALLY PURIFIED CYTOKINE ARKION LIFE SCIENCES LLC.INHIBITORY FACTOR.1819 1566/KOLNP/2005 223790 23-09-20087-IMINO DERIVATIVES OF CAMPTOTHECIN SIGMA-TAU INDUSTRIE FARMACEUTICHEHAVING ANTITUMOR ACTIVITYRIUNITE S.P.A.1820 1580/KOLNP/2003 223793 23-09-2008CONTROLLED RELEASE COMPOSITION ANDMETHOD OF PRODUCING THE SAME1821 01744/KOLNP/2005 223802 23-09-2008 A PYRIMIDONE DERIVATIVE SANOFI-AVENTIS1822 1156/KOLNP/2004 223821 23-09-2008A PHARMACEUTICAL COMPOSITION FORTREATING DIABETESKANEKA CORPORATIONPYRAZOLE DERIVATIVES MODULATORS OF1823 1347/KOLNP/2005 223830 23-09-2008 HEPATOCYTE GROWTH FACTOR (SCATTER ANGION BIOMEDICA CORPFACTOR) ACTIVITY1824 1710/KOLNP/2005 223842 23-09-20081825 1782/CAL/1998 223849 23-09-20081826 2676/KOLNP/2005 223857 23-09-20081827 498/KOLNP/2004 223875 23-09-2008SUBSTITUTED 2-(DIAZA-BICYCLO-ALKYL)-PYRIMIDONE DERIVATIVES8-AZABICYCLO[3.2.1.] OCTANE-3-METHANAMINE DERIVATIVES COMPOUNDSA GLUCOCORTICOSTEROID OF ANDROSTANESERIES AND COMPOSITION COMPRISING ITCARBONYLBENZOXAZINE COMPOUNDS FORENHANCING GLUTAMATERGIC SYNAPTICRESPONES.TAKEDA PHARMACEUTICAL COMPANYLIMITEDSANOFI-AVENTISSANOFI-SYNTHELABOGLAXO GROUP LIMITEDCORTEX PHARMACEUTICALS, INC1828 IN/PCT/2001/1355/KOL 223906 23-09-2008 A NOVEL XANTHONE COMPOUND ZENTARIS GMBH1829 IN/PCT/2002/00916/DEL 223915 23-09-2008MEDICAMENT SUITABLE FOR INHALATIONAND METHOD FOR PREPARING THE SAMEARAKIS LTD.,1830 1777/DELNP/2004 223916 23-09-2008A HETEROCYCLIC SUBSTITUTED PHENYLCONTAINING SULFONAMIDE COMPOUNDTIBOTEC PHARMACEUTICALS LTD1831 1113/DELNP/2004 223917 23-09-2008REVERSE TURN- MIMETIC COMPOUND OFFORMULA I AND COMPOSITION COMPRISINGTHE SAMECHOONGWAE PHARMA CORPORATION1832 295/MUM/2004 223931 24/09/2008A STERILE, LOW TOXICITY, STABLE,AQUEOUS, PHARMACEUTICAL COMPOSITIONSCOMPRISING OXAZAPHOSPHORINEANTINEOPLASTIC FOR PARENTERALADMINISTRATIONBHARAT SERUMS & VACCINES LTD.1833 371/MUM/2005 223934 24/09/2008 A HOMEOPATHIC MEDICINE DR. SHAH RAJESH NAROTTAM DAS

1834 2255/DELNP/2004 223946 24-09-20084-AMINO QUINAZOLINES,PHARMACEUTICALCOMPOSITIONS CONTAINING THESEBOEHRINGER INGELHIEM PHARMA GMBH &COMPOUNDS,AND PROCESS FOR PREPARING CO. KGTHEMA DIKETOPIPERAZINE COMPOUND OF1835 1570/DELNP/2004 223949 24-09-2008 FORMULA (I) AND A PHARMACEUTICAL GLAXO GROUP LIMITEDCOMPOSITION THEREOF1836 01251/DELNP/2004 223950 24-09-2008A COMPOUND 5-[4-[2-[N-METHYL-N-[2-PYRIDIL] AMINO] ETHOXY] BENZYL]THIAZOLIDINE-2, 4-DIONESMITHKLINE BEECHAM P.L.C.BENZENESULFONATE OR A SOLVATE1837 IN/PCT/2000/271/CHE 224017 24-09-2008A COMPOSITIONS FOR MAINTAINING THESTABILITY OF ADENOVIRUSESSCHERING CORPORATION1838 940/MUM/2005 224051 25/09/2008AQUEOUS ANAESTHETIC COMPOSITIONSCOMPRISING PROPOFOLBHARAT SERUMS & VACCINES LTD.1839 2114/DELNP/2005 224064 26-09-2008 A PHARMACEUTICAL COMPOSITION WARNER-LAMBERT COMPANY LLC.,1840 591/MUM/2001 224084 29/09/2008COMPOUNDS OF THE FORMULAE (III), (III-a)AND (III-b) AND PREPARATION PROCESS BAYER AKTIENGESELLSCHAFTTHEREOF1841 IN/PCT/2000/00736/MUM 224086 29/09/2008PHARMACEUTICAL PREPARATIONS FORBOEHRINGER INGELHEIM PHARMACEUTICALPROPELLANT DRIVEN METERED DOSEINCINHALERS1842 351/MUMNP/2006 224100 29-09-2008 COMPOSITIONS FOR AUGMENTINGKIBOW BIOTECH INC.1843 355/MUM/2003 224114 29/09/20081844 2150/DELNP/2005 224121 29-09-20081845 2703/DELNP/2004 224125 29-09-20081846 1208/KOLNP/2004 224135 01-10-20081847 2188/KOLNP/2005 224148 01-10-20081848 2089/KOLNP/2005 224151 01-10-20081849 1035/MUMNP/2006 224178 10-01-20081850 00628/DELNP/2004 224183 01-10-20081851 0903/DEL/1998 224185 01-10-2008KIDNEY FUNCTIONNOVEL BIODEGRADABLE ALIPHATICPOLYESTERS AND PHARMACEUTICALCOMPOSITIONS AND APPLICATIONS THEREOFPHARMACEUTICAL COMPOSITIONCOMPRISING FOR THE TREATMENT OFFUNCTIONAL BLADDER PROBLEMSVINOD CHINTAMANI MALSHE, PADMAVENKITACHALAM DEVARAJAN, SAYALEERANJAN SHASTRIBOEHRINGER INGELHEIM INTERNATIONALGMBHA 3-PHENYLSULFONYL-8 PIPERAZIN-1-YL-GLAXO GROUP LIMITEDQUINOLINE COMPOUNDNOVEL ARYLAMIDINE DERIVATIVE OR SALTTOYAMA CHEMICAL CO. LTD.THEREOF.14 AND 15 MEMBERED-RING COMPOUNDSGLAXO GROUP LIMITED.AND COMPOSITIONS COMPRISING THEM.CYTOTOXIC COMPOUNDS AND COMPOSITIONCOMPRISING THEMNOVEL COMPOUNDS AS JACK3 KINASEASTRA ZENECA ABMODULATORSSTABLE PHARMACEUTICAL FORMULATIONCOMPRISING A HMG-CoA REDUCTASE LEK PHARMACEUTICALS D. D.INHIBITORA 1,2,3,4-TETRAHYDRO-BENZOFURO [3.2-C]PYRIDINE COMPOUND OF FORMULA (I)SOCIETE DE CONSEILS DE RECHERCHES ETD'APPLICATIONS SCIENTIFIQUES S.A.S.JANSSEN PHARMACEUTICA N.V.

1852 00822/DELNP/2003 224186 01-10-2008QUINAZOLINE COMPOUNDS AND PROCESS BOEHRINGER INGELHEIM PHARMA GMBH &THEREOFCO. KG.PHARMACEUTICAL COMPOSITIONCONTAINING ANTI-INFLAMMATORY,1853 763/MUM/2004 224188 03-10-2008 ANTIHISTAMINIC AND DECONGESTANT LINCOLN PHARMACEUTICALS LIMITED(SUSTAINED RELEASE) FOR TREATIINGALLERGIC RHINITIS1854 1911/DEL/1998 224193 03-10-20082,4,4-TRISUBSTITUTED-1,3-DIOXOLANECOMPOUNDJANSSEN PHARMACEUTICA N.V.A PHARMACEUTICAL COMPOSITIONEXHIBITING ANTI-HYPERTENSIVE ACTIVITY1855 IN/PCT/2000/522/KOL 224203 03-10-2008COMPRISING IN COMBINATION AN EFFECTIVEUNIVERSITY OF MANITOBAAMOUNT OF A NON STEROIDAL ANTI-INFLAMMATORY DRUG (NSAID) AND ANEFFECTIVE AMOUNT OF A VITAMIN B6NOVEL STABLE PHARMACEUTICAL1856 845/MUM/2004 224215 07-10-2008COMPOSITIONS OF A BETA-ADRENORECEPTOR BLOCKER AND AIPCA LABORATORIES LIMITEDCALCIUM CHANNEL BLOCKER1857 513/CHENP/2005 224239 10-10-2008INDOLE-3-CARBOXAMIDES AS GLUCOKINASEF. HOFFMANN-LA ROCHE AG(GK) ACTIVATORS1858 420/CHENP/2005 224270 10-10-2008PYRROLIDONE DERIVATIVES AS MAOBINHIBITORSF. HOFFMANN-LA ROCHE AG1859 IN/PCT/2002/1521/CHE 224274 10-10-2008 4,5-DIHYDRO-1H-PYRAZOLE DERIVATIVES SOLVAY PHARMACEUTICALS B.V.1860 704/MAS/1995 224277 10-10-2008A CORYNEFORM L-GLUTAMIC ACIDPRODUCING BACTERIUMAJINOMOTO CO., INC.1861 IN/PCT/2002/1996/CHE 224279 10-10-2008STABILIZED AQUEOUS SUSPENSIONS FORPHARMACIA ITALIA S.P.A1862 IN/PCT/2002/2041/CHE 224280 10-10-20081863 1371/MAS/1996 224286 10-10-20081864 1638/MAS/1996 224287 10-10-20081865 2977/MAS/1997 224294 10-10-20081866 321/MAS/1997 224296 10-10-20081867 367/MAS/1996 224297 10-10-2008PARENTERAL USETHIENODIBENZOAZULENE COMPOUNDS ASTUMOR NECROSIS FACTOR INHIBITORA SYNERGISTIC PHARMACEUTICALCOMPOSITION FOR ENHANCINGHAEMOGLOBIN SYNTHESIS AND ZINCASSIMILATIONCOMPOSITIONS AND METHOD FOR THEPREVENTION AND TREATMENT OF PRIMARYAND METASTATIC NEOPLASTIC DISEASESAND INFETIOUS DISEASES WITH HEATSHOCK/STRESS PROTEINSPROPIOPHENONE DERIVATIVESPLIVA FARMACEUTSKA INDUSTRIJA,DIONICKO DRUSTVOTABLETS (INDIA) LIMITEDFORDHAM UNIVERSITYMITSUBISHI TANABE PHARMA CORPORATIONLIQUID COMPOSITION CONTAINING CALCIUMSMITHKLINE BEECHAM P.L.C.COMPOUNDNOVEL OLIGONUCLEOTIDE ANALOGS ANDHOECHST AKTIENGESELLSCHAFTTHE PROCESS FOR THEIR PREPARATION

1868 IN/PCT/2000/549/CHE 224304 10-10-2008SUSTAINED RELEASE FORMULATION OFMACROLIDE COMPOUNDSASTELLAS PHARMA INC1869 IN/PCT/2000/849/CHE 224305 10-10-2008COMPOUNDS WITH GROWTH HORMONERELEASING PROPERTIESNOVO NORDISK A/S1870 IN/PCT/2001/1010/CHE 224306 10-10-2008A KIT COMPRISING 4-H-1-BENZOPYRAN-4-ONEAVENTIS PHARMACEUTICALS INCDERIVATIVESCOMPOUNDS OF GENERAL FORMULA (I) FOR1871 IN/PCT/2001/1357/CHE 224308 10-10-2008 OXIDATIVE STRESS AND/OR ENDOTHELIAL NICOX S.ADYSFUNCTION1872 IN/PCT/2001/1473/CHE 224310 10-10-2008TRI-ARYL ACID DERIVATIVES AS PPARRECEPTOR LIGANDSSANOFI-AVENTIS DEUTSCHLAND GmbHPHARMACEUTICAL PRODUCT COMPRISING1873 IN/PCT/2001/1592/CHE 224311 10-10-2008THE ACTIVE SUBSTANCE DIAMORPHINE, ANDLTS LOHMANN THERAPIE-SYSTEME AGITS USE IN A PROCESS FOR TREATING OPIATEADDICTION1874 IN/PCT/2002/1360/CHE 224313 10-10-2008 A PURIFIED PEPTIDE CHAY 13 MEDICAL RESEARCH GROUP N.V1875 IN/PCT/2002/143/CHE 224314 10-10-2008FREE -CARBOLINE DRUG IN PARTICULATEFORM AND METHOD OF PREPARATION LILLY ICOS LLCTHEREOFA HIRUDIN PRECURSOR COMPRISING A1876 IN/PCT/2002/395/CHE 224315 10-10-2008 SIGNAL SEQUENCE FOR THE PRODUCTION OF SANOFI-AVENTIS DEUTSCHLAND GmbHLEU-HIRUDIN1877 IN/PCT/2002/530/CHE 224317 10-10-2008 TYROSINE KINASE INHIBITOR COMPOUNDS MERCK & CO., INC1878 IN/PCT/2002/828/CHE 224318 10-10-2008 4-PYRIDINYL-N-ACYL-L-PHENYLALANINES F. HOFFMANN-LA ROCHE AG1879 IN/PCT/2002/837/CHE 224319 10-10-2008UREA COMPOUNDS HAVING MUSACRINICRECEPTOR ANTAGONIST ACTIVITYTHERAVANCE, INC1880 717/CHENP/2003 224325 10-10-2008BENZODIAZEPINE DERIVATIVES AS GABA ARECEPTOR MODULATORSF. HOFFMANN - LA ROCHE AG1881 1696/CHENP/2003 224331 10-10-2008 ANTHRANILIC ACID AMIDES OF FORMULA I SANOFI-AVENTIS DEUTSCHLAND GmbH1882 IN/PCT/2002/00458/MUM 224350 10-10-2008SUBSTITUTED PYRIDINES AND PYRIDAZINESWITH ANGIOGENESIS INHIBITING ACTIVITYBAYER CORPORATION1883 3929/DELNP/2005 224354 13-10-2008AMINO CYCLOBUTYLAMIDE MODULATORSOF CHEMOKINE RECEPTOR ACTIVITYMERCK & CO INC.1884 4609/DELNP/2005 224358 13-10-20082-OXOAZEPAN DERIVATIVE CGRP RECEPTORANTAGONISTSMERCK & CO. INC.1885 165/DEL/2003 224359 13-10-2008A RECOMBINANT PROTEIN USEFUL FOR COUNCIL OF SCIENTIFIC AND INDUSTRIALINHIBITING ANTHRAX TOXINRESEARCH1886 838/MUMNP/2005 224362 13/10/2008BENZOTHIAZOLE DERIVATIVES AND THEIRUSE AS JNK MODULATORSLABORATOIRES SERONO SA1887 IN/PCT/2001/01388/MUM 224367 13/10/2008A HETEROCYCLIC SUBSTITUTEDAMINOAZACYLCESABBOTT LABORATORIES1888 02048/DELNP/2003 224369 13-10-2008 'PHARMACEUTICAL COMPOSITIONS" INDENA S.P.A.1889 3081/DELNP/2005 224370 13-10-2008 THE COMPOUNDS OF FORMULA (IV) AVENTIS PHARMA S.A.

1890 2694/DELNP/2004 224371 13-10-2008A CRYSTALS OF 2-(4-METHOXYBENZYL)PHENYL 6-O-ETHOXY-CARBONYL-β-D- KISSEI PHARMACEUTICAL CO., LTD.GLUCOPYRANOSIDE1891 1629/DELNP/2004 224372 13-10-2008A 2-{[2-(4-SUBSTITUTEDPHENYL)ETHY1]THIO}-3-[4-(2-{4-[(METHYLSULFONYL)OXY]-PHENOXY}ETHYL)PHENYL]PROPANOIC ACIDAstraZeneca ABAND PROCESS THEREOF1892 1098/DELNP/2004 224373 13-10-2008 ENANTIO ENRICHED COMPOUND SYNGENTA PARTICIPATIONS AG1893 5511/DELNP/2005 224374 13-10-2008A STARTING COMPOUND FOR A TROPANEDERIVATIVEPFIZER INC.1894 IN/PCT/2002/00049/DEL 224375 13-10-2008A QUATERNARY QUINUCLIDINE COMPOUNDOF FORMULA (I) AND PROCESS FORALMIRALL PRODESFARMA AGPREPARING THE SAME1895 2782/DELNP/2005 224376 13-10-2008A CATIONIC PORPHYRIN COMPOUNDS OFFORMULA IDESTINY PHARMA LIMITED1896 725/DELNP/2005 224377 13-10-2008PHARMACEUTICAL AGGREGATE WITHINCREASED DEFORMABILITY FOR IMPROVEDTRANSPORT THROUGH SEMI-PERMEABLEIDEA AGBARRIER1897 2714/DELNP/2005 224379 13-10-2008A DIARYLMETHYLIDENE PIPERIDINECOMPOUNDAstraZeneca AB1898 IN/PCT/2001/01112/DEL 224383 13-10-2008MESALAZINE CONTROLLED RELEASE ORALPHARMACEUTICAL COMPOSITIONSCOSMO TECHNOLOGIES LIMITED1899 1963/DELNP/2004 224399 14-10-2008PHARMACEUTICAL FORMULATION INCOLLOIDAL FORM HAVING GOODJAGOTEC AGPENETRATION ABILITY1900 01796/DELNP/2003 224402 14-10-2008A N-AROYL CYCLIC AMINES COMPOUND OFFORMULA (I)SMITHKLINE BEECHAM PLC1901 255/CHENP/2004 224408 15-10-2008COMPOSITION OF INSULIN FOR NASALADMINISTRATIONTRANSLATIONAL RESEARCH LTD1902 367/MUMNP/2004 224409 15/10/2008COMPOUNDS THAT INHIBIT FACTOR XAACTIVITYMORPHOCHEN AG1903 314/CHENP/2004 224410 15-10-2008SUBSTITUTED 6-(2-TOLYL)-TRIAZOLOPYRIMIDINESBASF AKTIENGESELLSCHAFT1904 1968/CHENP/2003 224417 15-10-2008(PYRIDO/THIENO)-[F]-OXAZEPIN-5-ONEDERIVATIVESN.V. ORGANON1905 2075/CHENP/2003 224419 15-10-2008 AN ISOQUINOLINE DERIVATIVE KYOTO PHARMACEUTICAL INDUSTRIES, LTD.1906 2087/CHENP/2003 224422 15-10-2008 TETRAHYDROQUINOLINE DERIVATIVES N.V. ORGANON1907 804/CHENP/2004 224423 15-10-2008COMPOUNDS, COMPOSITIONS AND METHODSOF USE FOR GLYPHOSATE SALTS OF ETHER BASF CORPORATION1908 1173/CHENP/2004 224427 15-10-2008AMINESLINEAR BASIC COMPOUNDS HAVING NK-2ANTAGONIST ACTIVITYMALESCI ISTITUTO FARMACOBIOLOGICOS.P.A.

SUBSTITUTED IMIDAZOLIDINES, METHOD FOR1909 1399/CHENP/2004 224428 15-10-2008 THE PRODUCTION THEREOF AND DRUG SANOFI-AVENTIS DEUTSCHLAND GMBHCONTAINING SUBSTITUTED IMIDAZOLIDINESNEW COMPOUNDS USEFUL FOR THE1910 3052/CHENP/2004 224431 15-10-2008 TREATMENT OF OBESITY, TYPE II DIABETES BIOVITRUM AB (PUBL)AND CNS DISORDERSHETEROCYCLIC COMPOUNDS HAVING1911 1695/CHENP/2004 224434 15-10-2008 ELASTASE-INHIBITORY ACTIVITY AND DAINIPPON SUMITOMO PHARMA CO., LTD.INTERMEDIATES THEREOFA TOPICAL COMPOSITION FOR TREATING THE PROCTER & GAMBLE COMPANY, ARCH1912 385/MUMNP/2005 224435 15/10/2008MICROBESCHEMICALS INC.PHOSPHONIUM SALTS AND METHODS OF1913 1765/KOLNP/2005 224446 14-10-2008CYIEC CANADA INC.THEIR PREPARATIONARYLPHENYL SUBSTITUTED CYCLIC1914 0619/DEL/1999 224472 16-10-2008 KETOENOLS COMPOUNDS AND A PROCESS BAYER AKTIENGESELLSCHAFTTHEREOFAZETIDINE DERIVATIVES AS CCR-3 RECEPTOR1915 2026/CHENP/2004 224473 16-10-2008NOVARTIS AGANTAGONISTS4,5-SUBSTITUTED THIAZOLE-2-CARBOXAMIDE1916 2038/CHENP/2004 224474 16-10-2008 DERIVATIVES AS CANNABINOID-CB1 SOLVAY PHARMACEUTICALS B.V.RECEPTOR MODULATORPIPERAZINYL-OR PIPERIDINYLAMIDE-1917 2142/CHENP/2004 224475 16-10-2008 SULFAMIC ACID AMIDES AS INHIBITORS OF NOVARTIS AGSTEROID SULFATASE2, 7-SUBSTITUTED INDOLES AND A PROCESS1918 380/CHENP/2005 224485 16-10-2008F. HOFFMANN-LA ROCHE AGFOR PRODUCING THE SAMEAN ADENINE COMPOUND OF FORMULA I AND1919 473/CHENP/2005 224488 16-10-2008 PHARMACEUTICAL COMPOSITIONDAINIPPON SUMITOMO PHARMA CO., LTD.CONTAINING THE SAMENAPHTHYRIDINE DERIVATIVES AND THEIR1920 1355/CHENP/2005 224490 16-10-2008SYNGENTA LIMITEDUSE AS FUNGICIDES1921 1317/CHENP/2004 224513 16-10-2008 XANTHINE OXIDASE INHIBITORS NIPPON CHEMIPHAR CO., LTDVACCINE COMPOSITIONS CONTAINING1922 2034/CHENP/2005 224517 16-10-2008 GANGLIOSIDE FOR SUBSTANCEOUSCENTRO DE INMUNOLOGIA MOLECULARADMINISTRATIONDERIVATIVES OF AMINOINDAZOLES, METHODOF PREPARATION AND INTERMEDIATES OF1923 1977/CHENP/2004 224544 16-10-2008 THE METHOD AS DRUGS ANDAVENTIS PHARMA S.APHARMACEUTICAL COMPOUNDSCONTAINING THEMNOVEL FORMULATIONS OF NSAID FOR1924 418/MUM/2003 224550 16/10/2008LYKA LABS LIMITEDRECTAL USE1925 IN/PCT/2002/01550/MUM 224552 16/10/2008 GROWTH HORMONE SECRET AGOGUES ZENTARIS AG1926 599/DEL/1998 224567 17-10-2008COMPOUND 2-(IMINOMETHYL) AMINO- SOCIETE DE CONSEILS DE RECHERCHES ETPHENYLD'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.)

1927 2684/DEL/1997 224571 17-10-2008 CYSTEINE ANALOGUE CONTAINING PEPTIDES ASTRA AKTIEBOLAGA PHARMACEUTICAL COMPOSITION FOR USE1928 00756/DELNP/2003 224580 20-10-2008 IN THE TREATMENT AND OR PREVENTION OF LABORATORIES SERONO SA.FIBROTIC DISEASE1929 1771/DEL/1996 224581 20-10-2008ERYTHRONOLIDE A DERIVATIVES OFFORMULA (I) AND PROCESS FOR PREPARING AVENTIS PHARMA S.A.THE SAME1930 0950/DEL/1995 224600 21-10-2008A QUINOLINE COMPOUND,OR SOLVATE ORSALT THEREOF, OF FORMULA (I) AS NK3ANTAGONISTS AND A PROCESS FORSMITHKLINE BEECHAM FARMACEUTICI S.p.A.PREPARING THE SAME1931 75/MAS/1998 224605 21-10-2008AQUEOUS SUSPENSION OF LOTEPREDNOL ETEBONATE FOR NASAL ADMINISTRATIONNICHOLAS BODOR1932 IN/PCT/2002/441/CHE 224606 21-10-2008A PHARMACEUTICAL COMPOSITIONYISSUM RESEARCH DEVELOPMENTCOMPANY OF THE HEBREW UNIVERSITY OFJERUSALEMPHARMACEUTICAL COMPOSITION1933 2588/CHENP/2004 224613 21-10-2008 COMPRISING A RENIN INHIBITOR, A CALCIUM NOVARTIS AGCHANNEL BLOCKER AND A DIURETICAN IRON-DEXTRAN COMPOUND AND A1934 IN/PCT/2000/429/CHE 224635 21-10-2008 PROCESS FOR PRODUCING SAID IRON- PHARMACOSMOS HOLDING A/SDEXTRAN COMPOUND1935 123/MAS/1996 224648 21-10-2008SUBSTITUTED THIOPHENESULFONYLUREA ORTHIOUREA OF THE FORMULA I AND A HOECHST AKTIENGESELLSCHAFTPROCESS FOR PREPARING THE SAMESUBSTITUTED BENZENESULFONYLURE ASAND THIOUREAS, PROCESSES FOR THEIR1936 214/MAS/1996 224649 21-10-2008PREPARATION AND USE OFHOECHST AKTIENGESELLSCHAFTPHARMACEUTICAL PREPARATIONS BASED ONTHESE COMPOUNDS AND MEDICAMENTSCONTAINING THEM1937 768/MAS/1998 224650 21-10-2008 GnRH ANTAGONISTS FERRING BV1938 IN/PCT/2001/1538/CHE 224651 21-10-2008PYMETROZINE DIHYDRATE AND TAUTOMERSSYNGENTA PARTICIPATIONS AGAND SALTS THEREOF1939 IN/PCT/2002/1150/CHE 224652 21-10-20082-AMINO-NICOTINAMIDE DERIVATIVES AND ANOVARTIS AGPROCESS FOR PREPARING THE SAME1940 2920/CHENP/2004 224654 21-10-2008NOVEL VARIANTS OF THE PAPMPOLYPEPTIDE OF BACTERIA OF GENUSAVENTIS PHARMA S.A1941 160/CHENP/2003 224662 21-10-2008 AN ISOLATED DNA THAT ENCODES A EISAI R & D MANAGEMENT CO. LTD.1942 IN/PCT/2002/841/CHE 224672 21-10-2008AMYCOMYCIN, A PROCESS FOR ITSPRODUCTION AND A PHARMACEUTICAL AVENTIS PHARMA DEUTSCHLAND GMBHCOMPOSITION COMPRISING THE SAME1943 IN/PCT/2002/1652/CHE 224677 21-10-2008A PHARMACEUTICAL COMPOSITION FOR THE RECKITT BENCKISER HEALTHCARE (UK)HEALING OF CELLSLIMITED

1944 1062/MAS/1998 224682 21-10-2008POLYPEPTIDES HAVING AMINOPEPTIDASEACTIVITY AND NECLEIC ACIDS ENCODING NOVOZYMES INCSAME1945 1482/MAS/1997 224684 21-10-2008A RECOMBINANT BACTERIUM FOR THEPRODUCTION OF RIBOFLAVINDSM IP ASSETS B V1946 1565/MAS/1997 224685 21-10-2008AN INSULIN OF THE FORMULA I WITH ANINCREASED ZINC BINDING POWERHOECHST AKTIENGESELLSCHAFT1947 1939/MAS/1997 224687 21-10-2008 GLP-2 DERIVATIVES NOVO NORDISK A/S1948 1469/CHE/2005 224688 21-10-2008ANTI-STRESS HERBAL FORMULATION AND VENKATESWARA AYURVEDA NILAYAMPROCESS FOR THE PREPARATION THEREOF LIMITEDBICYCLO[2.2.2]-OCT-1YL-1,2,4-TRIAZOLES AS1949 2392/DELNP/2005 224706 22-10-2008 INHIBITORS OF 11-BETA-HYDROXYSTERIOD MERCK & CO., INC.DEHYDROGENASE-11950 1621/KOLNP/2004 224723 22-10-2008A PHARMACEUTICAL COMPOSITION FORTREATING AN ECTOPARASITE INFESTATION PIEDMONT PHARMACEUTICALS, LLC.AND METHOD OF PREPARING THE SAME1951 2451/KOLNP/2005 224741 22-10-2008PHARMACEUTICAL COMPOSITIONCONTAINING NV!FGF FOR TREATINGMYCORDIAL OR SKELETAL ANGIOGENIC CENTELIONDISORDERS OR DEFECTS ASSOCIATED WITHHYPERCHOLESTEROLEMIA OR DIABETES1952 1740/KOLNP/2004 224746 22-10-2008ANTAGONISTIC PEPTIDES OFTHERATECHNOLOGIES INCPROSTAGLANDIN E2 RECEPTOR SUBTYPE EP4.A PHARMACEUTICAL COMPOSITION1953 184/CAL/1995 224747 22-10-2008 COMPRISING RALOXIFENE, A SURFACTANT ELI LILLY AND COMPANYAND A WATERSOLUBLE DILUENT.1954 17/KOLNP/2004 224748 22-10-2008 NOVEL ANTICONVULSANT DERIVATIVE ORTHO-MCNEIL PHARMACEUTICAL, INC.1955 1764/KOLNP/2004 224749 22-10-2008HUMANIZED IMMUNOMODULATORYMONOCLONAL ANTIBODIES FOR THETREATMEN OF NEOPLASTIC DISEASE ORCURE TECH LTD.IMMUNODEFICIENCY1956 1889/KOLNP/2004 224751 22-10-2008PHENYLALKANOIC ACID ANDPHENYLOXYALKANOIC ACID DERIVATIVES SMITHKLINE BEECHAM CORPORATIONAS HPPAR ACTIVATORS1957 195/KOLNP/2004 224752 22-10-2008ANTIBODY GLYCOSYLATION VARIANTSHAVING INCREASED ANTIBODY-DEPENDENT GLYCART BIOTECHNOLOGY AGCELLULAR CYTOTOXICITY1958 636/KOLNP/2003 224787 22-10-2008BACTERIAL GYRASE INHIBITORS,COMPOSITION COMPRISING IT AND METHODFOR ITS USE IN REDUCING BACTERIALVERTEX PHARMACEUTICALS INCORPORATEDQUANTITY IN EX-VIVO BIOLOGICAL SAMPLES1959 2916/DELNP/2004 224805 22-10-2008PHARMACEUTICAL COMPOSITIONSBOEHRINGER INGELHEIM PHARMA GMBH &CO. KG.1960 709/DEL/2003 224807 22-10-2008 BCG VACCINE AND UTILIZATION THEREOF JAPAN SCIENCE AND TECHNOLOGY AGENCY

1961 3275/DELNP/2005 224809 22-10-20081-DESAMINO-8-D-ARGINYL VASOPRESSINANALOGUSUNQ TECHNOLOGY TRANSFER LLC1962 2093/MAS/1996 224829 23-10-2008PURIFIED POLYPEPTIDE HAVING A RECEPTORSANOFI-SYNTHELABOACTIVITY SPECIFIC FOR IL-131963 2393/MAS/1997 224831 23-10-20083-AMIDOCHROMANYSULFONYL(THIO) UREASHOECHST AKTIENGESELLSCHAFTOF FORMULA IA POLYNUCLEOTIDE COMPRISING (CHIV)1964 IN/PCT/2000/638/CHE 224839 23-10-2008 GENOME COMPRISED OF CAEV AND HIV-1 UNIVERSITY OF SOUTHERN CALIFORNIACLEMENTSHYBRID POLYPEPTIDE COMPRISING AN1965 IN/PCT/2000/836/CHE 224841 23-10-2008 ENHANCER P[EPTIDE SEQUENCE LINKED TO A TRIMERIS, INC.CORE POLYPEPTIDEA CINNAMIDE COMPOUND HAVING CELL1966 IN/PCT/2001/1040/CHE 224842 23-10-2008 ADHESION ANTI-INFLAMMATORY AND ABBOTT LABORATORIESIMMUNE SUPPRESSIVE PROPERTIES1967 IN/PCT/2001/1315/CHE 224845 23-10-20081,4-BENZOTHIAZEPINE-1, 1-DIOXIDEDERIVATIVES SUBSTITUTED BY SUGARRADICALS, METHOD OF THEIR PRODUCTION SANOFI-AVENTIS DEUTSCHLAND GMBHTHEREOF AND A PHARMACEUTICALCOMPOSITION COMPRISING THE SAMECELL ADHESION INHIBITING ANTI-1968 IN/PCT/2001/1496/CHE 224848 23-10-2008 INFLAMMATORY AND IMMUNE-SUPPRESSIVE ABBOTT LABORATORIESCOMPOUNDS1969 IN/PCT/2001/508/CHE 224850 23-10-2008SUBSTITUTED PHENYL DERIVATIVES ANDTHEIR PREPARATIONNEUROSEARCH A/S1970 IN/PCT/2001/748/CHE 224851 23-10-2008 A STABLE PHARMACEUTICAL COMPOSITION DR. REDDY'S LABORATORIES LIMITED1971 IN/PCT/2002/1205/CHE 224852 23-10-2008DIBENZO (B,F) AZEPINE DERIVATIVES ANDTHEIR PREPARATIONNOVARTIS AG1972 IN/PCT/2002/604/CHE 224856 23-10-2008AROMATIC DI-KETO DERIVATIVES ASCLUCOSE-6-PHOSPHATE TRANSLOCASE SANOFI-AVENTIS DEUTSCHLAND GMBHINHIBITORS2-,3-,4- OR 5-SUBSTITUTED-N1-1973 573/CHENP/2003 224858 23-10-2008 (BENZENSULFONYL) INDOLES ANDTHEIR USE BIOVITRUM AB (PUBL)IN THERAPYNOVEL 1,2-DIPHEZYLAZETIDINONES AND A1974 956/CHENP/2003 224866 23-10-2008 METHOD OF PREPARING A MEDICAMENT SANOFI-AVENTIS DEUTSCHLAND GMBHCOMPRISING THE SAME1975 691/CHE/2005 224868 23-10-2008 UREA AMIDE DERIVATIVE KRISHNAN RAMUORALLY DELIVERABLE PHARMACEUTICALCOMPOSITION COMPRISING AN ACTIVE1976 1632/CHENP/2003 224886 24-10-2008COMPOUND HAVING AN AMINOSULFONYLPHARMACIA CORPORATIONGROUP (COX-2 INHIBITOR), A POLYETHYLENEGLYCOL AND A FREE RADICAL SCAVENGINGANTIOXIDANT

1977 169/CHENP/2004 224892 24-10-2008NOVEL HETEROARYL DERIVATIVESPOTENTLY BINDING TO THE 5-HT1AH. LUNDBECK A/S1978 173/CHENP/2004 224893 24-10-2008 NOVEL INDOLE DERIVATIVES H. LUNDBECK A/S1979 1960/CHENP/2003 224901 24-10-2008BENZOXAZEPINE DERIVATIVES AND APHARMACEUTICAL COMPOSITIONN.V. ORGANONCOMPRISING THE SAME1980 1431/CHENP/2004 224907 24-10-2008PHARMACEUTICAL COMPOSITIONSCOMPRISING METFORMINE ANDGLIBENCLAMIDE1981 3045/CHENP/2004 224908 24-10-20081982 1253/CHENP/2004 224912 24-10-20081983 800/CHENP/2004 224913 24-10-20081984 2508/CHENP/2004 224926 24-10-20081985 486/MUM/2000 224931 24/10/20081986 586/KOLNP/2004 224958 29-10-20081987 1079/KOLNP/2004 224962 29-10-20081988 1014/KOLNP/2005 224965 29-10-2008MORPHINAN DERIVATIVES THEQUATERNARY AMMONIUM SALTS THEREOFSUBSTITUTED IN POSITION 14BICYCLO (2.2.1) HEPTANES/HEPTENES AND ACOMPOSITION COMPRISING THEMCOMPOSITION COMPRISINGBISPHOSPHONATE, COX-2 INHIBITOR ANDTAXOTERE FOR GROWTH INHIBITION OFCANCER CELLSIRON DEXTRIN COMPOUNDS FOR THETREATMENT OF IRON DEFICIENCY ANAEMIAA CRYSTALLINE FORM OF (25, 3S)-N-(METHOXY-5-T-BUTYLPHENYLMETHYL-2-DIPHENYLMETHYL-1-AZOBICYCLO(2.2.2)OCTAN-3-AMINE CITRATESUBSTITUTED DIPHENYL HETEROCYCLESUSEFUL FOR TREATING HCV INFECTIONN-AMINOACETYL-PYRROLIDINE-2-CARBONITRILES AND THEIR USE AS DDP-IVINHIBITORSPHARMACEUTICAL FORMULATOINPROVIDING AN INCREASED BIOAVAILITY OFHYDROPHOBIC DRUGSMENARINI INTERNATIONAL OPERATIONSLUXEMBOURG S.AALCASYNN PHARMACEUTICALS GmbHGIVAUDAN SANOVARTIS AGPHARMACOSMOS HOLDING A/SPFIZER PRODUCT INCRIGEL PHARMACEUTICALS, INC.SANOFI-AVENTISALZA CORPORATION1989 1234/KOLNP/2005 224966 29-10-2008 A PHARMACEUTICAL PRODUCT ALKABELLO A/S1990 1065/KOLNP/2005 224977 29-10-20082-(2-HYDROXYBIPHENYL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINEDERIVATIVES AS FACTOR VIIA INHIBITORS1991 771/KOLNP/2005 224995 29-10-2008ANTI-CANCER AND ANTI-INFECTIOUSDISEASE COMPOSITIONS AND METHODS FORUSING SAMEAXYS PHARMACEUTICALS INC.CHIRON CORPORATION1992 701/CAL/1997 224996 29-10-2008 INHIBITORS OF IMPDH ENZYME VERTEX PHARMACEUTICALS INCORPORATED1993 866/KOLNP/2005 224998 29-10-2008THIENO[3,2-B]PYRIDINE-6 CARBONITRILESAND THIENO[2,3-B]PYRIDINE-5-WYETH1994 IN/PCT/2000/616/KOL 225003 29-10-2008 THERAPEUTIC BIARYL DERIVATIVES GLAXO GROUP LIMITED1995 IN/PCT/2002/759/KOL 225009 29-10-2008 CASPASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED1996 IN/PCT/2002/1026/KOL 225012 29-10-2008 AN IMMUNOGENIC COMPOSITION SMITHKLINE BEECHAM BIOLOGICALS S.A.

1997 3330/DELNP/2004 225015 29-10-2008ANTICOAGULANT FUSION PROTEINCOMPRISING A TARGETING PROTEINSCHERING AKTIENGESELLSCHAFT1998 IN/PCT/2001/1153/CHE 225016 30-10-2008 A HETEROCYCLIC COMPOUND DAINIPPON SUMITOMO PHARMA CO., LTDA COMPOSITION COMPRISING A1999 2683/CHENP/2004 225017 30-10-2008PURIFIED HEAT SHOCK PROTEIN UNIVERSITY OF CONNECTICUT HEALTHPREPARATION AND A PURIFIED CENTERIMMUNOREACTIVE REAGENT2000 326/MAS/2002 225023 30-10-2008PURINE DERIVATIVES, A PROCESS FOR THEPREPARATION OF THE SAMEASTRAZENECA AKTIEBOLAG2001 211/CHENP/2005 225026 30-10-2008A COMPOSITION COMPRISINGBIOREGULATORY ACTIVE INGREDIENTSBASF AKTIENGESELLSCHAFT2002 1675/CHENP/2005 225032 30-10-2008A COMPOSITION COMPRISINGALKANESULFONIC ACID ANDACETYCHOLINESTERASE INHIBITOR FOR -BELLUS HEALTH (INTERNATIONAL) LIMITEDAMLYOID RELATED DISEASE2003 938/CHENP/2005 225039 30-10-2008 ANTIVIRAL NUCLEOSIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG2004 1184/CHENP/2005 225052 30-10-2008NOVEL FLUOROGLYCOSIDE HETEROCYCLICDERIVATIVES AND A PHARMACEUTICAL SANOFI-AVENTIS DEUTSCHLAND GmbHCOMPOSITION COMPRISING THE SAME2005 903/CHENP/2005 225096 30-10-2008PHOSPHINIC ACID ANALOGS OFGLUTAMATEGIVAUDAN SA2006 826/CHENP/2005 225099 30-10-2008 INDOLE DERIVATIVES N.V. ORGANON2007 1021/CHENP/2005 225100 30-10-2008NUTRACEUTICAL COMPOSITIONSCOMPRISING EPIGALLOCATECHIN GALLATE DSM IP ASSETS B.VAND RASPBERRY KETONE2008 IN/PCT/2002/1049/CHE 225101 30-10-20083-(4,5-DIHYDROISOXAZOLE-5-YL)BENZOYLPYRAZOLEBASF AKTIENGESELLSCHAFT2009 802/CHENP/2005 225103 30-10-2008PYRIMIDO COMPOUNDS HAVINGF. HOFFMANN-LA ROCHE AG2010 467/BOM/1999 225117 31/10/20082011 3484/DEL/1998 225139 31-10-20082012 2937/DELNP/2004 225144 03-11-20082013 338/DEL/2002 225145 03-11-20082014 2979/DELNP/2004 225146 03-11-2008ANTIPROLIFERATIVE ACTIVITYAN ANTISEPTIC AND ANTI-MICROBIALPHARMACEUTICAL COMPOSITIONCOMPRISING FERACRYLUMSPHEROIDS CONTAINING TIAGABINEPREPARATION PROCESS ANDPHARMACEUTICAL COMPOSITIONSA PHARMACEUTICAL COMPOSITION FOR THECHEMOTHERAPEUTIC TREATMENT OFCANCERA NOVEL SYNERGISTIC RODENT REPELLENTLIQUID FORMULATIONOLIGONUCLEOTIDE PRIMERS HAVING SEQ IDNOS. 1 TO 21 AND A PROCESS FOR DETECTIONOF PARASITE SALMONELLA USINGOLIGONUCLEOTIDE PRIMERSPATEL DINESH SHANTILAL, KURANISHASHIKANT PRABHUDASLABORATOIRES DES PRODUITS ETHIQUESETHYPHARMCOUNCIL OF SCIENTIFIC & INDUSTRIALRESEARCHCOUNCIL OF SCIENTIFIC AND INDUSTRIALRESEARCHCOUNCIL OF SCIENTIFIC AND INDUSTRIALRESEARCH

2015 IN/PCT/2001/00956/MUM 225161 04-11-20082016 1052/MUMNP/2006 225162 04-11-2008BICYCLIC HETEROCYCLES,PHARMACEUTICAL COMPOSITIONSCONTAINING THESE COMPOUNDS, ANDPROCESSES FOR PREPARING THEMA DELAYED RELEASE PHARMACEUTICALCOMPOSITION2-ARYLIMINO-2,3-DIHYDROTHIAZOLESBOEHRINGER INGELHEIM PHARMA GMBH &CO. KG.SMITHKLINE BEECHAM CORPORATION2017 1380/MUMNP/2005 225167 04-11-2008SOCIETE DE CONSEILS DE RECHERCHES ETD'APPLICATIONS SCIENTIFIQUES S.A.S.2018 174/KOLNP/2004 225172 05-11-2008SYNTHESIS OF ITQ-17 IN THE ABSENCE OF CONSEJO SUPERIOR DE INVESTIGACIONESFLUORIDE IONSCIENTIFICASCHEMOKINE RECEPTOR BINDING2019 00593/KOLNP/2004 225173 05-11-2008 HETEROCYCLIC COMPOUNDS WITHANORMED INC.ENHANCED EFFICACY2020 623/KOLNP/2004 225174 05-11-2008ANTIMICROBIAL, SPORICIDAL COMPOSITIONAND TREATED PRODUCTS THEREOFMICROBAN PRODUCTS COMPANY2021 1081/KOLNP/2003 225180 05-11-2008PHOSPHONIUM PHOSPHINATE COMPOUNDSAND THEIR PREPERATIONCYTEC CANADA INC2,4,6-TRISUBSTITUTED PYRIMIDINES AS2022 1189/KOLNP/2005 225183 05-11-2008PHOSPHOTI-DYLINOSITOL (PI) 3-KINASEINHIBITORS AND THEIR USE IN THECHIRON CORPORATIONTREATMENT OF CANCER.2023 1191/KOLNP/2005 225187 05-11-2008 VITAMIN D RECEPTOR MODULATORS ELI LILLY AND COMPANYHISTONE DEACETYLASE INHIBITORS OF2024 01354/KOLNP/2005 225188 05-11-2008NOVEL BENZAMIDE DERIVATIVES WITHPOTENT DIFFERENTIATION AND ANTI-SHENZHEN CHIPSCREEN BIOCIENCES LTD.PROLIFERATION ACTIVITY2025 2554/KOLNP/2005 225202 05-11-20082026 1283/KOLNP/2004 225203 05-11-20082027 289/KOLNP/2005 225208 05-11-20082028 465/KOLNP/2003 225209 05-11-2008A COMPOSITION FOR TREATING SEVEREACUTE RESPIRATORY SYNDROME (SARS)NOVEL BETA-SHEET MIMETICS COMPOUNDSAND COMPOSITION CONTAINING THE SAMEPYRAZOLE COMPOSITIONS USEFUL ASINHIBITORS OF GSK-3A CRYSTALLINE NON-SOLVATEDANHYDROUS FORM OF 6-HYDROXY-3-(4-[2-(PIPERIDIN- 11-1-YL) ETHOXY] PHENOXY)-2-(4-MTHOXYPHENYL) BENZO [B] THIOPHENEWYETH HOLDINGS CORPORATIONMYRIAD GENETICS, INC.VERTEX PHARMACEUTICALS INCORPORATEDELI LILLY AND COMPANY2029 546/KOLNP/2003 225218 05-11-2008 GLF-1/FC FUSION PROTEINS ELI LILLY AND COMPANY2030 962/KOLNP/2004 225220 05-11-2008AMINO ALCOHOL DERIVATIVE ORPHOSPHONIC ACID DERIVATIVE ANDMEDICIANAL COMPOSITION CONTAININGTHESESANKYO COMPANY, LIMITED2031 1280/DEL/2003 225222 05-11-2008A COMPOSITION USEFUL FOR TREATINGACUTE AND CHRONIC MYELOID LEUKEMIACOUNCIL OF SCIENTIFIC AND INDUSTRIALRESEARCH

2032 IN/PCT/2001/9/KOL 225227 05-11-20082033 IN/PCT/2001/563/KOL 225231 05-11-20082034 IN/PCT/2001/1026/KOL 225233 05-11-20082035 IN/PCT/2001/331/KOL 225241 05-11-20082036 IN/PCT/2002/1070/KOL 225257 05-11-2008A NOVEL PARA-TERTIARY ALKYLPHENYLSUBSTITUTED TRIAZINES AND PYRIMIDINECOMPOUNDS.A POLYPEPTIDENOVEL VERBENONE DERIVATIVES PROCESSFOR THEIR PRODUCTION ANDPHARMACEUTICAL COMPOSITIONCYTEC TECHNOLOGY CORP. ,THE ADMINISTRATORS OF THE TULANEEDUCATION FUNDEUPHAR GROUP SRLUSE OF GLP-1 OR ANALOGS IN TREATMENT OFELI LILLY AND COMPANYSTOKEHUMANIZED ANTIBODIES THAT BINDAMYLOID BETA, POLYNUCLEIC ACID AND AWASHINGTON UNIVERSITYPHARMACEUTICAL COMPOSITIONCOMPRISING THE ANTIBODIES2037 IN/PCT/2002/1387/KOL 225267 05-11-2008 A LACCASE ENZYME VALTION TEKNILLINEN TUTKIMUSKESKUS2038 00473/DELNP/2004 225277 05-11-2008THE COMPOUND N-(2-BROMOPHENYL)-N'-[((R)-1-(5-TRIFLUOROMETHYL-2-PYRIDYL)PYRROLIDIN-3-YL)UREA"SMITHKLINE BEECHAM P.L.C.2039 804/MUM/2004 225279 05-11-20082040 256/MUMNP/2006 225281 05-11-20082041 3413/DELNP/2004 225292 06-11-20082042 IN/PCT/2002/00619/DEL 225293 06-11-2008A NOVEL SYNERGISTIC PHARMACEUTICALCOMPOSITIONCHIMERIC ANTIGENS FOR BREAKING HOSTTOLERANCE TO FOREIGN ANTIGENSA 3, 11-BRIDGED ERYTHROMYCINCOMPOUND, THE PROCESS OF PREPARING ITAND PHARMACEUTICAL COMPOSITIONCOMPRISING THE SAMETRIAROMATIC VITAMIN D ANALOGUES OFTHE FORMULA (I) AND COMPOSITIONTHEREOFINDOCO REMEDIES LIMITEDVIREXX MEDICAL CORP.ENANTA PHARMACEUTICALS INC.GALDERMA RESEARCH &DEVELOPMENT,S.N.C.2043 703/MUMNP/2004 225295 06-11-2008CICLESONIDE-CONTAINING STERILEAQUEOUS SUSPENSIONALTANA PHARMA AG2044 595/MUMNP/2004 225301 06-11-2008OPHTHALMOLOGICAL PHARMACEUTICALPREPARATIONALTANA PHARMA AG2045 476/MUMNP/2006 225302 06-11-2008AMINOPYRIDINE-DERIVATIVES ASINDUCTIBLE NO-SYNTHASE INHIBITORSALTANA PHARMA AG2046 754/DEL/1996 225304 06-11-2008 ARYLGLYCINAMIDE DERIVATIVES BOEHRINGER INGELHEIM KG.2047 0879/DEL/1998 225305 07-11-2008A PHARMACEUTICAL COMPOSITIONCOMPRISING TYROSINE AND 3 DE-O-ACYLATED MONOPHOSPHORYL LIPID A ANDPROCESS FOR THE PREPARATION THEREOFSMITHKLINE BEECHAM P.L.C.2048 473/MUMNP/2006 225310 07-11-20082049 49/MUM/2003 225311 07-11-2008IMIDAZOPYRIDINE-DERIVATIVES ASINDUCIBLE NO- SYNTHASE INHIBITORSANTI-FUNGAL COMPOSITION AND A PROCESSFOR MANUFACTURING THE ANTI-FUNGALCOMPOSITIONALTANA PHARMA AGDR. PATEL DINESH SHANTILAL,DR. PATELSACHIN DINESH,KURANI SHASHIKANTPRABHUDAS

2050 00229/DELNP/2004 225323 07-11-2008A PHARMACEUTICAL AND / OR COSMETICORAL COMPOSITIONSINDENA S.P.A.2051 00141/DELNP/2003 225324 07-11-2008A PHARMACEUTICAL COMPOSITION BEING ATABLET COMPRISING N-[(1-NBUTYL-4-PIPERIDINYL)METHYL]-3,-4-DIHYDRO-2H-LABORATOIRE GLAXOSMITHKLINE S.A.S.[1,3]OXAZINO[3,2-A]INDOLE-10-2052 1294/DEL/2005 225325 07-11-2008A COMPOSITION COMPRISINGCONFORMATIONAL ISOMERS OF TOLUIDINEBLUE O AND N-DEMETHYLATIONZILA BIOTECHNOLOGY INC.DERIVATIVES OF SAID ISOMERS2053 00584/DELNP/2004 225350 11-11-2008ANTI-COUGH,ANTI-TUSSIVE AND THROATCOUNCIL OF SCIENTIFIC AND INDUSTRIALSOOTHING SYNERGISTIC HERBALRESEARCHFORMULATION2054 2679/DELNP/2005 225360 11-11-2008 A COMPOSITION COMPRISING PEPTIDES DABUR RESEARCH FOUNDATION2055 192/MUM/2005 225372 11-11-2008SYNERGISTIC FORMULATION OF ANANTISPASMODIC AND AN ANALGESIC,ANTIPYRETIC AND ANTI-INFLAMMATORYSANJEEV KHANDELWALAGENT IN TABLET FORMAN ORAL MULTIPLE UNIT TABLET2056 2969/DEL/1996 225378 11-11-2008 COMPRISING A PROTON PUMP INHIBITOR AND ASTRA AKTIEBOLAGA NSAID2057 IN/PCT/2002/00144/MUM 225395 12-11-2008INTERLEUKIN-5 INHIBITING 6-AZAURACILDERIVATIVESJANSSEN PHARMACEUTICA N.V.2058 1050/MUMNP/2005 225400 12-11-20083-AMINO-1-PHENYL-1H[1,2,4]-TRIAZOLCOMPOUNDS OF FORMULA(I)SANOFI-SYNTHELABO2059 1026/KOLNP/2005 225411 12-11-2008COMBINATION THERAPY FOR THETREATMENT OF ACUTE LEUKEMIA AND WYETHMYELODYSPLASTIC SYNDROME2060 01213/KOLNP/2003 225416 12-11-2008 BENZAMIDINE DERIVATIVES SANKYO COMPANY, LIMITED2061 1708/KOLNP/2004 225423 12-11-2008MUTEINS OF PLACENTAL GROWTH FACTORTYPE 1, PREPARATION METHOD AND GEYMONAT S. P. A.APPLICATION THEREOF2062 01967/KOLNP/2004 225425 12-11-2008PHENYL-THIOPHENE TYPE VITAMIN DRECEPTOR MODULATORSELI LILLY AND COMPANY2063 2094/KOLNP/2005 225427 12-11-2008COMPOUNDS AS INHIBITORS HISTONEDEACETYLASEPHARMACYCLICS, INC.2064 1260/KOLNP/2005 225433 12-11-2008PROLYL OLIGOPEPTIDASE INHIBITORCOMPOUNDS AND PHARMACEUTICAL ORION CORPORATIONCOMPOSITION COMPRISING THEM2065 152/KOLNP/2003 225434 12-11-2008ANTI-TNF ANTIBODIES, COMPOSITIONS,METHODS AND USES.CENTOCOR, INC.,2066 295/KOLNP/2003 225439 12-11-2008PYRAZOLE COMPOUNDS USEFUL AS PROTEINVERTEX PHARMACEUTICALS INCORPORATEDKINASE INHIBITORS2067 303/KOLNP/2003 225440 12-11-2008A CYANOPYRROLIDINE ORCYANOTHIAZOLIDINE DERIVATIVETANABE SEIYAKU CO. LTD.

2068 434/KOLNP/2005 225441 12-11-2008PIPERIDINYL COMPOUNDS THATSELECTIVELY BIND INTEGRINSJANSSEN PHARMACEUTICA N.V.NOVEL INTERMEDIATE FOR CARBAPENEM2069 831/KOLNP/2005 225447 12-11-2008 COMPOUND FOR ORAL ADMINISTRATION AND KANEKA CORPORATIONPROCESS FOR PRODUCING THE SAMECARBOXYLIC ACID DERIVATIVES THAT2070 IN/PCT/2001/1211/KOL 225456 12-11-2008 INHIBIT THE BINDING OF INTEGRINS TO TEXAS BIOTECHNOLOGY CORPORATIONTHEIR RECEPTORS2071 IN/PCT/2002/125/KOL 225461 12-11-2008 NOVEL SPIRO COMPOUNDS BANYU PHARMACEUTICAL CO. LTD2072 IN/PCT/2002/141/KOL 225465 12-11-2008ANTIBACTERIAL HETEROBICYCLICSUBSTITUTED PHENYL OXAZOLIDINONES ORTHO-MCNEIL PHARMACEUTICAL, INCCOMPOUNDSA MODIFIED RELEASE BI-LAYER TABLET AND2073 IN/PCT/2002/1238/KOL 225468 12-11-2008 A MODIFIED RELEASE TABLET, CAPSULE AND ADAMS LABORATORIES INC.PHARMACEUTICAL PRODUCT2074 IN/PCT/2002/1273/KOL 225469 12-11-2008 A SERINE PROTEASE INHIBITORS ELI LILLY AND COMPANY2075 IN/PCT/2002/1416/KOL 225470 12-11-2008SUBSTITUTED PYRROLOPYRIDINONEDERIVATIVES USEFUL ASORTHO-MCNEIL PHARMACEUTICAL, INC.PHOSPHODIESTERASE INHIBITORS2076 IN/PCT/2002/1094/CHE 225558 19-11-2008 AN ANTIBODY OF THE PRESENT INVENTION NOVARTIS AG2077 IN/PCT/2002/126/CHE 225559 19-11-2008CORYNE BACTERIUM GLUTAMICUM GENESENCODING PROTEINS INVOLVED INMEMBRANE SYNTHESIS AND MEMBRANEBASF AKTIENGESELLSCHAFTTRANSPORT2078 2040/MAS/1998 225561 19-11-2008 OLIGONUCLEOTIDE ANALOGUES EXIQON A/S2079 IN/PCT/2002/1950/CHE 225570 19-11-2008A COMPOSITION COMPRISING CELECOXIBFOR RAPID PAIN RELIEFPHARMACIA CORPORATIONA BACTERICIDAL, BACTERIOSTATIC,2080 1245/MAS/1995 225571 19-11-2008FUNGICIDAL AND/OR FUNGISTATICNOVOZYMES A/SCOMPOSITION COMPRISING A BASIC PROTEINOR PEPTIDE2081 1263/MAS/1995 225572 19-11-2008A SOLID PHARMACEUTICAL COMPOSITIONAND A PROCESS FOR PREPARING THE SAMEN.V. ORGANONNOVEL PEPTIDES DERIVED FROM2082 1389/MAS/1995 225573 19-11-2008 AUTOANTIGEN FOR USE IN IMMUNOTHERAPY AKZO NOBEL N.VOF AUTOIMMUNE DISEASES2083 1839/MAS/1998 225582 19-11-20082-{3-[4-(2-T-BUTYL-6-TRIFLUOROMETHYL-4-PYRIMIDINYL)-1-PIPERAZINYL)PROPYL THIO}- ABBOTT GMBH & CO. KG4-PYRIMIDINOL FUMARATE1'-[4-[1-(4-FLUOROPHENYL)-1H-INDOLE-3-YL]-1-2084 2495/MAS/1998 225584 19-11-2008 BUTL]-SPIRO[ISOBENZOFURAN-1(3H),4'- H. LUNDBECK A/SPIPERIDINE] HYDROHALOGENIDESSUBSTITUTED IMIDAZOLIDINE DERIVATIVES,2085 2536/MAS/1998 225585 19-11-2008 THEIR PREPARATION AND PHARMACEUTICAL SANOFI-AVENTIS DEUTSCHLAND GMBHPREPARATIONS COMPRISING THEM

2086 2759/MAS/1997 225588 19-11-2008BENZOTHIOPHENECA RBOXAMIDECOMPOUNDSSHIONOGI & CO., LTD2087 464/MAS/1998 225590 19-11-2008A MEDICAMENT FOR USE IN THE TREATMENTASTRA ABOF MYCOBACTERIAL DISEASE2088 483/MAS/1999 225591 19-11-2008NOVEL TRICYCLIC COMPOUNDS, PROCES FORTHEIR PREPARATION AND PHARMACEUTICAL DR. REDDY'S LABORATORIES LTD.COMPOSITIONS CONTAINING THEM2089 715/MAS/1996 225593 19-11-2008PHARMACEUTICAL COMPOSITIONCONTAINING TIAGABINE AND ANTIOXIDANTNOVO NORDISK A/S2090 955/MAS/1996 225595 19-11-2008 NOVEL PEPTIDES ABBOTT GMBH & CO. KG2091 IN/PCT/2000/454/CHE 225597 19-11-2008 ANTITUMOR AGENT AJINOMOTO CO., INC2092 IN/PCT/2000/621/CHE 225599 19-11-2008 DISUBSTITUTED PIPERIDINE COMPOUNDS NOVO NORDISK A/S2093 IN/PCT/2000/647/CHE 225600 19-11-2008PHARMACEUTICAL COMPOSITION ANDMETHOD FOR PREPARATION THEREOFZHAO, CHAOYING2094 IN/PCT/2001/1004/CHE 225601 19-11-2008 AMIDE COMPOUNDS ASTELLAS PHARMA INC.ANTITHROMBOTIC COMPOSITION AND2095 IN/PCT/2001/1216/CHE 225602 19-11-2008 EFFECTIVE METHOD FOR PRESERVING BLOOD JALLAL MESSADEKEXVIVO2096 IN/PCT/2001/1605/CHE 225605 19-11-2008NOVEL 15-MEMBERED 8A AND 9A - LACTAMSPLIVA FARMACEUTSKA INDUSTRIJA,FROM THE CLASS OF 6-O-METHYL-DIONICKO DRUSTVOERYTHROMYCIN A2097 IN/PCT/2001/1714/CHE 225606 19-11-2008SULFONAMIDE AND SULFAMIDESUBSTITUTED IMIDAZOQUINOLINES3M INNOVATIVE PROPERTIES COMPANY2098 IN/PCT/2001/769/CHE 225608 19-11-2008 BENZOFURAN DERIVATIVES H. LUNDBECK A/S2099 IN/PCT/2001/950/CHE 225611 19-11-2008TRIAZOLE COMPOUNDS WITH DOPAMINE-D3-ABBOTT GMBH & CO. KG2100 IN/PCT/2002/1239/CHE 225613 19-11-20082101 199/KOLNP/2004 225634 19-11-20082102 01805/KOLNP/2005 225639 19-11-2008RECEPTOR AFFINITYCYTOKINE DERIVATIVES FOR CANCERTHERAPYAN ANTIGENIC COMPOSITION USEFUL FOREARLY DETECTION OF M. TUBERCULOSISDISEASE OR INFECTION FOR IMMUNIZING ASUBJECT AGAINST M. TUBERCULOSISINOVEL QUINOLINE,TETRAHYDROQUINAZOLINE, ANDPYRIMIDINE DERIVATIVES AND METHODS OFTREATMENT RELATED TO THE THEREOFFONDAZIONE CENTRO SAN RAFFAELE DELMONTE TABORNEW YORK UNIVERSITYTAISHO PHARMACEUTICAL CO. LTD.2103 1111/KOLNP/2003 225641 19-11-2008N-(2-ARYLETHYL) BENZYLAMINES ASANTAGONISTS OF THE 5-HT6 RECEPTORELI LILLY AND COMPANY2104 191/KOLNP/2003 225644 19-11-2008A SUBSTITUTED PYRAZOLES COMPOUND OFFORMULA (1)ORTHO MCNEIL PHARMACEUTICAL INC.2105 132/KOLNP/2005 225646 19-11-2008 CCK-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA, N.V.2106 409/KOLNP/2005 225649 19-11-2008 "ACETYL 2-HYDROXY-1,3 DIAMINOALKANES" ELAN PHARMACEUTICALS, INC.2107 441/KOLNP/2005 225650 19-11-20081,3-DIAMINO-2-HYDROXYPROPANE PRODRUGELAN PHARMACEUTICALS, INC.DERIVATIVES

1,2,4-OXADIAZOLE DERIVATIVES AS HPPAR2108 717/KOLNP/2003 225653 19-11-2008GLAXO GROUP LIMITEDALPHA AGONISTS2109 771/KOLNP/2003 225654 19-11-2008 A MACROHETEROCYCLIC COMPOUND ORTHO-MCNEIL PHARMACEUTICAL, INC.A POLYNUCLEOTIDE ENCODING A MODIFIED2110 IN/PCT/2001/774/KOL 225662 19-11-2008CHIRON CORPORATIONHIV ENV ENV POLYPEPTIDEARYL-CARBALDEHYDE OXIME DERIVATIVE2111 2070/KOLNP/2005 225665 19-11-2008WYETHCOMPOUNDSA SUBSTITUTED DIARYL ETHER AS OPIOID2112 457/KOLNP/2005 225666 19-11-2008ELI LILLY AND COMPANYRECEPTOR ANTAGONISTECHINOCANDIN PHARMACEUTICAL2113 IN/PCT/2001/994/KOL 225669 19-11-2008 FORMULATIONS CONTAINING MICELLE- ELI LILLY AND COMPANYFORMING SURFACTANTSBENZOYLPYRIDINE DERIVATIVE OR ITS SALT,FUNGICIDE CONTAINING IT AS AN ACTIVE2114 IN/PCT/2002/1520/KOL 225673 19-11-2008ISHIHARA SANGYO KAISHA, LTD.INGREDIENT, ITS PRODUCTION PROCESS ANDINTERMEDIATE FOR PRODUCING ITSMALL MOLECULE INHIBITORS OF2115 2324/DEL/1996 225681 20-11-2008GUILFORD PHARMACEUTICALS, INCROTAMASE ENZYME ACTIVITYA HERBAL COMPOSITION FOR TREATMENT OF2116 53/MUM/2007 225690 20/11/2008BAKSHI KANDARPKUMAR JANUBHAIORAL SUB MUCOUS FIBROSIS(OSMF)NOVEL DIPEPTIDYL PEPTIDASE IVINHIBITORS, PHARMACEUTICAL2117 1332/MUM/2004 225696 20/11/2008GLENMARK PHARMACEUTICALS S.A.COMPOSITIONS CONTAINING THEM, ANDPROCESS FOR THEIR PREPARATIONA BENZAZEPINE COMPOUND,2118 2232/DELNP/2005 225702 21-11-2008 PHARMACEUTICAL ACCEPTABLE SALT AND GLAXO GROUP LIMITEDCOMPOSITION THEREOFGLUCOCORTICOID RECEPTOR MODULATORBOEHRINGER INGELHEIM2119 2316/DELNP/2004 225733 25-11-2008 COMPOUND OF FORMULA (IA) ANDPHARMACEUTICALS, INC.PHARMACEUTICAL COMPOSITION THEREOFA PHARMACEUTICAL COMPOSITION2120 2088/DEL/1998 225734 25-11-2008 COMPRISING COMPOUND I, SULPHONYLUREA SMITHKLINE BEECHAM P.L.C.AND BIGUANIDE ANTIHYPERGLYCEMICDISUBSTITUTED BICYCLIC HETEROCYCLES BOEHRINGER INGELHEIM PHARMA GMBH &2121 0370/DEL/1998 225735 25-11-2008AND PROCESS FOR PREPARING THE SAME CO. KG.A PHARMACEUTICAL COMPOSITION IN ORAL2122 1425/DEL/1999 225738 26-11-2008TELIK INC.UNIT DOSAGE FORM2123 4054/DELNP/2004 225741 27-11-2008 A COMBINATION BAYER HEALTHCARE AG.2124 IN/PCT/2002/01875/MUM 225744 27/11/2008 STREPTOCOCCUS ANTIGENS ID BIOMEDICAL CORPORATIONAN ANTISEPTIC CLEANSING COMPOSITION NOVAPHARM RESEARCH (AUSTRALIA) PTY2125 1195/DEL/2002 225745 27-11-2008LIMITEDA TRANSDERMAL PHARMACEUTICAL2126 1372/DELNP/2004 225754 27-11-2008ZOLTAN DARDAICOMPOSITIONA LIPOXIN A4 ANALOGS AND COMPOSITION2127 01143/DELNP/2004 225777 28-11-2008SCHERING AKTIENGESELLSCHAFT,COMPRISING THE SAME

2128 630/CHENP/2003 225809 01-12-2008ACYL AND SULFONYL DERIVATIVES OF 6,9-DISUBSTITUTED 2-(TRANS-1,4-DIAMINOCYCLOHEXYL)-PURINES AND THEIRAVENTIS PHARMACEUTICALS INC.USE AS ANTIPROLIFERATIVE AGENTS2129 1137/CHENP/2003 225812 01-12-2008A PHARMACEUTICAL COMPOSITIONCOMPRISING ERYTHROPOIETINTHE KENNETH S. WARREN INSTITUTE, INC2130 1963/CHENP/2003 225849 01-12-2008N-FORMYL HYDROXYLAMINE COMPOUNDSAS INHIBITORS OF PDFVICURON PHARMACEUTICALS INC.2131 1053/CHENP/2004 225858 01-12-2008OLIGOPEPTIDES, COMPOSITIONS COMPRISINGTHEM AS CATHEPSINS INHIBITORS AND AVENTIS PHARMACEUTICALS INC.PROCESS FOR THEIR PREPARATION2132 1371/CHENP/2004 225859 01-12-2008A COMPOUND OF FORMULA III ASACTIVATORS OF GLUCOKINASE (GK)NOVO NORDISK A/S2133 1417/CHENP/2004 225860 01-12-2008A 2-AMINO-3-ALKOXY-6-FLUOROBICYCLO(3.1.0) HEXANE-2, 6-DICARBOXYLIC ACID TAISHO PHARMACEUTICAL CO., LTDDERIVATIVE2134 1506/CHENP/2004 225861 01-12-2008A NUTRIENT FORMULATION COMPRISINGPOLYPHENOLSRATH, MATTHIAS2135 2769/CHENP/2004 225862 01-12-2008COMBINATIONS COMPRISING EPOTHILONESAND PHARMACEUTICAL COMPOSITIONNOVARTIS AG2136 2998/CHENP/2004 225863 01-12-2008THERAPEUTIC AGENTS USEFUL FORTREATING PAINEURO-CELTIQUE, S.A2137 1568/CHENP/2004 225864 01-12-2008ARYLOXYPHENYL ANDARYLSULFANYLPHENYL DERIVATIVESH. LUNDBECK A/S2138 2112/CHENP/2004 225865 01-12-2008BENZOFURAN DERIVATIVESMITSUBISHI TANABE PHARMA CORPORATION2139 3154/CHENP/2004 225866 01-12-2008 A PYRAN COMPOUND OF FORMULA I GIVAUDAN SA2140 1469/CHENP/2005 225883 01-12-2008NOVEL PYROLE AND IMIDAZOLEDERIVATIVES AND A PROCESS FOR THE F. HOFFMANN-LA ROCHE AGMANUFACTURE OF THE SAMECOMPOSITIONS COMPRISING FETAL2141 1623/CHENP/2005 225884 01-12-2008HEMOGLOBIN AND BACTERIAL ENDOTOXINCLINIQUE LA PRAIRIE RESEARCH SAAND OPTIONALLY ADDITIONAL FETAL LIVERCOMPONENTS2142 2643/CHENP/2004 225905 01-12-2008A COMBINATION COMPRISING A DPP-IVINHIBITORNOVARTIS AG2143 735/DEL/2003 225919 03-12-2008A PHARMACEUTICAL COMPOSITION OF HIGH NATIONAL INSTITUTE OF PHARMACEUTICALMOLECULAR WEIGHT POLYMERIC DRUGS EDUCATION AND RESEARCH (NIPER)2144 1989/DEL/1998 225922 03-12-2008A SPIROAZABICYCLIC HETEROCYCLICAMINES OF FORMULA I AND PROCESSASTRA AKTIEBOLAG2145 1384/DEL/1996 225923 03-12-2008DIALKYL-HALOGENOPHENYL-SUBSTITUTEDKETOENOLS COMPOUNDS AND PROCESS BAYER AKTIENGESELLSCHAFTTHEREOF2146 00987/DELNP/2004 225925 03-12-2008A PHARMACEUTICAL VAGINAL COMPOSITION COLUMBIA LABORATORIES (BERMUDA)AND PROCESS FOR PREPARING THE SAME LIMITED

2147 668/MUM/2002 225930 03-12-2008DIRCTLY COMPRESSIBLE PHARMACEUTICALADJUVANT HAVING IMPROVEDPRANAV DHIRAJBHAI JOGANIFUNCTIONALITY2148 IN/PCT/2002/00849/DEL 225934 03-12-2008 AZETIDINE COMPOUNDS OF FORMULA (I) AVENTIS PHARMA S.A.2149 3480/DELNP/2005 225938 03-12-2008 A FACTOR VIII POLYPEPTIDE SK CHEMICALS CO., LTD.2150 IN/PCT/2001/1249/CHE 225942 04-12-2008AN IMMUNOGENIC COMPOSITION OF THEPRESENT INVENTIONSMITHKLINE BEECHAM BIOLOGICALS S A2151 1361/KOLNP/2005 225952 03-12-2008AROMATIC COMPOUNDS WITH HIV ASPARTYLPROTEASE INHIBITING ACTIVITIES AND PROCYON BIOPHARMA INCCOMPOSITIONS COMPRISING THEM2152 1695/KOLNP/2004 225955 03-12-2008 PREPARATIONS OF A SULFINYL ACETAMIDE. CEPHALON, INC.2153 329/KOLNP/2003 225972 03-12-2008 A PHARMACEUTICAL COMPOSITION NEW RIVER PHARMACEUTICALS, INC.2154 71/KOLNP/2005 225991 03-12-2008A SELECTIVE ESTROGEN RECEPTORMODULATORS COMPOUND CONTAINING A ELI LILLY AND COMPANYPHENYLSULFONYL GROUP OF FORMULA I.2155 794/KOLNP/2003 225992 03-12-2008 PYRAZOLE COMPOUNDS VERTEX PHARMACEUTICALS INCORPORATED2156 2099/CHENP/2005 225998 04-12-2008JUVENILE HORMONE COMPOSITIONS AND ASHLAND LICENSING AND INTELLECTUALMETHODS FOR MAKING SAMEPROPERTY LLC2157 1329/CHENP/2005 226013 04-12-2008PYRIDINO [2,3-D] PYRIMIDINE DERIVATIVESAS SELECTIVE KDR AND FGFR INHIBITORSF. HOFFMANN-LA ROCHE AG2158 2115/CHENP/2005 226021 04-12-20082,5 AND 2,6-SUBSTITUTEDTETRAHYDROISOQUINOLINES FOR USE AS 5- F. HOFFMANN-LA ROCHE AGHT6 MODULATORS2159 2503/CHENP/2005 226030 04-12-2008BENZO [1,2,5] OXADIAZOLES, AND BENZO[1,2,5] THIADIAZOLES USEFUL ASHISTOPATHOLOGICAL STAINING AGENTS,NOVARTIS AGIMAGING AGENTS AND BIOMARKERS2160 IN/PCT/2001/1388/CHE 226034 04-12-2008AN ISOLATED NUCLEIC ACID ENCODING AHUMAN AKT3 PROTEINAVENTIS PHARMACEUTICALS PRODUCTS INC2161 2545/CHENP/2005 226036 04-12-2008SOLID PHARMACEUTICAL COMPOSITIONSCOMPRISING SIP RECEPTOR AGONIST AND A NOVARTIS AGSUGAR ALCOHOL2162 1808/DELNP/2004 226041 05-12-2008 LIPASE INHIBITOR COMPOUNDS OSI PHARMACEUTICALS, INC2163 2196/DEL/2004 226058 05-12-20082-HALOGEN-6-ALKYL-PHENYL SUBSTITUTEDSPIROCYCLIC TETRAMIC ACID DERIVATIVESBAYER CROPSCIENCE AG2164 2682/DELNP/2004 226067 05-12-2008 2-OXAZOLAMINE COMPOUND PHARMAGENE LABORATORIES LIMITED2165 2034/DELNP/2005 226068 07-12-2008AN N2S2 CONJUGATE COMPOUNDBOARD OF REGENTS, THE UNIVERSITY OFTEXAS SYSTEM;A SUBSTITUTED 2-ACYLAMINOTHIAZOLE2166 6145/DELNP/2005 226084 08-12-2008 COMPOUND AND PHARMACEUTICAL ASTELLAS PHARMA INC.COMPOSITION THEREOF2167 IN/PCT/2002/00107/DEL 226086 08-12-2008A HETEROCYCLIC PHENYL OR PYRIDYLAMINO ACID COMPOUNDBRISTOL-MYERS SQUIBB COMPANY2168 2985/CHENP/2004 226093 10-12-2008SPIROCYCLIC PIPERIDINES AS MCH1ANTAGONISTS AND USES THEREOFH. LUNDBECK A/S

2169 1689/DELNP/2004 226122 10-12-2008COMPOUND OF GENERAL FORMULA (II)SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.)2170 1240/MAS/1997 226123 10-12-2008ANHYDROUS CRYSTALLINE R(-)-N-(4,4-DI(3-METHYLTHIEN-2-YL)BUT-3-ENYL)-NOVO NORDISK A/SNIPECOTICACID HYDROCHLORIDE2171 00932/KOLNP/2004 226125 08-12-2008EXTENDED RELEASE PHARMACEUTICALTABLET OF METFORMINBIOVAIL LABORATORIES INC.2172 125/MAS/1996 226126 10-12-2008COMPOUNDS WITH GROWTH HORMONERELEASING PROPERTIESNOVO NORDISK A/S2173 730/MAS/1998 226136 10-12-2008RECOMBINANT MICROORGANISMS CAPABLE UNIVERSITY OF FLORIDA RESEARCHOF FERMENTING CELLOBIOSEFOUNDATION, INC4-(PHENYL OR PYRIDYL)-IMIDAZOLE2174 IN/PCT/2002/909/CHE 226149 10-12-2008 DERIVATIVE NEUROPEPTIDE Y Y5 RECEPTOR SCHERING CORPORATIONANTAGONISTS2175 670/CHENP/2005 226167 10-12-2008 THERAPEUTIC PIPERAZINE COMPOUNDS EURO-CELTIQUE S.A2176 350/KOLNP/2004 226189 08-12-20082177 1262/DEL/1999 226223 12-12-20082179 662/DEL/2002 226242 15-12-2008THERAPEUTICALLY USEFULTRIETHYLENEGLYCOL CHOLESTERYLOLIGONUCLEOTIDES .4-ACETOXY-2Alpha -BENZOYLOXY-5Beta ,20-EPOXY-1, 7Beta, 10Beta-TRIHYDROXY-9-OXO-TAK-11-EN-13Alpha-YL(2R,3S)-3-TERT-BUTOXY-CARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE TIHYDRATEBIONICHE LIFE SCIENCES INC.AVENTIS PHARMA S.A. (FORMERLY KNOWN ASRHONE-POULENC RORER S.A.)2178 03/DEL/2002 226231 12-12-2008 A SYNERGISTIC HERBAL COMPOSITION DABUR RESEARCH FOUNDATIONA HERBAL PREPARATION AND A PROCESSFOR THE PREVENTION AND TREATMENT OFHYPERCHOLESTEROLEMIA ANDRAVI PATODIAHYPERTRIGLYCERDIEMIA2180 974/MUMNP/2006 226299 17/12/20082181 8/MUMNP/2003 226302 17/12/20082182 487/MAS/1995 226313 17-12-20082183 721/MAS/1995 226314 17-12-20082184 1110/MAS/2000 226315 17-12-20082185 508/MAS/1998 226319 17-12-20081-AMINOVYCLOHEXANE DERIVATIVES FORTHE TREATMENT OF AGITATION AND OTHERBEHAVIORAL DISORDERS, ESPECIALLYTHOSE ASSOCIATED WITH ALZHEIMER’SA PROTECTIVE POLYPEPTIDE AGAINSTBACILLUS ANTHRACIS, AND ITSPREPARATIONMERZ PHARMA GMBH & CO. KGAATHE SECRETARY OF STATE FOR DEFENCECOMPOUNDS USEFUL TO TREAT RETROVIRALPHARMACIA & UPJOHN COMPANYINFECTIONSSELECTIVE INHIBITORS OF INOS, A PROCESSFOR ITS PREPARATION, A PHARMACEUTICAL THE WELLCOME FOUNDATION LIMITEDFORMULATION COMPRISING THE SAMECOMPOSITION COMPRISING ASCORBIC ACIDAND PECTINA PHARMACEUTICAL COMPOSITIONCOMPRISING COMPOUND OF FORMULA I ANDTAXANESDSM IP ASSETS B.VABBOTT GmbH & Co. KG

2186 967/MAS/1997 226322 17-12-2008 ANTIMICROBIAL PEROXIDASE COMPOSITIONS NOVOZYMES A/S2187 1760/CHENP/2003 226344 17-12-20084-AMINO-5-PHENYL-7-CYCLOBUTYL-PYRROLONOVARTIS AG(2,3-D) PYRIMIDINE DERIVATIVESN-ARYLPHENYLACET AMIDE DERIVATIVES2188 1956/CHENP/2003 226350 17-12-2008 AND PHARMACEUTICAL COMPOSITION DAINIPPON PHARMACEUTICAL CO., LTDCONTAINING THE SAME2189 801/CHENP/2004 226357 17-12-2008NUCLEIC ACID CONSTRUCT ANDPHARMACEUTICAL COMPOSITIONVASCULAR BIOGENICS LTDCONTAINING THE SAME2190 1102/CHENP/2004 226359 17-12-2008NEW INDOLE DERIVATIVES AS FACTOR XAINHIBITORSSANOFI-AVENTIS DEUTSCHLAND GmbH2191 2848/CHENP/2004 226367 17-12-2008ARYL PIPERAZINE DERIVATIVES AND THEIRPHARMACEUTICAL COMPOSITIONBIOVITRUM AB (publ)COMPRISING THE SAME2192 3030/CHENP/2004 226369 17-12-2008 AMINOALCOHOL DERIVATIVES ASTELLAS PHARMA INC2193 1665/CHENP/2004 226370 17-12-2008COMPOSITION CONTAINING SPERMIDINE ASACTIVE PRINCIPLE FOR PHARMACEUTICAL GIULANI S.p.AOR DIETETIC USE FOR COMBATING HAIR LOSS2194 2025/CHENP/2004 226374 17-12-2008PYRIMIDINE DERIVATIVE AND A PROCESSFOR PREPARING THE SAMENOVARTIS AG2195 3157/CHENP/2004 226375 17-12-2008AMINOALKYLPYRI DINE DERIVATIVES AND ALEK PHARMACEUTICALS D.DPROCESS FOR THEIR PREPARATION2196 1305/KOLNP/2004 226395 17-12-2008 ANTI ALPHA-V BETA-6 ANTIBODIES BIOGEN INDEC MA INC.2197 3393/CHENP/2005 226403 17-12-2008 A CYANOFLUOROPYR ROLIDINE COMPOUND TAISHO PHARMACEUTICAL CO., LTD.2198 190/KOLNP/2003 226425 17-12-2008 A SUBSTITUTED PYRAZOLES COMPOUND ORTHO-MCNEIL PHARMACEUTICAL, INC.2199 1917/KOLNP/2005 226427 17-12-2008RECOMBINANT POLYEPITOPE POLYPEPTIDEFOR ENHANCING IMMUNE RESPONSE TOIMMUNODEFICIENCY VIRUSTHE GOVERNMENT OF THE UNITED STATES OFAMERICA, AS REPRESENTED BY THESECRETARY OF THE DEPARTMENT OF HEALTHAND HUMAN SERVICES, CENTERS FORDISEASE CONTROL AND PREVENTION2200 1977/KOLNP/2005 226428 17-12-2008NITROGEN-CONTAINING HETEROCYCLICDERIVATIVES.ASTELLAS PHARMA INC.2201 277/KOLNP/2003 226449 17-12-2008PYRIMIDINE AND PYRIDINE DERIVATIVES ASINHIBITORS OF GLYCOGEN SYNTHASE CHIRON CORPORATIONKINASE 32202 461/KOLNP/2003 226459 17-12-2008A PROTEIN FROM STREPTOCOCCUS GROUPS ACHIRON S.P.A.AND B2203 48/KOLNP/2005 226461 17-12-2008ANTIMICROBIAL MELAMINE RESIN ANDMICROBAN PRODUCTS COMPANYDECORATIVE LAMINATE MADE THEREFROMPHARMACEUTICAL COMPOSITION2204 601/KOLNP/2004 226475 17-12-2008 COMPRISING (AMINOIMINOMETHYL) AMINO)ALKANE CARBOXAMIDESMERCK PATENT GMBH

2205 881/KOLNP/2004 226499 17-12-2008COMPRESSED ORAL PHARMACEUTICALDOSAGE FORM, WITH AN ENTERICCOATING, WHICH CONTAINS AN ACID-LABORATORIOS DEL DR. ESTEVE, S.A.LABILE BENZIMIDAZOLE COMPOUND2206 IN/PCT/2001/144/KOL 226506 17-12-2008NITROGEN-CONTAINING HETEROCYLICCARBOXAMIDE DERIVATIVES OR SALTSTHEREOF AND ANTIVIRAL AGENTSTOYAMA CHEMICAL CO. LTD.COMPRISING THE SAME2207 01315/DELNP/2004 226540 18-12-2008A BENZIMIDAZO [2,1-B] [3] BENZAZEPINECOMPOUND OF FORMULA (I)JANSSEN PHARMACEUTICA N.V.,2208 3477/DEL/2005 226541 18-12-2008AN ANTI HIV-1 ACTIVE BACTERIAL ANDBACTULOVIRUS RECOMBINANT EPAP-1.DEPARTMENT OF BIOTECHNOLOGY2209 3335/DEL/1998 226566 19-12-2008A PYRIMIDINE COMPOUND OF FORMULA IMID-AMERICA COMMERCIALIZATIONUSEFUL FOR CONTROLLING UNDESIRABLECORPORATIONVEGETATIONA PHARMACEUTICAL COMPOSITION2210 01326/DELNP/2004 226603 19-12-2008 COMPRISING CROMOLYN SODIUM AND A EMISPHERE TECHNOLOGIES IncDELIVERY AGENT2211 00942/DELNP/2004 226605 22-12-2008A PHARMACEUTICAL MULTI -PARTICULATE,TABLET OR PELLETHERCULES INCORPORATED2212 1147/MUMNP/2006 226614 22/12/2008ANTI-OBESE IMMUNOGENIC HYBRIDPOLYPEPTIDES AND ANTI-OBESE VACCINE SJ BIOMED INC.COMPOSITION COMPRISING THE SAME2213 IN/PCT/2002/00223/DEL 226624 22-12-2008GLUCOPYRANOSYLOXYPYRAZOLEDERIVATIVES, MEDICINAL COMPOSITIONS KISSEI PHARMACEUTICAL CO. LTD.,CONTAINING THE SAME2214 362/DEL/2000 226628 22-12-2008A NOVEL ANTI-FUNGAL FORMULATIONCOUNCIL OF SCIENTIFIC AND INDUSTRIALACTIVE AGAINST A BROAD SPECTRUMRESEARCHDERMATOPHYTOSESCRYSTALLINE POLYMORPH A (FORM A) OF2215 02139/DELNP/2003 226632 22-12-2008 FLIBANSERIN 1 AND PROCESS FORBIDACHEM S.P.A.,PREPARING THE SAME2216 525/CHENP/2005 226650 23-12-2008SUBSTITUTED (THAIZOL-2-YL)-AMIDE ORSULFONAMIDE AS GLYCOKINASEACTIVATORS AND PHARMACEUTICALNOVARTIS AGCOMPOSITION COMPRISING THE SAME2217 1745/CHENP/2005 226671 23-12-2008NOVEL COMPOSITION COMPRISINGCAROTENOIDS AND A PROCESS FOR ITS DSM IP Assets B.VPREPARATION2218 2530/CHENP/2004 226690 23-12-2008 NOVEL VACCINE OF THE PRESENT INVENTION VAXCONSULTINGCOMPOUNDS THAT INHIBIT THE BINDING OF2219 1303/CHENP/2005 226698 23-12-2008 SDF-1OR1-TAC TO THE CHEMOKINERECEPTOR CCXCKR2CHEMOCENTRYX, INC

2220 1029/KOLNP/2004 226708 24-12-2008A PHARMACEUTICAL POWDER CARTRIDGEFOR POWDER INHALERSSOFOTEC GMBH & CO. KG.,2221 1230/KOLNP/2003 226721 24-12-2008CARBAMET COMPOUNDS FOR USE INPREVENTING OR TREATING PSYCHOTIC ORTHO-MCNEIL-PHARMACEUTICAL, INCDISORDERS .2222 158/KOLNP/2005 226739 24-12-20081-HETEROCYCLYLALKYL-3-SULFONYLAZAINDOLE OR-AZAINDAZOLEDERIVATIVES AS 5-HYDROXYTRYPTAMINE-6WYETHLIGANDS2223 1796/KOLNP/2004 226745 24-12-2008SUBSITUTED PHENYLSULFONAMIDEINHIBITORS OF BETA AMYLOID PRODUCTION WYETH2224 2559/KOLNP/2005 226756 24-12-2008IL-23 P40 SPECIFIC IMMUNOGLOBULINDERIVED PROTEINS, COMPOSITION ANDCENTOCOR, INC2225 613/KOLNP/2004 226779 24-12-2008PHARMACEUTICAL COMPOSITION BASED ONMICRONIZED PROGESTERONE, METHOD FOR BESINS INTERNATIONAL BELGIQUETHE PREPARATION THEREOF .2226 616/KOLNP/2006 226780 24-12-2008 AZOLE-BASED KINASE INHIBITORS CYTOPIA RESEARCH PTY LTD2227 924/KOLNP/2004 226798 24-12-2008A RECOMBINANT CANCER-ASSOCIATEDEPITOPE, VACCINES COMPRISING IT,ANTIBODIES BINDING TO SAID EPITOPE, KITS THE SCRIPPS RESEARCH INSTITUTEAND COMPOSITIONS COMPRISING SAIDANTIBODIES2228 1410/MUM/2005 226803 24/12/2008NOVEL ά-HYDRAZINO-α,β-UNSATURATEDNITRO COMPOUNDS AND METHODS OF INDIAN INSTITUTE OF TECHNOLOGY, BOMBAYPREPARATION THEREOF2229 936/CHENP/2005 226823 24-12-2008A PHARMACEUTICAL COMPOSITIONCOMPRISING OCTREOTIDE ACETATEMICROPARTICLES AND PROCESS OFNOVARTIS AGPREPARATION OF THE SAME2230 IN/PCT/2001/1184/CHE 226842 24-12-2008A HETEROCYCLIC SULFONAMIDE OFFORMULA I AND A PROCESS FOR PREPARING F. HOFFMANN-LA ROCHE AGTHE SAME2231 1540/CHENP/2005 226843 24-12-2008AMINO SUBSTITUTED HYDROXYPHENYLBENZOPHENONE DERIVATIVESCIBA HOLDING INC2232 2332/CHENP/2004 226847 24-12-2008 SUBSTITUTED TETRACYCLINE COMPOUNDS PARATEK PHARMACEUTICALS, INC2233 618/MUM/2004 226881 30/12/2008STABLE PHARMACEUTICAL PREPARATION OFSUBSTITUTED BENZIMIDAZOLELYKA LABS LIMITED2234 934/CAL/1997 226892 30-12-2008A CROSSLINKED ENZYME CRYSTALFORMULATION .ALTUS PHARMACEUTICALS INC.2235 IN/PCT/2001/223/KOL 226900 30-12-2008NUCLEIC ACIDS ENCODING A G-PROTEINTHE REGENTS OF THE UNIVERSITY OFCOUPLED RECEPTOR INVOLVED IN SENSORYCALIFORNIATRANSDUCTION

2236 776/MUM/2002 226950 31/12/2008NOVEL 1-[1-(HETERO)ARYL-1-PERHYDROXYALKYLM ETHYL]-PIPERAZINECOMPOUNDS, PROCESS FOR THESOLVAY PHARMACEUTICALS GMBHPREPARATION THEREOF AND MEDICAMENTSCONTAINING THESE COMPOUNDS2237 1418/CHENP/2005 226963 31-12-2008A PEPTIDE COMPOSITION TO INCREASEFIBRONECTINKIMBERLY-CLARK WORLDWIDE, INC2238 1803/CHENP/2005 226965 31-12-2008A TRIMERIC POLYPEPTIDE CONSTRUCT FORENDURING T CELL RESPONSEMICROMET AGNOVEL AROMATIC FLUOROGLYCOSIDE2239 1183/CHENP/2005 226978 31-12-2008 DERIVATIVES, PHARMACEUTICAL PRODUCTS SANOFI-AVENTIS DEUTSCHLAND GmbHCONTAINING SAID COMPOUNDSNOVEL INTERMEDIATES AND AN IMPROVED2240 1129/MAS/1998 226979 31-12-2008PROCESS FOR THE PREPARATION OFOMEPRAZOLE EMPLOYING THE SAIDNATCO PHARMA LTDINTERMEDIATES2241 111/MAS/1996 226993 31-12-2008 A PHARMACEUTICAL COMPOSITION NEURIM PHARMACEUTICALS (1991) LTD2242 1370/MAS/1996 226995 31-12-2008A SYNERGISTIC REJUVENATING ANDREVITALISING PHARMACEUTICALTABLETS (INDIA) LIMITEDCOMPOSITIONA BAKING COMPOSITION COMPRISING A2243 2824/MAS/1997 226998 31-12-2008 POLYPEPTIDE EXHIBITING PHOSPHOLIPASE A NOVOZYMES A/SACTIVITY2244 816/MAS/1998 226999 31-12-2008A HERBAL ANTIMICROBIALDERMATOLOGICAL DRUGNATURAL REMEDIES PVT. LTD2245 835/MAS/1998 227002 31-12-2008 ANTITHROMBOTIC COMPOUND N.V. ORGANON2246 IN/PCT/2001/1359/CHE 227005 31-12-2008 BICYCLE HETEROAROMATIC COMPOUNDS N.V. ORGANONHERBICIDAL COMPOSITIONS WITH2247 IN/PCT/2001/72/CHE 227007 31-12-2008 SUBSTITUTED PHENYLSULFONYLUREAS AND BAYER CROPSCIENCE AGA PROCESS FOR PREPARING THE SAMEA PHARMACEUTICAL COMPOSITIONCOMPRISING PHENYLACETYLGLUTAMINE,2248 IN/PCT/2001/79/CHE 227008 31-12-2008 PHENYLACETYLISOGLUTAMINE, AND/OR BURZYNSKI STANISLAW RPHENYLACETATE FOR THE TREATMENT OFNEOPLASTIC DISEASES2249 IN/PCT/2002/946/CHE 227009 31-12-2008SUBSTITUTED 8-ARYLQUINOLINEDERIVATIVES USEFUL ASMERCK FROSST CANADA & COPHOSPHODIESTERASES-4-INHIBITORS2250 1491/CHENP/2003 227025 31-12-2008COMBINATION OF A DOCETAXEL AND ACYCLIN-DEPENDANT KINASEAVENTIS PHARMA S.A2251 1555/CHENP/2003 227030 31-12-2008N-P-PROPARGYLOXPHENETHYL-THIOACETICACID AMIDES AND A PROCESS FORSYNGENTA PARTICIPATIONS AGPREPARING THE SAME2252 192/CHENP/2004 227041 31-12-2008IMIDAZOLIDINE DERIVATIVES AND THEIRPREPARATIONSANOFI AVENTIS DEUTSCHLAND GMBH

2253 351/CHENP/2004 227043 31-12-2008HYPERBRANCHED AMYLOPECTIN FOR USE INMETHODS FOR SURGICAL OR THERAPEUTICTREATMENT OF MAMMALS OR INSUPRAMOL PARENTERAL COLLOIDS GmbHDIAGNOSTIC METHODS, ESPECIALLY FOR USEAS A PLASMA VOLUME EXPANDER2254 1773/CHENP/2003 227050 31-12-2008NOVEL, ARYLSULFONAMIDE COMPOUNDSFOR THE TREATMENT OF OBESITY, TYPE II BIOVITRUM AB (PUBL)DIABETES AND CNS-DISORDERS2255 224/DEL/1999 227055 01-01-2009AN ISOLATED POLYNUCLEOTIDE MOLECULECOMPRISING THE COMPLETE AVEC OPEN-READING FRAME (ORF) OF STREPTOMYCESPFIZER PRODUCTS INC.AVERMITILIS2256 1980/CHENP/2003 227070 01-01-2009 QUINAZOLINE DERIVATIVES NOVARTIS AG2257 1716/CHENP/2004 227077 01-01-2009 N-PHENYL-2-PYRIMIDINE-AMINE NOVARTIS AG2258 1967/DELNP/2005 227091 01-01-2009 ISOINDOLINE DERIVATIVE Maruishi Pharmaceutical Co., Ltd.2259 1312/DEL/2001 227105 01-01-2009A NOVEL ALDOSE REDUCTASE INHIBITOR COUNCIL OF SCIENTIFIC AND INDUSTRIALRESEARCHA PHARMACEUTICAL COMPOSITION FOR THE2260 403/MUMNP/2006 227111 02-01-2009 TREATMENT OF A CANCEROUS OR PRE- MEDIGENE AGCANCEROUS LESION OF THE SKINAMIDINOPHENYL DERIVATIVES OF GENERAL2261 1642/DEL/1998 227112 02-01-2009 FORMULA (I) AND PROCESS FOR PREPARINGTHE SAMEA NOVEL 1-(2-CHLORO-5-METHYL-3-2262 1104/DEL/2001 227116 02-01-2009 PYRIDYLMETHYL)-2-NITROIMINOIMIDAZOLIDINE2263 160/MUMNP/2006 227119 02-01-2009PHARMACEUTICAL COMPOSITION OFADAMANTANE DERIVATIVESASTRA ZENECA AB2264 292/MAS/1999 227151 05-01-2009 ANTIBACTERIAL AGENTS VERNALIS (R&D) LTDSUBSTITUTED 4-2265 1236/CHENP/2004 227152 05-01-2009PHENYLTETRAHYDROISOQUINOLINES,METHOD FOR THE PRODUCTION THEREOF,AND MEDICAMENT CONTAINING THE SAMESOCIETE DE CONSEILS DE RECHERCHES ETD'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.)COUNCIL OF SCIENTIFIC AND INDUSTRIALRESEARCHSANOFI-AVENTIS DEUTSCHLAND GmbH2266 2729/CHENP/2004 227154 05-01-2009 SUBSTITUTED THIOPHENE DERIVATIVES SANOFI-AVENTIS DEUTSCHLAND GmbH2267 2763/CHENP/2004 227156 05-01-2009 ETHER SUBSTITUTED IMIDAZOPYRIDINES 3M INNOVATIVE PROPERTIES COMPANY2268 1759/CHENP/2004 227171 05-01-2009 GERANYL COMPOUNDS OHGEN RESEARCH LABORATORIES LTD2269 709/CHE/2004 227179 05-01-2009PEPTIDE ANTIGENS WHICH ELICIT HIGHHUMORAL IMMUNE RESPONSE AND LOW T-CELL RESPONSECENTRE FOR DNA FINGERPRINTING ANDDIAGNOSTICS [CDFD]2270 1872/CHENP/2004 227180 05-01-2009 5-PHENYLTHIAZOLE DERIVATIVES NOVARTIS AG2271 2671/CHENP/2004 227183 05-01-2009A FACTOR VII OR FACTOR VIIA POLYPEPTIDEVARIANTMAXYGEN HOLDINGS LTD2272 2956/CHENP/2005 227188 05-01-2009ISOQUINOLINE-3-CARBOXYLIC ACID AMIDESOF FORMULA INOVARTIS AG

2273 3509/CHENP/2005 227197 05-01-20098-AZA-BICYCLO[3,2,1]OCTANE DERIVATIVE OFNEUROSEARCH A/STHE FORMULA I2274 125/CHENP/2006 227211 05-01-2009 D-AMINO ACID PEPTIDES IMMUNOMEDICS, INC2275 81/CHENP/2006 227216 05-01-2009BENZOFURAN DERIVATIVES USEFUL FORTREATMENT OF MICROBIAL INFECTIONSARPIDA AG2276 86/CHENP/2006 227217 05-01-2009 SAQUINA VIR MESYLATE ORAL DOSAGE F. HOFFMANN-LA ROCHE AG2277 1295/CHENP/2004 227236 05-01-2009COMPOUNDS FOR DECREASING ACTIVITY OFHORMONE-SENSITIVE LIPASENOVO NORDISK A/S2278 2993/CHENP/2005 227245 05-01-2009COMPOSITIONS COMPRISING APOMORPHINEFOR PULMONARY INHALATIONVECTURA LTD.2279 5408/DELNP/2005 227257 05-01-2009BENZOPYRAN COMPOUNDS SUBSTITUTEDWITH THIOXOBENZOXAZOLESDONGBU HANNONG CHEMICAL CO. LTD.,2280 121/DEL/2000 227258 05-01-2009A PROPELLANT-FREE PHARMACEUTICALPREPARATIONBOEHRINGER INGELHEIM KG2281 00509/DELNP/2003 227260 05-01-2009 OXAPENEM COMPOUNDS AMURA LIMITED2282 01358/DELNP/2003 227276 06-01-2009SPIROTRICYCLIC DERIVATIVES AND THEIRUSE AS PHOSPHODIESTERASE-7 INHIBITORSWARNER-LAMBERT COMPANY LLC2283 816/KOLNP/2004 227294 06-01-2009DITHIOCARBAMATE DERIVATIVES AND THEIRNEED PHARMACEUTICALS S. R. L.USE AS ANTIBACTERIAL AGENTS .NEW STRAIN OF LACTIC ACID BACTERIUM2284 325/KOLNP/2004 227298 06-01-2009 AND EDIBLE COMPOSITIONS DRUGS AND ACTIAL FARMACEUTICA , LDAVETERINARY PRODUCTS CONTAINING IT .2285 IN/PCT/2002/01102/MUM 227305 06-01-2009A PHARMACEUTICAL COMPOSITIONSUITABLE FOR ORAL ADMINISTRATIONNICOX S.A2286 2386/DELNP/2005 227336 06-01-2009AZA TRICYCLIC COMPOUNDS USEFUL ASANTIBATERIAL AND B-LACTAMASEAVENTIS PHARMA S.A.INHIBITOR AND PREPARATION THEREOF2287 1255/MUMNP/2005 227344 07-01-2009PHARMACEUTICAL FORMULATIONCOMPRISING ANTI-OBESITY AGENT AND CIPLA LTDACIDULANT2288 2513/CHENP/2005 227391 07-01-20094-(2-PHENYLSULFANYL-PHENYL)-PIPERIDINEDERIVATIVES AS SEROTONIN REUPTAKE H. LUNDBECK A/SINHIBITORS2289 2814/CHENP/2005 227404 07-01-2009SUBSTITUTED ARYLAMIDES AS IPANTAGONISTSF. HOFFMANN-LA ROCHE AG1-OR 3-THIA-BENZONAPHTHOAZULENES AS2290 2522/CHENP/2004 227408 07-01-2009INHIBITORS OF TUMOUR NECROSIS FACTOR GLAXOSMITHKLINE ISTRAZIVACKI CENTARPRODUCTION AND INTERMEDIATES FOR THE ZAGREB D.O.OPREPARATION THEREOF2291 IN/PCT/2002/1817/CHE 227414 07-01-2009 NOVEL CYTOKINE RECEPTORS SCHERING CORPORATION2292 IN/PCT/2002/2117/CHE 227416 07-01-2009AN POLYPEPTIDE OF CYTOKINE PROTEINFAMILY AND A NUCLEOTIDE ENCODING THESAMEZYMOGENETICS, INC

2293 1355/MAS/1996 227418 07-01-2009CAMPTOTHECIN DERIVATIVES AND APROCESS FOR PREPARING THEMITSUBISHI TANABE PHARMA CORPORATIONCAMPTOTHECIN COMPOUND2294 2110/MAS/1997 227420 07-01-2009ANTIMYCOTIC AGENTS HAVING HIGH ACTIVESANOFI-AVENTIS DEUTSCHLAND GmbHCOMPOUND RELEASE2-AMINO-3(N-SUBSTITUTED CARBOXAMIDO)-2295 781/MAS/2001 227422 07-01-2009 4,5-POLYMETHYLENE THIOPHENEDr. SHAMANNA MOHANDERIVATIVES AND A PROCESS FOR2296 IN/PCT/2001/1211/CHE 227424 07-01-2009PHARMACEUTICAL COMPOSITIONS FORINTRAVITREAL INJECTION TO TREAT OR VITREO-RETINAL TECHNOLOGIES INCPREVENT DISORDERS OF THE EYE2297 IN/PCT/2001/1599/CHE 227425 07-01-2009A PHARMACEUTICAL COMPOSITIONCOMPRISING DIPHENYLETHYLENECALYX THERAPEUTICS, INCCOMPOUNDS2298 IN/PCT/2001/615/CHE 227426 07-01-2009AN ENZYMATIC ANTIMICROBIALCOMPOSITION COMPRISING LACCASE AND NOVOZYMES A/SENHANCING AGENT2299 IN/PCT/2001/922/CHE 227427 07-01-2009 A PHARMACEUTICAL FORMULATION 3M INNOVATIVE PROPERTIES COMPANY2300 IN/PCT/2002/890/CHE 227428 07-01-2009SUBSTITUTED BISINDOLYLMALEIMIDES FORTHE INHIBITION OF CELL PROLIFERATIONF HOFFMANN-LA ROCHE AG2301 IN/PCT/2002/965/CHE 227429 07-01-2009 AZAINDOLES AVENTIS PHARMA LIMITED2302 1715/CHENP/2003 227443 07-01-2009POLYNUCLEOTIDE DERIVED FROMERYTHROPOIETIN COMPRISING SNPGENODYSSEE2303 1354/CHENP/2003 227445 07-01-2009ARYL AND HETEROARYL UREA CHK1INHIBITORS FOR USE AS RADIOSENSITIZERS ICOS CORPORATIONAND CHEMOSENSITIZERS2304 1428/CHENP/2003 227446 07-01-2009A COMBINATION COMPRISINGCOMBRETASTATIN AND ANTICANCER AVENTIS PHARMA S.AAGENTS2305 1293/MUMNP/2005 227452 07-01-2009A PHARMACOLOGICALLY ACTIVE ANDSYNERGISTIC COMBINATION HAVING NEURIM PHARMACEUTICALS (1991) LTD.UTILITY IN TREATING INSOMNIA2306 3395/DELNP/2005 227466 07-01-2009A DIARYMETHYLPIPERAZINE COMPOUND OFFORMULA (I)MOUNT COOK BIOSCIENCES, INC.,2307 146/MUM/2005 227476 09-01-2009AN AYURVEDIC HERBAL HAIR OILCOMPOSITION AND PREPARATION THEREOFFKEDARNATH MOHANLAL LOHEPHARMACEUTICAL COMPOSITION FOR THE2308 2006/DEL/1996 227480 09-01-2009TREATMENT OF IRRETABLE BOWELNOVARTIS INTERNATIONALSYNDROME OR URINARY INCONTINENCE AND PHARMACEUTICAL LTD.ITS PREPARATION THEREOFHERBAL COMPOSITION FOR TREATMENT OF2309 811/MUM/2006 227492 09-01-2009 OLIGOSPERMIA AND TO INCREASESHARAD PAWAR COLLEGE OF PHARMACYSPERMMOTILITY2310 598/MUM/2004 227500 12-01-2009STABLE PARENTERAL PHARMACEUTICALPREPARATION OF COX-II INHIBITORLYKA LABS LIMITED

2311 4237/DELNP/2005 227505 12-01-2009 NOVEL PIPERIDINE DERIVATIVE ASTRAZENECA ABHETEROCYCLIC DERIVATIVES AS GPCR2312 699/MUMNP/2006 227515 12-01-2009PROSIDION LIMITEDRECEPTOR AGONISTS2313 1214/DEL/1999 227516 12-01-2009 AN ENZYME EXHIBITING LIGASE ACTIVITY DSM N.V.NOVEL BIOACTIVE FRACTIONS FROM A2314 1062/DEL/2003 227532 13-01-2009 NOVEL HERBAL EXTRACT OF SALICORNIA Council of Scientific and Industrial ResearchSPECIES HAVING ANTITUBERCULARA PHARMACEUTICAL AEROSOLFORMULATION AND A METHOD FOR THE2315 2398/DEL/1995 227545 13-01-2009ASTRAZENECA ABMANUFACTURE OF A POLYPEPTIDE AEROSOLFORMULATIONHERBAL COMPOSITION TO RELIEVE2316 1831/MUM/2006 227558 13/1/2009CHOPDA, CHETAN ASHOKOXIDATIVE STRESSAN IFNα-FC HYBRID RECOMBINANT PROTEINCONTAINING AN INTERFERON MOLECULE2317 2931/DEL/1996 227568 13-01-2009TANOX BIOSYSTEMS , INC.JOINED AT ITS C-TERMINAL END THROUGH APEPTIDE LINKER2318 3332/DELNP/2004 227571 13-01-2009 AN ANTICOAGULANT ANTIBODY SCHERING AKTIENGESELLSCHAFT,2319 997/DELNP/2005 227572 13-01-2009 FORMULATION FOR VITAMIN D COMPOUNDS BONE CARE INTERNATIONAL, INC.PHARMACEUTICAL COMPOSITION BASED ON2320 910/MUMNP/2003 227575 13/1/2009 MACROLIDES FOR TOPICAL APPLICATION IN LABORATOIRES THEAOPHTHALMOLOGYA BIOACTIVE CATIONIC AMPHIPHILE FORINTRACELLULAR DELIVERY OF THERAPEUTIC COUNCIL OF SCIENTIFIC AND INDUSTRIAL2321 01451/DELNP/2003 227577 13-01-2009MOLECULES AND A PROCESS FOR THE RESEARCHPREPARATION THEREOFA RECOMBINANT NUCLEIC ACID MOLECULE2322 296/DELNP/2006 227578 13-01-2009 USED FOR MAKING TRANSGENIC PLANTS AND MONSANTO TECHNOLOGY, LLC.,SEEDSA COMPOSITION OF SPORES OF2323 00182/DELNP/2004 227579 14-01-2009 NONPATHOGENIC BACTERIA OF THE SANOFI-SYNTHELABO OTC S.P.A.BACILLUS GENUSA HETEROCYCLIC [3,2-F]-QUINOLINONE OFFORMULA (I),HAVING AGONIST,PARTIAL2324 01284/DELNP/2003 227582 14-01-2009LIGAND PHARMACEUTICALS INCORPORATEDAGONIST OR ANTAGONIST ANDROGENRECEPTOR MODULATOR ACTIVITYCHIMERIC POLYPEPTIDE, METHOD FOR ITS2325 751/KOLNP/2004 227610 14-01-2009 MANUFACTURE AND COMPOSITIONASTERION LIMITEDCOMPRISING ITCALCIUM RECEPTOR MODULATINGTAKEDA PHARMACEUTICAL COMPANY2326 280/KOLNP/2005 227614 14-01-2009COMPOUND AND USE THEREOFLIMITED2327 1419/KOLNP/2004 227627 14-01-2009AN ISOLATED POLYPEPTIDE ANDTHE REGENTS OF THE UNIVERSITY OFCOMPOSITION COMPRISING ITCALIFORNIA

FARNESYL DIBENZODIAZEPINONES,2328 1419/KOLNP/2005 227630 14-01-2009 PROCESSES FOR THEIR PRODUCTION AND ECOPIO BIOSCIENCES INC.COMPOSITIONS COMPRISING THE SAMEPHARMACEUTICAL COMPOSITIONS WITH2329 992/KOLNP/2003 227633 14-01-2009 RECEPTOR TYROSINE KINASE INHIBITORS MERCK PATENT GMBHAND ANGIOGENESIS INHIBITORSA CRYSTALLINE, A-POLYLMORPHIC FORM OF(S,S,S)-N-(1-[2-CARBOXY-3-(N2-PFIZER RESEARCH AND DEVELOPMENT2330 1008/DEL/1995 227672 14-01-2009 MESYLLYSYLAMINO)-PROPYL]-1-COMPANY, N.V./S.A.CYCLOPENTYLCARBONYL)-TYROSINECOMPOUNDHERBAL COMPOSITIONS FOR TREATMENT OF2331 712/MUM/2003 227674 14/1/2009AYARE SHAMBABU DEVAPPAAIDS AND PREPARATION THEREOFA POLYPEPTIDE AGAINST INFLUENZA ORPARAINFLUENZA HAVING SIALIDASE2332 2646/DELNP/2005 227688 15-01-2009 ACTIVITY FOR PREVENTING INFECTION OF A YU, MangEUKARYOTIC CELL BY A INFLUENZA VIRUSOR PARAINFLUENZA VIRUS2333 184/DELNP/2006 227693 16-01-2009 SULFONAMIDE COMPOUNDS LABORATORIOS DEL DR. ESTEVE S.A.2334 IN/PCT/2002/00214/DEL 227697 16-01-2009 A COMPOSITION FOR REPAIRING TISSUE AERIS THERAPEUTICS INC.2335 IN/PCT/2000/00287/MUM 227702 16-01-2009 A PDE IV INHIBITING PYRIDINE COMPOUND JANSSEN PHARMACEUTICA N.V.NEW CARBOXAMIDE COMPOUNDS HAVINGMCH-ANTAGONISTIC ACTIVITY,BOEHRINGER INGELHEIM PHARMA GMBH &2336 566/DELNP/2005 227717 19-01-2009 PHARMACEUTICAL PREPARATIONSCO. KG.COMPRISING THESE COMPOUNDS ANDPROCESS FOR THEIR MANUFACTUREA SUBSTITUTED QUINOLONE ANDTHE REGENTS OF THE UNIVERSITY OF2337 3419/DELNP/2004 227725 19-01-2009COMPOSITION COMPRISING THE SAME CALIFORNIAA RODENT REPELLENT AND ANTIFUNGAL2338 1856/DEL/2004 227726 19-01-2009M/s. SPL'S SIDHARTHA LIMITEDCOMPOSITIONNOVEL PHTHALIMIDE AND ISOQUINOLINEUNIVERSITY OF VIRGINIA PATENT2339 1310/KOLNP/2003 227743 20-01-2009 DERIVATIVES, AND PHARMACEUTICALFOUNDATIONCOMPOSITION CONTAINING THE SAME2340 1624/KOLNP/2005 227758 20-01-2009 A PHAMACEUTICAL COMPOSITION PHARMACEUTICAL PRODUCTIONS, INC.POLYMER CONJUGATES WITH DECREASED2341 655/KOLNP/2005 227767 20-01-2009 ANTIGENICITY AND METHODS OFMOUNTAIN VIEW PHARMACEUTICALS, INC.PREPARATION THEREOF2342 2522/KOLNP/2005 227785 20-01-2009 GPL-1 ANALOG FUSION PROTEINS ELI LILLY AND COMPANYSEDATIVE NON-BENZODIAZEPINE2343 945/KOLNP/2004 227791 20-01-2009BIOVAIL LABORATORIES INTERNATIONAL SRLFORMULATIONSVITAMIN RECEPTOR BINDING DRUG2344 1541/KOLNP/2005 227807 20-01-2009ENDOCYTE, INC.DELIVERY CONJUGATESA PHARMACEUTICAL COMPOSITION FOR2345 873/MUMNP/2006 227826 20/1/2005 STIMULATING ENDOTHELIAL PRECURSOR EPOPLUS GMBH & CO. KG.CELLS

2346 IN/PCT/2001/00206/DEL 227830 20-01-2009AZETIDINE DERIVATIVES, PREPARATION ANDAVENTIS PHARMA S.A.MEDICINES CONTAINING THEM2347 3444/DELNP/2005 227833 20-01-2009PYRAZOLES AND METHODS OF MAKING ANDUSING THE SAMEBIOGEN IDEC MA INC.2348 1584/DEL/1995 227839 21-01-2009A PHARMACEUTICAL COMPOSITION FORORAL ADMINISTRATION AND A PROCESS ASTRA AKTIEBOLAGTHEREOF2349 00982/DELNP/2004 227840 21-01-2009A PHARMACEUTICAL VAGINAL COMPOSITION COLUMBIA LABORATORIES (BERMUDA)LIMITED2350 5399/DELNP/2005 227843 21-01-2009 TOPICAL COMPOSITION GALDERMA S.A.2351 809/BOM/1999 227850 21/01/2009THE NEW ERYTHROMYCIN COMPOUNDS OFFORMULA IAVENTIS PHARMA S.A.2352 273/MUM/2002 227852 21/1/2009SUBSTITUTEDPHENYLSULFONYLAMINOCARBONYL- BAYER AKTIENGESELLSCHAFTTRIAZOLINONE COMPOUND2353 2057/DEL/2004 227863 22-01-2009NOVEL SUBSTITUTED 1,2,4-TRIOXANES COUNCIL OF SCIENTIFIC AND INDUSTRIALRESEARCH2354 967/DEL/2004 227888 23-01-20093-PHENYL-3,7-DIAZABICYCLO[3.3.1]NONANECOMPOUNDS OF GENERAL FORMULA I AND A SOLVAY PHARMACEUTICALS GMBHPHARMACEUTICAL COMPOSTION THEREOF2355 3452/DELNP/2005 227895 23-01-2009 AMINO ALCOHOL DERIVATIVES KISSEI PHARMACEUTICAL CO., LTD.2356 2856/DELNP/2005 227910 23-01-2009A PROTEIN CONJUGATE AND A METHOD FORPREPARING THEREOFHANMI PHARM IND. CO., LTD.2357 1020/DELNP/2005 227911 23-01-2009 A VASCULOSTATIC AGENT TARGEGEN, INC.2358 1605/MAS/1998 227923 27-01-2009 DOLASTATIN 15 DERIVATIVES ABBOTT GmbH & Co. KG2359 267/CHENP/2004 227928 27-01-2009A PHARMACEUTICAL COMPOSITIONFORMULATED FOR SYSTEMICCOMBINATORX, INCADMINISTRATION2360 77/CHENP/2004 227930 27-01-2009A COMPOSITION CONTAINING A POLYMIDEAND ANTIOXIDANTRASCHIG GmbH2361 88/CHENP/2004 227931 27-01-2009A COMBINATION COMPRISING EPOTHILONESAND A PHARMACEUTICAL COMPOSITION NOVARTIS AGCOMPRISING THE SAME2362 96/CHENP/2004 227932 27-01-2009PHENYLACETAMIDO-THIAZOLE DERIVATIVESPHARMACIA ITALIA S.p.AAND A PROCESS FOR PREPARING THE SAMEA PHARMACEUTICAL COMPOSITION HAVING2363 2019/CHENP/2003 227933 27-01-2009 A MASKED TASTE AND METHOD FOR THE AVENTIS PHARMA S.APRODUCTION THEREOFNOVEL TRAIZOLE COMPOUNDS: PROCESS FOR2364 824/CHE/2003 227940 27-01-2009 THEIR PREPARATION AND PHARMACEUTICAL DR. REDDY'S LABORATORIES LTD.COMPOSITIONS CONTAINING THEMDIPEPTIDE DERIVATIVES HAVING A N-2365 1788/CHENP/2003 227945 27-01-2009 TERMINAL 2-THIOACYL GROUP ASNOVARTIS AGVASOPEPTIDASE INHIBITORS2366 600/CHENP/2004 227958 27-01-2009 SUBSTITUTED BENZIMIDAZOLE COMPOUNDS AVENTIS PHARMA S.A

2367 910/CHENP/2004 227963 27-01-2009PHARMACEUTICAL COMPOSITIONCOMPRISING PHENYL-PIPERAZINEDERIVATIVES AS SEROTININ REUPTAKEH. LUNDBECK A/SINHIBITORS2368 1007/CHENP/2004 227964 27-01-2009ACTIVATOR OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR 8NIPPON CHEMIPHAR CO., LTD2369 1019/CHENP/2004 227966 27-01-2009ARYL ANILINE B2, ADRENERGIC RECEPTORAGONIST COMPOUNDTHERAVANCE, INC2370 1086/CHENP/2004 227968 27-01-2009A PHARMACEUTICAL COMPOSITIONRECKITT BENCKISER HEALTHCARE (UK)COMPRISING PARACETAMOL AND A MASKINGLIMITEDCOMPONENT2371 1108/CHENP/2004 227970 27-01-2009 HETEROCYCLIC COMPOUNDS NOVARTIS AG2372 1426/CHENP/2004 227976 27-01-2009INDOLINONE DERIVATIVES USEFUL ASPROTEIN KINASE INHIBITORSTHERAVANCE, INC2373 2701/CHENP/2004 227978 27-01-2009A COMBINATION OF PYROLIDINE OFFORMULA IC AND AT LEAST ONE STATIONNOVARTIS AG2374 2826/CHENP/2004 227980 27-01-2009RING-SUBSTITUTEDDIPHENYLAZETIDINONES, PROCESS FORTHEIR PREPARATION AND MEDICAMENTSCOMPRISING THESE COMPOUNDSSANOFI-AVENTIS DEUTSCHLAND GmbH2375 1671/CHENP/2004 227987 27-01-20092376 1952/CHENP/2004 227988 27-01-20092377 2143/CHENP/2004 227989 27-01-2009PEPTIDE COMPRISING LESS THAN 10 AMINOACIDS AND CAPABLE OF SELF-AGGREGATINGUNDER PHYSIOLOGICAL CONDITIONSA SOLID PHARMACEUTICALCOMPOSITIONFOR TREATING ACYCLOOXYGENASE-2 DEPENDENT DISORDEROR CONDITIONMULTI-SUBSTITUTED SELECTIVE ANDROGENRECEPTOR MODULATORS AND METHOD OFUSE THEREOFTEL AVIV UNIVERSITY FUTURE TECHNOLOGYDEVELOPMENT L.PNOVARTIS AGTHE UNIVERSITY OF TENNESSEE RESEARCHFOUNDATION2378 3153/CHENP/2004 227991 27-01-2009 RETINOID-CONTAINING PREPARATIONS BASF AKTIENGESELLSCHAFT2379 613/CHENP/2005 227994 27-01-2009ORALLY ADMINISTERED PEPTIDESTHE REGENTS OF THE UNIVERSITY OFSYNERGIZESTATIN ACTIVITYCALIFORNIAA PROTEIN HAVING DIPEPTIDE-2380 1691/CHENP/2005 227999 27-01-2009 SYNTHESIZING ACTIVITY AND PROCESS FORPRODUCING DIPEPTIDESKYOWA HAKKO KOGYO CO., LTD2381 2206/CHENP/2005 228012 27-01-2009 QUINOLINONE/BENZOXAZINONE F. HOFFMANN-LA ROCHE AG2382 16/MUMNP/2004 228026 27/1/2009 VIRAL POLYMERASE INHIBITORS BOEHRINGER INGELHEIM (CANADA) LTD.2383 4095/DELNP/2005 228035 27-01-2009 BICYCLIC PIPERIDINE DERIVATIVES MERCK & CO. Inc.2384 1413/MUMNP/2005 228037 27/1/20092385 3350/DELNP/2005 228043 28-01-20092386 278/KOLNP/2005 228050 28-01-2009CMS PEPTIDES PATENT HOLDING COMPANYLIMITEDA PHARMACEUTICAL COMPOSITIONCOMPRISING A POLYPEPTIDESUBSTITUTED 3-HYDROXY -3-METHYL-5-OXO-InterMed Discovery GmbHPYRROLIDINESA LIPOPEPTIDETHE COUNCIL OF THE QUEENSLANDINSTITUTE OF MEDICAL RESEARCH

2387 1611/KOLNP/2005 228052 28-01-2009 A PEGYLATED GLP-1 COMPOUND ELI LILLY AND COMPANYORAL PHARMACEUTICAL FORMULATION INTHE FORM OF AQUEOUS SUSPENSION OF2388 1387/KOLNP/2004 228060 28-01-2009FLAMEL TECHNOLOGIESMICROCAPSULES FOR MODIFIED RELEASE OFAMOXICILLINPHENETHANOLAMINE DERIVATIVES FOR2389 971/KOLNP/2003 228065 28-01-2009GLAXO GROUP LIMITEDTREATMENT OF RESPIRATORY DISEASESNOVEL 14 AND 15 MEMBERRED RING2390 2192/KOLNP/2005 228079 28-01-2009GLAXO GROUP LIMITEDCOMPOUNDSA PHARMACEUTICAL COMPOSITIONCOMPRISING A PHARMACEUTICALLY2391 IN/PCT/2001/640/KOL 228081 28-01-2009EFFECTIVE AMOUNT OF AN INSULINMETABASIS THERAPEUTICS, INC.SENSITIZER AGENT AND APHARMACEUTICALLY EFFECTIVE AMOUNTOF AN FB PASE INHIBITORTRIAZOLE DERIVATIVES AS TACHYKININ2392 1603/KOLNP/2004 228083 28-01-2009ELI LILLY AND COMPANYRECEPTOR ANTAGONISTSAN IMMUNOGENIC ANALOGUE OF A HUMAN2393 2091/KOLNP/2005 228088 28-01-2009PHARMEXA A/STNF PROTEIN .PYRAZOLO [3,4-b] PYRIDINE COMPOUNDS,2394 1207/KOLNP/2005 228089 28-01-2009 AND THEIR USE AS PHOSPHODIESTERASE GLAXO GROUP LIMITEDINHIBITORS .2395 844/KOLNP/2004 228091 28-01-2009 N-HETEROARYLNICOTINAMIDE DERIVATIVE SANKY AGRO COMPANY LIMITED2396 2544/KOLNP/2005 228096 28-01-2009 HER 2 POLYPEPTIDE AND USE THEREOF . AFFIBODY AB2397 IN/PCT/2000/109/KOL 228098 28-01-2009 NEISSERIA MENNINGITIDIS ANTIGENS CHIRON SPAA PY-RICH IMMUNOSTIMULATORY NUCLEIC UNIVERSITY OF IOWA RESEARCH2398 IN/PCT/2002/351/KOL 228099 28-01-2009ACID .FOUNDATION2399 994/KOLNP/2004 228100 28-01-2009 AN ISOLATED POLYNUCLEOTIDE EVOLUTIONARY GENOMICS LLCESTER DERIVATIVES OF A2400 1342/KOLNP/2004 228103 28-01-2009 DECAHYDROISOQUINOLINE-3-CARBOXYLIC ELI LILLY AND COMPANYACID AS ANALGESICSANTILYMPHOMA TARGETING AGENTS WITH2401 1217/CHENP/2005 228150 28-01-2009 EFFECTOR AND AFFINITY FUNCTIONS LIKED MITRA MEDICAL TECHNOLOGY ABBY A TRIFUNCTIONAL REAGENTA COMPOSITION COMPRISING SSRI AND ACOMPOUND SELECTED FROM2402 669/CHENP/2005 228151 28-01-2009 CORTICOSTEROID, GLUCOCORTICOID COMBINATORX , INCORPORATEDRECEPTOR MODULATOR AND A NON-STEROIDAL CALCINEURIN INHIBITORA CONJUGATE FOR INHIBITING GLYCOGEN TEL AVIV UNIVERSITY FUTURE TECHNOLOGY2403 1191/CHENP/2005 228158 28-01-2009SYNTHASE KINASE-3DEVELOPMENT L.PBENZOAZOLYPIPERAZINE DERIVATIVES OF2404 1690/CHENP/2005 228162 28-01-2009EURO-CELTIQUE, S.A.FORMULA I2405 2055/CHENP/2005 228167 28-01-2009 PYRAZOLOPYRIDINE DERIVATIVES PALAU PHARMA, S.A.

2406 2262/CHENP/2005 228171 28-01-2009A COMPOSITION COMPRISING ACOMBINATION OF RAPAMYCIN OR ITS NOVARTIS AGDERIVATIVE AND PIMECROLIMUS2407 2515/CHENP/2005 228178 28-01-2009 PYRIDINES, PYRIMIDINES AND 1,3,5- IRM LLC2408 2524/CHENP/2005 228179 28-01-20094-(2-PHENYLSULFANYL-PHENYL)-1,2,3,6-TETRAHYDROPYRIDINE DERIVATIVES AS H. LUNDBECK A/SSEROTONIN REUPTAKE INHIBITORS2409 2527/CHENP/2005 228181 28-01-2009COMBINATION COMPRISING CARBOXAMIDESNOVARTIS AGAND AMPA ANTAGONISTDNA CONSTRUCTS AND METHODS TO2410 2554/CHENP/2005 228182 28-01-2009 ENHANCE THE PRODUCTION OFMONSANTO TECHNOLOGY, LLCCOMMERCIALLY VIABLE TRANSGENIC2411 2563/CHENP/2005 228183 28-01-2009AMINOPYRIMIDINE DERIVATIVES AND APROCESS FOR PREPARING THE SAMENOVARTIS AG2412 2915/CHENP/2005 228203 28-01-2009HUMAN-ANTI-HUMAN CD3 BINDINGMOLECULESMICROMET AG2413 759/CHE/2006 228212 28-01-20092-(3-METHANESULFONYL OXYPROPYLOXY)-5-SUMITOMO CHEMICAL COMPANY, LIMITEDTRIFLUOROMETHYLPYRIDINESULFONAMIDE DERIVATIVES HAVING AN2414 IN/PCT/2002/1705/CHE 228214 28-01-2009 OXAMIAZOLE RING AND PHARMACEUTICAL SHIONOGI & CO., LTDCOMPOSITION CONTAINING THE SAME2415 668/MAS/1998 228220 28-01-2009VACCINES AGAINST INFECTIONS CAUSED BYYF VIRUS; YF INFECTIOUS cDNA, METHODFOR PRODUCING A RECOMBINANT YF VIRUS FUNDACAO OSWALDO CRUZ - FIOCRUZFROM THE YF INFECTIOUS cDNA ANDPLASMIDS TO ASSEMBLE THE YF INFECTIOUS2416 IN/PCT/2002/1012/CHE 228222 28-01-2009NOVEL HETEROCYCLIC COMPOUNDS ANDSALTS THEREOFKYOTO PHARMACEUTICAL INDUSTRIES, LTD2417 IN/PCT/2002/326/CHE 228224 28-01-2009ARYLMETHYL-CARBONYLAMINO-THIAZOLEDERIVATIVESPHARMACIA ITALIA S.P.A2418 IN/PCT/2002/786/CHE 228226 28-01-2009 3-METHYLENE STEROID DERIVATIVES N.V. ORGANON2419 IN/PCT/2002/789/CHE 228227 28-01-2009 ANTIDIABETIC COMPOUND OF FORMULA I CALYX THERAPEUTICS, INC2420 IN/PCT/2002/01879/MUM 228242 29/1/2009PHARMACEUTICAL PREPARATION FOR THETREATMENT OF BACTERIAL AND PARASITIC BIOAGENCY AGINFECTIONS2421 4101/DELNP/2005 228250 29-01-2009ANILIDE DERIVATIVE MODULATORS OFMETABOTROPIC GLUTAMATE RECEPTORSMERCK & Co. Inc.2422 377/DEL/2002 228257 12-01-2007A composition for treating inflammation diseasesCouncil of Scientific and Industrial Researchor pathological conditions involving inflammation2423 00258/DELNP/2004 228354 03-02-2009 INDANE ACETIC ACID OF FORMULA I BAYER PHARMACEUTICALS CORPORATION2424 IN/PCT/2002/00621/DEL 228357 03-02-2009 A N-6 SUBSTITUTED 7-DEAZAPURINE OSI PHARMACEUTICALS, INC.2425 2194/KOLNP/2005 228384 04-02-2009MACROLIDES SUBSTITUTED AT THE 4"-POSITIONPLIVA-ISTRAZIVACKI INSTITUT d.o.o .2426 2493/KOLNP/2005 228387 04-02-2009 A PEPTIDE AFFYMAX, INC.

2427 IN/PCT/2000/530/KOL 228403 04-02-2009STABILIZED PROTEIN CRYSTALS,FORMULATIONS CONTAINING THEM AND ALTUS BIOLOGICS INC.METHODS OF MAKING THEM2428 1838/KOLNP/2004 228404 04-02-2009 PRODRUGS OF EXCITATORY AMINO ACIDS ELI LILLY AND COMPANY2429 306/KOLNP/2006 228424 04-02-2009A PHARMACEUTICAL COMPOSITIONCOMPRISING A THERAPEUTICALLYEFFECTIVE SYNERGISTIC AMOUNT OF ATHYBRIDON, INC.LEAST ONE IMMUNOMER COMPOUND2430 969/MAS/1998 228460 05-02-2009 MYCOBACTERIAL INHIBITORS ASTRA AB2431 IN/PCT/2002/1431/CHE 228462 05-02-2009SUBSTITUTED BETA-CARBOLINES WITH IKB-KINASE INHIBITING ACTIVITYSANOFI-AVENTIS DEUTSCHLAND GMBH2432 IN/PCT/2002/1698/CHE 228463 05-02-2009A POLYAMIDE NUCLEIC DERIVATIVE OFFORMULA ISANOFI-AVENTIS DEUTSCHLAND GmbH2433 1922/MAS/1997 228564 05-02-2009 GLP-1 DERIVATIVES NOVO NORDISK A/S2434 2422/MAS/1997 228565 05-02-2009 NOVEL 20(S)-CAMPTOTHECIN COMPOUNDS DR. REDDYS LABORATORIES LTD2435 700/CHENP/2003 228571 05-02-2009HETEROCYCLYLALKYL PIPERIDINECOMPOUND AND A PROCESS FOR PREPARINGNOVEXEL2436 850/CHENP/2003 228574 05-02-2009ANGIOGENESIS INHIBITOR COMPOUND OFFORMULA XVPRAECIS PHARMACEUTICALS INC2437 347/CHENP/2004 228596 05-02-2009A COMPOSITION COMPRISING 1-4BENZOTHIEPINE 1,1-DIOXIDE DERIVATIVES SANOFI-AVENTIS DEUTSCHLAND GmbHAND EZETIMIBE2438 684/CHENP/2004 228620 05-02-2009AN ANTI-CANCER COMPOSITION AND AMETHOD OF PRODUCING THE SAMECANCER RESEARCH TECHNOLOGY LIMITED2439 965/CHENP/2004 228624 05-02-2009 NAPHTYRIDINE DERIVATIVES NOVARTIS AG2440 3123/CHENP/2004 228626 05-02-2009PLEUROMUTILIN DERIVATIVES ASANTIMICROBIALS2441 1922/CHENP/2004 228638 05-02-2009CYCLIC AMINOALKYL IMMUNOFFECTORCOMPOUNDSCORIXA CORPORATION1-OXA-3-AZA-DIBENZOAZULENES AS2442 2523/CHENP/2004 228640 05-02-2009INHIBITORS OF TUMOUR NECROSIS FACTORPRODUCTION AND INTERMEDIATES FOR THEPRODUCTION THEREOFNABRIVA THERAPEUTICS FORSCHUNGSGMBHPLIVA - ISTRAZIVACKI INSTITUT d.o.o2443 3416/CHENP/2005 228644 05-02-2009 DIPHENYLUREA DERIVATIVES NEUROSEARCH A/S2444 2464/CHENP/2004 228652 05-02-2009A PHARMACEUTICAL COMPOSITIONCOMPRISING A CONJUGATE OF A CYTOKINEMOLMED SpA2445 4138/DELNP/2005 228709 10-02-2009LIQUID PHARMACEUTICAL COMPOSITIONCOMPRISING FOLLICLE-STIMULATINGHORMONE(FSH) OR A VARIANT THEREOFARES TRADING S.A.2446 1258/DELNP/2006 228724 10-02-20092447 2719/DELNP/2004 228730 11-02-20092448 1264/KOLNP/2005 228748 10-02-2009ANTITUMORAL ANALOGUES OF KAHALALIDEPHARMA MAR, S.A.U.FBENZAMIDE COMPOUND AND PROCESS FORAstraZeneca ABPREPARING THE SAMEHUMAN GROWTH HORMONE CRYSTALS ANDMETHODS FOR PREPARING THEMALTUS PHARMACEUTICALS INC.

2449 1660/KOLNP/2005 228778 10-02-2009A VACCINE COMPOSITION COMPRISINGPOLYPEPTIDE ADJUVANT AND AN ANTIGENADJUVANTIX LIMITED2450 941/KOLNP/2005 228784 10-02-2009STABILIZED, SOLID-STATE POLYPEPTIDEPARTICLESALZA CORPORATION2451 1359/KOLNP/2003 228787 11-02-2009 PYRROLE COMPOUND ELI LILLY AND COMPANY2452 796/KOLNP/2003 228789 11-02-2009 PYRAZOLE COMPOUNDS VERTEX PHARMACEUTICALS INCORPORATED2453 51/KOLNP/2003 228800 11-02-2009NOVEL INDOLE DERIVATIVES AND THEIR USEZENTARIS GMBHAS MEDICAMENTS .2454 731/KOLNP/2005 228801 11-02-2009 BIOCIDAL POLYMERS AND THE USE THEREOF AUBURN UNIVERSITY2455 822/KOLNP/2004 228805 11-02-2009 A PHARMACEUTICAL COMPOSITION NOVACEA, INC.2456 2212/CHENP/2004 228816 11-02-2009AMINO-METHYL SUBSTITUTEDTETRACYCLINE COMPOUNDPARATEK PHARMACEUTICALS, INC2457 1905/CHENP/2005 228820 11-02-2009NOVEL BICYCLIC COMPOUNDS AND APROCESS FOR PREPARING THE SAMEIRM LLC2458 2460/CHENP/2005 228821 11-02-2009NOVEL OXAZOLE DERIVATIVES, THEIRMANUFACTURE AND USE ASF. HOFFMANN-LA ROCHE AGPHARMACEUTICAL AGENTS2459 2654/CHENP/2005 228822 11-02-2009A COMPOSITION COMPRISING AN ACTIVEMACROMOLECULAR PRINCIPLE AND ANAROMATIC ALCOHOL ABSORPTIONAXCESS LIMITEDENHANCERCONTROLLED RELEASE PRESS-COATED2460 7/CHENP/2006 228847 11-02-2009 FORMULATIONS OF WATER -SOLUBLE ACTIVE ALPHARMA, INCAGENTS2461 2039/CHENP/2005 228851 11-02-2009A COMPOUND OF FORMULA I AS PPARRECEPTOR MODULATORSSANOFI-AVENTIS DEUTSCHLAND GmbH2462 2058/CHENP/2005 228852 11-02-2009 NOVEL DIAZABICYCLIC ARYL DERIVATIVES NEUROSEARCH A/S2463 2782/CHENP/2005 228872 11-02-2009PHOSPHOLIPASE AND METHOD OFPRODUCING ITNOVOZYMES A/S2464 7/MAS/1998 228906 11-02-2009ANALOGS OF PARATHYROID HARMONE SOCIETE DE CONSEILS DE RECHERCHES ETD'APPLICATIONS SCIENTIFIQUES SASA PHARMACEUTICAL COMPOSITION2465 970/MAS/2002 228907 11-02-2009 COMPRISING TEGASEROD AND A PROCESS NOVARTIS AGFOR ITS PRODUCTION2466 993/MAS/1998 228908 11-02-2009SULFONYLAMINOCARBOXYLIC ACIDSANOFI-AVENTIS DEUTSCHLAND GmbH2467 IN/PCT/2001/1662/CHE 228910 11-02-2009COMPOUNDSHALO DERIVATIVES OF 9-DEOXO-9A-AZA-9A-HOMERYTHROMYCIN A AND A PROCESS FORPREPARING THE SAMEPLIVA, FARMACEUTSKA INDUSTRIJA,DIONICKO DRUSTVO2468 547/DELNP/2005 228922 12-02-2009 CYSTEINE PROTEASE INHIBITORS AMURA THERAPEUTICS LTD.,2469 0661/DEL/1997 228930 13-02-2009SUBSTITUTED PHENYLKETOENOLSCOMPOUNDS OF THE FORMULA (I)BAYER AKTIENGESELLSCHAFT2470 1357/MUM/2004 228932 13/02/2009NOVEL SALTS OF PHARMACEUTICAL ACTIVEINGREDIENTCIPLA LIMITED

2471 IN/PCT/2002/710/CHE 228938 13-02-2009AN ANTIGENIC PROTEIN OF SHRIMP WHITESPOT SYNDROME VIRUSINTERVET INTERNATIONAL B.V2472 1249/CHENP/2003 228950 13-02-2009ACYLATED 6,7,8,9-TETRAHYDRO-5H-BENZOCYCLOHEPTENYL AMINESSANOFI-AVENTIS DEUTSCHLAND GmbH2473 1381/CHENP/2003 228956 13-02-2009IMIDAZOLIDINE DERIVATIVES AND THEIRPREPARATIONSANOFI-AVENTIS DEUTSCHLAND GmbH2474 100/CHENP/2004 228963 13-02-2009PHARMACEUTICAL COMPOSITIONS AND USETHEREOFNOVARTIS AG2475 277/CHENP/2004 228967 13-02-2009HUMAN MINI-ANTIBODY CYTOTOXIC FORTUMOR CELLS WHICH EXPRESS THE ERBB2 BIOTECNOL S ARECEPTOR2476 819/CHENP/2004 228998 13-02-2009 3-SUBSTITUTED-4-PYRIMIDONE COMPOUND SANOFI-SYNTHELABON-((3-OXO2, 3-DIHYDRO-1H-ISOINDOL-1-YL),2477 2706/CHENP/2004 229002 13-02-2009 ACETYL) GUANIDINE DERIVATIVES AS NHE-1- SANOFI-AVENTIS DEUTSCHLAND GMBHINHIBITORS2478 2787/CHENP/2004 229003 13-02-200911-BETA-HYDROXYSTEROIDDEHYDROGENASE 1 INHIBITORSMERCK & CO., INC.2479 2844/CHENP/2004 229006 13-02-2009CATIONICALLY SUBSTITUTED DIPHENYLAZETIDINONES, AND MEDICAMENTS SANOFI-AVENTIS DEUTSCHLAND GMBHCONTAINING SAID COMPOUNDS2480 2877/CHENP/2004 229007 13-02-20091-THIA 3AZA-DIBENZOAZULENES ANDPROCESS FOR PREPARING THE SAMEPLIVA-ISTRAZIVACKI INSTITUT D.O.O.1,2-DIAZA-DIBENZOAZULENES AS INHIBITORS2481 2879/CHENP/2004 229008 13-02-2009OF TUMOUR NECROSIS FACTOR PRODUCTIONPLIVA-ISTRAZIVACKI INSTITUT D.O.O.AND INTERMEDIATES FOR THE PREPARATIONTHEREOF2482 2103/CHENP/2004 229010 13-02-2009A COMPOSITION FOR CHRONICADMINISTRATIONELAN PHARMACEUTICALS, INC.2483 2362/CHENP/2004 229021 13-02-2009FUSION PROTEIN, POLYNUCLEOTIDE ANDFRAUNHOFER-GESELLSCHAFT ZURMETHOD FOR THE PRODUCTION OFFORDERUNG DER ANGEWANDTENASCOMYCETA-RESISTANT TRANSGENICFORSCHUNG E.V.PLANT2484 47/CHENP/2006 229024 13-02-2009PHARMACEUTICAL COMPOSITIONSCOMPRISING PERANHYDROCYCLODEXTRINNOVARTIS AG2485 2386/CHENP/2004 229028 13-02-2009A COMPOSITION COMPRISING ALKOXYLATEDBASF AKTIENGESELLSCHAFT2-PROPYLHEPTANOLS2486 1541/CHENP/2005 229030 13-02-2009BENZOXAZOLE DERIVATIVES AND PROCESSFOR PREPARING THE SAMEF. HOFFMANN-LA ROCHE AG2487 2624/CHENP/2005 229041 13-02-2009IMMUNOMODULATING HETEROCYCLICCOMPOUNDSMEDIGENE LTD2488 2857/CHENP/2005 229042 13-02-2009OXIME DERIVATIVES, A PROCESS FORPREPARING THE OXIME DERIVATIVE AND A F. HOFFMANN-LA ROCHE AGMEDICAMENT COMPRISING THE SAME2489 IN/PCT/2002/00193/DEL 229050 13-02-2009A METABOTOPIC GLUTAMATE RECEPTOR-ACTIVE COMPOUNDASTRAZENECA AB

2490 1538/CHENP/2004 229051 13-02-2009PHARMACEUTICAL COMPOSITIONSCOMPRISING VALSARTAN AND NEPNOVARTIS AGINHIBITORS2491 IN/PCT/2002/139/CHE 229062 13-02-2009PROTEINS DERIVED FROM WHITE SPOTSYNDROME VIRUS AND USES THEREOFINTERVET INTERNATIONAL B.V2492 2072/CHENP/2005 229079 13-02-2009DIARYLCYCLOALKYL DERIVATIVES ANDMETHOD FOR THEIR PRODUCTIONSANOFI-AVENTIS DEUTSCHLAND GmbH2493 965/CHENP/2005 229096 13-02-2009N-PHENYLANTHRANILIC ACID DERIVATIVES,HAVING A HYDROXYALKYL OR APOLYALKYLENE GLYCOL RESIDUERAMOT AT TEL AVIV UNIVERSITY LTDATTACHED THERETO AND PHARMACEUTICALCOMPOSITIONS CONTAINING SAME2494 3047/CHENP/2005 229118 13-02-2009AZAINDOLE-DERIVATIVES AS FACTOR XaSANOFI-AVENTIS DEUTSCHLAND GmbHINHIBITORS2495 1075/MAS/1999 229131 13-02-2009 NOVEL INDANYLIDENE COMPOUNDS DSM IP ASSETS B.V2496 IN/PCT/2000/110/CHE 229146 13-02-2009N-BENZYL-3-INDENYLACETAMIDESCOMPOUNDS FOR TREATING NEOPLASIACELL PATHWAYS, INC2497 IN/PCT/2001/782/CHE 229147 13-02-2009ANALOGUES OF GLP-1SOCIETE DE CONSEILS DE RECHERCHES ETD'APPLICATIONS SCIENTIFIQUES SAS2498 IN/PCT/2002/1216/CHE 229148 13-02-2009 A POLYPEPTIDE CONJUGATE MAXYGEN HOLDINGS LTD2499 798/CHENP/2003 229152 13-02-2009 NUCLEIC ACID ADJUVANTS POWDERJECT VACCINES, INC2500 1485/CHENP/2003 229161 13-02-2009PROTEIN PARTICIPATING IN RESTORATIONINSTITUT NATIONAL DE LA RECHERCHEFROM CYTOPLASMIC MALE STERILITY TOAGRONOMIQUEFERTILITY AND GENE ENCODING THE SAME2501 1582/CHENP/2003 229166 13-02-2009BIPIPERIDINE DERIVATIVES AND PROCESSFOR PREPARING THE SAMENOVARTIS AG2502 70/CHENP/2004 229177 13-02-2009HUMAN MONOCLONAL ANTIBODIES TOEPIDERMAL GROWTH FACTOR RECEPTOR GENMAB A/S(EGFR)2503 411/CHENP/2004 229181 13-02-2009HUMAN CDR-GRAFTED ANTIBODY WHICHSPECIFICALLY REACTS WITH ANEXTRACELLULAR REGION OF CCR4 ANDKYOWA HAKKO KOGYO CO., LTDFRAGMENT THEREOF2504 496/CHENP/2004 229184 13-02-2009PHENOXYACETIX ACID DERIVATIVES AND ANACTIVATOR OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR δ CONTAINING THENIPPON CHEMIPHAR CO., LTDSAME2505 823/CHE/2003 229190 13-02-2009AN IMPROVED AND STABLEPHARMACEUTICAL COMPOSITION AND A NATCO PHARMA LIMITEDPROCESS FOR ITS PREPARATION2506 1885/CHENP/2003 229202 13-02-2009CYCLOALKANECARBOXYLIC ACIDDERIVATIVESGIVAUDAN SA2507 2059/CHENP/2003 229208 13-02-2009A CONGUGATE COMPRISING A BACTERIALSUPERANTIGEN WITH SUBSTITUTIONS ANDAN ANTIBODY MOIETYACTIVE BIOTECH AB

2508 1162/CHENP/2004 229217 13-02-2009COMPOUNDS FOR TREATMENT OFINFLAMMATION, DIABETES AND RELATED THERACOS, INCDISORDERS2509 1179/CHENP/2004 229220 13-02-2009 PYRIMIDINE COMPOUNDS SYNTA PHARMACEUTICALS, CORP2510 1440/CHENP/2004 229222 13-02-2009BIPYRIDINYL DERIVATIVES AS A HIGHLYSELECTIVE CYCLOOXYGENASE-2 INHIBITOR CJ CHEILJEDANG CORPORATIONAND METHOD FOR PREPARING THE SAME2511 3006/CHENP/2004 229227 13-02-2009NOVEL THIOPHENYLGLYCOSIDECOMPOUNDS, METHODS FOR PRODUCTIONTHEREOF AND MEDICAMEANTS COMPRISINGSANOFI AVENTIS DEUTSCHLAND GmbHSAID COMPOUNDS2512 3143/CHENP/2004 229228 13-02-2009 ACYLATED ARYLCYCLOALKYLAMINES SANOFI-AVENTIS DEUTSCHLAND GmbH2513 1564/CHENP/2004 229230 13-02-2009NOVEL PEPTIDES AS NS3-SERINE PROTEASEINHIBITORS OF HEPATITIS C VIRUSSCHERING CORPORATIONNOVEL PHARMACEUTICAL COMPOSITIONS2514 952/CHE/2003 229235 13-02-2009FOR CONTROLLED RELEASE DRUG DELIVERYKOLAPALLY VENKATA RAMANA MURTHYSYSTEM BASED ON NOVEL POLYSACCHARIDEEXCIPIENT (HUPU GUM)2515 4201/DELNP/2006 229243 16-02-2009A PIPERIDINE COMPOUND AND A PROCESSFOR PREPARING THE SAME THEREOFASTRAZENECA AB2516 144/DELNP/2006 229245 16-02-2009A QUINOLONE COMPOUND AND APHARMACEUTICAL COMPOSITIONASTELLAS PHARMA, INC.COMPRISING THE SAME2517 IN/PCT/2002/1927/CHE 229250 16-02-2009INHIBITORS OF PI3Kδ AND METHOD OFINHIBITING PI3Kδ IN LEUKOCYTES,ICOS CORPORATIONOSTEOCLASTS AND CANCER CELLS2518 293/MAS/1995 229252 16-02-2009AN ISOLATED POLYPEPTIDE ANDAPPLICATIONS THEREOFASTRA RESEARCH CENTRE INDIA2519 1834/MAS/1996 229255 16-02-2009GONADOTROPINS WITH NON NATIVEDISULFIDE BRIDGESN.V. ORGANON2520 654/MAS/1996 229258 16-02-2009COMPOSITION FOR MODULATING THEHUMAN SEXUAL RESPONSEREPROS THERAPEUTICS INC2521 1047/CHENP/2003 229266 16-02-2009 PYRIDO [2,3-D] PYRIMIDINE DERIVATIVES AMGEN INC2522 305/CHENP/2004 229268 16-02-2009 A COMPOSITION COMPRISING PECTIN DSM IP Assets B.V2523 452/CHENP/2004 229269 16-02-2009AN ANTIBODY OR ANTIGEN BINDINGFRAGMENT AND A PHARMACEUTICAL ABGENOMICS COCOMPOSITION COMPRISING THE SAME2524 524/CHENP/2004 229270 16-02-200917ALPHA-HYDROXY-14BETA-STEROIDS WITHHORMONAL EFFECTN.V. ORGANON2525 788/CHE/2003 229271 16-02-2009AN IMPROVED PHARMACEUTICALCOMPOSITION CONTAINING ESOMEPRAZOLE NATCO PHARMA LIMITEDAND A PROCESS FOR ITS PREPARATION2526 2030/CHENP/2003 229272 16-02-2009PYRROLOPYRIMIDINES AS PROTEIN KINASEINHIBITORSAVENTIS PHARMACEUTICALS, INC

2527 842/CHENP/2004 229276 16-02-20092528 1040/CHENP/2004 229277 16-02-20092529 2950/CHENP/2004 229279 16-02-20092530 2130/CHENP/2004 229282 16-02-20092531 1245/CHENP/2005 229288 16-02-2009DERIVATIVES OF 4-(THIO ORSELENOXANTHENE-9-YLIDENE)-PIPERIDINEOR ACRIDINE AND ITS USE AS A SELECTIVE 5-HT2B RECEPTOR ANTAGONISTNOVEL α-OXYGENATE OR α-THIOLATEDCARBOXYLIC ACID PHENETHYLAMIDEDERIVATESNOVEL PIPERIDINE COMPOUNDA NOVEL PLEUROMUTILIN DERIVATIVERECOMBINANT NUCLEIC ACID MOLECULECOMPRISING WEST NILE VIRUS AND YELLOWFEVER VIRUSBIOFRONTERA PHARMACEUTICALS GmbHSYNGENTA PARTICIPATIONS AGMITSUBISHI TANABE PHARMA CORPORATIONNABRIVA THERAPEUTICS FORSCHUNGSGmbHACAMBIS, INC2532 1561/CHENP/2005 229289 16-02-2009HUMAN MONOCLONAL ANTIBODIES AGAINSTGENMAB A/SINTERLEUKIN 8 (IL-8)2533 610/CHE/2003 229292 16-02-2009PHARMACEUTICAL COMPOSITIONSCONTAINING FOSFOMYCIN TROMETHAMOLZAMBON GROUP S.p.A2534 1997/CHENP/2005 229294 16-02-2009ANTHRACYCLINE-ANTIBODY CONJUGATESAND A PROCESS FOR PREPARING THE SAMEIMMUNOMEDICS, INC2535 1395/CHENP/2005 229313 16-02-2009 NEW PYRIDAZIN-3(2H)-ONE DERIVATIVES LABORATORIOS ALMIRALL S.A2536 703/MAS/2000 229323 16-02-2009 PYRIMIDINE DERIVATIVE DSM IP ASSETS B.V2537 3108/CHENP/2005 229329 16-02-2009 DITHIOKETAL COMPOUNDS BIOCON LIMITED2538 928/MAS/1997 229331 16-02-2009AN OMP106 POLYPEPTIDE OF MORAXELLACATARRHALIS AND A DNA ENCODING THE ANTEX BIOLOGICS, INCSAME2539 IN/PCT/2001/406/CHE 229347 16-02-2009 CYTOKINE RECEPTOR ZALPHA11 ZYMOGENETICS, INC2540 2375/CHENP/2004 229361 17-02-20092541 558/CHENP/2005 229362 17-02-20092542 922/CHENP/2005 229365 17-02-20092543 1433/CHENP/2005 229368 17-02-20092544 1994/CHENP/2005 229369 17-02-20092545 2573/CHENP/2004 229370 17-02-20092546 IN/PCT/2002/344/CHE 229375 17-02-2009RE-EPITHELIALIZING PHARMACEUTICALCOMPOSITIONS COMPRISING XANTHAN GUMPOLYPEPTIDES INVOLVED IN SPIRAMYCINBIOSYNTHESIS, NUCLEOTIDE SEQUENCESENCODING SAID POLYPEPTIDESSIFI S.p.AAVENTIS PHARMA S.AHUMAN MONOCLONAL ANTIBODIES AGAINSTGENMAB A/SCD20NOVEL COMPOUNDS FOR TREATINGDECIPHERA PHARMACEUTICALS, LLCONCOLOGICAL CONDITIONSA COMBINATION FOR TREATING TREATMENTELAN PHARMACEUTICALS, INCOF DEMYELINATIONPYRIDYLCARBOXAMIDE DERIVATIVE ANDBAYER CROPSCIENCE GmbHPROCESS FOR PREPARING THE SAMEAN OLIGONUCLEOTIDE COMPRISING A NON-HOMOPOLYMERIC SEQUENCE OFGERON CORPORATIONNUCLEOSIDE SUBUNITS

2547 729/MAS/1999 229377 17-02-2009A SYNERGISTIC PHARMACEUTICALCOMPOSITION COMPRISING BETA-LACTUM ORCHID CHEMICALS & PHARMACEUTICALSANTIBIOTIC AND POLYSACCHARIDE USEFUL LTDIN THE TREATMENT OF MICROBIAL2548 1800/CHENP/2005 229390 17-02-20092-CYANOPYRROLOPYRIMIDINES ANDPROCESS FOR PREPARING THE SAMENOVARTIS AG2549 2258/CHENP/2005 229392 17-02-2009A COMPOSITION COMPRISING NsIDI ANDNsIDIE FOR DECREASINGCOMBINATORX INCORPORATEDPROINFLAMMATORY CYTOKINE SECRETION2550 2424/CHENP/2004 229394 17-02-2009 PYRAZOLE COMPOUNDS CARLSBAD TECHNOLOGY, INC2551 2757/CHENP/2005 229419 17-02-2009PYRROLOIMIDAZOLE DERIVATIVES, THEIRPREPARATION, AND PHARMACEUTICAL NIKEM RESEARCH S.R.LCOMPOSITION CONTAINING THEM2552 3539/CHENP/2005 229428 17-02-2009SULFONAMIDE SUBSTITUTEDIMIDAZOQUINOLINES3M INNOVATIVE PROPERTIES COMPANY2553 351/MUMNP/2005 229456 17/2/2009A BISAMIDE COMPOUND OF FORMULA IUSEFUL AS INHIBITORS OF THE PRODUCTION ASTRA ZENECA ABOF CYTOKINES2554 780/DEL/1998 229458 17-02-2009 DIARYLPROPYLAMINE DERIVATIVES PHARMACIA & UPJOHN AB2555 512/CAL/2000 229467 18-02-2009TRIAZOLE DERIVATIVES HAVINGANTIFUNGAL ACTIVITYSANKYO COMPANY, LIMITED2556 315/KOL/2004 229472 18-02-2009 ORGANOSILICON COMPOUNDS DEGUSSA AG2557 1893/KOLNP/2004 229473 18-02-2009 NOVEL BENZIMIDAZOLE DERIVATIVES BANYU PHARMACEUTICAL CO. LTD.2558 445/KOLNP/2006 229479 18-02-2009ANTAGONISTIC SYNTHETIC PEPTIDE THE ADMINISTRATORS OF THE TULANEANALOGS OF HORMONE-RELEASING EDUCATIONAL FUND2559 483/KOLNP/2004 229486 18-02-2009NEW ORIPAVINE DERIVATIVES AND THEIRUSES AS PHARMACEUTICALZHEJIANG XIANJU PHARMACEUTICAL CO. LTD.2560 1562/KOLNP/2003 229497 18-02-2009N-[BENZOYL]-PHENYLSULFONAMIDECOMPOUNDSELI LILLY AND COMPANY2561 1925/KOLNP/2004 229502 18-02-2009N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR JANSSEN PHARMACEUTICA N.V.INHIBITORS2562 167/CHENP/2006 229527 18-02-2009A STABLE PHARMACEUTICAL COMPOSITIONCOMPRISING AT LEAST ONE AZETIDINE AVENTIS PHARMA S.A.DERIVATIVE2563 3506/CHENP/2005 229557 18-02-2009A PHARMACEUTICAL COMPOSITIONCOMPRISING GABOXADOL ANDESCITALOPRAM OR A PHARMACEUTICALLYH. LUNDBECK A/SACCEPTABLE SALT THEREOFPIPERAZINYLPYRIDINE COMPOUNDS AND2564 2586/CHENP/2004 229569 18-02-2009 PHAMACEUTICAL COMPOSITION COMPRISING BIOVITRUM AB (publ)THE SAME2565 2986/CHENP/2004 229572 18-02-2009 AN ORAL PHARMACEUTICAL COMPOSITION TEMREL LIMITED2566 1522/CHENP/2005 229575 18-02-20092-PYROLIDONE DERIVATIVES ASPROSTAGLANDIN AGONISTSF. HOFFMANN-LA ROCHE AG

2-ALKYNYL-AND-2-ALKENYL-PYRAZOLO-[4,3-2567 3116/CHENP/2005 229581 18-02-2009 e]-1,2,4-TRIAZOLO-[1,5-c]-PYRIMIDINE SCHERING CORPORATIONADENOSINE A2A RECEPTOR ANTAGONISTSPARENTERAL PHARMACEUTICAL2568 3498/CHENP/2005 229591 18-02-2009 COMPOSITION COMPRISING SOMATOSTATIN NOVARTIS AGAND TARTARIC ACID2-AMINOBICYCLO[3.1.0]HEXANE-2,6-2569 3529/CHENP/2005 229603 18-02-2009TAISHO PHARMACEUTICAL CO., LTDDICARBOXYLIC ESTER DERIVATIVE(+)-1-(3,4-DICHLOROPHENYL)-3-2570 1224/CHENP/2003 229614 18-02-2009 AZABICYCLO[3.1.0]HEXANE AND a DOV PHARMACEUTICAL, INCCOMPOSITION COMPRISING THE SAMEA MULTIPLE RELEASE ANTIDIABETIC2571 889/MUM/2004 229618 18/2/2009IPCA LABORATORIES LIMITEDPHARMACEUTICAL TABLET COMPOSITIONA PHARMACEUTICAL COMPOSITION FOR THE2572 2049/DELNP/2005 229621 18-02-2009WARNER-LAMBERT COMPANY LLCTREATMENT OF A MAMMAL2573 1066/DEL/2000 229622 18-02-2009 A NEW BENZIMIDAZOLE DERIVATIVES FAES FARMA, S.A.ITOPRIDE HYDROCHLORIDE CONTROLLED2574 360/MUM/2004 229637 19/2/2009LYKA LABS LIMITEDRELEASE TABLETS2575 1846/CHENP/2004 229653 19-02-2009 NOVEL POLYMORPHS OF EFAVIRENZ HETERO DRUGS LIMITEDA CONJUGATE COMPRISING A PROTOZOAN2576 1999/CHENP/2003 229681 19-02-2009 INFECTED CELL TARGETING AGENT AND AN FAULK PHARMACEUTICALS, INCANTI PROTOZOAN DRUGSOMATOSTATIN OR BOMBESINTHE ADMINISTRATORS OF THE TULANE2577 817/CHENP/2004 229686 19-02-2009ANALOGS CONJUGATEEDUCATIONAL FUNDIMIDAZOPYRIDINES COMPOUND OF FORMULA2578 1231/CHENP/2004 229690 19-02-20093M INNOVATIVE PROPERTIES COMPANY(I)ACYLATED, HETEROARYL-CONDENSED2579 3150/CHENP/2004 229691 19-02-2009SANOFI-AVENTIS DEUTSCHLAND GmbHCYCLOALKENYLAMINESA PHARMACEUTICAL COMPOSITION2580 2105/CHENP/2004 229696 19-02-2009 COMPRISING ANBANYU PHARMACEUTICAL CO., LTDINDOLOPYRROLOCARBAZOLE DERIVATIVECOMPOSITION COMPRISING AMYLOID BETA 1-2581 3167/CHENP/2004 229697 19-02-2009CYTOS BIOTECHNOLOGY AG6 ANTIGEN ARRAYS2582 1438/CHENP/2005 229712 19-02-2009 ANTI INFLAMMATORY COMPOUND DECIPHERA PHARMACEUTICALS, LLCIMPROVED GASTRIN RELEASING PEPTIDE2583 1606/CHENP/2005 229713 19-02-2009BRACCO IMAGING S.p.ACOMPOUNDSA PHARMACEUTICAL COMPOSITION2584 2919/CHENP/2005 229717 19-02-2009 COMPRISING A BISPECIFIC SINGLE CHAIN MICROMET AGANTIBODY CONSTRUCTSYNERGISTIC COMBINATIONS OF MACROLIDE2585 2498/CHENP/2005 229723 19-02-2009 T-CELL MODULATOR ORNOVARTIS AGIMMUNOSUPPRESSANT AND A RETINOIDISOXAZOLE COMPOUNDS AS INHIBITORS OF2586 1845/CHENP/2005 229727 19-02-2009VERNALIS (CAMBRIDGE) LIMITEDHEAT SHOCK PROTEINS

SUBSTITUTED N-ARYLHETROCYCLES,2587 1902/CHENP/2005 229729 19-02-2009 METHOD FOR PRODUCTION AND USE AVENTIS PHARMA DEUTSCHLAND GmbHTHEREOF AS MEDICAMENTSPEPTIDE INHIBITORS OF THROMBIN AS2588 2068/CHENP/2005 229731 19-02-2009NATIONAL RESEARCH COUNCIL OF CANADAPOTENT ANTICOAGULANTSA PEPTIDIC COMPOUND WITH AFFINITY TO2589 2070/CHENP/2005 229732 19-02-2009ACADEMISCH ZIEKENHUIS LEIDENBACTERIAL AND FUNGAL TOXINS2590 2160/CHENP/2005 229735 19-02-2009 1-AMINO 1H-IMIDAZOQUINOLINES 3M INNOVATIVE PROPERTIES COMPANYSTABLE PHARMACEUTICAL COMPOSITION OF2591 818/MUM/2003 229743 20/2/2009CADILA PHARMACEUTICALS LTD.RABEPRAZOLEAMINO ACID DIAMIDES IN NON ALPHAPOSITION WHICH ARE USEFUL AS ADJUVANTS2592 344/CHENP/2006 229758 20-02-2009LABORATORIOS FARMACEUTICOS ROVI S.AFOR ADMINISTRATION OF BIOLOGICALACTIVE AGENTS2593 3560/CHENP/2005 229774 20-02-2009 STATIN DERIVATIVES NICOX S.AA COMPOSITION FOR PHARMACEUTICAL OR2594 716/CHENP/2006 229804 20-02-2009 DIETARY OR COSMETIC PURPOSE FOR GIULIANI S.p.AADMINISTRATION IN HUMANSA HETEROCYCLIC AMIDE COMPOUND AND A SANTHERA PHARMACEUTICALS (SCHWEIZ)2595 2104/CHENP/2006 229818 20-02-2009PROCESS FOR PREPARATION THEREOF GMBHPYRIDAZINE DERIVATIVE AND A2596 372/CHENP/2006 229821 20-02-2009 PHARMACEUTICAL COMPOSITIONXENON PHARMACEUTICALS INC.COMPRISING THE SAMEA LIQUID ORAL DOSAGE FORMULATIONCOMPRISING WATER, 5-METHYL -2 -(2' -2597 2228/CHENP/2005 229827 20-02-2009NOVARTIS AGCHLORO6'-FLUOROANILINO)PHENYLACETICACIDA MEDICAMENT COMPRISING A COMPOUND2598 3035/CHENP/2005 229831 20-02-2009MARGETTS, GEORGEOF FORMULA (I)2599 2561/CHENP/2005 229835 20-02-2009 SUBSTITUTED DIPHENYL AZETIDINONE SANOFI-AVENTIS DEUTSCHLAND GmbHAN ESTROGEN-LIKE ORGAN-SELECTIVEMEDICAMENT COMPOSITION COMPRISING2600 IN/PCT/2000/00267/MUM 229865 23/2/2009BIONORICA AGEXTRACTS FROM IRIS PLANTS, CIMICIFUGARACEMOSA AND TECTORIGENINNOVEL COMPOUNDS HAVINGHYPOLIPIDEMIC, HYPOCHOLESTEREMIC2601 57/MUM/2000 229871 23/2/2009 ACTIVITIES: PROCESS FOR THEIRCADILA HEALTHCARE LIMITEDPREPARATION AND PHARMACEUTICALCOMPOSITIONS CONTAINING THEM2602 2559/MAS/1998 229904 24-02-2009 CARBOHYDRATE DERIVATIVES SANOFI-SYNTHELABO2603 IN/PCT/2000/260/CHE 229906 24-02-2009 TOBACCO PRODUCTS WITH VITAMIN E ROUSSEAU RESEARCH, INCAMINO ACID PARTICLES FOR POWDER2604 IN/PCT/2001/786/CHE 229907 24-02-2009VECTURA LIMITEDCOMPOSITIONS FOR DRY POWDER INHALERS

2605 1557/CHENP/2003 229915 24-02-2009BETA-CARBOLINE COMPOUNDS, A PROCESSFOR THEIR PREPARATION ANDPHARMACEUTICAL COMPOSITIONSNOVARTIS AGCONTAINING THEM2606 282/CHENP/2004 229918 24-02-2009A POLYPEPTIDE CONJUGATES EXHIBITING G-CSF ACTIVITYMAXYGEN HOLDINGS LTD2607 349/CHENP/2004 229920 24-02-2009COMPOSITION CONTAINING ANTIPSYCHOTICMEDICATION AND GLUCOCORTICOIDRECEPTOR ANTAGONIST FOR WEIGHT CORCEPT THERAPEUTICS, INCREDUCTION ASSOCIATED WITHANTIPSYCHOTIC MEDICATIONS2608 1746/CHENP/2003 229926 24-02-2009NEW POLYNUCLEOTIDES AND POLYPEPTIDESGENODYSSEEOF THE IFNα-17 GENE2609 1014/CHENP/2004 229933 24-02-2009PHOSPHONITE COMPOUNDS AND TRANSITIONBASF AKTIENGESELLSCHAFTMETAL COMPLEXES OBTAINED THEREFORMA POLYPEPTIDE HAVING ANTIMICROBIAL2610 1078/CHENP/2004 229934 24-02-2009 ACTIVITY AND A POLYNUCLEOTIDENOVOZYMES A/SENCODING THE SAME2611 IN/PCT/2002/949/CHE 229936 24-02-2009CYCLIC AMP-SPECIFIC PHOSPHODIESTERASEINHIBITORSICOS CORPORATION2612 IN/PCT/2002/118/CHE 229945 24-02-2009 A PHARMACEUTICAL CARRIER COMPOSITION AVENTIS PHARMACEUTICALS INC2613 1825/CHENP/2005 229946 24-02-20094-AMINOPYRIMIDINE-5-ONE DERIVATIVES OFTHE FORMULA IF. HOFFMANN-LA ROCHE AG2614 3354/CHENP/2005 229949 24-02-2009SUBSTITUTED PHENYL PROPYL-AMINEDERIVATIVESNOVARTIS AG2615 3255/CHENP/2005 229965 24-02-2009N-ALKYNYL-2-HETEROARYLOXYALKYLAMIDES AS SYNGENTA LIMITEDFUNGICIDES2616 1102/DELNP/2003 229989 24-02-2009"N-(ARYL/HETEROARYL)-N'-(PHENYLETHYL)-UREA COMPOUND OF GENERAL FORMULA I"LABORATORIOS ALMIRALL.2617 3057/CHENP/2005 230028 24-02-2009BENZOTHIAZOLE DERIVATIVES ASADENOSINE RECEPTOR LIGANDSF. HOFFMANN-LA ROCHE AG2618 294/MAS/2002 230039 24-02-2009RECOMBINANT RABIES VIRUS MUTANTS ANDINTERVET INTERNATIONAL B.V.VACCINES COMPRISING THE SAME2619 2075/CHENP/2005 230046 24-02-2009ARYLCYCLOALKYL-SUBSTITUTED ALKANOICSANOFI-AVENTIS DEUTSCHLAND GmbHACID COMPOUND OF FORMULA (I)2620 2550/CHENP/2005 230053 24-02-2009THIADIBENZOAZULENE DERIVATIVES FORTHE TREATMENT OF INFLAMMATORYPLIVA-ISTRAZIVACKI INSTITUT d.o.o2621 3196/CHENP/2005 230059 24-02-2009PHARMACEUTICAL FORMULATION FOR THERECKITT BENCKISER HEALTHCARE (UK)TREATMENT OF GROGGINESS, DROWSINESSLIMITEDOR LEATHERGY ON WAKING AFTER SLEEPING2622 976/CHE/2005 230065 24-02-2009A PYRAZOLE DERIVATIVE AND ANINORGANIC FERTILIZER COMPRISING THEBASF AKTIENGESELLSCHAFT

2623 3222/CHENP/2005 230072 24-02-2009NOVEL PHARMACEUTICAL COMPOSIATIONCOMPRISING AN INHIBITOR OF THE t-PAPAION DEUTSCHLAND GmbHMEDIATED ACTIVATION OF THE GLUTAMATERECEPTOR AND A THROMBOLYTIC2624 2980/CHENP/2004 230075 24-02-2009A SECONDARY AMINO ANILINIC PIPERIDINECOMPOUNDH. LUNDBECK A/S2625 1070/CHENP/2003 230078 24-02-2009 SUBSTITUTED ALKYLAMINE DERIVATIVES AMGEN INC2626 1479/CHENP/2003 230089 24-02-2009NOVEL HUMAN COAGULATION FACTOR VIIDERIVATIVESNOVO NORDISK HEALTH CARE AG2627 980/MUMNP/2005 230106 25/2/2009NEW COMBINATIONS AND NEW USE OFSELECTED PHARMACEUTICALLY ACTIVE ALTANA PHARMA AGCOMPOUNDS2628 1336/MUMNP/2005 230107 25/2/2009 IMIDAZOPYRIDINE INTERMEDIATES ALTANA PHARMA AG2629 1148/KOLNP/2004 230111 25-02-2009FORMULATION FOR ORAL ADMINISTRATIONFOR THE TREATMENT OF TYPE 2 DIABETESEMISPHERE TECHNOLOGIES, INC.2630 1268/KOLNP/2005 230114 25-02-2009ANTIBODIES TO NERVE GROWTH FACTOR(NGF) USEFUL FOR MANAGEMENT OF PAINRINAT NEUROSCIENCE CORP.2631 36/KOLNP/2006 230115 25-02-2009STABLE PHARMACEUTICAL COMPOSITION OFMERCK EPROVA AG5, 10-METHYLENE-TEROHYDROFOLATEMEDICAMENT COMPRISING A AN ACTIVE2632 2705/KOLNP/2005 230120 25-02-2009 COMPOUND, HYDROXYGUANIDINECOMPOUNDSWILEX AG2633 520/KOLNP/2005 230127 25-02-2009A PHARMACEUTICAL COMPOSITIONTHE REGENTS OF THE UNIVERSITY OFCALIFORNIA2634 631/KOLNP/2006 230146 25-02-2009POXVIRUS VECTOR ENCODING PROSTATESPECIFIC ANTIGENS FOR TREATMENT OF VIRAX DEVELOPMENT PTY LTDPROSTATE CANCER2635 556/KOLNP/2006 230152 25-02-2009A PHARMACEUTICAL LIQUID FORMULATIONOF OXALIPLATIN FOR PARENTERALMAYNE PHARMA LIMITEDADMINISTRATION2636 1395/KOLNP/2004 230155 25-02-2009A COMBINATION COMPRISING PEPTIDEDERIVATIVES AND A CYTOSTATICPREPARATION FOR REDUCINGHEMATOTOXICITY OF THE CYTOSTATICPREPARATION2637 2737/KOLNP/2005 230158 25-02-2009 THIOTUNGSTATE DERIVATIVES ATTENUON LLC2638 1600/KOLNP/2004 230159 25-02-2009COMPOSITIONS AND METHODS FORTREATING AND PREVENTING NECROSISNATHAN, ILANAPHARMACEUTICAL COMPOSITIONS2639 488/MUMNP/2006 230173 25/2/2009 COMPRISING CYCLOHEXYLAMINE AND MERZ PHARMA GMBH & CO. KGAAAMINOADAMANTANE DERIVATIVES2640 2325/KOLNP/2005 230182 25-02-2009A CYCLOALKYL-BENZOPYRAN COMPOUNDAND PHARMACEUTICAL COMPOSITIONTHEREOFOBSCHESTVO S OGRANICHENNOIOTVETSTVENNOSTIYU "PHARMENTERPRISES"ELILILLY AND COMPANY

2641 664/MUM/2001 230188 25/2/2009BIPHENYLCARBOXAMIDEES OF THEFORMULA (I) AND PROCESS THEREOFBAYER AKTIENGESELLSCHAFT2642 583/KOLNP/2006 230192 25-02-2009 AN AQUEOUS PHARMACEUTICAL SOLUTION MERCK PATENT GMBH2643 364/MUM/2004 230200 25/2/2009GASTRIC RETENTION DRUG DELIVERYSYSTEM IN THE FORM OF A COATED TABLETOR COATED CAPSULE AND PROCESS FORSUN PHARMACEUTICAL INDUSTRIES LTDPREPARING THE SAME.2644 753/KOLNP/2005 230210 25-02-2009 COMPOSITION AS INFLUENZA THERAPEUTIC MASSACHUSETTS INSTITUTE OF TECHNOLOGY2645 2193/KOLNP/2005 230221 25-02-2009NOVEL 14 AND 15 MEMBERED RINGCOMPOUNDSGLAXO GROUP LIMITED2646 982/CHENP/2004 230232 25-02-20092-AMINO-4-HETEROARYLETHYL THIAZOLINEDERIVATIVES AND PHARMACEUTICAL AVENTIS PHARMA S.A.COMPOSITION INCLUDING THE SAME2647 1254/CHENP/2004 230238 25-02-2009A MOLECULAR CONJUGATE COMPRISING AHUMAN MONOCLONAL ANTIBODY TO CELLDEX THERAPEUTICS, INC.DENDRITIC CELLS2648 1348/CHE/2004 230242 25-02-2009AN ANTI DIABETIC HERBAL FORMULATIONAND THE PROCESS OF PREPARING THE SAMERANGASAMY VEERAMANI2649 1849/CHENP/2005 230243 25-02-2009 ANTIBODIES WITH VARIANT Fc REGIONS MACROGENICS, INC.2650 1908/CHENP/2005 230246 25-02-2009PIPERIDINE-BENZENESULFONAMIDEDERIVATIVESF. HOFFMANN-LA ROCHE AGMONOCLINIC 2-CHLORO- (4'-2651 2263/CHENP/2005 230247 25-02-2009 CHLOROBIPHENYL-2-YL) NICOTINAMIDE AND BASF AKTIENGESELLSCHAFTA PROCESS FOR PREPARING THE SAME2652 3338/CHENP/2005 230250 25-02-2009 ANTIMICROBIAL POLYPEPTIDES NOVOZYMES A/S2653 2751/CHENP/2005 230252 25-02-2009SUBSTITUTED INDOLINE AND INDOLEDERIVATIVESH. LUNDBECK A/S2654 2736/CHENP/2005 230280 25-02-2009RECOMBINANT ANTIBODIES ANDFRAGMENTS WHICH RECOGNIZE N-CENTRO DE IMMUNOLOGIA MOLECULARGLYCOLYL-GM3 GANGLIOSIDE2655 2951/CHENP/2005 230281 25-02-2009 A NOVEL PYRIMIDINE COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED2656 226/CHENP/2006 230288 25-02-2009A PHARMACEUTICAL PREPARATION INCOMBINATION OF BISPHOSPHONATENOVARTIS AG2657 1465/CHENP/2006 230292 25-02-20091H-IMIDAZOLE DERIVATIVES ASCANNABINOID RECEPTOR MODULATORSSOLVAY PHARMACEUTICALS B.V2658 288/CHENP/2006 230294 25-02-2009A TOPICAL COMPOSITION IN THE FORM OF ANORAL GEL FOR RECURRENT ORAL APHTOUS BIOPLAX LIMITEDULCERS2659 376/CHENP/2006 230295 25-02-2009PYRIDAZINE DERIVATIVES AS THERAPEUTICAGENTSXENON PHARMACEUTICALS INC2660 2953/CHENP/2005 230298 25-02-20092-IMIDAZO-BENZOTHIAZOLE DERIVATIVESAND PROCESSES FOR THEIR PREPARATIONF. HOFFMANN-LA ROCHE AG2661 2037/CHENP/2005 230310 25-02-20091,3-SUBSTITUTED CYCLOALKYL DERIVATIVESAND A PHARMACEUTICAL COMPOSITIONCOMPRISING THE SAMESANOFI-AVENTIS DEUTSCHLAND GmbH

2662 2042/CHENP/2005 230311 25-02-2009CYCLOALKYL-METHOXY SUBSTITUTEDACETIC ACID DERIVATIVE COMPOUND OF SANOFI-AVENTIS DEUTSCHLAND GmbHFORMULA (I)2663 2071/CHENP/2005 230313 25-02-2009 INHIBITORS OF CYSTEINE PROTEASES NOVARTIS AG2664 2169/CHENP/2005 230314 25-02-20095-PHENYLTHIAZOLE DERIVATIVES AND THEIRNOVARTIS AGPREPARATION2665 2496/CHENP/2005 230315 25-02-2009COMPOSITIONS MICROBIAL AND PARASITICINFECTIONS IN ANIMALSSCHERING-PLOUGH LTD2666 877/KOLNP/2004 230331 25-02-2009CARBOXAMIDINE DERIVATIVES AND THEIRUSE IN THE TREATMENT OF VASCULAR BIOREX KUTATO ES FEJLESZTO RTDISEASES2667 325/KOL/2003 230347 25-02-2009POLYMER COATED MICROPARTICLES FORSUSTAINED RELEASEETHICON, INC.2668 295/KOLNP/2006 230348 25-02-2009MATRIX METALLOPROTEINASE INHIBITORCOMPOUNDSGLAXO GROUP LIMITED2669 159/KOLNP/2006 230354 25-02-2009 ANTIVIRAL COMPOUNDS AND METHODS BIOTRON LIMITED2670 4117/DELNP/2005 230361 26-02-2009PHARMACEUTICAL COMPOSITIONS OF HSP90INHIBITORS HAVING LONG AND MEDIUM CONFORMA THERAPEUTICS CORPORATIONCHAIN TRIGLYCERIDES2671 1119/MUM/2005 230382 26/2/2009 MODIFIED RELEASE NSAID COMPOSITIONS THEMIS LABORATORIES PRIVATE LIMITED2672 721/MUM/2004 230383 26/2/2009A DELAYED-ONSET AND CONTROLLEDRELEASE MATRIX FORMULATION OF ASELECTIVE SEROTONIN REUPTAKEIPCA LABORATORIES LIMITEDINHIBITORS-PAROXETINE2673 1198/CHENP/2003 230401 26-02-2009A PHARMACEUTICAL ANTITHROMBOTICCOMBINATIONMESSADEK, JALLAL2674 1252/CHENP/2003 230402 26-02-2009 ACYLATED INDANYL AMINES SANOFI-AVENTIS DEUTSCHLAND GMBH2675 242/CHENP/2006 230427 26-02-2009METHODS AND COMPOSITIONS FORBELLUS HEALTH (INTERNATIONAL)LIMITEDTREATING AMYLOID-RELATED DISEASES2676 3144/CHENP/2005 230448 26-02-2009 A PYRIMIDINE DERIVATIVE OF FORMULA (I) ACTIMIS PHARMACEUTICALS, INC2677 641/CHENP/2006 230453 26-02-2009 ISOXAZOLINE DERIVATIVE LG LIFE SCIENCES, LTD2678 712/CHENP/2006 230468 26-02-2009SUBSTITUTED IMIDAZOPYRIMIDINES FOR THELABORATORIOS S.A.L.V.A.T. S.APREVENTION AND TREATMENT OF CANCER2679 78/CHENP/2006 230473 26-02-2009SUBSTITUTED TETRAHYDRO - PYRAZOLO[3,4-C]PYRIDINESAVENTIS PHARMA S.A2680 2130/CHENP/2006 230476 26-02-2009SECRETED NEURAL APOPTOSIS INHIBITINGPROTEINSAVENTIS PHARMACEUTICALS, INC2681 2572/CHENP/2005 230485 26-02-2009PYRIMIDO COMPOUNDS AND APHARMACEUTICAL COMPOSITIONF. HOFFMANN-LA ROCHE AGCOMPRISING THE SAME2682 IN/PCT/2001/77/CHE 230492 27-02-2009 AMINO ACID PHENYL ESTER DERIVATIVES N.V. ORGANON2683 1525/CHENP/2003 230498 27-02-2009PIPERIDINE DERIVATIVE AS CCR5ANTAGONISTSSCHERING CORPORATION

2684 650/CHENP/2004 230522 27-02-2009A PHARMACEUTICAL COMPOSITIONCOMPRISING COMPOUNDS OF FORMULA (1)(GIBBERELLINS) AND A PROCESS FOR THEAUSTRALIAN BIOMEDICAL COMPANY PTY LTDPREPARATION OF GIBBERELLINSPROTEINS WITH REPETITIVE BACTERIAL-IG-2685 2867/CHENP/2004 230531 27-02-2009 LIKE (BIG) DOMAINS PRESENT IN LEPTOSPIRA FUNDACAO OSWALDO CRUZ-FIOCRUZSPECIESBENZOTHIAZOLE DERIVATIVE COMPOUNDS2686 3210/CHENP/2005 230545 27-02-2009 OF FORMULA (I) AND A PROCESS FOR F. HOFFMANN-LA ROCHE AGPREPARING THE SAME2687 495/CHENP/2005 230553 27-02-2009A NOVEL 1,4-DIAZABICYCLOALKANEDERIVATIVE AND A PHARMACEUTICAL NEUROSEARCH A/SCOMPOSITION COMPRISING THE SAME2688 1754/CHENP/2005 230556 27-02-2009NEW CRYSTALLINE MODIFICATION OF 2-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-N-[6-(1,1-DIOXO1N6-THIOMORPHOLIN-4-YL)-4-(4- F. HOFFMANN-LA ROCHE AGFLUORO-2-METHYL-PHENYL)-PYRIDIN-3-YL]-NMETHYL-ISOBUTYRAMIDE2689 00211/DELNP/2004 230572 27-02-2009 A NOVEL BENZYL CARBAMATES Ferring BV2690 878/DEL/1999 230589 27-02-2009 PYRROLO [2,3-D] PYRIMIDINE COMPOUNDS PFIZER PRODUCTS, INC.2691 36/CHENP/2006 230602 27-02-2009 IMIDAZOLE DERIVATIVES III F. HOFFMANN-LA ROCHE AG2692 2655/CHENP/2005 230603 27-02-2009 QUINAZOLINE COMPOUNDS F. HOFFMANN-LA ROCHE AG2693 2948/CHENP/2005 230604 27-02-2009NOVEL 1,2,4-OXADIAZOLE BENZOIC ACIDCOMPOUNDS AND PHARMACEUTICAL PTC THERAPEUTICS, INC,COMPOSITION COMPRISING THE SAME2694 2719/CHENP/2005 230609 27-02-2009ANTI-IL-22RA ANTIBODIES AND BINDINGPARTNERSZYMOGENETICS, INC.2695 2445/CHENP/2006 230619 27-02-2009 ANTIMICROBIAL COMPOSITIONS BASF AKTIENGESELLSCHAFT2696 1264/CHENP/2006 230659 27-02-2009A PARTICULATE COMPOSITION FORRAPID DISINTEGRATING TABLETS IN FUJI CHEMICAL INDUSTRY CO., LTDORAL CAVITY2697 826/CHENP/2006 230669 27-02-2009ANTIBODIES AGAINST INTERLEUKIN-1RECEPTOR AND USES THEREOFF. HOFFMANN-LA ROCHE AG2698 1763/CHENP/2006 230672 27-02-2009ANTI-IGFR1 ANTIBODY THERAPEUTICCOMBINATIONSSCHERING CORPORATION2699 2352/CHENP/2006 230674 27-02-2009PIPERIDINE COMPOUND AND PROCESS FORPREPARING THE SAMEMITSUBISHI TANABE PHARMA CORPORATION2700 2374/CHENP/2006 230675 27-02-2009A NUCLEIC ACID MOLECULE ENCODING AAVENTIS PHARMACEUTICALS, INCNOVEL PROSTAGLANDIN RECEPTOR PROTEIN2701 506/CHENP/2006 230681 27-02-2009PIPERAZINE WITH OR-SUBSTITUTED PHENYLF. HOFFMANN-LA ROCHE AGGROUP AND THEIR USE AS GLYT1 INHIBITORSA PHARMACEUTICAL COMPOSITION2702 IN/PCT/2001/1488/CHE 230686 27-02-2009COMPRISING EPO, AN EPO RECEPTORACTIVITY MODULATOR, AN EPO-ACTIVATEDRECEPTOR MODULATOR OR A COMBINATIONTHE KENNETH S. WARREN INSTITUTE, INC

2703 2186/CHENP/2005 230705 27-02-2009IMIDAZOL-4-YL-ETHYNYL-PYRIDINEDERIVATIVESF. HOFFMANN-LA ROCHE AG2704 IN/PCT/2001/1227/CHE 230713 27-02-2009POLYPEPTIDE OF THE HUMANIMMUNOGLOBULIN SUPERFAMILYLABORATOIRES SERONO S.A2705 2529/CHENP/2005 230715 27-02-2009QUINOLINE-2-ONE-DERIVATIVES FOR THETREATMENT OF AIRWAYS DISEASESNOVARTIS AG2706 3221/CHENP/2005 230720 27-02-2009A MEDICAMENT COMPRISING NOVELAZETIDINE DERIVATIVES WITH CB1VERNALIS RESEARCH LIMITEDRECEPTOR ANTAGONIST OR REVERSE2707 1110/CHENP/2003 230744 27-02-2009COMPOSITIONS COMPRISINGCYCLOHEXAMANTANECHEVRON U.S.A. INC2708 838/DEL/2003 230753 27-02-2009A HERBAL HYPOGLYCEMIC COMPOUND FORCONTROLLING DIABETES MELLITUSINDIAN COUNCIL OF MEDICAL RESEARCH2709 IN/PCT/2002/00507/DEL 231102 02-03-2009A CRYSTALLINE POLYMORPH OF THEHYDROCHLORIDE SALT OF N-(3-ETHYNYLPHENYL)-6,7-BIS(2-OSI PHARMACEUTICALS, INC.METHOXYETHOXY)-4-QUINAZOLINAMINE2710 861/DEL/2004 231109 03-03-2009A VACCINE FOR THE DEVELOPMENT OFIMMUNOLOGICAL MEMORYNATIONAL INSTITUTE OF IMMUNOLOGY2711 1235/CHENP/2003 231114 03-03-2009 THERAPEUTIC BINDING MOLECULES NOVARTIS AG2712 1813/CHE/2005 231146 03-03-2009ANTI-DIABETIC HERBO-MINERALVENKATESWARA AYURVEDA NILAYAMCOMPOSITION AND PROCESS FOR THELIMITEDPREPARATION THEREOF2713 1/CHENP/2006 231154 03-03-20092-SUBSTITUTED PHENYL-5,7-DIHYDROCARBYL-3,7-DIHYDROPYRROLO [2,3-d] PYRIMIDIN-4-ONE DERIVATIVES, AND A METHOD OFPREPARATION THEREOFTIANJIN NORTH PHARMA SCI-TECH CO.,LTD.2714 290/CHENP/2006 231180 03-03-2009SUBSTITUTED LACTAMS AND A PROCESS FORNOVARTIS AGPREPARING THE SAME2715 1363/CHENP/2005 231194 03-03-2009 ARYL-QUINAZOLINE DERIVATIVES NOVARTIS AG2716 121/CHENP/2006 231205 03-03-2009 NEW BENZAMIDES AS PPARy MODULATORS LABORATORIOS S.A.L.V.A.T. S.A2717 2875/DEL/1997 231227 03-03-2009A PHARMACEUTICAL COMPOSITION FORSTOPPING OVULATIONLABORATOIRE THERAMEX S.A2718 2528/DELNP/2005 231228 03-03-2009A THIOPHENE-2-CARBOXYLIC ACIDCOMPOUND AND A PHARMACEUTICAL VIROCHEM PHARMA INC.COMPOSITION COMPRISING THE SAME2719 1373/CHENP/2006 231230 04-03-2009NOVEL KETO-OXADIAZOLE DERIVATIVES ASCATHEPSIN INHIBITORSAVENTIS PHARMACEUTICALS, INC.2720 445/CHENP/2006 231238 04-03-2009 A MHC CLASS II ANTIGENIC PEPTIDE F. HOFFMANN-LA ROCHE AG2721 3183/CHENP/2005 231245 04-03-2009A COMPOSITION COMPRISINGANTIBACTERIAL DRUG AND CARRIERSSCHERING-PLOUGH LTD2722 3502/CHENP/2005 231249 04-03-2009TABLET COMPRISING FLUVASTATIN ANDCARMELLOSE CALCIUMNOVARTIS AG

2723 2376/CHENP/2005 231260 04-03-20092724 2444/CHENP/2004 231264 04-03-20092725 343/CHENP/2006 231271 04-03-20092726 2073/CHENP/2005 231299 04-03-20092727 2614/CHENP/2005 231300 04-03-2009SUBSTITUTED 4-PHENYLTETRAHYDROISOQUINOLINES ANDMETHOD FOR THE PRODUCTION THEREOFPHARMACEUTICAL DOSAGE FORM ANDMETHOD FOR THE PRODUCTION THEREOFGLYCOGEN SYNTHASE KINASE-3 INHIBITORSSANOFI AVENTIS DEUTSCHLAND GMBHROHM GmbH & Co. KGTEL AVIV UNIVERSITY FUTURE TECHNOLOGYDEVELOPMENT L.P.CYCLOALKYL-SUBSTITUTED ALKANOIC ACIDSANOFI-AVENTIS DEUTSCHLAND GmbHDERIVATIVES7-([1,4]DIOXAN-2-YL)-BENZOTHIAZOLEDERIVATIVES AS ADENOSINE RECEPTOR F. HOFFMANN-LA ROCHE AGLIGANDS2728 1454/CHENP/2005 231312 04-03-2009PYRIMIDINE - SULFAMIDES AS ENDOTHELIANACTELION PHARMACEUTICALS LTD.RECEPTOR ANTAGONIST2729 2045/CHENP/2005 231313 04-03-2009CYCLOALKYL DERIVATIVE COMPOUND OFFORMULA (I)SANOFI-AVENTIS DEUTSCHLAND GMBH2730 2772/CHENP/2005 231315 04-03-20092, 3, 6-TRISUBSTITUTED-4-PYRIMIDONEDERIVATIVESMITSUBISHI TANABE PHARMA CORPORATION2731 2992/CHENP/2004 231319 04-03-2009POLYPEPTIDE OF RNF3 GENE INVOLVED INTHE PROLIFERATION MECHANISM OF CELLSONCOTHERAPY SCIENCE, INC.2732 1803/CHENP/2004 231320 04-03-2009 CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS ZYMOGENETICS, INC.2733 2435/CHENP/2004 231326 04-03-2009 NOVEL DIAZABICYCLONONENE DERIVATIVES ACTELION PHARMACEUTICALS LTD.2734 1278/KOLNP/2005 231337 04-03-2009NOVEL ANTICONVULSANT DERIVATIVESSALTSORTHO-MCNELL PHARMACEUTICAL, INC.N-[3-(3-SUBSTITUTED-PYRAZOLO[1,5-2735 2638/KOLNP/2005 231346 04-03-2009A]PYRIMIDIN-7-YL)PHENYL]-SULFONAMIDES,FERRER INTERNACIONAL, S.A.PROCESS FOR THEIR PREPARATION ANDCOMPOSITIONS COMPRISING THEM2736 2291/KOLNP/2005 231348 04-03-2009 THIENYL FUSED PYRIMIDINYL COMPOUNDS CHIRON CORPORATION2737 63/CAL/1995 231354 04-03-2009GLYCOPEPTIDE ANTIBIOTIC DERIVATIVESAND PROCESS OF PREPARATION THEREOFELI LILLY AND COMPANY2738 255/KOLNP/2006 231358 04-03-2009COMPOUNDS AND FORMULATIONS FORORAL DELIVERY OF PEPTIDESEMISPHERE TECHNOLOGIES, INC2739 1842/KOLNP/2005 231361 04-03-2009NEW PIPERIDI-NYLAMINO-THIENO[2, 3-D]PYRIMIDINE COMPOUNDSEPIX DELAWARE INCA COMPOUND AND COMPOSITION FOR2740 1779/KOLNP/2004 231362 04-03-2009 TARGETING AN IMAGING AGENT TO CELLS OF ENDOCYTE, INC.AN ANIMAL2741 2602/KOLNP/2005 231366 04-03-20092742 535/KOLNP/2004 231382 04-03-20092743 1478/KOLNP/2003 231384 04-03-2009ISOLATED NUCLEIC ACID CODING FOR APOLYPEPTIDE HAVING ACCTOHYDROXY ACIDSYNTHETASE (AHAS) ACTIVITYAN -[BENZOYL]-HETEROARYSULFONAMIDECOMPOUNDSA PHARMACEUTICAL COMPOSITIONEXHIBITING ANTI-TUMOR ACTIVITYDEGUSSA AGELI LILLY AND COMPANYPTS INTERNATIONAL, INC.

NOVEL 14 AND 15 MEMBERED-RING2744 2197/KOLNP/2005 231395 04-03-2009PLIVA-ISTRAZIVACKI INSTITUT D.O.C.COMPOUNDSA COMPOSITION OF NON-ERGOT D2/D32745 42/KOLNP/2003 231399 04-03-2009 RECEPTOR AGONISTS TO TREATHOLMAN ANDREW J.FIBROMYALGIA2-PROPYNYL ADENOSINE ANALOGS HAVINGUNIVERSITY OF VIRGINIA PATENT2746 383/KOLNP/2004 231411 04-03-2009 A2A AGONIST ACTIVITY AND COMPOSITIONSFOUNDATIONTHEREOFPHARMACEUTICAL COMPOSITIONS FOR ORAL2747 800/CAL/1998 231417 04-03-2009ROMARK LABORATORIES, L. C.ADMINISTRATIONNOVEL COMPOUNDS THAT ACTIVATE HUMAN2748 1895/KOLNP/2004 231425 04-03-2009 PEROXISOME PROLIFERATOR ACTIVATED SMITHKLINE BEECHAM CORPORATIONRECEPTORS .SUBSTITUTED INDOLEALKANOIC ACID THE INSTITUTES FOR PHARMACEUTICAL2749 IN/PCT/2000/457/KOL 231439 04-03-2009COMPOUND .DISCOVERY, INC.BORONIC ACID AND ESTER COMPOUNDS,PHARMACEUTICAL COMPOUNDS COMPRISING2750 565/KOLNP/2006 231455 04-03-2009CEPHALON, INC.THEM AND PROCESS FOR THEIRPREPARATION .2751 IN/PCT/2002/479/KOL 231456 04-03-2009 BENZAMIDE COMPOUNDS MILLENNIUM PHARMACEUTICALS, INC. ,NOVEL SUSTAINED RELEASE2752 1300/KOLNP/2004 231459 04-03-2009 PHARMACEUTICAL COMPOUNDS TO PREVENT NEW RIVER PHARMACEUTICALS INC.ABUSE OF CONTROLLED SUBSTANCESAN IMPLANTABLE, ANTIPROLIFERATIVEAGENT-ADMINISTERING PERIVASCULAR2753 903/KOLNP/2003 231461 04-03-2009 SLEEVE ADAPTED TO BE PLACED IN CONTACT VASCULAR THERAPIES, LLCWITH THE EXTERIOR OF A VASCULARSTRUCTURECOMPOUNDS WITH SELECTIVE ACTIVITY ON2754 IN/PCT/2000/423/KOL 231464 04-03-2009ACADIA PHARMACEUTICALS, INC.M1 MUSCARINIC RECEPTORSSUBSTITUTED 2-PYRIMIDINYL-6,7,8,9-TETRAHYDROPURIMIDO[1,2-A] PYRIMIDIN-4-2755 204/KOLNP/2004 231465 04-03-2009ONE AND 7-PYRIMIDINYL-2,3-SANOFI-AVENTISDIHYDROIMIDAZO[1,2-A] PYRIMIDIN-5(1H)ONE DERIVATIVES FORNEURODEGENERATIVE DISORDERSNOVEL BENZOPHENONE DERIVATIVES OR2756 591/KOLNP/2004 231471 04-03-2009TOYAMA CHEMICAL CO. LTD.SALTS THEREOFPOWDERED PHARMACEUTICAL2757 3496/DELNP/2005 231485 05-03-2009BRITANNIA PHARMACEUTICALS LIMITEDFORMULATION2758 2733/DEL/1997 231489 05-03-2009 A QUINAZOLINE COMPOUND ASTRAZENECA UK LIMITEDALPHA-AMINO ACID AMIDE COMPOUNDS AND2759 0002/DEL/2001 231492 05-03-2009CHIESI FARMACEUTICI SPAPREPARATION THEREOF

2760 3714/DELNP/2005 231497 05-03-2009PYRAZOLO[1,5-A]PYRIMIDINE COMPOUND ORPHARMACEUTICALLY ACCEPTABLE SALTS TEIJIN PHARMA LIMITEDTHEREOF2761 4803/DELNP/2005 231499 05-03-2009 PHENYL SUBSTITUTED CYCLIC DERIVATIVES BAYER CropScience AG.2762 1041/MUM/2003 231503 05-03-2009 2- SUBSTITUTED 2-PHENYL-1, 3-DIKETONES BAYER CROPSCIENCE2763 173/MUM/2004 231504 05-03-2009STABLE PHARMACEUTICAL COMPOSITIONCOMPRISING OF AN ANGIOTENSIN IIIPCA LABORATORIES LIMITEDRECEPTOR ANTAGONIST AND A DIURETICHERBICIDES BASED ON SUBSTITUTED THIEN-3-2764 811/MUM/2002 231521 05-03-2009 YL-SULPHONYLAMINO[THIO]-CARBONYLTRIAZOLIN[ETHI]ONESBAYER AKTIENGESELLSCHAFT2765 812/DELNP/2005 231557 06-03-2009 IMIDAZOLOPYRIDINE COMPOUNDS BIOGEN IDEC MA INC.2766 365/DEL/2001 231658 07-03-2009A NOVEL SUBSTITUTED CALIX(4) PYRROLE2767 IN/PCT/2001/00938/DEL 231676 07-03-20092768 3906/DELNP/2004 231704 09-03-20092769 1279/DEL/2003 231705 09-03-20092770 3887/DELNP/2005 231707 09-03-20092771 IN/PCT/2001/00822/DEL 231777 09-03-2009A STABLE COMPOSITION COMPRISINGEPIDERMAL GROWTH FACTOR AS AN ACTIVEINGREDIENTA 2 -AZETIDINONE COMPOUND OF FORMULA(I) AND PROCESS FOR PREPARING THE SAMENOVEL ANTICANCER DITERPENECOMPOUNDSAN ORAL COMPOSITION SUITABLE AS AHYPOGLYCEMIC AGENTA CYCLIC PEPTIDE MELANOCORTINRECEPTOR LIGANDS ANALOGA SUBSTITUTED ECTEINASCIDIN COMPOUNDHAVING ANTI-TUMOURAL ACTIVITYCOUNCIL OF SCIENTIFIC AND INDUSTRIALRESEARCHDAEWOONG PHARM. CO. LTD.ASTRAZENECA ABCOUNCIL OF SCIENTIFIC & INDUSTRIALRESEARCHAYURVEDIC-LIFE INTERNATIONAL, LLC.THE PROCTER & GAMBLE COMPANY2772 IN/PCT/2002/01010/DEL 231788 09-03-2009PHARMA MAR, S.A.2773 IN/PCT/2001/00611/DEL 231810 09-03-2009 POLYHYDROXYPYRAZINE COMPOUNDS AVENTIS PHARMA S.A.2774 602/MUMNP/2004 231906 13/3/2009COMPOUNDS OF FORMULA (I) AND PROCESSFOR PREPARING THE SAMESANOFI SYNTHELABORATORY2775 IN/PCT/2002/00759/DEL 231911 13-03-2009COMPOUNDS OF N-DEACETYLTHIOCOCHICINE OF FORMULA (I)INDENA S.P.A.A pharmaceutical composition containing insulin as2776 1885/DELNP/2004 231927 13-03-2009the active agent and the delivery agent being theEMISPHERE TECHNOLOGIES, INC.monosodium salt of 4-CNAB (Sodium N-[4-(4-chloro-2hydroxybenzoyl)amino1 butanoic acid)2777 2183/DELNP/2003 231930 13-03-20091-PHEHYLSULFONYL-1,3--DIHYDRO-2H-INDOL-SANOFI-SYNTHELABO2ONE COMPOUNDS2778 1713/DELNP/2004 231960 14-03-2009PHARMACEUTICAL SUSPENSION FOR ORALADMINISTRATIONPHARMACIA CORPORATION2779 1364/DELNP/2005 232024 14-03-2009NOVEL COMPOUNDS AND THEIR USE AS PRAR-PHARMACIA CORPORATIONMODULATORS.2780 1787/DELNP/2005 232053 15-03-2009 A FAST-DISPERSING SOLID DOSAGE FORM R.P. SCHERER TECHNOLOGIES, INC.2781 734/CHENP/2006 232231 16-03-20091-(β-D-GLUCOPYRANOSYL)-3-(2-THIENYLMETHYL)BENZENE DERIVATIVESMITSUBISHI TANABE PHARMA CORPORATION

2782 3387/CHENP/2005 232234 16-03-2009 DRUG CONJUGATE COMPOSITION IMMUNOGEN, INC2783 2071/CHENP/2006 232248 16-03-2009SUBSTITUTED 1H-PYRROLO[3,2-B, 3,2-C, AND2,3-C]PYRIDINE-2-CARBOXAMIDES ANDRELATED ANALOGS AS INHIBITORS OFAVENTIS PHARMACEUTICALS, INCCASEIN KINASE I EPSILON2784 1778/CHENP/2006 232271 16-03-20092-HYDROXY-3-N-HETEROCYCLYLALKYL-AMINO-PROPYL-PHOSPHINIC ACIDSNOVARTIS AG2785 2098/CHENP/2006 232272 16-03-2009SOLID DISPERSIONS OR SOLIDDISPERSION PHARMACEUTICALPREPARATIONS OF PHENYLALANINEAJINOMOTO CO., INCDERIVATIVES2786 34/MUMNP/2006 232287 16/3/2009FUSED COMPOUNDS THAT INHIBITVANILLOID RECEPTOR SUBTYPE 1 (VR1)ABBOTT LABORATORIES2787 2387/CHENP/2005 232293 16-03-2009SYNTHESIS OF 2-CHLOROMETHYL-6-METHYLBENZOIC ACID ESTERSSANOFI-AVENTIS DEUTSCHLAND GmbH2788 IN/PCT/2002/00773/MUM 232300 16/3/2009 A PHOSPHONIC DIAMIDE OF FORMULA IA METABASIS THERAPEUTICS, INC.2789 2226/CHENP/2005 232301 16-03-2009A SUBSTITUTED PIPERIDINES AS MDM2-p53INHIBITORSF. HOFFMANN-LA ROCHE AG2790 3476/CHENP/2005 232303 16-03-2009AN ANTIBODY OR ANTIGEN-BINDINGPORTION THEREOF WHICH BINDS TO MEDAREX, INCBACILLUS ANTHRACIS PROTECTIVE ANTIGEN2791 937/MUMNP/2005 232328 16/3/2009MODIFIED TERT PROMOTER WITH ENHANCEDINDUSTRY-ACADEMIC COOPERATIONTUMOR-SPECIFICITY AND STRENGTH ANDFOUNDATION YONSEI UNIVERSITY,KIM, JOO-RECOMBINANT VECTOR COMPRISING THEHANGSAME2792 395/MUMNP/2006 232350 16/3/2009 NOVEL HYPOCHOLESTEROLEMIC LIPIDEON BIOTECHNOLOGY AGINDAZOLE COMPOUNDS AND2793 IN/PCT/2001/01148/DEL 232353 16-03-2009PHARMACEUTICAL COMPOSITIONS FORAGOURON PHARAMACEUTICALS, INC.INHIBITING PROTEIN KINASES, AND METHODSFOR THEIR USE"NOVEL SUBSTITUTED 3-CYANOTHIOPHENE2794 4711/DELNP/2005 232354 17-10-2005 ACETAMIDES AS GLUCAGON RECEPTOR F. HOFFMANN-LA ROCHE AGANTAGONISTS OF GENERAL FORMULA (I)"2795 238/MUMNP/2006 232444 16/3/2009FUSED AZABICYCLIC COMPOUNDS THATINHIBIT VANILLOID SUBTYPE 1 (VR1)ABBOTT LABORATORIESACYLATED AND NON-ACYLATED IMIDAZO[2,1-2796 2571/KOLNP/2005 232527 18-03-2009 B]-1,3,4,-THIADIAZOLE-2-SULFONAMIDES, AND AEGERA THERAPEUT CS INC.USES THERE OF

2797 2043/CHENP/2005 232652 20-03-20092798 60/DELNP/2006 232730 20-03-20092799 1361/DEL/1999 232860 21-03-20092800 298/KOLNP/2003 233032 25-03-20092801 90/KOL/2005 233040 25-03-20092802 00471/DELNP/2004 233057 25-03-20092803 53/DELNP/2006 233092 26-03-20092804 1132/DEL/2001 233125 26-03-20092805 1721/DELNP/2004 233155 27-03-20092806 IN/PCT/2002/01168/DEL 233235 27-03-20092807 01131/DELNP/2003 233340 28-03-20092808 IN/PCT/2002/00945/DEL 233341 28-03-20092809 00961/DELNP/2003 233345 28-03-20092810 92/DELNP/2006 233424 30-03-20092811 2090/DELNP/2004 233569 30-03-20093-METHYL-2 (3-(2-PHENYL-OXAZOL-4-YLMETHOXY)-CYCLOHEXANECARBONYL-AMINOBUTYRIC ACID DERIVATIVES ANDSANOFI-AVENTIS DEUTSCHLAND GmbHRELATED COMPOUNDS AS PPARMODULATORS FOR THE TREATMENT OFTYPE 2 DIABETES ANDATHEROSCLEROSISA MORPHOLINOMETHYL-BENZIMIDAZOL-2-YLPYRAZOLE COMPOUND OF THEASTEX THERAPEUTICS LIMITEDFORMULA(VII)A PHARMACEUTICAL COMPOSITIONPFIZER PRODUCTS INC.CONTAINING SERTRALINEIMMUNOGENIC COMPOSTION FOR INDUCINGTHE AUSTIN RESEARCH INSTITUTEIMMUNE RESPONSE IN A SUBJECTNOVEL ORALLY ADMINISTRABLE ANTI-DIABETIC COMPOUNDS, PROCESS FORBIRLA INSTITUTE OF TECHNOLOGYPRODUCING THEM AND THERAPEUTICCOMPOSITIONS CONTAINING THE SAME .SUBSTITUTED DIHYDROPTERIDINONE OF BOEHRINGER INGELHEIM PHARMA GMBH &GENERAL FORMULA (I)CO. KG.A PYRROLO(3,4-C) PYRAZOLE COMPOUND OFPFIZER ITALIA S.R.LFORMULA(I)CONTROLLED-RELEASE MICROGRANULES LABORATOIRES DES PRODUITS ETHIQUESCONTAINING CISPLATINETHYPHARMALPHA-[N-SULFONAMIDO]ACETAMIDEBRISTOL-MYERS SQUIBB COMPANYDERIVATIVES AS BETA-AMYLOID INHIBITORSA RADIOPHARAMACEUTICAL COMPOUND OFBRISTOL-MYERS SQUIBB PHARMA COMPANYFORMULA (I)A PHENYLAMINE COMPOUND HAVING PDE4MEMORY PHARMACEUTICALS CORPORATIONINBIBITOR ACTIVITYOLIGOSACCHARIDES OF FORMULA (I) HAVINGAVENTIS PHARMA S.A.ANTI-INFLAMMATORY PROPERTIESNOVEL QUINUCLIDINE DERIVATIVES ANDMEDICINAL COMPOSITIONS CONTAINING THE ALMIRALL AG.,SAMEPYRIMIDINE-2,4-DIONE AS GONADOTROPINRELEASING HORMONE RECEPTORNEUROCRINE BIOSCIENCES, INC.ANTAGONSTSPHARMACEUTICAL COMPOSITIONGALDERMA RESEARCH & DEVELOPMENT,COMPRISING AR LEAST A RETINOID ANDS.N.CBENZOYL PEROXIDE

2812 3209/DELNP/2005 233622 31-03-20092813 1969/DELNP/2004 233625 31-03-2009A COMPOSITION FOR TREATMENT ANDPREVENTION OF MAMMALDERMATOLOGICAL LESIONS, AND METHODFOR MANUFACTURE THEREOFTRIAROMATIC VITAMIN D ANALOGUES ANDPHARMACEUTICAL COMPOSITION THEREOFAURIGA INTERNATIONAL S.A.GALDERMA RESEARCH & DEVELOPMENTS.N.C.2814 4155/DELNP/2005 233626 31-03-2009 A PURIFIED GLYCOPROTEIN HALOZYME, INC.2815 3802/DELNP/2005 233627 31-03-2009 A COMPOUND OF FORMULA (I) BAYER PHARMACEUTICALS CORPORATION2816 IN/PCT/2000/00208/DEL 233631 31-03-2009A RECOMBINANT POLYPEPTIDE FORINDUCING AN IMMUNE RESPONSE SPECIFICFOR GROUP B STREPTOCOCCUSID BIOMEDICAL CORPORATION.2817 2007/DELNP/2003 233635 31-03-2009NON-LIPOSOMAL PHARAMACEUTICALFORMULATIONS AND METHODS OFPREPARING THE SAMEWESTERN CENTER FOR DRUG DEVELOPMENT,COLLEGE OF PHARMACY, WESTERNUNIVERSITY OF HEALTH SCIENCES2818 3837/DELNP/2004 233638 01-04-2009 PHARMACEUTICAL SALTS OF REBOXETINE PFIZER ITALIA S.R.L2819 82/DELNP/2006 233639 01-04-2009COMPOUND HAVING ANTI-HCV ACTION ANDITS PRODUCTION METHODCHUGAI SEIYAKU KABUSHIKI KAISHA2820 2729/KOLNP/2005 233642 01-04-2009 A PEG LINKED POLYPEPTIDE DOMANTIS LIMITED2821 2624/KOLNP/2005 233649 01-04-2009A RACEMATE, DIASTEREOISOMER, OD BOEHRINGER INGELHEIM INTERNATIONALOPTICAL ISOMER OF A COMPOUNDGMBH2822 IN/PCT/2001/133/KOL 233652 01-04-2009 A PEG CONJUGATE OF URICASE MOUNTAIN VIEW PHARMCEUTICALS. INC.2823 287/KOLNP/2005 233686 01-04-2009PHARMA CEUTICALLY ACCEPTABLE BASEADDITION SALTS .TRIGEN LIMITED2824 2766/DELNP/2004 233695 01-04-2009 A THIAZOLIDINEDIONES COMPOUNDS CHONG KUN DANG PHARMACEUTICAL CORP.2825 180/MAS/2002 233701 02-04-2009NOVEL CRYSTALLINE FORM FO 5-[4-[[3-METHYL-4-OXO-3,4-DIHYDROQUINAZOLIN-2-YL]METHOXY]BENZYL]THIAZOLIDINE-2,4-DIONE POTASSIUM SALTDR. REDDY'S LABORATORIES LIMITED2826 IN/PCT/2002/1103/CHE 233704 02-04-2009PHARMACEUTICAL PARENTERALCOMPOSITION CONTAINING ABIPHOSPHONATEF. HOFFMANN LA ROCHE AG2827 1836/CHENP/2003 233705 02-04-2009 TACI-IMMUNOGLOBULIN FUSION PROTEINS ZYMOGENETICS, INC2828 1609/CHENP/2005 233714 02-04-2009COMPOUNDS FOR PREVENTION ANDTREATMENT OF VIRAL INFECTIONS ANDCOMPOSITIONS THEREOF2829 IN/PCT/2002/1998/CHE 233717 02-04-20092830 IN/PCT/2000/775/CHE 233722 02-04-20092831 883/CHENP/2006 233728 02-04-20092832 1798/CHENP/2004 233745 02-04-2009NOVEL HETROCYCLIC ANALOGS OFDIPHENYLETHYLENE COMPOUNDSA PHARMACEUTICAL COMPOSITIONCOMPRISING PEG-IFN-α2A1,3-DISUBSTITUTED AZETIDINE COMPOUNDSAND PROCESS FOR PREPARATION OF THECOMPOUNDSNOVEL CYTOKINE ZCYTOR17 LIGANDPOLYPEPTIDECHUGAI SEIYAKU KABUSHIKI KAISHATHERACOS, INCF. HOFFMANN-LA ROCHE AGNOVARTIS AGZYMOGENETICS, INC

2833 800/CHENP/2005 233747 02-04-20092834 1037/DEL/2004 233755 06-04-20092835 1841/DELNP/2006 233759 06-04-2009PYRIMIDO[4,5-D] PYRIMIDINE DERIVATIVESWITH ANTICANCER ACTIVITYPHARMACOGENETIC MARKER OF HUMANTRANSFORMING GROWTH FACTOR BETA1(TGFß1) FOR PREDICTING PREDISPODITION TOIMMUNOLOGICAL DISORDERSSUSTAINED-RELEASE MICROGRANULESCONTAINING GINKGO BILOBA EXTRACT ANDTHE PROCESS FOR PREPARATION THEREOFF. HOFFMANN-LA ROCHE AGCOUNCIL OF SCIENTIFIC & INDUSTRIALRESEARCHETHYPHARM2836 637/KOLNP/2006 233764 08-04-2009ADAMANTANE AND AZABICYCLO-OCTANEAND NONANE DERIVATIVESSANOFI-AVENTIS2837 1202/KOLNP/2005 233794 08-04-2009 A VACCINE COMPOSITION ADJUVANTIX LIMITED2838 5484/DELNP/2005 233807 08-04-2009DIKETOPIPERAZINE,OR A PHYSIOLOGICALLYACCEPTABLE SALR THEREOFDMI BIOSCIENCES, INC.2839 4483/DELNP/2005 233808 08-04-2009 TOPICAL L-CARNITINE COMPOSITIONS LONZA INC.2840 83/DELNP/2006 233809 08-04-2009 AN ANTIBODY OR PORTION THEREOF FIBROGEN INC.2841 3045/DELNP/2004 233812 09-04-2009HIV PROTEASE INHIBITOR PHOSPHONATEANALOGUESGILEAD SCIENCES, INC.2842 704/DEL/1999 233813 09-04-20092-[2-CHLOROPHENYL]-3,4-DIHYDRO-2H-BAYER AKTIENGESELLSCHAFTPHYRROLE COMPOUNDS OF THE FORMULA (I)2843 195/DELNP/2006 233821 13-04-2009 INDOLYL COMPOUNDS F. HOFFMANN-LA ROCHE AG2844 410/DELNP/2006 233822 13-04-2009 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA A/SSUBSTITUTED DIHYDROPYRANO INDOLE-3,4-DIONE DERIVATIVES AND 3-OXOACETIC ACID2845 1076/KOLNP/2005 233836 16-04-2009SUBSTITUTED 2-HYDROXYMETHYLINDOLEDERIVATIVES AS INHIBITORS OFWYETHPLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)2846 3412/DELNP/2005 233845 16-04-2009 BETULINC ACID DERVATIVE NOVELIX PHARMACEUTICALS, INC.2847 1447/KOLNP/2005 233848 16-04-2009 OLIGOSACCHARIDE DERIVATIVE SANKYO COMPANY, LIMITED2848 1249/KOLNP/2005 233851 16-04-2009ACYLAMINOTHIAZOLE DERIVATIVECOMPOUNDSSANOFI AVENTIS2849 1275/KOLNP/2004 233870 16-04-2009HEMIASTERLIN DERIVATIVES AND USESTHEROFEISAI R&D MANAGEMENT COMPANY LTD.2850 2526/KOLNP/2005 233877 16-04-2009 A HETEROLOGOUS FUSION PROTEIN ELI LILLY AND COMPANY2851 606/KOLNP/2004 233878 16-04-2009NOVEL 1,2,4-THIADIAZOLE DERIVATIVES AS ORTHO-MCNEIL PHARMACEUTICALMELANOCORTIN RECEPTOR MODULATORS CORPORATION2852 575/KOLNP/2005 233880 16-04-2009NEUTRALIZING ANTIBODIES AGAINST GDF-8AND USES THEREFORWYETH2853 964/KOLNP/2003 233884 16-04-2009 HETEROCYCLIC INHIBITORS OF ERK2 VERTEX PHARMACEUTICALS INCORPORATED2854 443/CAL/1999 233888 16-04-2009 REPLICATION DEFECTIVE HIV VACCINE GENECURE LLC

2855 298/DEL/1997 233893 16-04-2009A MIXTURE SUBSTANTIALLY FREE OFPOLYPHENOL AND STEROL DERIVATIVESOBTAINABLE BY EUGENIA JAMBOLANALAMARCK SEEDS, THEIR PREPARATION ANDTHEIR USE AS MEDICAMENTSINSTITUT MALGACHE DE RECHERCHESAPPLIQUEES2856 87/DELNP/2006 233898 17-04-2009 A NOVEL PYRIMIDINE COMPOUND NEUROGEN CORPORATION2857 3686/DELNP/2005 233899 17-04-2009SULFONAMIDE SUBSTITUTED XANTHINECOMPOUNDS FOR USE AS PEPCK INHIBITORSF. HOFFMANN-LA ROCHE AG2858 3353/DELNP/2005 233903 17-04-2009A SUSTAINED RELEASE DRUG DEVICEADAPTED FOR IMPLANTATION IN ORADJACENT TO THE EYEPSIVIDA, INC.2859 2564/DELNP/2004 233906 20-04-2009A SYNERGISTIC ANTIBIOTICPHARMACEUTICAL COMPOSITION HAVINGENHANCED BIOACTIVITYCOUNCIL OF SCIENTIFIC AND INDUSTRIALRESEARCH2860 157/DELNP/2006 233908 21-04-2009SMALL INTERFERING RNA MOLECULES FOR THE TRUSTEES OF THE UNIVERSITY OFINHIBITING EXPRESSION OF SYK KINASE PENNSYLVANIA2861 3782/DELNP/2005 233919 21-04-2009INJECTABLE LIQUID PHARMACEUTICALCOMPOSITION OF PARACETAMOLNGUYEN-XUAN THO2862 240/DEL/2003 233940 22-04-2009PYRIDINYLOXY PHENYL METHANOL ESTERS COUNCIL OF SCIENTIFIC AND INDUSTRIALRESEARCH2863 4127/DELNP/2005 233947 22-04-2009A FORMULATION FOR A METERED DOSE BOEHRINGER INGELHEIMINHALERPHARMACEUTICALS, INC.2864 3904/DELNP/2004 233979 24-04-2009AN ORTHO- SUBSTITUTED BENZOIC ACIDCOMPOUND OF FORMULA (I)ASTRAZENECA AB2865 5403/DELNP/2005 233990 27-04-2009A RESPIRATORY TRACT COMPOSITION FORTHE TREATMENT OF COLD AND INFLUENZA- THE PROCTER & GAMBLE COMPANYLIKE SYMPTOMS2866 2474/KOLNP/2005 234003 29-04-2009 MULTILAYER ORODISPERSIBLE TABLET ETHYPHARM2867 122/KOLNP/2005 234013 29-04-2009A COMPOSITION COMPRISING ANIMMUNOSTIMULATORY NUCLEIC ACID .COLEY PHARMACEUTICAL GROUP, INC.2868 1388/KOLNP/2003 234017 29-04-2009A CONJUGATE OF AN INJECTED BACTERIALEFFECTOR PROTEIN AND A CARRIER THATTARGETS THE EFFECTOR PROTEIN TO ATARGET CELLHEALTH PROTECTION AGENCY2869 IN/PCT/2002/1299/KOL 234019 29-04-20092870 IN/PCT/2002/01074/MUM 234024 29/4/20092871 3167/DELNP/2005 234040 30-04-20092872 699/MUM/2005 234048 01-05-2009INTRACELLULAR PATHOGEN VACCINES FORPREVENTING DISEASES IN MAMMALS .NOVEL EPOTHILONE COMPOUND ANDPROCESS THEREOFA PYRAZOLE COMPOUND AND APHARMACEUTICAL COMPOSITION THEREOFA NOVEL HERBAL PRODUCT FOR TREATINGABNORMAL CONDITIONS OF BONES AND APROCESS FOR MAKING THE SAMETHE REGENTS OF THE UNIVERSITY OFCALIFORNIABRISTOL- MAYERS SQUIBB CO,DAIICHI PHARMACEUTICAL CO., LTD.KARANDE TULASHIDAS NAMADEO,KARANDERAYCHAND BANDU2873 1221/MUM/2004 234061 04-05-2009 STAVUDINE CONTROLLED RELEASE TABLET EMCURE PHARAMACEUTICALS LIMITED

A RECOMBINANT NUCLEIC ACID MOLECULE RHEIN BIOTECH GESELLSCHAFT FUR NEUE2874 IN/PCT/2001/1470/CHE 234069 05-05-2009BIOTECHNOLOGISCHE PROZESSE UND,PRODUKTE mbH2875 2813/CHENP/2005 234088 05-05-2009 AMINOPROPANOL DERIVATIVES NOVARTIS AG2876 2660/CHENP/2005 234089 05-05-2009PHARMACEUTICAL COMPOSITIONS OF CETPINHIBITORSJAPAN TOBACCO, INC2877 251/CHENP/2006 234091 05-05-2009A COMPOSITION COMPRISING 3-AMINO-1PROPANE SULFONIC ACID AND ANNEUROCHEM (INTERNATIONAL) LIMITEDADDITIONAL COMPONENT2878 71/CHENP/2006 234092 05-05-2009BENZENESULFONYLAMINO COMPOUNDS ANDA PHARMACEUTICAL COMPOSITIONS NOVARTIS AGCONTAINING THESE COMPOUNDS2879 3151/CHENP/2005 234093 05-05-2009 NOVEL NUTRACEUTICAL COMPOSITIONS DSM IP Assets B.V2880 558/CHENP/2004 234097 05-05-2009 CHEMICAL COMPOUNDS AVENTIS PHARMA S.A2881 1009/CHENP/2006 234098 05-05-2009AMIDE-TYPE CARBOXAMIDE COMPOUNDSMITSUBISHI TANABE PHARMA CORPORATION2882 142/CHENP/2006 234099 05-05-2009 NOVEL HETEROARYL DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD2883 1196/CHENP/2004 234100 05-05-2009TRANSDERMAL THERAPEUTIC SYSTEMSCONTAINING STEROID HORMONES AND LTS LOHMANN THERAPIE-SYSTEME AGPROPYLENE GLYCOL MONOCAPRYLATE2884 3524/CHENP/2005 234101 05-05-20095-MEMBERED HETEROCYCLE-BASED P38KINASE INHIBITORSNOVARTIS AG2885 1027/CHENP/2006 234102 05-05-2009HEXA- AND OCTAHYDRO-PYRIDO[1,2-A]PYRAZINE DERIVATIVES WITH NK1 SOLVAY PHARMACEUTICALS B.VANTAGONISTIC ACTIVITY2886 2827/CHENP/2005 234103 05-05-2009A STABLE BIOLOGICAL AQUEOUSFORMULATION FOR TREATMENT OFSCHERING CORPORATIONINFECTIOUS DISEASE2887 913/CHENP/2006 234104 05-05-2009NOVEL STRUCTURAL ANALOGS OFCOROSOLIC ACID HAVING ANTI-DIABETIC GOKARAJU, Ganga, RajuAND ANTI-INFLAMMATORY PROPERTIES2888 447/MAS/1995 234107 05-05-2009CEPHALOSPORIN SYNTHESISNABRIVA THERAPEUTICS FORSCHUNGSGmbHARYLAMINO SUBSTITUTED HETEROCYCLIC2889 3236/CHENP/2005 234108 05-05-2009 COMPOUNDS WITH p38 KINASE INHIBITING NOVARTIS AGACTIVITY2890 3051/CHENP/2005 234110 05-05-20092,3,4,5-TETRAHYDROBENZO[F][1,4] OXAZEPINE-F. HOFFMANN-LA ROCHE AG5-CARBOXYLIC ACID AMIDE DERIVATIVES2891 386/CHENP/2006 234111 05-05-2009 BICYCLIC COMPOUNDS AS PDF INHIBITORS IRM LLC2892 IN/PCT/2002/787/CHE 234112 05-05-20096-MERCAPTO-CYCLODEXTRIN DERIVATIVES:REVERSAL AGENTS FOR DRUG-INDUCED N.V. ORGANONNEUROMUSCULAR BLOCK2893 1489/MAS/1996 234115 05-05-20092,3-DIOXO-1,2,3,4-TETRAHYDROQUINOXALINYL DERIVATIVESNOVARTIS AG

2894 IN/PCT/2001/313/CHE 234116 05-05-2009A PHARMACEUTICAL FORMULATIONCOMPRISING SUBSTITUTEDSANOFI-AVENTIS DEUTSCHLAND GmbHBENZENESULFONYL (THIO) UREAS AND BETA-RECEPTOR BLOCKERSCOMPOSITIONS AND METHODS FOR PRIMING2895 480/CHENP/2004 234117 05-05-2009 MONOCYTIC DENDRITIC CELLS AND T CELLS NORTHWEST BIOTHERAPEUTICS, INCFOR TH-1 RESPONSE2896 1058/CHENP/2006 234120 06-05-2009SOLID PHARMACEUTICAL COMPOSITIONCOMPRISING TACROLIMUSLIFECYCLE PHARMA A/S2897 IN/PCT/2002/425/CHE 234121 06-05-2009 ORAL CONTROLLED RELEASE NOVARTIS AG2898 2800/CHENP/2006 234129 06-05-2009CRYSTALLINE POLYMORPHS OF A CXC-CHEMOKINE RECEPTOR LIGAND AND SCHERING CORPORATIONPROCESSES FOR PREPARING THE SAME2899 90/KOLNP/2006 234135 06-05-2009MELDONIUM SALTS, PROCESS FOR THEIRPREPARATION AND PHARMACEUTICAL JOINT STOCK COMPANY GRINDEKSCOMPOSITION COMPRISING THEM .2900 2077/CHENP/2004 234136 06-05-2009RECOMBINANT PARAINFLUENZA VIRUSEXPRESSION SYSTEMS AND VACCINESCOMPRISING HETEROLOGOUS ANTIGENSMEDIMMUNE VACCINES, INCDERIVED FROM METAPNEUMOVIRUS2901 1314/CHENP/2006 234139 06-05-2009COMPOSITIONS FOR CONTROLLINGPARASITES COMPRISING ABAMECTIN ANDINTERVET INTERNATIONAL B.V2902 16/CHENP/2006 234141 06-05-2009 HYDROXYALKYLAMIDES F. HOFFMANN-LA ROCHE AGA SUBSTITUTED 4-HYDROXY-2903 491/DEL/1997 234149 06-05-2009 PHENYLALCANOIC ACID COMPOUND HAVING GLAXO GROUP LIMITEDTHE FORMULA (I)STABLE LIPOSOMAL NEBULIZING2904 517/MUM/2004 234153 07-05-2009 INHALATION FORMULATIONS FORBAJAJ AMRITA,KHALE ANUBHACONTROLLED PULMONARY DELIVERY2905 376/MUM/2000 234155 07-05-2009SUBSTITUTED THIENOCYCLOALK(EN)YLAMINO-1,3,5-TRIAZINESBAYER AKTIENGESELLSCHAFT2906 806/DEL/1997 234208 08-05-2009EPROSARTAN DIHYDATE AND A PROCESS FORSMITHKLINE BEECHAM CORPORATIONITS PRODUCTION AND FORMULATION2907 IN/PCT/2001/00826/DEL 234220 11-05-2009CAMPTOTHECIN ANALOGUES OF GENERAL SOCIETE DE CONSEILS DE RECHERCHES ET D'FORMULA (IA) AND COMPOSITION THEREOF APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.)2908 2107/DELNP/2006 234227 12-05-2009 A 2-PYRIDONE COMPOUND ASTRAZENECA AB2909 1981/KOLNP/2005 234234 12-05-2009DERIVATIVES OF PIPERIDINYL- ANDPIPERAZINYL-ALKYL CARBAMATES,PREPARATION METHODS THEREOF ANDSANOFI-AVENTISAPPLICATION OF SAME IN THERAPEUTICS2910 1610/CAL/1997 234237 12-05-2009 EXTENDED RELEASE FORMULATION WYETH2911 2038/DELNP/2004 234262 14-05-2009ALKYLAMMONIUM SALTS OF OMEPRAZOLEAND ESOMEPRAZOLEAstraZeneca AB,

NOVEL 4, 10ß-DIACETOXY-2A-BENZOYLOXY-5ß, 20-EPOXY-1-HYDROXY-9-OXO-19-2912 70/DEL/2000 234265 14-05-2009NORCYCLOPROPA[G] TAX-11-EN-13A-YL (2R, 3AVENTIS PHARMA S.A.S)-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATEDEHYDRATE COMPOUNDAN ANTI-INFLAMMATORY, ANTIARTHRITIC2913 2191/DEL/1996 234274 15-05-2009 AND A VASCULODILATOR HERBAL OIL FROM DR. PUSHPA KHANNAMOMORDICA CHARANTIA L. (BITTER GOURD)A COMPOSITION COMPRISING A STRAIN OF2914 842/DELNP/2006 234280 15-05-2009OTSUKA PHARMACEUTICAL CO., LTD.LACTIC ACID BACTERIA2915 848/MAS/1998 234284 18-05-2009 PHARMACEUTICAL DOSAGE UNITS N V ORGANONIMMUNOSUPPRESSANT COMPOUNDS AND2916 3053/CHENP/2005 234286 18-05-2009IRM LLCCOMPOSITIONSIMMUNOSUPPRESSANT COMPOUNDS AND2917 3060/CHENP/2005 234287 18-05-2009IRM LLCCOMPOSITIONSIMMUNOSUPPRESSANT COMPOUNDS AND2918 3054/CHENP/2005 234288 18-05-2009IRM LLCCOMPOSITIONSA COMPOSITION COMPRISING2919 2381/CHENP/2005 234298 19-05-2009 IMMUNOSTIMULATORY SUBSTANCE CYTOS BIOTECHNOLOGY AGPACKAGED INTO VIRUS LIKE PARTICLEA PHARMACEUTICAL COMPOSITION OF2920 2457/CHENP/2005 234299 19-05-2009NOVARTIS AGMYCOPHENOLIC ACID OR A SALT THEREOF11-PHENYL-DIBENZODIAZEPINE DERIVATIVES2921 2560/CHENP/2005 234300 19-05-2009NOVARTIS AGAS RXR - ANTAGONISTSCOMPOUNDS OF FORMULA I AND A PROCESS2922 2848/CHENP/2005 234301 19-05-2009NOVARTIS AGFOR THEIR PREPARATIONCGRP ANTAGONIST COMPOUNDS FOR2923 359/CHENP/2005 234303 19-05-2009ACTAVIS GROUP HFTREATMENT OF PSORIASISPHARMACEUTICAL COMPOSITIONS SUITABLE BOEHRINGER INGELHEIM PHARMA GMBH &2924 3079/DELNP/2004 234306 19-05-2009FOR INHALATIONCO. KG.,PHARMACEUTICAL PREPARATIONBOEHRINGER INGELHEIM INTERNATIONAL2925 1473/DELNP/2006 234307 19-05-2009 CONTAINING 2,2-DIPHENYL-PROPIONIC ESTER-GMBHMETHOBROMIDE OF FORMULA 12-ALKYL 4,5 DISUBSTITUTED 6-COUNCIL OF SCIENTIFIC & INDUSTRIAL2926 473/DEL/2003 234308 19-05-2009METHOXYPRIMAQUINONE ANALOGUES RESEARCHA NOVEL THERMOSTABLE PROTEIN2927 1035/DEL/2002 234309 19-05-2009DEPARTMENT OF SCIENCE & TECHNOLOGYCONJUGATE PROBEISOTHIAZOLECARBOXAMIDES OF THE2928 3307/DEL/1998 234311 20-05-2009BAYER AKTIENGESELLSCHAFTFORMULA (I)PHARMACEUTICAL COMPOSITION FOR THE2929 118/DELNP/2006 234312 20-05-2009 ADMINISTRATION OF PIRIBEDIL BY THE LES LABORATOIRES SERVIERNASAL ROUTEANTIFUNGAL FORMULATION ITSCOUNCIL OF SCIENTIFIC & INDUSTRIAL2930 11/DEL/2004 234314 20-05-2009PREPARATION AND USE THREOFRESEARCH

2931 1683/DEL/2004 234315 20-05-20092932 112/DELNP/2006 234316 20-05-2009ATORVASTATIN CALCIUM IN APHARMACEUTICAL FORM, COMPOSITIONTHREOF, AND PHARMACEUTICALFORMULATION COMPRISING ATORVASTATINCALCIUMSOLID ORODISPERSIBLE PHARMACEUTICALCOMPOSITION OF COMPOUND A OF FORMULA(I) ANA PROCESS THEREOFLEK PHARMACEUTICAL AND CHEMICALCOMPANY D.D.LES LABORATOIRES SERVIERBOEHRINGER INGELHEIM PHARMA GMBH &CO. KG.2933 2420/DELNP/2004 234320 21-05-2009PHARMACEUTICAL PREPARATIONCONSISTING OF TIOTROPIUM BROMIDE2934 IN/PCT/2001/01628/MUM 234324 21/5/2009 ANTIPSYCHOTIC CYCLIC N-ARALKYL AMINES SANOFI SYNTHELABORATORY2935 1393/MUMNP/2005 234325 21/5/2009COMPOSITION COMPRISING A PDE4 INHIBITORNYCOMED GMBHAND A PDE5 INHIBITORCONJUGATES OF THERAPEUTIC OR2936 2152/CHENP/2004 234340 25-05-2009 CYTOTOXIC AGENTS AND BIOLOGICALLYACTIVE PEPTIDESTHE ADMINISTRATORS OF THE TULANEEDUCATIONAL FUND2937 1237/CHENP/2004 234342 25-05-2009 IMIDAZOQUINOLINES COMPOUNDS 3M INNOVATIVE PROPERTIES COMPANY2938 274/CHENP/2006 234346 25-05-20093, 4-DISUBSTITUTED 1H-PYRAZOLECOMPOUNDS AND THEIR USE AS CYCLINDEPENDENT KINASES (CDK) AND GLYCOGENSYNTHASE KINASE-3 (GSK-3) MODULATORSASTEX THERAPEUTICS LIMITED2939 1146/CHENP/2006 234347 25-05-2009BICYCLO'3.1.1HEPTANE SUBSTITUTEDBENZIMIDAZOLONE AND QUINAZOLINONEDERIVATIVES AS AGONISTS ON HUMAN ORL1RECEPTORSSOLVAY PHARMACEUTICALS B.V.2940 3333/CHENP/2005 234361 26-05-2009 ANTIMICROBIAL POLYPEPTIDES NOVOZYMES A/S2941 270/CHE/2004 234366 26-05-2009 NOVEL CONDENSED PYRIMIDONES ORCHID RESEARCH LABORATORIES LTD2942 3617/CHENP/2005 234376 26-05-2009 BENZALDOXIM COMPOUNDS BASF AKTIENGESELLSCHAFT2943 2373/CHENP/2005 234377 26-05-2009A COMPOSITION COMPRISING OFTRIGLYCERIDES USEFUL IN NORMALIZATION SUNTORY LIMITEDOF INFRADIAN RHYTHM2944 2854/CHENP/2006 234400 27-05-2009 SUBSTITUTED DIUREA COMPOUNDS ACTIVE BIOTECH AB2945 794/CHENP/2006 234401 27-05-2009 THIENOPYRAZOLES AVENTIS PHARMACEUTICALS INC.2946 2271/CHENP/2005 234402 27-05-20092-(BUTYL-1-SULFONYLAMINO)-N-[1(R)-(6-METHOXYPYRIDIN-3-YL)-PROPYL]-BENZAMIDE, AND PHARMACEUTICALSANOFI-AVENTIS DEUTSCHLAND GMBHPREPARATIONS CONTAINING SAID2947 715/CHENP/2006 234406 27-05-2009A PHARMACEUTICAL LIPOSOMALFORMULATION FOR PHOTODYNAMIC CERAMOPTEC INDUSTRIES, INC.THERAPY2948 515/CHENP/2006 234408 27-05-2009CEPHALOSPORIN ACYLASE MUTANT ANDSANDOZ AGMETHOD FOR PREPARING 7-ACA USING SAMEA COMPOSITION FOR INHIBITING THE2949 1353/MUMNP/2005 234425 28/5/2009 GROWTH OF ANTIBIOTIC RESISTANT OFBACTERIA BY USING PENTANE-1,5-DIOLAMBRIA DERMATOLOGY AB

2950 1015/MUMNP/2006 234427 28/5/2009SUBSTITUTED THIENO-AND THIAZOLO -[2, 3-D] PYRIDINES AS INHIBITORS OF TIE2ASTRA ZENECA AB2951 5395/DELNP/2005 234438 28-05-2009STABLE, AQUEOUS SOLUTION OF HUMANERYTHROPOIETIN, NOT CONTAINING SERUM LG LIFE SCIENCES LTD.ALBUMIN2952 563/MUMNP/2005 234459 28/5/20091-PHENACY-3-PHENYL-3-PIPERIDYETHYLCOMPOUND FOR USE IN PATHOLOGICALPHENOMENA INVOLVING TACHYKININ SANOFI-SYNTHELABOSYSTEM AND PHARMACEUTICALCOMPOSITION CONTAINING THE SAME2953 446/MUM/2005 234460 28/5/2009PHARMACEUTICAL COMPOSITIONCONSISTING OF COX-II INHIBITOR AND LYKA LABS LIMITEDMUSCLE RELAXANT2954 926/MUM/2003 234461 28/5/2009NOVEL DUAL RELEASE COMBINATION OF ACARDIOVASCULAR DRUG COMPRISING IPCA LABORATORIES LIMITEDANTIHYPERTENSIVE AND DIURETIC AGENTS2955 341/MUMNP/2005 234466 28/5/2009 NONSTEROIDAL ANTIINFLAMMATORIES SCHERING AKTIENGESELLSCHAFT2956 1140/MUM/2004 234470 28/5/2009 PARENTERAL FORMULATION LYKA LABS LIMITED2957 158/MUMNP/2004 234478 28/5/2009DUAL ACTION ANTIBIOTICESMORPHOCHEM AKTIENGESELLISCHAFT FURKOMBINATORISCHE2958 1032/DEL/2002 234519 04-06-2009PHARMACEUTICAL COMPOSITION OF NATIONAL INSTITUTE OF PHARMACEUTICALKETOROLACEDUCATION AND RESEARCH (NIPER)A COMPOSITION COMPRISING 1,1,1,33,3-2959 3850/DELNP/2005 234521 04-06-2009 PENTAFLUOROBUTANE (HFC-365mfc) AND SOLVAY [SOCIETE ANONYME]1,1,1,3,3-PENTAFLUOROPROPANE (HFC-245fa)2960 1049/CHENP/2006 234522 04-06-2009AN ORAL DOSAGE FORM AND METHOD FORTHE PREPARATION OF THE SAMELIFECYCLE PHARMA A/S2961 299/CHENP/2006 234523 04-06-2009NOVEL DIBENZO[B,F]OXEPINE-10-CARBOXAMIDES AND PHARMACEUTICAL NOVARTIS AGUSES THEREOF2962 2069/DELNP/2004 234530 04-06-2009NOVEL BENZOFURAN AND BENZOTHIOPHENEBAYER PHARMACEUTICALS CORPORATIONCOMPOUNDSA SUBSTITUTED PYRROLO (2-3 DIHYDRO)2963 4455/DELNP/2005 234533 05-06-2009PYRIDINE COMPOUND OF FORMULA (IV)CONTAINING PYRAZOLE SUBSTITUTED BYSMITHKLINE BEECHAM (CORK) LIMITEDIMIDAZOLIDIN-2-ONE2964 265/DELNP/2006 234534 05-06-2009TRIAZOLOPYRIMIDINE COMPOUND ASGLYCOGEN SYNTHASE KINASE 3 INHIBITORSJANSSEN PHARMACEUTICA N. V.2965 188/DELNP/2006 234536 05-06-2009BENZOXAZINONE-DERIVED SULFONAMIDECOMPOUNDS AND PROCESS FORLABORATORIOS DEL DR. ESTEVE S. A.PREPARATION THEREOF2966 5405/DELNP/2005 234548 05-06-2009A COMPOUND OF BENZOPYRAN DERIVATIVESSUBSTITUED WITH A BENZIMIDAZOLEDERIVATIVE AND PHARMACETICALLACCEPTABLE SALTS THEREOFDONGBU HANNONG CHEMICAL CO., LTD.

2967 IN/PCT/2001/00742/DEL 234551 08-06-20092968 00949/DELNP/2003 234552 08-06-20092969 526/DELNP/2005 234555 08-06-20092970 15/DELNP/2005 234557 08-06-20092971 2305/DELNP/2004 234560 08-06-20092972 1974/DELNP/2005 234561 08-06-20092973 382/DELNP/2004 234568 08-06-20092974 192/DELNP/2006 234577 09-06-20092975 374/KOLNP/2003 234590 10-06-20092976 IN/PCT/2001/515/CHE 234619 10-06-20092977 2204/CHENP/2006 234623 10-06-20092978 3261/CHENP/2005 234630 10-06-20092979 1179/MAS/1997 234631 10-06-20092980 2748/CHENP/2006 234634 10-06-20092981 1019/CHENP/2006 234639 10-06-20092982 1908/CHENP/2004 234659 10-06-20092983 3185/CHENP/2005 234660 10-06-2009A PHARMACEUTICAL COMPOSITIONCOMPRISING BETA-D-2',3'-DIDEHYDRO-2',3'-DIDEOXY-5-FLUOROCYTIDINE FORTREATMENT HIV INFECTIONTHERAPEUTIC COMPOSITION AND METHODOF MANUFACTURE THEREOFFORMULATION OF HUMAN ANTIBODIES FORTREATING TNF-ALPHA ASSOCIATEDDISORDERSA COMPOUND 2-[(1S,2R)-2-HYDROXY-2-(4-HYDROXY-PHENYL)-1-METHYL-ETHYL]-ISOINDOLINE -1,3-DIONEFUSION POLYPEPTIDE FOR EXPRESSION IN AHOST CELLA PEPTIDE OF FORMULA (I) AND THEPHARMACEUTICAL COMPOSITIONCOMPRISING SAID PEPTIDEFUNCTIONALIZED BENZOTRIAZOLECOMPOUNDPHARMACEUTICAL COMPOSITIONSEMORY UNIVERSITYRXKINETIX, INC.ABBOTT BIOTECHNOLOGY LTD.,KISSEI PHARMACEUTICAL CO., LTD.,NEWCASTLE UNIVERSITY VENTURES LIMITEDZEALAND PHARMA A/S,COUNCIL OF SCIENTIFIC & INDUSTRIALRESEARCHBOEHRINGER INGELHEIM INTERNATIONALGMBHA CYANO-ARYL(OR CYANOHETEROARYL) -CARBONYL-PIPERAZINYL- PYRIMIDINEDERIVATIVE.RECOMBINANT NEWCASTLE DISEASE VIRUSRNA EXPRESSION SYSTEMS AND VACCINESA PHARMACEUTICAL FORMULATIONCOMPRISING A2A RECEPTOR ANTAGONISTS SCHERING CORPORATIONION-PAIRED WITH SODIUM DUCOSATEARYL-HETEROAROMATIC PRODUCTS,AVENTIS PHARMA S.ACOMPOSITIONS COMPRISING THEMA CONCENTRATED LIQUID FORMULATIONCIBA HOLDING INCHAVING ANTIMICROBIAL ACTIVITY1,2-DI(CYCLIC)SUBSTITUTED BENZENECOMPOUNDSPYRIDYLACETYLENES AND COMPOSITIONSNOVARTIS AGTHEREOFHUMAN MONOCLONAL ANTIBODIES TOPROSTATE SPECIFIC MEMBRANE ANTIGEN MEDAREX, INC.(PSMA)N-EPSILON AND N-ALPHA DERIVATIZEDHISTIDINE AND METHOD FOR PREPARING THE UNIVERSITY OF ZURICHSAMELABORATORIOS DEL DR. ESTEVE, S.A.MOUNT SINAI SCHOOL OF MEDICINE OF NEWYORK UNIVERSITYEISAI R&D MANAGEMENT CO., LTD

2984 5989/DELNP/2005 234665 10-06-2009PHARMACEUTICAL COMPOSITION AS SOLIDDOSAGE FORM AND METHOD FORFERRING B.V.,MANUFACTURING THEREOF2985 301/MAS/2001 234701 12-06-2009NEW MONOCYCLIC DERIVATIVES OF ARYLACIDS, PROCESS FOR THEIR PREPARATIONAND PHARMACEUTICAL COMPOSITIONSDR. REDDY'S LABORATORIES LTDCONTAINING THEM2986 490/CHENP/2006 234742 12-06-2009 SUBSTITUTED TETRACYCLINE COMPOUNDS PARATEK PHARMACEUTICALS, INC.2987 498/CHENP/2004 234745 15-06-2009SUBSTITUTED ISOXAZOLINE COMPOUND ANDPROCESS FOR PREPARATION OF THECIBA HOLDING INCCOMPOUND2988 356/CHENP/2006 234746 15-06-2009PYRIDYL DERIVATIVES AS HUMAN STEAROYLXENON PHARMACEUTICALS INCCOA DESATURASE INHIBITORS2989 3087/CHENP/2005 234750 15-06-2009BENZOTHIAZOL CARBAMIC ACID ESTERS OFTHE GENERAL FORMULA IF. HOFFMANN-LA ROCHE AG2990 805/CHENP/2006 234751 15-06-2009NOVEL ANALOGS OF 3-O-ACETYL-11-KETO-B-BOSWELLIC ACIDGOKARAJU, Ganga, Raju2991 2347/CHENP/2005 234754 15-06-2009SUBSTITUTED P-DIAMINOBENZENEDERIVATIVESH. LUNDBECK A/S2992 457/CHE/2004 234756 15-06-2009MYCOBACTERIUM TUBERCULOSIS SPECIFICPROTEIN AND GENE, AND ITS APPLICATIONSINDIAN INSTITUTE OF SCIENCE,2993 3411/CHENP/2005 234757 15-06-2009 CIS-IMIDAZOLINES AS MDM2 INHIBITORS F. HOFFMANN-LA ROCHE AG2994 848/MUMNP/2006 234764 15/6/2009 NOVEL COMPOUNDS ASTRA ZENECA AB2995 957/CHE/2004 234765 15-06-2009DELAYED RELEASE FORMULATIONCONTAINING VENLAFAXINE AND A PROCESS NATCO PHARMA LIMITEDFOR PREPARING THE SAME2996 3058/CHENP/2005 234767 15-06-2009BENZIMIDAZOLE-2-CARBOXYLIC AMIDES ASSANOFI-AVENTIS DEUTSCHLAND GMBH2997 IN/PCT/2001/773/CHE 234774 15-06-2009FACTOR Xa INHIBITORSGLP-1 ANALOGUESSOCIETE DE CONSEILS DE RECHERCHES ETD'APPLICATIONS SCIENTIFIQUES SAS2998 3049/CHENP/2005 234776 15-06-2009IMMUNOSUPPRESSANT COMPOUNDS AND APHARMACEUTICAL COMPOSITIONIRM LLCCOMPRISING THE SAME2999 175/CHENP/2006 234784 15-06-2009PHARMACEUTICALY COMPOSITIONCOMPRISING AZETIDINE DERIVATIVESAVENTIS PHARMA S.A.3000 163/CHENP/2004 234785 15-06-2009AMINE COMPOUNDS AND CURABLECOMPOSITIONS DERIVED THEREFROMAMINO ACID DERIVED PRODRUGS OF3001 625/MUMNP/2005 234798 15/6/2009 PROPOFOL, COMPOSITIONS AND USES XENOPORT INCTHEREOF3002 340/MUMNP/2005 234848 17/6/2009 COMPOUND OF GENERAL FORMULA (A) UCB FARCHIM S A ( AG-LTD)A NOVEL DRUG DELIVERY SYSTEM FOR3003 1164/MUM/2003 234860 18/6/2009 PROTON PUMP INHIBITORS AND PROCESS LYKA LABS LIMITEDTHEREOFVIRGINIA TECH INTELLECTUAL PROPERTIES,INC

3004 780/MUM/2003 234868 18/6/2009NOVEL PARENTERAL FORMULATION FORPROTON PUMP INHIBITORCADILA HEALTHCARE LIMITED3005 IN/PCT/2002/00672/MUM 234872 18/6/20091,2 BIARYLBENZIMIDAZOLES AND THEIRPHARMACEUTICAL USESCHERING AKTIENGESELLSCHAFT3006 1301/MUMNP/2005 234873 18/6/2009TETRAHYDROQUINOLINE ANALOGUES ASMUSCARINIC AGONISTSACADIA PHARMACEUTICALS INC3007 1025/MUMNP/2003 234874 18/6/2009 PHARMACEUTICAL COMBINATIONS ASTRAZENECA AB3008 158/MAS/2000 234888 19-06-2009A HERBAL COMPOSITION HAVING ANTIALLERGIC PROPERTIES AND A PROCESS FOR NATURAL REMEDIES PRIVATE LTDTHE PREPARATION THEREOF3009 00717/DELNP/2003 234894 19-06-2009 A CARBAPENEM COMPOUND MEIJI SEIKA KAISHA, LTD.3010 2534/DELNP/2004 234899 19-06-2009PHARMACEUTICAL COMPOSITIONCOMPRISING ADAPALENE FOR THETREATMENT OF DERMATOLOGICALGALDERMA RESEARCH & DEVELOPMENT,AILMENTS3011 755/MUMNP/2004 234908 19/6/2009ANTHELMINTIC ORAL HOMOGENEOUSVETERINARY PASTESMERIAL LLC3012 IN/PCT/2001/00453/MUM 234910 19/6/2009A PHARMACEUTICAL COMPOSITIONCONTAINING ACE INHIBITORS AND USING WARNER LAMBERT COMPANYMAGNESIUM OXIDE AS STABILIZER3013 IN/PCT/2002/00718/MUM 234913 19/6/2009AN IMMUNOGENIC PROTEIN IN STERILEFORM.MEDICAL RESEARCH COUNCIL,INTERNATONAL AIDS VACCINEINITIVE,UNIVERSITY OF NAIROBI3014 510/MUMNP/2003 234943 22/6/2009PHARMACEUTICAL PREPARATION IN THEFORM OF A SUSPENSION COMPRISING AN ALTANA PHARMA AGACID LABILE ACTIVE INGREDIENT3015 324/BOM/1999 234967 23/6/2009SUSTAINED RELEASE PHARMACEUTICALCOMPOSITION FOR CONTROLLING ASTHMACIPLA LIMITED3016 195/BOM/1999 234968 23/6/2009THE COMPOSITION FOR TABLETS FORREDUCING CHOLESTEROLCIPLA LIMITED3017 181/BOM/1999 234969 23/6/2009A PHARMACEUTICAL COMPOSITION FORTOPICAL APPLICATIONCIPLA LIMITED3018 4039/DELNP/2005 234975 23-06-2009PROTEIN CONJUGATE HAVING PROLONGED INHANMI PHARM. CO., LTD.VIVO HALF-LIFEPHENYL - PIPERAZINYL ALKYLAMINO3019 1183/DEL/1997 234977 23-06-2009COMPOUNDS HAVING THE FORMULA I,PHARMACEUTICAL COMPOSITION ANDJANSSEN PHARMACEUTICA N.V.,PROCESS FOR PREPARING THE SAME3020 3169/DELNP/2005 234985 23-06-2009A MULTIPARTICULACE MILNACIPRANCOMPOSITION FOR ORAL ADMINISTRATIONCOLLEGIUM PHARMACEUTICAL INC.3021 00285/DELNP/2003 235002 24-06-2009''PEPTIDE DERIVED FROM HIV-1 REGULATORYPROTEIN, ANTIGENS HAVING SAID PEPTIDESAND VACCINE COMPOSITION OF SAIDANTIGEN"BIONOR IMMUNO AS

3022 1586/DEL/2004 235036 24-06-2009COMPOUNDS WHICH INHIBIT THE RELEASEOF INFLAMMATORY CYTOKINESTHE PROCTER & GAMBLE COMPANY3023 1497/KOLNP/2003 235040 24-06-2009ANTISENSE OLIGONUCLEOTIDE AGAINSTYISSUM RESEARCH DEVELOPMENT COMPANYHUMAN ACETYLCHOLINESTERSASE (ACHE)OF THE HEBREW UNIVERSITY OF JERUSALEMAND USES THEREOF3024 1187/KOLNP/2004 235041 24-06-2009MODIFIED RELEASE FORMULATIONS OF ATLEAST ONE FORM OF TRAMADOLBIOVAIL LABORATORIES INC.3025 917/DEL/1997 235042 24-06-2009SUBSTITUTED [2-(1-PIPERAZINYL) ETHOXY]METHYL COMPOUNDS OF FORMULA (I)UCB, S.A.,3026 179/CAL/1995 235043 24-06-2009 A THROMBIN INHIBITOR ASTRAZENECA AB3027 1362/KOLNP/2004 235046 24-06-2009 A RECOMBINANT ANTI-HFASL ANTIBODY ELI LILLY AND COMPANY3028 3254/DELNP/2006 235051 24-06-2009A QUINAZOLINE DERIVATIVES AND APROCESS FOR PREPARING THE SAMEASTRAZENECA AB.3029 1991/KOLNP/2004 235066 24-06-2009 AEROSOL DENTIFRICE FORMULATION GLAXO GROUP LIMITED3030 518/KOLNP/2004 235081 24-06-2009A COMPOSITION COMPRISING AN ISOLATED MHEALTH PROTECTION AGENCYTUBERCULOSIS PEPTIDE .A PHARMACEUTICAL COMPOSITION OF 2.5 MGOF THE PENTASACCHARIDE METHYL O-(2, 3, A-TRI-O-METHYL-6-O- SULFO- α-D-GLUCOPYRANOSYL)-(1→4)-O-(2, 3-DI-O-METHYL-β-D- GLUCOPYRANOSYL3031 964/KOLNP/2004 235082 24-06-2009 URONIC ACID)- (1→4)-O-(2, 3, 6-TRI-O- SANOFI-AVENTIS3032 4659/DELNP/2005 235086 24-06-2009SULFO-α-D- GLUCOPYRANOSYL)-(1→4)-O-(2, 3-DI-O-METHYL-α-2, 3, 6-TRI-O-SULFO- α-D-GLUCOPYRANOSIDE)OR A PHARMACEUTICALLY ACCEPTABLESALT THEREOFA 4,4-DIFLUORO- 1,2,3,4-TERAHYDRO-5H- 1 -BENZAZEPINE COMPOUNDASTELLAS PHARMA INC.,3033 1635/MAS/1995 235104 25-06-2009A DENTAL COMPOSITION FOR RELIEVINGDENTIN HYPERSENSITIVITYSUN MEDICAL CO., LTD.,3034 1092/MAS/1995 235113 25-06-2009 SOMATOSTATIN PEPTIDES NOVARTIS AG3035 1217/CHENP/2004 235114 25-06-2009A PHARMACEUTICAL FORMULATION OF UNIVERSIDADE FEDERAL DE MINAS GERAIS-ANGIOTENSIN-(1-7)UFMGNOVEL FUSED 1,3-DIHYDRO-IMIDAZOLE RING3036 1470/CHENP/2005 235115 25-06-2009 COMPOUNDS HAVING DPPIV-INHIBITING EISAI R & D MANAGEMENT CO., LTD.ACTIVITIES3037 2106/CHENP/2006 235117 25-06-2009HETEROCYCLIC ASPARTYL PROTEASEINHIBITORSSCHERING CORPORATION3038 2240/MAS/1996 235118 25-06-2009NOVEL PEPTIDES, THE PREPARATION AND AMEDICAMENT COMPRISING THE SAMEABBOTT GMBH & CO. KG3039 IN/PCT/2002/154/CHE 235200 25-06-2009A METHOD FOR PEPTIDE SYNTHESIS, ACOMPOSITION OF PEPTIDE FRAGMENTS ANDPEPTIDES MADE THEREBYTRIMERIS, INC.

3040 2901/CHENP/2006 235210 25-06-2009NEW COMBINATIONS OF AN ANTI EMETICAGENT AND AN ENKEPHALINASE INHIBITORBIOPROJET3041 104/MAS/1998 235211 26-06-20093-HETEROCYCLYL-SUBSTITUTED BENZOYLDERIVATIVESBASF AKTIENGESELLSCHAFT3042 1565/CHENP/2006 235214 26-06-2009 AMIDOACETONITRILE DERIVATIVES NOVARTIS AG3043 3409/CHENP/2005 235240 29-06-2009 CIS-2,4,5-TRIARYL-IMIDAZOLINES F. HOFFMANN-LA ROCHE AG3044 IN/PCT/2002/49/CHE 235243 29-06-2009A COMPOSITION FOR TREATMENT OFEXTERNAL SECRETION DISORDERSSUCAMPO AG3045 2294/CHENP/2006 235246 29-06-20091-(AZOLIN-2-YL) AMINO-1,2-DIPHENYLETHANE COMPOUNDS FOR BASF AKTIENGESELLSCHAFT ,COMBATING INSECTS, ARACHNIDS AND3046 2728/CHENP/2005 235248 29-06-2009BENZENESULFONAMIDE DERIVATIVE OFFORMULA IACTIMIS PHARMACEUTICALS, INC.,3047 1892/MAS/1998 235302 30-06-2009 N-AROYLPHENYLALANINE DERIVATIVES F HOFFMANN-LA ROCHE AG3048 1947/CHENP/2005 235323 30-06-2009NON-NUCLEOSIDE REVERSE TRANSCRIPTASEINHIBITORSF. HOFFMANN-LA ROCHE AG(R)-2-AMINO-1,4-DIHYDRO-6-METHYL-4-(3-NITROPHENYL)-3,5-PYRIDINEDICARBOXYLIC3049 1217/KOLNP/2005 235390 01-07-2009ACID 3-(1-DIPHENYLMETHYLAZETIDIN-3-YL)ESTER 5-ISOPROPYL ESTER OR ASANKYO COMPANY, LIMITED.PHARMACOLOGICALLY ACCEPTABLE SALTTHEREOF3050 1341/KOLNP/2004 235392 01-07-2009 SUBSTITUTED PIPERAZINE COMPOUNDS . ELI LILLY AND COMPANY3051 608/KOLNP/2004 235407 01-07-2009NOVEL1,2,4-THIADIAZOLIUM DERIVATIVES AS ORTHO-MCNEIL PHARMACEUTICALMELANOCORTIN RECEPTOR MODULATORS CORPORATIONA COMPOSITION COMPRISING SELECTIVE3052 1635/KOLNP/2005 235410 01-07-2009 SEROTOTONIN 2A/2C RECEPTOR INVERSE ACADIA PHARMACEUTICALS INC.AGNOIST3053 3110/DELNP/2005 235425 02-07-2009HIV REPLICATION INHIBITING PYRIMIDINESAND TRIAZINESTIBOTEC PHARMACEUTICALS LTD.3054 3094/DELNP/2005 235438 02-07-2009NOVEL COMPOUNDS USEFUL AS AN ANTI-PROLIFERATIVE AGENTS OR ANTI-CANCERAGENTS OR THIOREDOXIN/THIOREDOXINCANCER RESEARCH TECHNOLOGY LIMITEDREDUCTASE INHITIBORS3055 176/DELNP/2006 235442 02-07-2009A PHARMACEUTICAL, COSMETIC, DIETETICOR NUTRACEUTICAL COMPOSITIONINDENA S.P.A3056 6158/DELNP/2005 235444 03-07-2009STABLE PHARMACEUTICAL COMPOSITIONSOF 2-AZA-BICYCLO[3.3.0]-OCTANE-3-TEVA PHARMACEUTICAL INDUSTRIES LTD.CARBOXYLIC ACID DERIVATIVES3057 2830/DEL/1998 235466 03-07-2009A DRUG FORMULATION IN THE FORM OFDIFFUSION-CONTROLLED PELLETS HAVINGCONTROLLED RELEASE OF AN ACTIVEBAYER AKTIENGESELLSCHAFTCOMPOUND3058 294/DELNP/2006 235495 06-07-2009 A TABLET FORMULATION SMITHKLINE BEECHAM (CORK) LIMITED

3059 5604/DELNP/2006 235498 06-07-2009A DRY PHARMACEUTICAL COMPOSITIONCOMPRISING DALBAVANCINVICURON PHARMACEUTICALS INC3060 302/DELNP/2004 235505 07-07-2009"ANTIGENIC COMPOSITIONS COMPRISINGANTIGEN IN A LIPID FORMULATION"UNIVERSITY OF OTAGOA MEDICAL AEROSOL FORMULATION FOR3061 1142/KOLNP/2003 235522 08-07-2009 INHALATION BASED ON A CARBOXYLIC ACID JAGOTEC AGSALT AS SOLID EXCIPIENT3062 741/KOLNP/2005 235527 08-07-2009 A PHARMACEUTICAL GEL PREPARATION ZENTARIS GMBH3063 724/KOLNP/2004 235531 08-07-2009AN EMULSION FOR TOPICAL APPLICATION TOYISSUM RESEARCH DEVELOPMENT COMPANYTHE SURFACE OF AN EYE AND AOF THE HEBREW UNIVERSITY OF JERUSALEMPHARMACEUTICAL COMPOSITION3064 688/KOLNP/2006 235539 08-07-2009CONTROLLED RELEASE STERILE INJECTABLEOTSUKA PHARMACEUTICAL CO., LTD.ARIPIPRAZOLE FORMULATION AND METHOD .WATER SOLUBLE ORGANIC SOLVENT FROM3065 1610/CAL/1998 235540 08-07-2009 PRODUCTS AND PHARMACEUTICALTEVA PHARMACEUTICAL WORKS PLCFORMULATION .3066 IN/PCT/2002/1119/KOL 235545 08-07-2009A PHARMACEUTICAL COMPOSITION, APHARMACEUTICAL DOSAGE UNIT AND A WYETHPHARMACEUTICAL PACK THEREOF .3067 2370/KOLNP/2005 235555 08-07-2009NITROGEN-CONTAINING HETEROARYLCOMPOUNDS AND THEIR USE IN INCREASING FIBROGEN , INC.ENDOGENOUS ERYTHROPOIETIN .3068 2481/KOLNP/2005 235559 08-07-2009 PROPIONAMIDE DERIVATIVE COMPOUNDS . ORION CORPORATION3069 1316/KOLNP/2005 235579 08-07-2009MEDICINAL COMPOSITION FOR THESIGMA-TAU INDUSTRIE FARMACEUTICHEPROPHYLAXIS AND TREATMENT OFRIUNITE S.p.A.HYPERGLYCAEMIA.3070 277/KOLNP/2005 235581 08-07-20093071 473/KOLNP/2005 235586 08-07-2009NOVEL IMMUNOGENIC LIPOPEPTIDESCOMPRISING T-HELPER AND CYTOTOXIC TLYMPHOCYTE (CTL) EPITOPES.PYRAZOLO[3,4-B]PYRIDINE COMPOUNDS, ANDTHEIR USE AS PHOSPHODIESTERASEINHIBITORS.THE COUNCIL OF THE QUEENSLANDINSTITUTE OF MEDICAL RESEARCHGLAXO GROUP LIMITED3072 167/KOLNP/2005 235596 08-07-2009 IMMUNOSTIMULATORY NUCLEIC ACIDS COLEY PHARMACEUTICAL GROUP, INC.A METHOD OF PRODUCING AN3073 1295/MUMNP/2007 235632 09-07-2009ANALGESIC COMPOSITION AND ACAMBRIDGE SCIENTIFIC PTY LTD.COMPOSITION PRODUCED THEREFROM3074 934/KOLNP/2006 235646 11-09-2009DERIVATIVES OF N-''PHENYL (PIPERIDINE-2YL) METHYL BENZAMIDE, IN THERAPEUTICS SANOFI-AVENTIS3075 1467/KOLNP/2004 235677 29-07-2009 A PHARMACEUTICAL COMPOSITION COLEY PHARMACEUTICAL GMBH3076 1636/KOLNP/2005 235678 29-07-2009THIENOPYRIMIDINE COMPOUNDS AND USE TAKEDA PHARMACEUTICAL COMPANYTHEREOF .LIMITED3077 2472/KOLNP/2005 235681 29-07-2009PYRIDINO[1,2-A]PYRIMIDIN-4-ONECOMPOUNDS AS ANTICANCER AGENTS .CHIRON CORPORATION

3078 1735/KOLNP/2006 235693 07-08-2009DERIVATIVES OF 1-PIPERAZINE- AND 1-HOMOPIPERAZINE-CARBOXYLATES,PREPARATION METHOD THEREOF AND USESANOFI AVENTISOF SAME AS INHIBITORS OF THE FAAH3079 2914/DEL/1997 235699 10-08-2009 HALOGENOPYRIMIDINE COMPOUNDS BAYER AKTIENGESELLSCHAFT3080 982/DELNP/2006 235712 12-08-2009A PURIFIED MODIFIED IL-4 MUREIN RECEPTORAEROVANCE ,INC3081 2498/DELNP/2004 235713 12-08-20093082 3230/CHENP/2005 235728 17-08-2009ANTAGONIST10-O-P-HYDROXYBENZOYIAUCUBIN USEFULAS AN HEPATOPROTETANTPHARMACEUTICAL COMPOSITIONCOMPRISING A PHARMACEUTICALLYACCEPTABLE DOSAGE OF DSPA"COUNCIL OF SCIENTIFIC AND INDUSTRIALRESEARCHPAION DEUTSCHLAND GMBH3083 879/DELNP/2003 235731 18-08-2009PHARMACEUTICAL COMPOSITIONFEBREX MEDICAL RESEARCH &COMPRISING A PEPTIDEDEVELOPMENT GmbH3084 704/DEL/2000 235732 19-08-2009NOVEL PEPTIDE ANALOG OF SUBSTANCE PCONTAINING DIALKYLATED AMINO ACIDSDABUR RESEARCH FOUNDATION3085 173/DELNP/2006 235744 20-08-2009 FUSIDIC ACID DERIVATIVES LEO PHARMA A/S3086 IN/PCT/2000/00175/DEL 235746 20-08-2009A COVALENTLY REACTIVE ANTIGEN ANALOG UNIVERSITY OF NEBRASKA BOARD OFREGENTSA HEXAHYDRO-2, 2-DIMETHYL-5-(2-3087 832/DEL/2003 235763 24-08-2009 NITROETHYL)- [1,3]DIOXOLO[4,5-B]PYRAZINECOMPOUNDINDIAN COUNCIL OF MEDICAL RESEARCH3088 951/MUMNP/2005 235765 25/8/20093089 2510/DEL/2004 235775 26-08-20093090 97/DELNP/2005 235777 26-08-2009LIQUID PHARMACEUTICAL FORMULATIONSOF PALONOSETRONANTIBIOTIC COMBINATIONS FOR PROVIDINGTOTAL SOLUTION TO THE TREATMENT OFINFECTIONSISOLATED DNA OBTAINABLE FROMMETHYLOPHILUS METHYLOTROPHUS CODINGFOR AN MMEI-LIKE ENDONCLEASE AND AMETHOD FOR PRODUCING THE SAMEHELSINN HEALTHCARE SAVENUS REMEDIES LIMITEDNEW ENGLAND BIOLABS, INC.3091 177/DELNP/2006 235778 26-08-2009AGONIST POLYPEPTIDE OF A HUMANRECEPTORUNIVERSITY OF MARYLAND, BALTIMORE3092 3666/DELNP/2005 235779 26-08-2009 IMPROVED ANTITUMORAL TREATMENTS PHARMA MAR, S.A.3093 582/MUM/2003 235782 26/8/2009NOVEL ANTIINFECTIVE COMPOUNDS,PROCESS FOR THEIR PREPARATION ANDPHARMACEUTICAL COMPOSITIONSCONTAINING THEMCADILA HEALTHCARE LIMITED3094 837/MUMNP/2003 235793 28/8/2009 A NEUBLASTIN POLYPEPTIDE BIOGEN IDEC MA INC.,,NS GENE A/S3095 6/DELNP/2005 235798 28-08-2009N-PHENYL-(2R, 5S) DIMETHYLPIPERAZINEDERIVATIVEASTELLAS PHARMA INC.3096 22/DELNP/2004 235804 31-08-2009AN AEROSOL FORMULATION AND PROCESSFOR PREPARATION THEREOFCHIESI FARMACEUTICI S.P.A.3097 581/KOLNP/2004 235809 31-08-2009A CANCER-CELL INHIBITING COMPOSITION LYCORED NATURAL PRODUCTS INDUSTRIESLTD.

3098 262/KOL/2006 235813 02-09-2009A POTABLE HERBAL COMPOSITION ANDVALUE ADDED PRODUCTS FROM BETELLEAVES, AND PROCESS FOR PREPARING THEDATTA PROF., DR. SIDDHARTHASAME3099 1271/KOLNP/2005 235814 02-09-2009A TOPICAL COMPOSITION FOR THECYTOGENIX INC.TREATMENT OF HSV-RELATED PATHOLOGIES3100 1457/KOLNP/2003 235824 02-09-2009MEDICAMENT CONTAINING AN EFFECTOR OFTHE GLUTATHIONE METABOLISM TOGETHERSERUMWERK BERNBURG AGWITH α-LIPOIC ACID FOR USE IN KIDNEYREPLACEMENT THERAPY3101 293/KOLNP/2003 235831 02-09-2009PYRAZOLE COMPOUNDS USEFUL AS PROTEINVERTEX PHARMACEUTICALS INCORPORATEDKINASE INHIBITORS3102 826/KOLNP/2003 235833 02-09-2009A STABILISED PHARMACEUTICALCOMPOSITION IN SOLID DOSAGE FORMPFIZER LIMITED3103 1718/KOLNP/2005 235844 02-09-20093-SUBSTITUTED-2(ARYLALKYL)-1-AZABICYCLOALKANES ANDPHARMACEUTICAL COMPOSITIONSTARGACEPT, INC.COMPRISING THEM3104 1202/MUMNP/2006 235852 02-09-2009TRI (CYCLO) SUBSTITUTED AMIDECOMPOUNDSPROSIDION LIMITED3105 IN/PCT/2001/197/KOL 235859 02-09-2009A COMPOSITION COMPRISING MICRONISEDPARTICLES OF COLLSTIN SULPHOMETHATE PHARMAX LIMITEDSODIUM3106 1973/CHENP/2006 235892 02-09-2009ANTIGEN BINDING MOLECULES WITHINCREASED FC RECEPTOR BINDING AFFINITY GLYCART BIOTECHNOLOGY AGAND EFFECTOR FUNCTION3107 5537/DELNP/2005 235893 03-09-2009 A NOVEL CYCLIC SULFONAMIDES MERCK SHARP & DOHME LIMITED3108 1665/KOLNP/2005 235911 03-09-2009 ARYLPIPERAZINYL COMPOUNDS PREDIX PHARMACEUTICALS HOLDINGS INC.PHENYL-AND PYRIDYLPIPERIDINE-3109 1370/KOLNP/2005 235914 03-09-2009 DERIVATIVES AS MODULATORS OF GLUCOSE ARENA PHARMACEUTICALS, INC.METABOLISMCOMBINATION OF COMPOUND (A) OFFORMULA (I), OPRIONALLY IN THE FORM OF3110 1446/DELNP/2006 235920 07-09-2009 AN OPTICAL ISOMER AND CLOPIDOGREL OR LES LABORATOIRES SERVIERONE OF ITS PHARMACEUTICALLYACCEPTABLE SALTS3111 1300/KOLNP/2006 235935 09-09-2009AN ISOLATED ANTI-INTERFERON ALPHAMONOCLONAL ANTIBODY, OR ANTIGEN MEDAREX, INC.BINDING PORTION THEREOF3112 937/DELNP/2005 235943 09-09-2009 NOVEL HETEROCYCLIC COMPOUNDS BAYER HEALTHCARE AG,3113 323/KOLNP/2006 235946 10-09-2009AN ISOLATED SPECIFIC BINDING MEMBER CAMBRIDGE ANTIBODY TECHNOLOGYFOR HUMAN IL-13LIMITED3114 2626/KOLNP/2005 235947 10-09-2009AN ANTIMICROBIAL COMPOUND ANDPHARMACEUTICALLY ACCEPTABLE SALTMIGENIX INC.

3115 94/KOLNP/2006 235952 10-09-2009TRISUBSTITUTED ARYL AND HETEROARYLDERIVATIVES AS MODULATORS OFMETABOLISM AND THE PROPHYLAXIS AND ARENA PHARMACEUTICALS INC.TREATMENT OF DISORDERS RELATEDTHERETO3116 IN/PCT/2001/262/KOL 235953 10-09-2009AN ARYL/HETEROARYL PHOSPHONATECOMPOUND OF FORMULA (I) ANDMETABASIS THERPEUTICS, INC.DERIVATIVES THEREOF3117 1747/KOLNP/2005 235958 10-09-2009ARYLVINYLAZACYCLOALKANE COMPOUNDSAND METHODS OF PREPARATION AND USE TARGACEPT, INC.THEREOF3118 439/KOLNP/2005 235959 10-09-2009ANTIDEPRESSANT INDOLEALKYLDERIVATIVES OF HETEROCYCLE-FUSED WYETHBENZODIOXAN METHYLAMINES3119 1709/KOLNP/2005 235970 10-09-2009DIHYDROSPIRO-[CYCLOALKYL]-PYRIMIDONEDERIVATIVES AND MEDICAMENTCONSTITUTING THE SAME FOR TREATMENTSANOFI-AVENTISOF NEURODEGENERATIVE DISEASES3120 60/KOLNP/2003 235972 10-09-2009 TYROSINE DERIVATIVE COMPOUNDS ARRAY BIOPHARMA, INC.3121 2389/KOLNP/2005 235978 10-09-2009AMINOCYCLOHEXYL ETHER COMPOUNDSAND USES THEREOFCARDIOME PHARMA CORP.3122 675/KOLNP/2006 235980 10-09-20097-AMINO ALKYLIDENYL-HETEROCYCLICQUINOLONES AND NAPHTHYRIDONESJANSSEN PHARMACEUTICA, N.V.3123 450/MUM/2004 236004 14/9/2009 AMORPHOUS ZIPRASIDONE HYDROCHLORIDE LUPIN LIMITED3124 1253/MUM/2003 236009 15/9/2009A KIT CONTAINING A VACCINE AND ANIMMUNOLOGICAL ADJUVANTSERUM INSTITUTE OF INDIA LTDA SERINE GLYCEROPHOSPHOLIPID3125 1297/KOLNP/2006 236010 15-09-2009CONJUGATE WITH EPA AND DHA OR AENZYMOTEC LTD.MIXTURE THEREOF AND A PHARMACEUTICALCOMPOSITION, COMRISING IT3126 2479/KOLNP/2005 236043 17-09-2009 A CHIMERIC PROTEIN. SYNTONIX PHARMACEUTICALS, INC.3127 2058/KOLNP/2005 236045 17-09-2009N-[(PIPERAZINYL)HETARYL]ARYLSULFONAMIDE COMPOUNDS WITH AFFINITY FOR THEABBOTT GMBH & CO. KGDOPAMINE D3 RECEPTOR3128 359/KOLNP/2006 236081 23-09-2009INHIBITORS OF SERINE PROTEASES,PARTICULARLY HCV VS3-NS4A PROTEASEVERTEX PHARMACEUTICALS INCORPORATED3129 929/KOLNP/2004 236088 23-09-2009 AN EXTENDED GLP-1 PEPTIDE ELI LILLY AND COMPANY3130 4432/DELNP/2005 236093 23-09-2009ANTISENSE OLIGONUCLEOTIDESPHOSPHOROTHIOATE AGAINST SMAD7GIULIANI INTERNATIONAL LIMITED3131 396/MUM/2004 236112 24/9/2009A RECOMBINANT ALPHA INTERFERON FUSIONRELIANCE LIFE SCIENCES PRIVATE LIMITEDPROTEIN3132 3451/DEL/1998 236117 25-09-2009COMPOSITION FOR USE AS MEDICAMENTCOMPRISING AZELAIC ACIDINTENDIS GMBH

3133 720/DELNP/2005 236122 29-09-2009PHARMACEUTICAL COMPOSITIONCOMPRISING CYCLOSPORIN FOR ORAL PATEL, SATISHCHANDRA PUNAMBHAIADMINISTRATION3134 721/DELNP/2005 236123 29-09-2009ORAL PHARMACEUTICAL COMPOSITIONSCOMPRISING CYCLOSPORINPATEL, SATISHCHANDRA PUNAMBHAI3135 1012/KOLNP/2004 236133 30-09-2009LYOPHILISED PHARMACEUTICALPREPARATION OF MONO-OR POLYCLONAL MERCK PATENT GMBHANTIBODIES3136 3700/DELNP/2004 236147 30-09-2009POWDER PHARMACEUTICALCOMPOSITIONS,USES COMPRISINGANHYDROUS DEHYDROEPIANDROSTERONE EPIGENESIS PHARMACEUTICALS. LLCPARTICLES OF RESPIRABLE OR INHALABLESIZE3137 601/DELNP/2005 236153 01-10-2009 A PHARMACEUTICAL COMPOSITION ASTELLAS PHARMA INC.3138 886/DELNP/2003 236165 07-10-2009VACCINE COMPOSITION CONTAININGTRANSFORMING GROWTH FACTORCENTRO DE IMMUNOLOGIA MOLECULARALPHA(TGF-ALPHA)3139 1188/KOLNP/2005 236172 07-10-2009NOVEL 2', 5' -OLIGOADENYLIC ACIDANALOGUES.SANKYO COMPANY, LIMITED.3140 762/KOLNP/2004 236190 07-10-2009A CHIMERIC HUMARISED OR CRD GRAFTEDANTI BODY CAPABLE OF INHIBITING HUMAN CENTOCOR INC.1L-6AN ISOLATED MAMMALIAN ANTI 1L-123141 150/KOLNP/2003 236195 07-10-2009 ANTIBODY AND A COMPOSITION COMPRISING CENTOCOR, INC.THE SAMEFLUORO-AND TRIFLU0ROALKYL-CONTANING3142 1845/KOLNP/2005 236201 07-10-2009HETEROCYCLIC SULFONAMIDE INHIBITORSOF BETA AMYLOID PRODUCTION ANDWYETHDERIVATIVES THEREOF3143 5410/DELNP/2005 236206 07-10-2009 TOOTH WHITENING COMPOSITIONS DMI BIOSCIENCES, INC.3144 4163/DELNP/2005 236212 08-10-2009A PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INTERNATIONALGMBH,COMPOSITION FOR PREVEVTING OR3145 3906/DELNP/2005 236215 08-10-2009 TREATING NON-AUREUS OR NON-BALABAN NAOMIEPIDERMIDIS STAPH AND OTHER BACTERIAL3146 1710/DELNP/2005 236232 12-10-2009DIPEPTIDYL PEPTIDASE-IV INHIBITORS USEFUL FOR PREVENTION OF DIABETESMERCK & CO., INC.3147 2529/MAS/1997 236234 12-10-2009VACCINE COMPOSITION COMPRISINGDIPHTHERIA, TETANUS AND ACELLULAR SMITHKLINE BEECHAM BIOLOGICALS S.A.PERTUSSIS3148 1507/DELNP/2003 236268 14-10-2009N-(ARYL)-2-ARYLETHENESULFONAMIDES TEMPLE UNIVERSITY-OF THECOMMONWEALTH SYSTEM OF HIGHEREDUCTATION

3149 4136/DELNP/2006 236269 14-10-20093150 178/KOLNP/2006 236288 15-10-20093151 IN/PCT/2002/00815/DEL 236301 15-10-20093152 90/KOLNP/2004 236326 22-10-20093153 512/KOLNP/2004 236327 22-10-20093154 522/KOLNP/2006 236333 22-10-20093155 1906/KOLNP/2004 236340 22-10-20093156 4946/DELNP/2005 236363 22-10-20093157 912/MUM/2005 236368 26/10/20093158 2673/DELNP/2006 236376 26-10-20093159 1551/MUM/2005 236383 27/10/20093160 3820/DELNP/2005 236395 28-10-20093161 1144/MUMNP/2006 236402 28/10/20093162 1270/KOLNP/2006 236405 29-10-2009PHARMACEUTICAL COMPOSITIONCOMPRISING METFORMIN AND FIBRATE ANSPROCESS FOR PREPARATION THEREOFQUINOLINONE DERIVATIES AS INHIBITORS OFC-FMS KINASEFULL-LENGTH INFECTIOUS cDNA CLONES OFTICK BORNE FLAVIVIRUSSAPOGENIN COMPOUNDS PROCESS FOR THEIRPREPARATION AND PHARMACEUTICALCOMPOSITION COMPRISING THEMCOMPOUNDS OF FORMULA (2R, 4R/S)-2-({[5-(4-FLUORO-PHENYL)-PYRIDIN-3YLMETHYLJAMINO)-METHYL)-CHROMAN-4-AND A PROCESS FOR PREPARING THE SAMEAN ISOLATED NUCLEIC ACID MOLECULEENCODING A HUMAN LIVER X RECEPTORALPHA (LXRX) VARIANT POLYPEPTIDE OR ACOMPLEMENT ENCODING AN LXRX VARIANTPOLYPEPTIDEFOURNIER LABORATORIES IRELAND LIMITEDJANSSEN PHARMACEUTICA, N.V.THE GOVERNMENT OF THE UNITED STATES OFAMERICA AS REPRESENTED BY THESECRETARY, DEPARTMENT OF HEALTH ANDHUMAN SERVICESPANAGIN PHARMACEUTICALS INC.MERCK PATENT GMBHWYETHN-ARYL DIAZASPIRACYLIC COMPOUNDS ANDTARGACEPT INC.METHODS OF PREPARATIONPHARMACEUTICAL COMPOSITION IN THESCHERING AKTIENGESELLSCHAFTFORM OF A HYDROGELA PHARMACEUTICAL COMPOSITIONCOMPRISING A MUCOLYTIC AGENT AND ANINVENTIA HEALTHCARE PRIVATE LIMITEDANTI-BACTERIAL AGENT AND A PROCESS FORPREPARTION THEREOFA 3-CYCLOALKYL AMINO PYRROLIDINECOMPOUND OF THE FORMULA I AND THECOMPOSITION SOMPRISING THE SAMENOVEL SULFOXIMINE DERIVATIVES AS P38MAP KINASE INHIBITORSA PHARMACEUTICAL COMPOSITION FORENHANCING THE IMMUNE RESPONSE TO ANANTIGENNOVEL HETEROCYCLYL-SUBSTITUTEDHYDROXY-6-PHENYLPHENANTHRIDINESNON-THERAPEUTIC ALIMENTARYFORMULATION FOR ANIMAL NUTRITIONCOMPRISING A STABLE DERIVATIVE ORVITAMIN EINCYTE CORPORATIONCADILA HEALTHCARE LIMITEDHASUMI LLC (DBA SHUKOKAIINTERNATIONAL)NYCOMED GMBHADISSEO FRANCE S.A.S.3163 632/KOLNP/2005 236413 29-10-2009 A COMPOSITION CONSISTING OF MODAFINIL CEPHALON, INC3164 1262/KOLNP/2004 236419 29-10-2009 PURINE DERIVATIVES AS KINASE INHIBITORS ELI LILLY AND COMPANY

3165 70/KOLNP/2005 236431 29-10-2009 NOVEL COMPOUNDS KARO BIO AB3166 65/MUMNP/2006 236437 29/10/2009 POLYTRIMETHYLENE ETHER GLYCOL E. I. DU PONT DE NEMOURS AND COMPANY3167 417/MUMNP/2007 236438 29/10/2009NOVEL POLYMORPH OF 3- HYDROXY-3-(3'-SULFAMYL-4'-CHLOROPHENYL)IPCA LABORATORIES LIMITEDPHTHALIMIDINE3168 2591/CHENP/2004 236461 30-10-2009A PENTAFLUOROSULFANYL-BENZOYLGUANIDINESANOFI-AVENTIS DEUTSCHLAND GMBH3169 2911/DELNP/2005 236473 04-11-2009NEW-1-ACETOXY-3-(SUBSTITUTED PHENYL)PROPENE COMPOUNDSUBE INDUSTRIES LTD3170 41/MUMNP/2008 236492 04-11-2009ETHYNYL-SUBSTITUTEDTETRAHYDROQUINOLINONE DERIVATIVESAND THEIR USE AS MODULATORS OFMERZ PHARMA GMBH & CO. KGAAMETABOTROPIC GLUTAMATE RECEPTORS3171 1028/CHENP/2006 236498 05-11-2009BENZIMIDAZOLONE AND QUINAZOLINONECOMPOUNDS AS AGONISTS ON HUMAN ORL1 SOLVAY PHARMACEUTICALS B.V.RECEPTORS3172 2572/CHENP/2006 236500 05-11-2009A CRYSTALLINE FROM OF THE SALT OF 4-(3-CHLORO-4-(CYCLOPROPYLAMINOCARBONYL)AMINO- EISAI R&D MANAGEMENT CO., LTDPHENOXY)-7-METHOXY-6-QUINOLINECARBOXAMIDE3173 246/KOLNP/2006 236506 05-11-2009PYRIMIDINES USEFUL AS MODULATORS OFVOLTAGE-GATED ION CHANNELSVERTEX PHARMACEUTICALS INCORPORATED3174 1266/KOLNP/2005 236510 05-11-2009A COMPLEX COMPRISING A PRE-FORMEDALTUS PHARMACEUTICALS INCPROTEIN CRYSTAL AND AN IONIC COMPOUNDTHE POLYMORPHIC FORM A OF 4-[6-ACETYL-3-3175 3511/CHENP/2005 236542 09-11-2009[3-(4-ACETYL-3-HYDROXY-2-PROPYLPHENYLTHIO)PROPOXY]BUTYRICMEDICINOVA, INC.ACID AND A PROCESS FOR PREPARING THE3176 608/DELNP/2006 236560 10-11-2009PHARMACEUTICAL COMPOSITIONS ANDMETHODS FOR ACCELERATING WOUND HEALOR LTD.HEALINGA WATER-SOLUBLE COMPOSITION3177 604/MUMNP/2005 236566 11-11-2009COMPRISING A BIOACTIVE LIPOPHILIC NATIONAL RESEARCH COUNCIL OFCOMPOUND AND A SOLUBIILIZING CANADAAGENT1 - (3 - CHLORO - 2 - FLUOROBENZYL) - 3 - (2 -3178 IN/PCT/2002/1352/KOL 236576 11-11-2009HYDROXYETHYL) - THIOUREA, AND ALKYLESTERS, AND PHARMACEUTICALLYALLERGAN, INC.ACCFEPTABLE SALTS THEREOF3179 3764/DELNP/2005 236577 11-11-2009A COMPOSITION FORMULATED FORINTRAMUSCULAR INJECTIONSCHERING AKTIENGESELLSCHAFT3180 36/KOLNP/2005 236587 11-11-2009A SUBSTITUTED PYRIMIDINE COMPOUND ASINHIBITOR OF PROTEIN KINASEVERTEX PHARMACEUTICALS INCORPORATED

NOVEL THIAZOLYBIPHENYLAMIDES AND3181 776/DELNP/2005 236599 11-11-2009BAYER CROPSCIENCE AG,PROCESS THEREOF4, 10-DIACETOXY-BENZOYLOXY- 20-EPOXY-1,7-DIHYDROXY-9-OXO-TAX-11-EN-13-YL (2R,3S)-3182 1367/DEL/1999 236601 11-11-2009RHONE-POULENC RORER S.A.,3-BENZOYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE TRIHYDRATETETRAHYDROQUINOLINONES AND THEIR USE3183 945/MUMNP/2006 236602 12-11-2009 AS ANTAGONISTS OF METABOTROPIC MERZ PHARMA GMBH & CO. KGAAGLUTAMATE RECEPTORSSUBSTITUTED 2-THIO-3,5-DICYANO-4-ARYL-6- BAYER SCHERING PHARMA3184 IN/PCT/2002/00331/MUM 236620 12-11-2009AMINOPYRIDINESAKTIENGESELLSCHAFTAN EPOXYTRICOSA TRIENOLIDE COMPOUND3185 296/DELNP/2005 236652 13-11-2009EISAI R & D MANAGEMENT CO. LTD.REPRESENTED BY THE FORMULA (1)3186 350/DELNP/2005 236654 16-11-2009 A COMPOUND HAVING THE FORMULA (I) TIBOTEC PHARMACEUTICALS LTD.,A HYDRATE SALT OF 5-[4-[2-N-METHYL-N-(2-PYRIDYL) AMINO)ETHOXY]THIAZOLIDIANE-2,-3187 552/DEL/2003 236656 16-11-2009SMITHKLINE BEECHAM P.L.C.4-DIONE,MALEIC ACID AND ITS USE INMEDICINE"PIPERDINE CONTAINING COMPOUND AS3188 390/MUMNP/2005 236659 16/11/2009BRIDGE PHARMA, INCDERMAL ANESTHETIC AGENTS4-[2-(AMINOMETHYL)- 1,3-THIAZOL-4-YL]-2,6-SOCIETE DE CONSEIL DE RECHERCHES ET D'3189 IN/PCT/2002/00415/ MUM 236661 16/11/2009 DI(TERTBUTYL)PHENOL OR A SALT OF SUCHAPPLICATIOMNA COMPOUND3190 437/MUM/2003 236664 16/11/2009 AN ORAL RELEASE FORMULATION CADILA HEALTHCARE LIMITEDA COMPOSITION, COMPRISING N-(3-METHOXY-5-METHYLPYRAZIN-2-YL)-2-(4-[1,3,4-3191 1405/DELNP/2005 236669 16-11-2009OXADIAZOL-2-YL]PHENYL) PYRIDINE-3-ASTRAZENECA ABSULPHONAMIDE AND AN EPIDERMALGROWTH FACTOR RECEPTOR TYROSINEKINASE INHIBITORA 7-AZAINDOLES COMPOUND AND A PROCESS3192 2350/KOLNP/2005 236683 17-11-2009ELBION AGFOR PREPARING THE SAMEPHARMACEUTICAL COMPOSITIONS3193 887/DELNP/2003 236697 17-11-2009 ENHANCING THE IMMUNOGENICITY OF CENTRO DE IMMUNOLOGIA MOLECULARPOORLY IMMUNOGENIC ANTIGENSA THERAPEUTIC COMPOSITION FOR TOPICAL3194 296/KOL/2005 236701 17-11-2009 APPLICATION AND PROCESS FOR PREPARING SHOMENATH ROY CHOWDHURYTHE SAME3195 2242/KOLNP/2005 236704 17-11-2009 CYANOACRYLATE COMPOSITIONS LOCTITE (R & D) LIMITED3196 1392/DELNP/2005 236720 17-11-2009AN IMMUNOGENIC COMPOSITIONCONSISTING OF A RECOMBINANT BACILLECALMETTE GUERINTHE REGENTS OF THE UNIVERSITY OFCALIFORNIA

3197 391/DELNP/2003 236723 17-11-20093198 1400/CHENP/2006 236730 18-11-20093199 660/CHENP/2006 236744 18-11-20093200 1261/DELNP/2005 236752 19-11-20093201 2721/DELNP/2004 236771 20-11-2009RECOMBINANT CHIMER HEPATITIS B CORE(HBC) PROTEIN MOLECULE'CELLDEXTHERAPEUTICS LIMITEDA PHARMACEUTICAL KIT FOR TREATINGAMYLOID-ASSOCIATED DISEASESCOMPOUND OF FORMULA I AS PROTEINKINASE INHIBITORSNOVEL HERBAL COMPOSITION AS MEMORYENHANCER IN ALZHEIMERS CONDITIONA PHARMACEUTICAL COMPOSITION FORORAL ADMINISTRATIONCONJUGATED BIOLOGICAL MOLECULES ANDATON PHARMA, INC.TEL AVIV UNIVERSITY FUTURE TECHNOLOGYDEVELOPMENT L.P.IRM LLCCOUNCIL OF SCIENTIFIC & INDUSTRIALRESEARCHATON PHARMA, INC.3202 5752/DELNP/2005 236772 23-11-2009THEIR PREPARATION'POLYTHERICS LIMITED5-PHENYL-4-METHYLTHIAZOL-2-YL-AMINE AS3203 693/CHENP/2006 236785 23-11-2009 INHIBITORS OF PHOSPHATIDYLINONSIT OLN 3 NOVARTIS AGKINASE ENZYMES (PI3)3204 688/CHENP/2006 236787 23-11-2009 AMINOPROPANOL DERIVATIVES NOVARTIS AGNOVEL PHENYL AMINO PYRIMIDINE3205 908/CHE/2004 236791 23-11-2009 DERIVATIVES AND PROCESSES FOR THE NATCO PHARMA LIMITEDPREPARATION THEREOF3206 831/CHENP/2006 236792 23-11-20093207 815/CHENP/2006 236793 23-11-2009A THERAPEUTIC COMBINATION OFCHOLESTEROL BIOSYNTHESIS INHIBITORAND PPAR ACTIVATORSUBSTITUTED 1- (2-AMINO-BENZOL) -PIPERAZINE AS GLYCINE UPTAKE INHIBITORSFOR THE TREATMENT OF PSYCHOSESSCHERING CORPORATIONF. HOFFMANN-LA ROCHE AG3208 220/DELNP/2005 236811 23-11-2009A NOVEL SUBSTITUTED QUINOLINECOMPOUNDJANSSEN PHARMACEUTICA N.V.3209 1404/CHENP/2006 236817 24-11-2009A PHARMACEUTICAL COMPOSITIONCONTAINING RIMONABANTSANOFI-AVENTIS3210 3424/DEL/1998 236833 24-11-2009 A PHARMACEUTICAL COMPOSITION JANSSEN PHARMACEUTICA N.V3211 254/MAS/2000 236846 25-11-2009COMPOSITION FOR ANTI MICROBIALTREATMENTCIBA HOLDING INC3212 3356/CHENP/2005 236851 25-11-2009HETEROARYL-SUBSTITUTED IMIDAZOLEDERIVATIVES AS GLUTAMATE RECEPTORANTAGONISTSF. HOFFMANN-LA ROCHE AG3213 253/CHENP/2006 236856 25-11-20093214 3608/CHENP/2006 236857 25-11-2009STABLE RADIOPHARMACEUTICALCOMPOSITIONS AND METHODS FORPREPARATION1,3,4-OXADIAZOL-2-ONES AS PEROXISOMEPROLIFERATOR ACTIVATED RECEPTOR(PPAR)DELTA MODULATIONSBRACCO IMAGING S.P.A.AVENTS PHARMACEUTICALS, INC3215 2167/CHENP/2006 236862 25-11-2009 NOVEL OXAZOLIDINONE DERIVATIVES DONG-A PHARM.CO.,LTD.

3216 2909/CHENP/2006 236864 25-11-2009PYRAZOLOPYRIMIDINE-DERIVATIVES ASCYCLIN DEPENDENT KINASE INHIBITORSSCHERING CORPORATION3217 2052/DELNP/2004 236896 26-11-2009CYCLOALKYL INHIBITORS OF POTASSIUMCHANNEL FUNCTIONBRISTOL-MYERS SQUIBB COMPANY3218 0341/DEL/1998 236897 26-11-2009 ARYLSULFONAMIDES AND ANALOGUES BAYER AKTIENGESELLSCHAFT3219 503/CAL/1997 236910 26-11-2009A COMPOSITION COMPRISING 6- HYDROXYL -2 - (4 - HYDROXYL - PHENYL) - 3 - [4 - (2 -PIPERIDINOETHOXY) BENZOYL] BENZOELI LILLY AND COMPANY[B]THIOPHENE HYDROCHLORIDE3220 551/CHENP/2004 236919 26-11-2009COMPOSITION USEFUL IN ENHANCINGIMMUNE RESPONSECYTOS BIOTECHNOLOGY AG3221 1836/KOLNP/2004 236926 26-11-2009A PHARMACEUTICAL COMPOSITION FORIMPROVING CEREBRAL FUNCTIONTOYAMA CHEMICAL CO. LTD.3222 462/DELNP/2005 236938 26-11-2009PYRAZOLE DERIVATIVE,MEDICINALCOMPOSITION CONTAINING THESAME,MEDICINAL USE THEREOF,ANDKISSEI PHARMACEUTICAL CO.,LTD.,INTERMEDIATE FOR PRODUCTION THEREOF3223 4625/DELNP/2005 236954 26-11-2009A STABILIZED HSA-FREE LIQUIDPHARMACEUTICAL COMPOSITIONARES TRADING S.A.3224 3931/DELNP/2005 236995 27-11-2009BIARYL SUBSTITUTED TRIAZOLES AS SODIUMMERCK & CO. INC.CHANNEL BLOCKERSCEFTRIAXONE AND SULBACTUMCOMBINATION FOR COMBATING B-3225 2411/DEL/2004 236996 27-11-2009 LACTAMASE-MEDIATED ANTIBIOTIC VENUS REMEDIES LIMITEDRESISTANCE USING B-LACTAMASEINHIBITORS USEFUL FOR INJECTION.3226 669/MAS/1995 237009 30-11-2009BENZOHETEROCYCLIC DERIVATIVES OTSUKA PHARMACEUTICAL COMPANYLIMITED2,4 DI (HETERO) -ARYLAMINO-PYRIMIDINE3227 889/CHENP/2006 237010 30-11-2009 DERIVATIVES AS ZAP-70 AND/OR SYK NOVARTIS AGINHIBITORS3228 2358/CHENP/2005 237027 01-12-2009"BENZYL-PYRIDAZINONS AS REVERSETRANSCRIPTASE INHIBITORSF. HOFFMANN-LA ROCHE AG3229 845/CHENP/2007 237029 01-12-2009TYROSINE DERIVATIVES AS PPAR-GAMMA-MODULATORSLABORATORIOS SALVAT S.A.3230 90/CAL/1998 237051 02-12-2009NOVEL MODIFICATIONS OF 2-AMINO-4-(4-FLUORBENZYL-AMINO)-ETHOXYCARBONYLAMINOBENZENE, ANDVIATRIS GMBH & CO. KGPROCESSES FOR THEIR PREPARATION3231 560/DEL/2001 237070 03-12-2009A COMPOSITION FOR THE TREATMENT OFVITILIGOMULTI PHARMA CO.,3232 1717/MUM/2006 237073 03-12-2009A PHARMACEUTICAL COMPOSITION FOR THEEFFICACIOUS TREATMENT OF IRONDEFICIENCY RELATED DISEASES ANDTHEREOF'WANBURY LIMITED

3233 21/CHENP/2006 237090 04-12-20093234 3033/CHENP/2006 237094 04-12-20093235 3947/DELNP/2005 237110 04-12-20093236 1280/DELNP/2006 237125 04-12-2009COMPOUNDS HAVING ASPARTIC PROTEASENOVARTIS AGINHIBITING ACTIVITYIMIDAZOLINE DERIVATIVES HAVING CB1-SOLVAY PHARMACEUTICALS B.V.ANTAGONISTIC ACTIVITYSUBSTITUTED AZABICYCLO HEXANEDERIVATIVES AS MUSCARINIC RECEPTOR RANBAXY LABORATORIES LIMITEDANTAGONISTSA TOPICAL PHARMACEUTICAL FORMULATION WARNER-LAMBERT COMPANY LLC.3237 3366/DELNP/2006 237127 04-12-2009SPAY-DRIED POWDER CONTAINING A LOW - BOERINGER INGELHEIM PHARMA GMBH & CO.MOLECULAR DEXTRANKG.3238 4536/DELNP/2005 237138 07-12-2009COMPOSTIONS FOR CONTROLLING PARASITESBAYER ANIMAL HEALTH GMBHON ANIMALS3239 1084/MUMNP/2006 237168 09-12-2009AZEOTROPIC OR PSEUDO AZEOTROPICCOMPOSITIONSSOLVAY (SOCIETE ANONYME)3240 988/DELNP/2006 237182 09-12-2009 PYRROLOPYRIMIDINONE DERIVATIVE TEIJIN PHARMA LIMITED3241 5785/DELNP/2005 237190 09-12-2009DIAMINOPYRROLOQUINAZOLINESCOMPOUNDS AS PROTEIN TYROSINE F. HOFFMANN-LA ROCHE AGPHOSPHATASE INHIBITORS3242 923/MUM/2006 237191 09-12-2009HERBAL COMPOSITION FOR TREATMENT OFPSORIASISBABULAL BHAWARLAL JAIN3243 924/MUM/2006 237192 09-12-2009HERBAL COMPOSITION FOR TREATMENT OFDIABETESBABULAL BHAWARLAL JAIN3244 IN/PCT/2001/00713/MUM 237206 10-12-2009A VACCINE COMPRISING ANIMMUNOSTIMULANTCORIXA CORPORATION3245 410/MUMNP/2005 237235 10-12-2009AN ISOLATED POLYNUCLEOTIDE ENCODINGA POLYPEPTIDESHIRE BIOCHEM INC.3246 4728/DELNP/2005 237238 10-12-2009ARYL-SUBSTITUTED PYRAZOLE COMPOUNDSBRISTOL-MYERS SQUIBB COMPANYUSEFUL AS KINASE INHIBITORS3247 536/DELNP/2005 237250 11-12-2009A PHARMACEUTICAL COMPOSITION FOR USEIN THE TREATMENT OF CANCERASTRAZENEECA AB3248 837/CHE/2006 237261 11-12-2009A CRYSTALLINE FORM B4 OF ATORVASTATINBIOCON LIMITEDMAGNESIUM AND A PROCESS THEREOF3249 2100/CHE/2006 237262 11-12-2009 NOVEL PYRIMIDINEDIONE DERIVATIVES ORCHID RESEARCH LABORATORIES LIMITED3250 2101/CHE/2006 237263 11-12-2009 NOVEL DIARYL PYRIMIDINONE DERIVATIVES ORCHID RESEARCH LABORATORIES LIMITED3251 3324/CHENP/2005 237268 14-12-20091.3.4-TRIAZA-PHENALENE AND 1,3,4,6-TETRAAZAPHENALENE DERIVATIVESF. HOFFMANN-LA ROCHE AG3252 638/CHENP/2006 237273 14-12-2009A SOLID ORAL DOSAGE FORM COMPRISINGVALSARTANNOVARTIS AG3253 1050/CHENP/2006 237274 14-12-2009COMPOUND CAPABLE OF BINDING S1PRECEPTOR AND PHARMACEUTICAL USE ONO PHARMACEUTICAL CO., LTD.THEREOF3254 2274/CHENP/2006 237279 14-12-2009A PHARMACEUTICAL FORMULATIONCOMPRISING ZOLEDRONIC ACID AND ANINACTIVE INGREDIENTNOVARTIS AG

3255 303/CHENP/2006 237281 14-12-2009A COMPOSITION COMPRISING AChEINHIBITOR AND mGluR2 ANTAGONISTF. HOFFMANN-LA ROCHE AGA NOVEL POTASSIUM CHANNEL MODULATOR NATIONAL CENTRE FOR BIOLOGICAL3256 3667/CHENP/2006 237287 14-12-2009SCIENCES ,TATA INSTITUTE OFPEPTIDEFUNDAMENTAL RESEARCH3257 2777/CHENP/2006 237291 14-12-20091,3,5-TRISUBSTITUTED 4,5-DIHYDRO-1H-PYRAZOLE DERIVATIVES HAVING CB1- SOLVAY PHARMACEUTICALS B.V.ANTAGONISTIC ACTIVITY3258 3644/CHENP/2006 237294 14-12-20091,3,4-OXADIAZOL-2-ONES AS PPAR DELTAMODULATORS AND THEIR USE THEREOFAVENTIS PHARMACEUTICALS, INC3259 1086/MUMNP/2006 237295 14/12/2009NOVEL HYDROXY-6-HETEROARYLPHENANTHRIDINES AND THEIR ALTANA PHARMA AGUSE AS PDE4 INHIBITORS3260 1323/CHENP/2006 237296 14-12-2009 SULPHONAMIDES BASF Aktiengesellschaft3261 285/MUMNP/2007 237297 14/12/2009NUTRITIONAL COMPOSITIONS FOR TREATINGABBOTT LABORATORIESOR PREVENTING OSTEOPOROSIS3262 341/MUMNP/2006 237299 14/12/2009CRYSTALLINE FORM OF GAMA-AMINOBUTYRIC ACID ANALOGXENOPORT, INC3263 3664/CHENP/2006 237312 15-12-2009ISOLATION OF 4-BETA-SULFATOETHYLSULFONYLANILINE-2- BASF AKTIENGESELLSCHAFTSULFONIC ACID3264 4353/CHENP/2006 237317 15-12-2009SUBSTITUTED PYRAZINECARBOXYLIC ACIDANILIDE DERIVATIVES OR SALTS THEREOF NIHON NOHYAKU CO.,LTDAND INTERMEDIATES OF THE SAME3265 1637/DELNP/2004 237331 16-12-2009THE LIQUID COMPOSITION FOR PROMOTINGPLANT GROWTH, WHICH INCLUDES NANO- CHOI, KWANG-SOOPARTICLE TITANIUM DIOXIDE3266 5889/DELNP/2005 237336 16-12-2009A PHARMACEUTIAL OR DIETETICCOMPOSITIONUNVERSITY OF HULL3267 3409/DELNP/2004 237340 16-12-2009COMPOSITION FOR IMPROVING ABSORPTIONNESTEC S.A.OF VITAMIN E BY A PET ANIMAL3268 857/DELNP/2003 237349 16-12-2009INDANYLIDENE COMPOUNDS OF THEFORMULASYMRISE GMBH & CO. KG3269 1621/CAL/1996 237363 17-12-2009NOVEL CYCLOPOEPTIDES FOR USE AS MERCK PATENT GESELLSCHAFT MITADHESION INHIBITORSBESCHRANKTER HAFTUNG3270 5945/DELNP/2005 237365 17-12-2009BENZODIAZEPINE CGRP RECEPTORANTAGONISTSMERCK & CO. INC.3271 4254/CHENP/2006 237372 17-12-2009 SUBSTITUTED 2-QUINOLYL-OXAZOLES SCHERING CORPORATION3272 859/MUMNP/2007 237387 18/12/2009A PHARMACEUTICAL COMPOSITIONCOMPRISING POLYETHYLENE GLYCOL AND THE UNIVERSITY OF CHICAGOINFANT FORMULA3273 1291/CHENP/2003 237390 18-12-2009NUCLEOSIDE COMPOUNDS AS INHIBITORS OF 1. ISIS PHARMACEUTICALS, INC 2. MERCK &RNA-DEPENDENT RNA VIRAL POLYMERASE CO., INC.3274 1808/CHENP/2006 237394 18-12-2009 HETEROCYCLIC COMPOUNDS REDDY US THERAPEUTICS, INC.

3275 4817/CHENP/2006 237397 18-12-2009COMPOUND OF FORMULA I AS NEUROKININ-1SCHERING CORPORATIONRECEPTOR ANTAGONISTS3276 912/CHENP/2006 237407 18-12-2009CORONAVIRUS, NUCLEIC ACID, PROTEIN, ANDAMSTERDAM INSTITUTE OF VIRAL GENOMICSMETHODS FOR THE GENERATION OFB.V.VACCINE, MEDICAMENTS AND DIAGNOSTICS3277 1353/DELNP/2005 237417 21-12-2009 CONTROLLED RELEASE MICROSPHERES CATHERINE G. AMBROSE3278 3003/CHENP/2004 237430 22-12-2009 INHIBITORS OF TYROSINE KINASES NOVARTIS AG3279 5861/DELNP/2005 237432 22-12-2009NOVEL COMPOUNDS THAT MODULATE PPARY GALDERMA RESEARCH & DEVELOPMENT,TYPE RECEPTORSS.N.C.3280 5539/DELNP/2005 237436 22-12-2009ISOQUINOLINE COMPOUNDS AND THEIR USEAS GFAT INHIBITORSF. HOFFMANN-LA ROCHE AG3281 204/DELNP/2004 237446 22-12-2009COMPOUND CO-002 AND ITS SALTS FOR USEIN CANCER TREATMENTLU, ZHIMIN3282 368/KOLNP/2006 237473 23-12-2009AN AVIRULENT LAWSONIAINTRACELLULARIS ISOLATEBOEHRINGER INGELHEIM VETMEDICA, INC3283 73/KOLNP/2006 237476 23-12-2009 A SPIROBENZAZEPINES COMPOMD JANSSEN PHARMACEUTICA N.V3284 312/DELNP/2005 237507 23-12-2009COMPOSITION CONTAINING AN ANDROGENIC11ß-HALOGEN STEROID AND A GESTAGEN ASWELL AS A MALE CONTRACEPTIVE AGENTSCHERING AKTIENGESELLSCHAFT,BASED ON THIS COMPOSITION3285 1709/DELNP/2005 237517 24-12-2009NOVEL INDAZOLE COMPOUNDS ASPOTASSIUM CHANNEL BLOCKERS USEFUL MERCK & CO.,INC.FOR THE TREATMENT OF OCULAR3286 3394/DELNP/2005 237521 24-12-2009A PURIFIED PEPTIDE WHICH ACTIVATES THEGUANYLATE CYCLASE C RECEPTOR FOR USE IRONWOOD PHARMACEUTICALS, INC.IN GASTROINTESTINAL DISORDERS3287 116/CAL/1999 237551 29-12-2009A PHARMACEUTICAL, DIETETIC ANDNUTRITIONAL COMPOSITIONMENDES S. R. L.3288 222/CAL/1999 237569 29-12-2009A HERBAL COMPOSITION FOR THETREATMENT OF CHRONIC OBSTRUCTIVEPULMONARY DISEASE, BRONCHITIS ANDDALMIA CENTRE FOR BIOTECHNOLOGYRESPIRATORY DISORDERS3289 857/KOLNP/2005 237579 29-12-2009A COMPOSITION FOR CELLULARTHERAPY AND A METHOD OFENCAPSULATING A BIOLOGICALNOVOCELL, INC.MATERIALTUMOR-ASSOCIATED ANTIGEN DERIVATIVES3290 2322/CHENP/2007 237591 29-12-2009FROM THEM USED FOR THE PREPARATION OFSMITHKLINE BEECHAM BIOLOGICALS S AFUSION PROTEINS AND OF COMPOSITIONSFOR VACCINATION3291 923/CHENP/2006 237596 29-12-2009PHARMACEUTICAL PRODUCTS COMPRISINGBISPHOSPHONATESNOVARTIS AG

3292 327/CHENP/2006 237601 29-12-2009SUBCUTANEOUS IMPLANTS HAVING LIMITEDINITIAL RELEASE OF THE ACTIVE PRINCIPALAND SUBSEQUENT LINEARLY VARYINGMEDIOLANUM PHARMACEUTICALS LIMITEDEXTENDED RELEASE THEROF3293 3016/CHENP/2007 237606 29-12-2009COMPOSITIONS HAVING A HIGH ANTIVIRALAND ANTIBACTERIAL EFFICACYTHE DIAL CORPORATION3294 2091/CHENP/2006 237612 29-12-2009HYDRONOPOL DERIVATIVES AS AGONISTS ONSOLVAY PHARMACEUTICALS GMBHHUMAN ORL1 RECEPTORS3295 781/CHE/2003 237613 29-12-2009NOVEL PROTOCOL FOR ISOLATION ANDM/S AVESTHA GENGRAINE TECHNOLOGIESPURIFICATION OF NUCLEIC ACIDS FROMPVT LTDTERMINALIA ARJUNA3296 360/MAS/1999 237614 29-12-2009 STYRYLSULFONE ANTICANCER AGENTS TEMPLE UNIVERCITY3297 3094/CHENP/2006 237616 29-12-2009NOVEL KETOAMIDES WITH CYCLIC P4'S ASINHIBITORS OF NS3 SERINE PROTEASE OF SCHERING CORPORATIONHEPATITIS C VIRUS3298 2347/CHENP/2007 237624 30-12-2009A COMBINATION WHICH COMPRISES ANANTIDIARRHEAL AGENT AND ANNOVARTIS AGEPOTHILONE DERIVATIVE3299 4423/CHENP/2006 237626 30-12-2009PHARMACEUTICAL COMPOSITIONCONSISTING OF ERLOTINIB AND CISPLATINF.HOFFMANN-LA ROCHE AG3300 1423/CHENP/2006 237627 30-12-2009HYBRID ENZYME COMPRISINGCARBOHYDRATE - BINDING MODULE AND NOVOZYMES NORTH AMERICA, INC.CATALYTIC MODULE OF A GLUCOAMYLASE3301 IN/PCT/2000/162/CHE 237644 31-12-2009 SYNTHETIC OPIOID PEPTIDE AMIDES CARA THERPEUTICS INC.,3302 1281/DEL/1997 237649 31-12-2009SUBSTITUTEDSULFONYLAMINO(THIO)CARBONYLBAYER AKTIENGESELLSCHAFTCOMPOUNDS3303 1058/CHE/2006 237655 01-01-2010LYOPHILISED COMPOSITION COMPRISINGEPOTHILONENOVARTIS AG3304 IN/PCT/2002/962/CHE 237656 01-01-2010A SUBSTITUTED 4-(PHENYL-N-ALKYL)-PIPERIDINE COMPOUNDNSAB, Filial af NeuroSearch Sweden AB, Sverige3305 102/CHENP/2007 237689 04-01-20105-AMINO-2,4,7-TRIOXO-3,4,7,8-TETRAHYDRO-2H-PYRIDIO[2,3-D]PYRIMIDINE DERIVATIVESAND A PHARMACEUTICAL COMPOSITIONJAPAN TOBACCO, INCCOMPRISING THE SAME3306 1069/CHENP/2004 237742 06-01-2010A PURE EXO/EXO-TRICYCLO[5.2.1.0(2.6)]-DEC-9-SHOGOO PHARMACEUTICALS AGYL-XANTHOGENATE3307 1137/CHENP/2006 237744 06-01-2010PYRAZOLOPYRIDINES AND ANALOGSTHEREOF3M INNOVATIVE PROPERTIES COMPANY3308 5285/DELNP/2005 237745 06-01-2010COMPOSITIONS COMPRISING FACTOR VIII NATIONAL INSTITUTE FOR BIOLOGICALAND FACTOR IXA FOR TREATINGSTANDARDS AND CONTROL (NIBSC)COMBINATION OF A MACROLIDE T-CELL3309 2520/CHENP/2005 237746 06-01-2010IMMUNOMODULATOR AND A CALCIFEROLFOR THE TREATMENT OF SKIN DISEASES OROF INFLAMMATORY BOWEL DISEASENOVARTIS AG

3310 1389/MUMNP/2005 237747 18/12/2009A COMPOUND [3aR-(3aa, 4a, 6a, 6aa)]-2-[[6-[[5-amino-6-chloro-2-(propylthio)-4-pyrimidinyl]amino]tetrahydro-2,2-dimethyl-3aHcyclopenta[d][1,3]dioxol-4-yl]oxy]ethanolASTRA ZENECA AB3311 399/DELNP/2005 237755 06-01-2010 A HYBRID MACROLIDE-SREROID COMPOUND PLIVA-ISTRAZIVACKI INSTITUT D.O.O.3312 2182/CHENP/2005 237757 06-01-2010 INDAZOLE DERIVATIVES KYOWA HAKKO KOGYO CO., LTD3313 1339/DELNP/2005 237759 06-01-2010A PHARMACEUTICAL COMPOSITION FORTREATING DYSKINESIAMOTAC NEUROSCIENCE LIMITED3314 1558/KOLNP/2004 237763 07-01-2010HETEROTRICYCLYL 6-ALKYLIDENE-PENEMSWYETH3315 1063/DELNP/2004 237793 07-01-2010AS BETA-LACTAMASE INHIBITORSA RECOMBINANT ADENOVIRUSTHE TRUSTEES OF THE UNIVERSITY OFPENNSYLVANIA3316 5944/DELNP/2005 237826 08-01-2010N-ALKYL PHENYLCARBOXAMIDE BETA-SECRETASE INHIBITORS FOR THE TRETMENT MERCK & CO. INC.OF ALZHEINER'S DISEASE3317 873/MUM/2004 237834 08-01-2010A NOVEL COMPOSITION FOR INHIBITING THEGROWTH OF MAMMALIANKONDHALKAR MRINMAYEE BHUSHAN3318 390/MUMNP/2006 237837 08-01-2010SYNERGISTIC FORMULATION OFANTIOXIDANTS AND ANTIMYCOBACTERIAL SHELGAONKAR, MeenaAGENTS: A METHOD OF MAKING THE SAME3319 1013/KOLNP/2003 237846 11-01-2010QUINOLINE, ISOQUINOLINE ANDPHTHALAZINE DERIVATIVES ASANTAGONISTS OF THE GONADOTROPIN-ZENTARIS GMBHRELEASING HORMONE3320 786/KOLNP/2004 237852 11-01-2010TRIAZOLO-QUINOLIN DERIVATIVES USEFULAS ADENOSINE RECEPTOR LIGANDSSANOFI-AVENTIS3321 1212/KOLNP/2003 237853 11-01-2010AGENT FOR CURING CHRONIC OBSTRUCTIVEPULMONARY DISEASEOTSUKA PHARMACEUTICAL CO. LTD.3322 948/CHENP/2006 237857 11-01-2010A COMPOSITION FOR IMAGING PANCREASBOARD OF REGENTS, THE UNIVERSITY OFCOMPRISING AN ANTIDIABETIC AGENT, ATEXAS SYSTEMCHELATOR AND A CHELATED METAL IONDELTA-AMINO-GAMMA-HYDROXY-OMEGA-3323 1921/CHENP/2006 237859 11-01-2010 ARYL-ALKANOIC ACID AMIDES AS RENIN NOVARTIS AGINHIBITORS3324 2426/CHENP/2004 237861 11-01-2010ANTISENSE IAP NUCLEOBASE OLIGOMERSAND USES THEROFAEGERA THERAPEUTICS ,INC3325 2500/CHENP/2006 237862 11-01-2010 IP-10 ANTIBODIES AND THEIR USES MEDAREX, INC.3326 1338/DELNP/2005 237864 11-01-2010A PHARMACEUTICAL COMPOSITION FORBASAL GANGLIA RELATED MOVEMENTDISORDERSMOTAC NEUROSCIENCE LIMITED3327 3017/DELNP/2005 237866 11-01-2010A PHARMACEUTICAL COMPOSITION3328 780/DELNP/2003 237867 11-01-2010 A SUBSTITUTED MANDELIC ACID ASTRAZENECA ABINSTITUTE OF MATERIA MEDICA,CHINESEACADEMY OF MEDICAL SCIENCES

3329 2411/DELNP/2005 237868 11-01-2010A SUBSTITUTED 1-N-PHENYLAMINO-1H-IMIDAZOLE COMPOUND AS AROMATASE LABORATOIRE THERAMEXINHIBITORS3330 1756/KOLNP/2005 237893 12-01-2010RNA INTERFERENCE BASED METHODS ANDCOMPOSITIONS FOR INHIBITING HBV GENE CAPITALBIO CORPOTIONEXPRESSION3331 2712/KOLNP/2005 237908 12-01-2010 DIPHENYLPYRIDINE COMPOUNDS SANOFI-AVENTIS3332 3665/DELNP/2005 237910 12-01-2010 A RECOMBINANT NUCLEIC ACID MOLECULE ATHENIX CORPORATION3333 5904/DELNP/2005 237911 12-01-2010AN ANTIBODY THAT BINDS TO AT LEAST TWODIFFERENT HUMAN INHIBITORY KILLER IG- INNATE PHARMA S.A.LIKE RECEPTOR (KIR)GENE PRODUCTSA PHARMACEUTICAL COMPOSITION3334 3212/DELNP/2005 237943 14-01-2010 COMPRISING A FRAGMENT OF Aß CONSISTING ELAN PHARMA INTERNATIONAL LIMITEDOF THE AMINO ACID SEQUENCE KLVFFAED3335 00218/DELNP/2003 237949 14-01-2010IMMUNOGENIC COMPOSITIONS COMPRISINGSTREPTOCOCCUS PNEUMONIAE PROTEINSSMITHKLINE BEECHAM BIOLOGICALS SA3336 00361/DELNP/2004 237953 14-01-2010A IMMUNOGEN FOR ALZHEIMER'S DISEASEAND OTHER DISEASES CHARACTERIZED BY PHARMEXA A/S,DEPOSITION OF AMYLOID3337 1400/DELNP/2006 237959 14-01-2010A DELAYED RELEASE ORAL SOLIDCOMPOSITIONPENWEST PHARMACEUTICALS CO.3338 1078/DELNP/2006 237971 15-01-2010A PREPARATION OF YEAST CELL WALLS OFYEAST OF THE GENUS SACCHAROMYCES LESAFFRE ET COMPAGNIECEREVISIAE3339 1432/DELNP/2006 237972 15-01-2010A MONOCLONAL ANTIBODY OR ANTIGEN-BINDING PORTION THEREOFBRISTON-MYERS SQUIBB COMPANY3340 2384/DELNP/2005 237983 15-01-2010COUMARIN COMPOUND,METHOD OFINSTITUTE OF MATERIA MEDICA,CHINESEPREPARING AND COMPOSITION COMPRISINGACADEMY OF MEDICAL SCIENCESTHE SAMENUCLEIC ACID MOLECULES AND OTHER3341 IN/PCT/2002/00674/DEL 237996 18-01-2010 MOLECULES ASSOCIATED WITH SOYBEAN MONSANTO TECHNOLOGY LLCCYST NEMATODE RESISTANCE3342 666/MUMNP/2007 238004 18/01/20101- AMINOCYCLOHEXANE-DERIVATIVES FORTHE TREATMENT OF MULTIPLE SCLEROSISEMOTIONAL LABILITY AND PSEUDOBULBARMERZ PHARMA GMBH & CO. KGAAAFFECT3343 107/MUMNP/2007 238006 18/01/2010A PHARMACEUTICAL COMPOSITION FOR THEBRIGHT FUTURE PHARMACEUTICALTREATMENT OF PROSTATIC HYPERPLASIALABORATORIES LIMITEDAND PROSTATITIS3344 1127/CHE/2005 238017 18-01-2010AMINOARYL SULPHONAMIDE DERIVATIVESAS FUNCTIONAL 5-TH6 LIGANDSSUVEN LIFE SCIENCES LIMITED3345 907/CHENP/2006 238020 18-01-2010A NOVEL CARBOXYLIC ACID COMPOUND ANDA PHARMACEUTICAL COMPOSITIONCOMPRISING THE SAMEONO PHARMACEUTICAL CO., LTD.

3346 3616/CHENP/2006 238025 18-01-2010TETRAHYDROQUINOLINE DERIVATIVES ANDA PROCESS FOR PREPARING THE SAMEMITSUBISHI TANABE PHARMA CORPORATION3347 1255/DELNP/2006 238041 19-01-2010 A COMPOUND OF THE FORMULA I PFIZER PRODUCTS INC.3348 5216/DELNP/2005 238050 19-01-2010PHARMACEUTICAL COMPOSITION AND KITCOMPRISING SAID COMPOSITIONJAPAN TOBACCO INC.3349 2142/DELNP/2003 238077 20-01-2010A FACIAL CREAM FOR EXTERNALTREATMENT OF VISIBLE SUN INJURIESMACRONOVA AB3350 1263/CAL/1998 238092 21-01-2010A COMPOSITION FOR AFFECTINGJOHNSON & JOHNSON CONSUMERCHANGES IN MAMMLIAN SKINCOMPANIES, INC.PIGMENTATION3351 421/CHE/2005 238128 21-01-2010 NOVEL HETEROCYCLIC DERIVATIVES ORCHID RESEARCH LABORATORIES LTD3352 1830/CHENP/2006 238129 21-01-2010 ORGANIC COMPOUNDS NOVARTIS AG3353 519/KOLNP/2005 238133 21-01-2010 A PHARMACEUTICALY ACCEPTABLE SALT EURO-CELTIQUE S.A.3354 4030/DELNP/2004 238165 21-01-2010 A PHARMACEUTICAL COMPOSITION ASTELLAS PHARMA INC3355 103/CHENP/2006 238176 22-01-2010ANTIBODIES AGAINST INSULIN-LIKE GROWTHF. HOFFMANN-LA ROCHE AGFACTOR I RECEPTOR AND USES THEREOFA PHARMACEUTICAL COMPOSITION3356 00142/DELNP/2003 238188 22-01-2010COMPRISING THE HYDROCHLORIDE SALT OFSB 207266 AND PROCESS FOR PREPARING THESMITHKLINE BEECHAM P.L.CSAME3357 1439/CHENP/2006 238201 25-01-2010ORAL ANTIDEPRESSANT FORMULATIONCOMPRISING ACETYLSALICYLIC ACID TO KRIWIN, PhilippeACCELERATE ONSET OF ACTION3358 932/KOLNP/2006 238220 25-01-2010DERIVATIVES OF N-[HETEROARYL(PIPERIDINE-2-YL)METHYL]BENZAMIDE, PREPARATIONSANOFI-AVENTISMETHOD THEREOF AND APPLICATION OF3359 5563/DELNP/2005 238221 25-01-2010TRIHETEROCYCLIC COMPOUNDSCOMPOSITIONS, AND METHODS FORGEMIN X BIOTECHNOLOGIES INC.TREATING CANCER OR VIRAL DISEASES3360 2306/CHENP/2006 238247 27-01-2010A PHARMACEUTICAL FORMULATIONCONTAINING TOLTERODINEPFIZER HEALTH ABA POLYHERBAL PREPARATION USEFUL FOR3361 1255/DEL/2002 238258 27-01-2010 THE PREVENTION OF ATHEROSCLEROSIS AND DEPARTMENT OF BIOTECHNOLOGYHYPERLIPIDEMIA3362 IN/PCT/2001/763/KOL 238277 28-01-2010SUBSTITUTED 2-ALKYNYL-ADENOSINEDERIVATIVES, ITS PHARMACEUTICALLY UNIVERSITY OF VIRGINIA PATENTACCEPTABLE SALTS AND COMPOSITION FOUNDATIONCOMPRISING IT3363 807/KOLNP/2005 238286 28-01-2010RECOMBINANT ESCHERICHIA COLI FOR THEPREPARATION OF D-AMINO ACIDSDEGUSSA AG3364 738/DEL/2002 238290 28-01-2010 AN ANTI-FERTILITY COMPOSITION RAJESH KUMAR3365 761/KOLNP/2006 238295 28-01-20106-ARYL-7-HALO-IMIDAZO[1,2-A] PYRIMIDINESWYETH HOLDINGS CORPORATIONAS ANTICANCER AGENT

3366 2379/KOLNP/2005 238300 28-01-20103367 377/DELNP/2004 238309 28-01-20103368 1443/CHENP/2006 238316 28-01-20103369 3026/CHENP/2006 238333 28-01-20103370 740/CHE/2003 238352 29-01-20103371 642/CAL/1996 238365 03-02-2010[1, 2, 4, ] TRIAZOLO [1, 5, A] PYRIMIDIN-2-NIPPON KAYAKU KABUSHIKI KAISHAYLUREA DERIVATIVE AND USE THEREOFNOVEL SYNERGISTIC HERBAL COMPOSITIONCOUNCIL OF SCIENTIFIC & INDUSTRIALAS BRAIN TONIC AND METHOD FORRESEARCHPREPARATION THEREOFA PHARMCEUTICAL COMPOSITIONTHE KENNETH S. WARREN INSTITUTE, INC.COMPRISING TISSUE PROTECTIVE CYTOKINESGLIMEPIRIDE- AND INSULIN-INDUCEDGLYCOSYLPHOSPHATIDYLINOSITOL-SPECIFIC SANOFI-AVENTIS DEUTSCHLAND GMBHPHOSPHOLIPASE C REGULATIONMETALLOTHIONEIN-LIKE PROTEINM/S AVESTHA GENGRAINE TECHNOLOGIESPOSSESSING BIOREMEDIATIVE AGRO ANDPRIVATE LIMITEDPHARMA UTILITIESA RESPIRABLE PARTICLE-BASEDPHARMACEUTICAL FORMULATION FORDELIVERING A MEDICAMENT VIAINSUFFLATIONPENWEST PHARMACEUTICALSCOMPANY3372 1715/DELNP/2006 238397 03-02-2010A STABLE COMPRESSED VACCINECOMPOSTIOINABIC BIOLOGICAL LABORATORIES LTD3373 4127/DELNP/2006 238399 03-02-2010A COMPOUND OF FORMULA (I) ANDFORMULATION COMPRISING THE SAMESMITHKLINE BEECHAM CORPORATION3374 1211/CHENP/2006 238403 04-02-2010A PHARMACEUTICAL COMPOSITIONCOMPRISING 5-METHYL-2-(2’-CHLORO-6’- NOVARTIS AGFLUOROANILINO)PHENYLACETIC ACID3375 2266/CHENP/2006 238410 04-02-2010" BICYCLIC HETEROCYCLIC COMPOUND OFFORMULA (I)NOVARTIS AG3376 1115/MUMNP/2007 238424 02-04-2010A TRIAZOLO [4,5-d]PYRIMIDINE COMPOUNDOF FORMULA (II)ASTRA ZENECA AB3377 325/CHE/2003 238426 04-02-2010 "ISONONYL BENZOATES OXENO OLEFINCHEMIE GMBH3378 1499/CHENP/2005 238445 05-02-2010COMPOSITION COMPRISING PEPTIDENANOSTRUCTURES AND METHOD OF RAMOT AT TEL AVIV UNIVERSITY LTDMANUFACTURING SAME3379 5915/DELNP/2005 238463 05-02-2010HEXAHYDROPYRIDOISOQINOLINES AS DPP-IVF. HOFFMANN-LA ROCHE AGINHIBITORS3380 78/DELNP/2005 238508 09-02-2010A SUBSTITUTED PYRROLOTRIAZINECOMPOUNDBRISTOL-MYERS SQUIBB COMPANY3381 1104/KOLNP/2006 238514 09-02-2010 BENZOIMIDAZOLE COMPOUNDS JANSSEN PHARMACEUTICA N.V.DIARYLMETHYLIDENE PIPERIDINE3382 4901/DELNP/2005 238519 09-02-2010 DERIVATIVES, PREPARATIONS THEREOF AND ASTRA ZENECA ABUSES THEREOFFUSED HETEROCYCLIC DERIVATIVE,3383 4473/DELNP/2005 238524 09-02-2010 MEDICINAL COMPOSITION CONTAINING THE KISSEI PHARMACEUTICAL CO.,LTDSAME, AND MEDICINAL USE THEREOF3384 5605/DELNP/2005 238530 09-02-2010 A COMPOSITION GERON CORPORATION

3385 01436/DELNP/2003 238542 10-02-20103386 1581/KOLNP/2003 238543 10-02-20103387 2581/KOLNP/2005 238544 10-02-20103388 2417/KOLNP/2005 238557 10-02-20103389 1525/KOLNP/2003 238564 10-02-2010COATED IMMEDIATE-RELEASE GRANULESAND GRANULATESSUSTAINED RELEASE COMPOSITION ANDPROCESS FOR PRODUCING THE SAMENUCLEIC ACID SEQUENCES ENCODING ANDCOMPOSITIONS COMPRISING IGE SIGNALPEPTIDE AND/OR IL-15 AND METHODS FORUSING THE SAMECOLLOIDAL SILVER COMPOSITIONHAVING ANTIMICROBIAL PROPERTIESA NON-EFFERVESCENT DOSAGE FORMINTENDED TO BE SWALLOWEDDIRECTLY SUCH AS A SWALLOW TABLETOR CAPSULE FORMULATIONETHYPHARMTAKEDA PHARMACEUTICAL COMPANYLIMITEDTHE TRUSTEES OF THE UNIVERSITY OFPENNSYLVANIAAMERICAN BIOTECH LABSSMITHKLINE BEECHAM P.L.C.AN ESSENTIALLY LACTOSE-FREE STABLE3390 2878/DELNP/2004 238577 10-02-2010 ORAL PHARMACEUTICAL COMPOSITION OF RUDOLF PERLPHOSPHOLIPID DERIVATIVESA PHARMACEUTICAL COMPOSITION FOR3391 3550/DELNP/2005 238585 11-02-2010OTSUKA PHARMACEUTIAL CO., LTD.INHIBITING PTENPHARMACEUTICAL COMPOSITIONCONTAINING RAPAMYCIN 42-ESTER WITH 3-3392 431/KOLNP/2005 238592 11-02-2010WYETHHYDROXY-2-(HYDROXYMETHYL)-2-METHYLPROPIONIC ACIDA HETEROCYCLOALKYL COMPOUND OF3393 829/DEL/2006 238620 12-02-2010LES LABORATOIRES SERVIERFORMULA (I)SUSTAINED RELEASE MATRIXING AGENTSSHREE S. K. PATEL COLLEGE OF3394 335/MUM/2006 238629 15/2/2010 BASED ON NATURAL ADJUVANTS ANDPHARMACEUTICAL EDUCATION & RESEARCHPROCESS FOR PREPARATION THEREOFA NOVAL ANTIFUNGAL/ANTICANCER COUNCIL OF SCIENTIFIC & INDUSTRIAL3395 3824/DELNP/2005 238637 15-02-2010COMPOSITIONRESEARCHANDROGEN RECEPTOR MODULATORS AND3396 5253/DELNP/2005 238642 15-02-2010MERCK & CO., INC.METHODS OF USE THEREOF.DANSYL HYDRAZONE OF 3ß-HYDROXY-5-OXO-3397 1270/DELNP/2006 238645 15-02-2010THE SCRIPPS RESEARCH INSTITUTE5, 6-SECOCHOLESTAN-6-ALPOLYPEPTIDE HAVING AN IMPROVED3398 299/DELNP/2006 238652 16-02-2010TRANSGENE S.A.CYTOSINE DEAMINASE ACTIVITYSTABILIZED SYNTHETIC IMMUNOGEN3399 1935/DELNP/2004 238664 16-02-2010UNITED BIOMEDICAL INC.DELIVERY SYSTEM3400 1422/DELNP/2005 238669 16-02-2010 A PHENYLETHANOLAMINE COMPOUND SHENYANG PHARMACEUTICAL UNIVERSITYARYLINDENOPYRIDIENS AND3401 894/KOLNP/2006 238670 17-02-2010 ARYLINDENOPYRIMIDINES AND THEIR USE ORTHO-MCNEIL PHARMACEUTICAL, INC.AS ADENOSINE AZA RECEPTOR ANTAGONIST3,6-DISUBSTITUTED AZABICYCLO HEXANE3402 3829/DELNP/2005 238680 17-02-2010 DERIVATIVES AS MUSCARINIC RECEPTOR RANBAXY LABORATORIES LIMITEDANTAGONISTS

3403 1365/KOLNP/2004 238698 17-02-2010AN IODOTHYRONINE COMPOUNDCOVALENTLY BOUND TO A CARRIER TOREDUCE PATIENT VARIABILITY OF THYROIDNEW RIVER PHARMACEUTICALS INC.SERUM LEVELS AMONG A GROUP OF3404 31/KOLNP/2004 238699 17-02-20101-[4-(5-CYANOINDOL-3-YL) BUTYL]-4-(2-CARBAMOYL-BENZOFURAN-5-YL)-PIPERAZINE HYDROCHLORIDE SOLVATE INMERCK PATENT GMBHITS CRYSTALLINE MODIFICATION3405 2272/KOLNP/2005 238709 17-02-2010A COMPOSITION FOR INFLUENZA VIRUSPRODUCTIONWISCONSIN ALUMNI RESEARCH FOUNDATION3406 2347/KOLNP/2005 238719 18-02-2010A COMPOSITION CONSISTING ESSENTIALLYOF A PHARMACEUTICALLY ACCEPTABLEEXCIPIENT AND A POLYNUCLEOTIDECHIRON CORPORATIONABSORBED TO A CATIONIC MICROPARTICLE3407 13/KOLNP/2004 238734 18-02-2010NEW COMPOUNDS WHICH ARE POTENTINHIBITORS OF NA+/CA2+ EXCHANGEMECHANISM AND ARE USEFUL IN THEORION CORPORATIONTREATMENT OF ARRHYTHMIAS3408 2854/DELNP/2004 238746 18-02-2010A PEPTIDE OR A FRAGMENT THEREOF INBICYCLIC FORM THAT SUBSTANTIALLY ARK THERAPEUTICS LTD.RETAINS NP-1 ANTAGONISTIC ACTIVITY3409 3653/DELNP/2006 238751 18-02-2010 A PHARMACEUTICAL FORMULATION AMYLIN PHARMACEUTICALS, INC.3410 2698/DELNP/2005 238765 19-02-2010A MODIFIED ANTIMICROBIAL PEPTIDEINHIBITORHILLMAN, YITZCHAK3411 1728/CHENP/2005 238777 19-02-2010AMYLOID B(1-42) OLIGOMERS, DERIVATIVESTHEREOF AND ANTIBODIES THERETO, ABBOTT GMBH & CO. KGMETHODS OF PREPARATION THEREOF3412 4307/CHENP/2006 238785 19-02-2010A COMPOUND OF FORMULA 1a AS PPARMODULATORSIRM LLC3413 377/CHE/2003 238786 19-02-2010A COMPOSITION FOR TREATING ORLESSENING THE SEVERITY OF DIABETIC CLINIGENE INTERNATIONAL PRIVATE LIMITEDNEPHROPATHY IN A HUMAN PATIENT3414 585/DELNP/2005 238805 23-02-2010A TRIAZOLOPYRIDINE COMPOUND USEFUL INSTIMULATING ENDOGENOUS PRODUCTION PFIZER INC.OR RELEASE OF GROWTH HORMONEBRIS3415 5339/DELNP/2006 238808 23-02-2010FORMAMIDE DERIVATIVES USEFUL ASADRENOCEPTOR "PFIZER INC3416 170/DELNP/2005 238815 23-02-2010A PHARMACEUTICAL COMPOSITION USEFULFOR PREPARING A MEDICAMENT FOR THE BIOGEN IDEC MA INC.TREATMENT OF GLOMERULONEPHRITIS3417 1392/KOLNP/2004 238831 24-02-2010A SUBSTITUTED PYRIDINOYLIPIERIDINESCOMPOUND AS 5-HT IF AGONISTSELI LILLY AND COMPANY

3418 787/KOLNP/2004 238836 24-02-2010IMIDAZOQUINOLINE DERIVATIVES, PROCESSFOR ITS PREPARATION ANDPHARMACEUTICAL COMPOSITIONSANOFI-AVENTISCOMPRISING THEMDIETARY SUPPLEMENT FOR TREATMENT AND3419 4868/DELNP/2005 238843 24-02-2010PREVENTION OF DIGESTIVE TRACT ULCERS INFREEDOM HEALTH, LLCEQUINES AND OTHER ANIMALS ANDMETHODS THEREOF3420 127/KOLNP/2006 238845 24-02-2010A NON-TOXIC MUCOSAL DISINFECTANTCOMPOSITIONVIAMONTE, MANUEL JR.3421 IN/PCT/2002/248/KOL 238846 24-02-2010INDOLE DERIVATIVES AND THEIR USE ASSHTZA LIGANDSMERCK PATENT GMBH3422 4738/DELNP/2005 238872 24-02-2010 COMPOSITIONS FOR AFFECTING, WEIGHT OREXIGEN THERAPEUTICS INC,3423 2092/KOLNP/2005 238876 24-02-2010AZA SPIRO ALKANE DERIVATIVES ASINHIBITORS OF METALLOPROTEASESINCYTE CORPORATION3424 2021/CHENP/2006 238924 26-02-2010PHARMACEUTICAL PREPARATIONCONTAINING GABAPENTINZAMBON GROUP S.P.A.3425 1966/KOLNP/2005 238998 03-03-2010A C-GLYCOSIDE COMPOUND OR A SALTTHEREOFASTELLAS PHARMA INC.3426 783/KOLNP/2003 239017 03-03-2010AN ANILINE DERIVATIVE OR A SALTTHEREOFISHIHARA SANGYO KAISHA, LTD.3427 63/KOLNP/2006 239021 03-03-2010CONJUGATED COMPLEMENT CASCADEINHIBITORSORTHO MCNEIL PHARMACEUTICAL, INC3428 IN/PCT/2001/1145/KOL 239040 03-03-2010DIETARY OR PHARMACEUTICAL ORVETERINARY COMPOSITIONACTIAL FARMACEUTICA LDA.3429 122/CHE/2004 239060 04-03-2010A NOVEL SYNERGISTIC HERBALFORMULATION FOR DIABETES CURELANSON BIO TECH PRIVATE LIMITED3430 1692/CHENP/2004 239065 04-03-2010 NOVEL ARYL- AND HIGH POINT PHARMACEUTICALS LLC3431 3037/DELNP/2005 239071 04-03-2010A PHARMACEUTICAL COMPOSITION FOR THETREATMENT OF ACUTE DISORDERS BY OREXO ABSUBLINGUAL3432 337/MUMNP/2004 239087 04-03-2010A PHARMACEUTICAL COMPOSITIONCONTAINING SUBSTITUTED BICYCLO [3.3.1]NONAN-2,4,9-TRIONES AS AN ACTIVEINGREDIENTS FOR PROPHYLACTIC AND/OR DIAGENICS INTERNATIONAL CORPORATION3433 1252/MUMNP/2005 239088 04-03-2010THERAPEUTIC TREATMENT OF NEOPLASTICOR CANCEROUS DISEASE AND VIRALDISEASESCOMBINATION OF AN NMDA RECEPTORANTAGONIST AND A SELECTIVE SEROTONINREPUTAKE INHIBITOR FOR THE TREATMENTOF DEPRESSION AND OTHER MOODDISORDERSFOREST LABORATORIES INC.

3434 1202/CHENP/2007 239098 05-03-2010CONTROL OF PARASITES IN ANIMALS BY THEUSE OF NOVELSCHERING-PLOUGH LTD.TRIFLUOROMETHANESULFONANILIDE OXIMEETHER DERIVATIVESAN ANTIGENIC POLYPEPTIDIC COMPOSITION3435 2188/DELNP/2006 239115 09-03-2010 AT LEAST TWO DIFFERENT MSP-3-C/D-LINK INSTITUT PASTEURPEPTIDE MOTIFS3436 1583/CAL/1997 239133 09-03-2010A TABLET WITH CONTROLLED RELEASESANOFI-AVENTISOF ALFUZOSIN HYDROCHLORIDEBENZIMIDAZOLE, BENZTHIAZOLE AND3437 467/KOLNP/2006 239134 09-03-2010 BENZOXAZOLE DERIVATIVES AND THEIR USE JANSSEN PHARMACEUTICA N.V.AS LTA4H MODULATORS3438 1996/KOLNP/2004 239147 09-03-2010 AN ISOLATED POLYPEPTIDE VACCINEX, INC.3439 244/KOLNP/2003 239157 09-03-2010QUINOLINONE DERIVATIVES AS TYROSINEKINASE INHIBITORSCHIRON CORPORATION3440 IN/PCT/2002/1198/KOL 239158 09-03-2010A PHARMACEUTICAL COMPOSITIONCOMPRISING LIGAND-IMMUNOGENPURDUE RESEARCH FOUNDATIONCONJUGATE3441 1805/DELNP/2003 239167 09-03-2010 A SUSTANED RELEASE ORAL COMPOSITION EURO-CELTIQUE, S.A.3442 847/KOLNP/2004 239188 10-03-20103-β-D-RIBOFURANOSYLTHIAZOLO [4,5,-d]PYRIDIMINE NUCLEOSIDES COMPOUNDSANADYS PHARMACEUTICALS, INC.3443 432/KOLNP/2006 239192 10-03-2010ANTISENSE OLIGONUCLEOTIDE MODULATIONISIS PHARMACEUTICALS, INCOF ELF4E EXPRESSION3444 3468/DELNP/2004 239208 10-03-2010IMMEDIATE RELEASE PHARMACEUTICALFORMULATIONASTRAZENECA AB3445 1064/DELNP/2007 239394 17-03-2010SULPHONAMIDE COMPOUND OF FORMULA (I)GLAXO GROUP LIMITEDAND COMPOSITION COMPRISING THE SAME3446 682/CHE/2005 239399 17-03-2010 NOVEL COMPOUNDS ORCHID RESEARCH LABORATORIES LTD3447 279/CHE/2005 239408 18-03-2010 NOVEL TYROSINE DERIVATIVES ORCHID RESEARCH LABORATORIES LTD3448 1030/CHENP/2004 239430 19-03-2010PEPTIDE PURIFICATION BY MEANS OF METALNOVO NORDISK A/SION AFFINITY CHROMATOGRAPHY3449 1084/MUMNP/2005 239431 19/3/2010NEW DERIVATIVES OF HYDANTOINS,THIOHYDANTOINS, PYRIMIDINEDIONES AND SOCIETE DE CONSEILS DE RECHERCHES ETTHIOXOPYRIMIDINONES, THEIRDAPPLICATIONS SCIENTIFIQUES (S. C. R. A. S)PREPARATION PROCESSES AND THEIR USE AS3450 1537/DELNP/2006 239481 23-03-2010PHARMACEUTICAL COMPOSITIOINCOMPRISING A SELECTIVE I1 IMIDAZOLINESOLVAY PHARMACEUTICALS GMBHRECEPTOR AGONIST AND AN ANGIOTENSIN IIRECEPTOR BLOCKERA PHARMACEUTICALLY ACCEPTABLE SOLID3451 512/MUMNP/2006 239482 23/3/2010 ORAL FORMULATION COMPRISINGSUMATRIPTAN SUCCINATECIPLA LIMITED

3452 4627/DELNP/2005 239487 23-03-20103453 145/KOLNP/2004 239512 24-03-20103454 1820/KOLNP/2005 239513 24-03-20103455 1139/KOLNP/2004 239514 24-03-2010QUINAZOLINE COMPOUNDS OF FORMULA(I),PHARMACEUTICAL COMPOSITION ANDPROCESS FOR PREPERING THE SAMESPIRO COMPOUNDS AS NEUROPEPTUDERECEPTOR ANTAGONISTSOMATOSTATIN-DOPAMINE CHIMERICANALOGS2,4 - PYRIMIDINEDIAMINE COMPOUNDS ANDTHEIR USESA PHARMACEUTICAL COMPOSITIONASTRAZENECA ABBANYU PHARMACEUTICAL CO.LTD.SOCIETE DE CONSEILS DE RECHERCHES ETD'APPLICATIONS SCIENTIFIQUES S.A.S.RIGEL PHARMACEUTICALS, INC.LYCORED NATURAL PRODUCTS INDUSTRIESLTD.3M INNOVATIVE PROPERTIES COMPANY3456 IN/PCT/2002/1166/KOL 239517 24-03-20103457 845/CHENP/2006 239523 24-03-2010ANTIMICROBIAL COMPOSITIONS ANDMETHODS3458 189/KOLNP/2003 239531 24-03-2010 SUBSTITUTED PYRAZOLES ORTHO MCNEIL PHARMACEUTICAL INCINHIBITORS OF MACROPHAGE MIGRATION3459 1360/KOLNP/2003 239532 24-03-2010 INHIBITORY FACTOR AND METHODS FOR AVANIR PHARMACEUTICALSINDENTIFYING THE SAME3460 2218/KOLNP/2005 239542 24-03-2010NOVEL IMMUNOGENIC COMPOSITIONS FORTHE PREVENTION AND TREATMENT OFMENINGOCOCCAL DISEASEWYETH HOLDINGS CORPORATION3461 772/KOLNP/2006 239543 24-03-20102-AMIDO-4-ARYLOXYL-1-CARBONYLPYRROLIDINE DERIVATIVESVERTEX PHARMACEUTICALS INCORPORATED3462 1955/KOLNP/2005 239547 24-03-2010QUINAZOLINES USEFUL AS MODULATORS OFION CHANNELSVERTEX PHARMACEUTICALS INCORPORATED3463 1698/KOLNP/2004 239549 24-03-2010ANTI TUBERCULAR DRUG COMPOSITIONS DEPARTMENT OF HEALTH AND HUMANAND METHODSSERVICES3464 869/KOLNP/2003 239551 24-03-2010 PYRAZOLE COMPOUNDS VERTEX PHARMACEUTICALS INCORPORATED3465 660/CAL/1995 239553 24-03-2010 AN AMIDE OR SULFONAMIDE COMPOUND VERTEX PHARMACEUTICALS INCORPORATED3466 1908/CHENP/2006 239560 24-03-2010PHARMACEUTICAL COMPOUNDS FOROXIDATIVE STRESS AND/OR ENDOTHELIALDYSFUNCTIONS OF MODERATE INTENSITYNICOX S A3467 57/MUM/2005 239572 25-03-2010 HERBAL CONTRACEPTIVE FORMULATIONS SINGH KAMALINDER KAUR3468 4943/DELNP/2005 239580 25-03-2010NEW THIADIAZINE COMOUNDS, A PROCESSFOR THEIR PREPARATION ANDPHARMACEUTICAL COMPOSITIONSCONTAINING THEMLES LABORATORIES SERVIER3469 3791/DELNP/2006 239582 25-03-20103470 2105/DELNP/2005 239594 25-03-20103471 1337/MUMNP/2005 239596 25-03-2010SULFONAMIDE DERIVATIVES FOR THETREATMENT OF DISEASESPHARMACEUTICAL COMPOSITIONCOMPRISING DEXTRAN SULFATE EFFECTIVEFOR PREVENTING INSTANT BLOOD-MEDIATED INFLAMMATORY REACTIONDOSAGE FORM CONTAINING PANTOPRAZOLEAS ACTIVE INGREDIENTPFIZER INC.PROPHYMED ABNYCOMED GMBH

3472 513/DEL/2005 239621 26-03-20103473 3812/DELNP/2005 239622 26-03-20103474 52/DELNP/2003 239628 28-03-20103475 42/DEL/2004 239632 28-03-20104-OXO-4,6,7,8- TETRAHYDRO-PYRROLO [1,2-A]PYRAZINE-6- CARBOXAMIDE COMPOUNDS OFFORMULA (I)A PHARMACEUTICAL COMPOSITIONCONTAINING FIBRATE AND ORLISTATA PHARMACETICAL COMPOSITION FORMODULATING A CELLULAR ACTIVITY OFCELLS SUCH AS HEREIN DESCRIBED OF ANANIMALA SYNERGISTIC COMPOSITION FORTREATMENTOF GENERALIZED STABLE/NON-STABLE AND SEGMENTAL VITILIGO,VITILIGO, PATCHES NOT RESPONDING TOPUV-A THERAPY AND FAST SPREADINGLES LABORATOIRES SERVIERFOURNIER LABORATORIES, IRELANDLIMITED, LTD.SANDERS, IRAABBURI RAMAIAH3476 6215/DELNP/2006 239635 29-03-2010 A COMPOSITION AMYLIN PHARMACEUTICALS,INC3477 5655/DELNP/2005 239638 29-03-2010A SUBSTITUTED PARACYLOPHANE OFFORMULA (I)JOHNSON MATTHEY PLC3478 4944/DELNP/2006 239640 29-03-2010 A CARBOXYLATED INDOLE COMPOUND SHENYANG PHARMACEUTICAL UNIVERSITY3479 4646/DELNP/2005 239641 29-03-2010DELIVERY SYSTEMS OF HOMOGENEOUS,THERMOREVERSIBLE GEL FILM CONTAININGKAPPA-2 CARRAGEENANFMC CORPORATION3480 2522/DELNP/2006 239646 29-03-20103481 2285/DEL/2004 239657 29-03-20103482 2040/KOLNP/2006 239691 30-03-20103483 3847/DELNP/2005 239704 30-03-20103484 2170/DEL/2005 239710 30-03-2010A COMPOSITION FOR THE TRAETMENT OFCONDITIONS ASSOCIATED WITH ELEVATEDCHOLESTEROL LEVELS2-ETHYL-4,6-DIMETHYLPHENYL-SUBSTITUTED TETRAMIC ACID DERIVATIVESOF FORMULA (I) AND PROCESS OFTHE PROCTER & GAMBLE COMPANYBAYER CROPSCIENCE AG2-(HETERO) ARYL-SUBSTITUTEDMERCK PATENT GMBHTETRAHYDROQUINOLINE DERIVATIVESMICROFLUIDIZED OIL-IN-WATER EMULSIONSPFIZER PRODUCTS INC.AND VACCINE COMPOSITIONS1,7-BIS(ALKYL)-1,4,7,10-TETRAAZACYCLODECAN OR SPECIFIC 1,7-BIS(6-HYDROYX-2,2-DIMETHYL-1,3-DIOXEPAN-SCHERING AKTIENGESELLSCHAFT5-YL)-1,4,7,10-TETRAAZACYCLODECAN3485 6000/DELNP/2005 239716 30-03-2010PHARMACEUTICAL FORMULATIONCOMPRISING LEVOTHYROXINE SODIUMGLAXO GROUP LIMITED,NOVEL HYDROXAMATES AND3486 1918/KOLNP/2005 239748 31-03-2010 PHARMACEUTICAL COMPOSITIONAXYS PHARMACEUTICALS INC.CONTAINING THE SAME3487 19/KOLNP/2006 239781 31-03-2010 4-ARYLAMINO QUINAZOLINE COMPOUNDS MYRIAD GENETICS, INC.3488 242/KOLNP/2005 239795 31-03-2010N-SUBSTITUTE-2-OXODIHYDROPYRIDINEDERIVATIVES AS NPY ANTAGONISTSBANYU PHARMACEUTICAL CO. LTD.

* N.B.- Twenty- year term of patent is calculated from the date of filing of application and not from the date of grant of patent.